Drug_NDC|Drug_cpa_description|Drug_cpa_url|Drug_cpa_EffDate|Drug_cpa_EndDate 00002143380|DPP-4 Inhibitors|https://paxpress.txpa.hidinc.com/dpp4_inhibitor.pdf|09/25/2018| 00002143480|DPP-4 Inhibitors|https://paxpress.txpa.hidinc.com/dpp4_inhibitor.pdf|09/25/2018| 00002143611|CGRP Agents Prophylaxis|https://paxpress.txpa.hidinc.com/cgrpchronic.pdf|11/22/2022| 00002144509|Cytokine and CAM Antagonists|https://paxpress.txpa.hidinc.com/cytokine.pdf|03/27/2018| 00002144511|Cytokine and CAM Antagonists|https://paxpress.txpa.hidinc.com/cytokine.pdf|03/27/2018| 00002144527|Cytokine and CAM Antagonists|https://paxpress.txpa.hidinc.com/cytokine.pdf|03/27/2018| 00002237711|CGRP Agents Prophylaxis|https://paxpress.txpa.hidinc.com/cgrpchronic.pdf|11/22/2022| 00002311509|CGRP Agents Prophylaxis|https://paxpress.txpa.hidinc.com/cgrpchronic.pdf|11/22/2022| 00002322730|ADD/ADHD Agents|https://paxpress.txpa.hidinc.com/add_adhd_agents.pdf|02/13/2014| 00002322830|ADD/ADHD Agents|https://paxpress.txpa.hidinc.com/add_adhd_agents.pdf|02/13/2014| 00002322930|ADD/ADHD Agents|https://paxpress.txpa.hidinc.com/add_adhd_agents.pdf|02/13/2014| 00002323030|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016| 00002323130|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016| 00002323830|ADD/ADHD Agents|https://paxpress.txpa.hidinc.com/add_adhd_agents.pdf|02/13/2014| 00002323930|ADD/ADHD Agents|https://paxpress.txpa.hidinc.com/add_adhd_agents.pdf|02/13/2014| 00002325030|ADD/ADHD Agents|https://paxpress.txpa.hidinc.com/add_adhd_agents.pdf|02/13/2014| 00002325130|ADD/ADHD Agents|https://paxpress.txpa.hidinc.com/add_adhd_agents.pdf|02/13/2014| 00002411230|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016| 00002411530|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016| 00002411630|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016| 00002411730|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016| 00002418230|Cytokine and CAM Antagonists|https://paxpress.txpa.hidinc.com/cytokine.pdf|06/25/2019| 00002418430|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/04/2016| 00002441530|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016| 00002442030|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016| 00002445385|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016| 00002445485|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016| 00002445585|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016| 00002445685|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016| 00002473230|Cytokine and CAM Antagonists|https://paxpress.txpa.hidinc.com/cytokine.pdf|06/25/2019| 00002759701|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016| 00002763511|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016| 00002763611|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016| 00002763711|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016| 00002771401|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/04/2016| 00002771459|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/04/2016| 00002772401|Cytokine and CAM Antagonists|https://paxpress.txpa.hidinc.com/cytokine.pdf|03/27/2018| 00002772411|Cytokine and CAM Antagonists|https://paxpress.txpa.hidinc.com/cytokine.pdf|03/27/2018| 00002775201|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/04/2016| 00002775205|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/04/2016| 00002814701|Growth Hormones|https://paxpress.txpa.hidinc.com/gh.pdf|01/31/2011| 00002814801|Growth Hormones|https://paxpress.txpa.hidinc.com/gh.pdf|01/31/2011| 00002814901|Growth Hormones|https://paxpress.txpa.hidinc.com/gh.pdf|01/31/2011| 00003089321|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 00003089331|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 00003089421|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 00003089431|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 00003089470|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 00003089511|Cytokine and CAM Antagonists|https://paxpress.txpa.hidinc.com/cytokine.pdf|07/27/2023| 00003218811|Cytokine and CAM Antagonists|https://paxpress.txpa.hidinc.com/cytokine.pdf|03/27/2018| 00003218851|Cytokine and CAM Antagonists|https://paxpress.txpa.hidinc.com/cytokine.pdf|03/27/2018| 00003281411|Cytokine and CAM Antagonists|https://paxpress.txpa.hidinc.com/cytokine.pdf|03/27/2018| 00003281811|Cytokine and CAM Antagonists|https://paxpress.txpa.hidinc.com/cytokine.pdf|03/27/2018| 00003376474|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 00004005801|Anxiolytics and Sedative-Hypnotics|https://paxpress.txpa.hidinc.com/ash.pdf|01/31/2011| 00004005801|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017| 00004006801|Anxiolytics and Sedative-Hypnotics|https://paxpress.txpa.hidinc.com/ash.pdf|01/31/2011| 00004006801|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017| 00004009801|Anxiolytics and Sedative-Hypnotics|https://paxpress.txpa.hidinc.com/ash.pdf|01/31/2011|08/23/2023 00004009801|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017|08/23/2023 00006000530|Anxiolytics and Sedative-Hypnotics|https://paxpress.txpa.hidinc.com/ash.pdf|01/31/2011| 00006003330|Anxiolytics and Sedative-Hypnotics|https://paxpress.txpa.hidinc.com/ash.pdf|01/31/2011| 00006007861|DPP-4 Inhibitors|https://paxpress.txpa.hidinc.com/dpp4_inhibitor.pdf|09/25/2018| 00006007862|DPP-4 Inhibitors|https://paxpress.txpa.hidinc.com/dpp4_inhibitor.pdf|09/25/2018| 00006007882|DPP-4 Inhibitors|https://paxpress.txpa.hidinc.com/dpp4_inhibitor.pdf|09/25/2018| 00006008061|DPP-4 Inhibitors|https://paxpress.txpa.hidinc.com/dpp4_inhibitor.pdf|09/25/2018| 00006008062|DPP-4 Inhibitors|https://paxpress.txpa.hidinc.com/dpp4_inhibitor.pdf|09/25/2018| 00006008082|DPP-4 Inhibitors|https://paxpress.txpa.hidinc.com/dpp4_inhibitor.pdf|09/25/2018| 00006008131|DPP-4 Inhibitors|https://paxpress.txpa.hidinc.com/dpp4_inhibitor.pdf|09/25/2018| 00006008154|DPP-4 Inhibitors|https://paxpress.txpa.hidinc.com/dpp4_inhibitor.pdf|09/25/2018| 00006008182|DPP-4 Inhibitors|https://paxpress.txpa.hidinc.com/dpp4_inhibitor.pdf|09/25/2018| 00006011231|DPP-4 Inhibitors|https://paxpress.txpa.hidinc.com/dpp4_inhibitor.pdf|09/25/2018| 00006011254|DPP-4 Inhibitors|https://paxpress.txpa.hidinc.com/dpp4_inhibitor.pdf|09/25/2018| 00006022131|DPP-4 Inhibitors|https://paxpress.txpa.hidinc.com/dpp4_inhibitor.pdf|09/25/2018| 00006022154|DPP-4 Inhibitors|https://paxpress.txpa.hidinc.com/dpp4_inhibitor.pdf|09/25/2018| 00006027728|DPP-4 Inhibitors|https://paxpress.txpa.hidinc.com/dpp4_inhibitor.pdf|09/25/2018| 00006027731|DPP-4 Inhibitors|https://paxpress.txpa.hidinc.com/dpp4_inhibitor.pdf|09/25/2018| 00006027754|DPP-4 Inhibitors|https://paxpress.txpa.hidinc.com/dpp4_inhibitor.pdf|09/25/2018| 00006027782|DPP-4 Inhibitors|https://paxpress.txpa.hidinc.com/dpp4_inhibitor.pdf|09/25/2018| 00006032530|Anxiolytics and Sedative-Hypnotics|https://paxpress.txpa.hidinc.com/ash.pdf|01/31/2011| 00006033530|Anxiolytics and Sedative-Hypnotics|https://paxpress.txpa.hidinc.com/ash.pdf|01/31/2011| 00006046102|Antiemetic Agents|https://paxpress.txpa.hidinc.com/antiemetics.pdf|01/31/2011| 00006057561|DPP-4 Inhibitors|https://paxpress.txpa.hidinc.com/dpp4_inhibitor.pdf|09/25/2018| 00006057562|DPP-4 Inhibitors|https://paxpress.txpa.hidinc.com/dpp4_inhibitor.pdf|09/25/2018| 00006057582|DPP-4 Inhibitors|https://paxpress.txpa.hidinc.com/dpp4_inhibitor.pdf|09/25/2018| 00006057761|DPP-4 Inhibitors|https://paxpress.txpa.hidinc.com/dpp4_inhibitor.pdf|09/25/2018| 00006057762|DPP-4 Inhibitors|https://paxpress.txpa.hidinc.com/dpp4_inhibitor.pdf|09/25/2018| 00006057782|DPP-4 Inhibitors|https://paxpress.txpa.hidinc.com/dpp4_inhibitor.pdf|09/25/2018| 00006074731|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|08/23/2023 00006074754|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|08/23/2023 00006074931|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/04/2016|08/23/2023 00006095154|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 00006095231|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|08/23/2023 00006095254|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 00006096031|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|08/23/2023 00006096054|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 00006171131|Leukotriene Modifiers|https://paxpress.txpa.hidinc.com/leukotriene.pdf|12/15/2015|08/23/2023 00006380118|Antimigraine Agents Triptans|https://paxpress.txpa.hidinc.com/triptans.pdf|04/04/2023|08/23/2023 00006386203|Antiemetic Agents|https://paxpress.txpa.hidinc.com/antiemetics.pdf|01/31/2011| 00006536303|SGLT2 Inhibitors Clinical|https://paxpress.txpa.hidinc.com/SGLT2.pdf|05/23/2023| 00006536306|SGLT2 Inhibitors Clinical|https://paxpress.txpa.hidinc.com/SGLT2.pdf|05/23/2023| 00006536307|SGLT2 Inhibitors Clinical|https://paxpress.txpa.hidinc.com/SGLT2.pdf|05/23/2023|08/23/2023 00006536403|SGLT2 Inhibitors Clinical|https://paxpress.txpa.hidinc.com/SGLT2.pdf|05/23/2023| 00006536406|SGLT2 Inhibitors Clinical|https://paxpress.txpa.hidinc.com/SGLT2.pdf|05/23/2023| 00006536407|SGLT2 Inhibitors Clinical|https://paxpress.txpa.hidinc.com/SGLT2.pdf|05/23/2023|08/23/2023 00006536703|DPP-4 Inhibitors|https://paxpress.txpa.hidinc.com/dpp4_inhibitor.pdf|09/25/2018| 00006536706|DPP-4 Inhibitors|https://paxpress.txpa.hidinc.com/dpp4_inhibitor.pdf|09/25/2018| 00006536803|DPP-4 Inhibitors|https://paxpress.txpa.hidinc.com/dpp4_inhibitor.pdf|09/25/2018| 00006536806|DPP-4 Inhibitors|https://paxpress.txpa.hidinc.com/dpp4_inhibitor.pdf|09/25/2018| 00006536903|SGLT2 Inhibitors Clinical|https://paxpress.txpa.hidinc.com/SGLT2.pdf|05/23/2023| 00006536906|SGLT2 Inhibitors Clinical|https://paxpress.txpa.hidinc.com/SGLT2.pdf|05/23/2023| 00006536907|SGLT2 Inhibitors Clinical|https://paxpress.txpa.hidinc.com/SGLT2.pdf|05/23/2023|08/23/2023 00006537003|SGLT2 Inhibitors Clinical|https://paxpress.txpa.hidinc.com/SGLT2.pdf|05/23/2023| 00006537006|SGLT2 Inhibitors Clinical|https://paxpress.txpa.hidinc.com/SGLT2.pdf|05/23/2023| 00006537007|SGLT2 Inhibitors Clinical|https://paxpress.txpa.hidinc.com/SGLT2.pdf|05/23/2023|08/23/2023 00006537303|SGLT2 Inhibitors Clinical|https://paxpress.txpa.hidinc.com/SGLT2.pdf|05/23/2023| 00006537306|SGLT2 Inhibitors Clinical|https://paxpress.txpa.hidinc.com/SGLT2.pdf|05/23/2023| 00006537307|SGLT2 Inhibitors Clinical|https://paxpress.txpa.hidinc.com/SGLT2.pdf|05/23/2023|08/23/2023 00006537403|SGLT2 Inhibitors Clinical|https://paxpress.txpa.hidinc.com/SGLT2.pdf|05/23/2023| 00006537406|SGLT2 Inhibitors Clinical|https://paxpress.txpa.hidinc.com/SGLT2.pdf|05/23/2023| 00006537407|SGLT2 Inhibitors Clinical|https://paxpress.txpa.hidinc.com/SGLT2.pdf|05/23/2023|08/23/2023 00006927531|Leukotriene Modifiers|https://paxpress.txpa.hidinc.com/leukotriene.pdf|12/15/2015| 00008112312|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 00009001201|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 00009002201|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 00009002901|Anxiolytics and Sedative-Hypnotics|https://paxpress.txpa.hidinc.com/ash.pdf|05/28/2015| 00009002901|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017| 00009002902|Anxiolytics and Sedative-Hypnotics|https://paxpress.txpa.hidinc.com/ash.pdf|05/28/2015| 00009002902|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017| 00009003101|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 00009004401|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 00009005501|Anxiolytics and Sedative-Hypnotics|https://paxpress.txpa.hidinc.com/ash.pdf|05/28/2015| 00009005501|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017| 00009005503|Anxiolytics and Sedative-Hypnotics|https://paxpress.txpa.hidinc.com/ash.pdf|05/28/2015| 00009005503|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017| 00009005602|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 00009005604|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 00009005707|Anxiolytics and Sedative-Hypnotics|https://paxpress.txpa.hidinc.com/ash.pdf|05/28/2015| 00009005707|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017| 00009005907|Anxiolytics and Sedative-Hypnotics|https://paxpress.txpa.hidinc.com/ash.pdf|05/28/2015| 00009005907|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017| 00009006607|Anxiolytics and Sedative-Hypnotics|https://paxpress.txpa.hidinc.com/ash.pdf|05/28/2015| 00009006607|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017| 00009006807|Anxiolytics and Sedative-Hypnotics|https://paxpress.txpa.hidinc.com/ash.pdf|05/28/2015| 00009006807|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017| 00009007301|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 00009009001|Anxiolytics and Sedative-Hypnotics|https://paxpress.txpa.hidinc.com/ash.pdf|05/28/2015| 00009009001|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017| 00009009004|Anxiolytics and Sedative-Hypnotics|https://paxpress.txpa.hidinc.com/ash.pdf|05/28/2015| 00009009004|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017| 00009009401|Anxiolytics and Sedative-Hypnotics|https://paxpress.txpa.hidinc.com/ash.pdf|05/28/2015| 00009009401|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017| 00009027101|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 00013215036|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|07/10/2024 00013262681|Growth Hormones|https://paxpress.txpa.hidinc.com/gh.pdf|01/31/2011| 00013264681|Growth Hormones|https://paxpress.txpa.hidinc.com/gh.pdf|01/31/2011| 00013264902|Growth Hormones|https://paxpress.txpa.hidinc.com/gh.pdf|01/31/2011| 00013265002|Growth Hormones|https://paxpress.txpa.hidinc.com/gh.pdf|01/31/2011| 00013265102|Growth Hormones|https://paxpress.txpa.hidinc.com/gh.pdf|01/31/2011| 00013265202|Growth Hormones|https://paxpress.txpa.hidinc.com/gh.pdf|01/31/2011| 00013265302|Growth Hormones|https://paxpress.txpa.hidinc.com/gh.pdf|01/31/2011| 00013265402|Growth Hormones|https://paxpress.txpa.hidinc.com/gh.pdf|01/31/2011| 00013265502|Growth Hormones|https://paxpress.txpa.hidinc.com/gh.pdf|01/31/2011| 00013265602|Growth Hormones|https://paxpress.txpa.hidinc.com/gh.pdf|01/31/2011| 00013265702|Growth Hormones|https://paxpress.txpa.hidinc.com/gh.pdf|01/31/2011| 00013265802|Growth Hormones|https://paxpress.txpa.hidinc.com/gh.pdf|01/31/2011| 00023350731|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 00023649810|CGRP Agents Acute|https://paxpress.txpa.hidinc.com/cgrpacute.pdf|04/04/2023| 00023650110|CGRP Agents Acute|https://paxpress.txpa.hidinc.com/cgrpacute.pdf|04/04/2023| 00023650116|CGRP Agents Acute|https://paxpress.txpa.hidinc.com/cgrpacute.pdf|04/04/2023| 00024540131|Anxiolytics and Sedative-Hypnotics|https://paxpress.txpa.hidinc.com/ash.pdf|01/31/2011| 00024542131|Anxiolytics and Sedative-Hypnotics|https://paxpress.txpa.hidinc.com/ash.pdf|01/31/2011| 00024550131|Anxiolytics and Sedative-Hypnotics|https://paxpress.txpa.hidinc.com/ash.pdf|01/31/2011| 00024552131|Anxiolytics and Sedative-Hypnotics|https://paxpress.txpa.hidinc.com/ash.pdf|01/31/2011| 00024574502|DPP-4 Inhibitors|https://paxpress.txpa.hidinc.com/dpp4_inhibitor.pdf|09/25/2018|09/30/2023 00024574702|DPP-4 Inhibitors|https://paxpress.txpa.hidinc.com/dpp4_inhibitor.pdf|09/25/2018|09/30/2023 00024576105|DPP-4 Inhibitors|https://paxpress.txpa.hidinc.com/dpp4_inhibitor.pdf|09/25/2018| 00024585090|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 00024585130|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 00024585230|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 00024585530|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 00024585630|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 00024590801|Cytokine and CAM Antagonists|https://paxpress.txpa.hidinc.com/cytokine.pdf|03/27/2018| 00024591001|Cytokine and CAM Antagonists|https://paxpress.txpa.hidinc.com/cytokine.pdf|03/27/2018| 00024591102|Dupixent|https://paxpress.txpa.hidinc.com/dupixent.pdf|10/31/2017| 00024591401|Dupixent|https://paxpress.txpa.hidinc.com/dupixent.pdf|10/31/2017| 00024591502|Dupixent|https://paxpress.txpa.hidinc.com/dupixent.pdf|10/31/2017| 00024591801|Dupixent|https://paxpress.txpa.hidinc.com/dupixent.pdf|10/31/2017| 00024591900|Dupixent|https://paxpress.txpa.hidinc.com/dupixent.pdf|10/31/2017| 00024591902|Dupixent|https://paxpress.txpa.hidinc.com/dupixent.pdf|10/31/2017| 00024592001|Cytokine and CAM Antagonists|https://paxpress.txpa.hidinc.com/cytokine.pdf|03/27/2018| 00024592201|Cytokine and CAM Antagonists|https://paxpress.txpa.hidinc.com/cytokine.pdf|03/27/2018| 00025101131|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|07/10/2024 00025102131|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|10/17/2023 00025138131|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 00025141160|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 00025141190|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 00025142160|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 00025151501|COX-2 Inhibitors|https://paxpress.txpa.hidinc.com/cox2.pdf|01/31/2011| 00025151501|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/04/2016| 00025152031|COX-2 Inhibitors|https://paxpress.txpa.hidinc.com/cox2.pdf|01/31/2011| 00025152031|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/04/2016| 00025152034|COX-2 Inhibitors|https://paxpress.txpa.hidinc.com/cox2.pdf|01/31/2011| 00025152034|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/04/2016| 00025152051|COX-2 Inhibitors|https://paxpress.txpa.hidinc.com/cox2.pdf|01/31/2011| 00025152051|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/04/2016| 00025152531|COX-2 Inhibitors|https://paxpress.txpa.hidinc.com/cox2.pdf|01/31/2011| 00025152531|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/04/2016| 00025152534|COX-2 Inhibitors|https://paxpress.txpa.hidinc.com/cox2.pdf|01/31/2011| 00025152534|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/04/2016| 00025152551|COX-2 Inhibitors|https://paxpress.txpa.hidinc.com/cox2.pdf|01/31/2011| 00025152551|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/04/2016| 00025153002|COX-2 Inhibitors|https://paxpress.txpa.hidinc.com/cox2.pdf|01/31/2011| 00025153002|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/04/2016| 00037200101|Carisoprodol Overuse|https://paxpress.txpa.hidinc.com/soma.pdf|01/31/2011| 00037200101|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017| 00037225010|Carisoprodol Overuse|https://paxpress.txpa.hidinc.com/soma.pdf|01/31/2011| 00037225010|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017| 00046074905|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 00046087221|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 00046110081|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 00046110091|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 00046110181|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 00046110281|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 00046110291|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 00046110381|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 00046110481|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 00046110491|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 00046110511|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 00046110611|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 00046110711|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 00046110811|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 00049005460|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016| 00049233045|Antimigraine Agents Triptans|https://paxpress.txpa.hidinc.com/triptans.pdf|04/04/2023| 00049234005|Antimigraine Agents Triptans|https://paxpress.txpa.hidinc.com/triptans.pdf|04/04/2023| 00049234045|Antimigraine Agents Triptans|https://paxpress.txpa.hidinc.com/triptans.pdf|04/04/2023| 00049392083|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016| 00054001720|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 00054001820|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 00054001825|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 00054001829|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 00054001920|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 00054001925|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 00054006344|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016|05/31/2024 00054008425|Anxiolytics and Sedative-Hypnotics|https://paxpress.txpa.hidinc.com/ash.pdf|01/31/2011| 00054008525|Anxiolytics and Sedative-Hypnotics|https://paxpress.txpa.hidinc.com/ash.pdf|01/31/2011| 00054008813|Phosphate Binders|https://paxpress.txpa.hidinc.com/phosphate_binders.pdf|01/31/2011| 00054008826|Phosphate Binders|https://paxpress.txpa.hidinc.com/phosphate_binders.pdf|01/31/2011| 00054017613|Buprenorphine Agents|https://paxpress.txpa.hidinc.com/buprenorphine_agents.pdf|12/05/2014| 00054017613|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017| 00054017713|Buprenorphine Agents|https://paxpress.txpa.hidinc.com/buprenorphine_agents.pdf|12/05/2014| 00054017713|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017| 00054018813|Buprenorphine Agents|https://paxpress.txpa.hidinc.com/buprenorphine_agents.pdf|04/23/2013| 00054018813|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017| 00054018913|Buprenorphine Agents|https://paxpress.txpa.hidinc.com/buprenorphine_agents.pdf|04/23/2013| 00054018913|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017| 00054023525|Opiate Overutilization|https://paxpress.txpa.hidinc.com/opiate.pdf|11/05/2013| 00054023525|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017| 00054023525|Opioid Clinical Policy (MME and days supply limits)|https://paxpress.txpa.hidinc.com/opc.pdf|09/01/2020| 00054023625|Opiate Overutilization|https://paxpress.txpa.hidinc.com/opiate.pdf|11/05/2013| 00054023625|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017| 00054023625|Opioid Clinical Policy (MME and days supply limits)|https://paxpress.txpa.hidinc.com/opc.pdf|09/01/2020| 00054023749|Opiate Overutilization|https://paxpress.txpa.hidinc.com/opiate.pdf|11/05/2013| 00054023749|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017| 00054023749|Opioid Clinical Policy (MME and days supply limits)|https://paxpress.txpa.hidinc.com/opc.pdf|09/01/2020| 00054023763|Opiate Overutilization|https://paxpress.txpa.hidinc.com/opiate.pdf|11/05/2013| 00054023763|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017| 00054023763|Opioid Clinical Policy (MME and days supply limits)|https://paxpress.txpa.hidinc.com/opc.pdf|09/01/2020| 00054023849|Opiate Overutilization|https://paxpress.txpa.hidinc.com/opiate.pdf|11/05/2013| 00054023849|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017| 00054023849|Opioid Clinical Policy (MME and days supply limits)|https://paxpress.txpa.hidinc.com/opc.pdf|09/01/2020| 00054023863|Opiate Overutilization|https://paxpress.txpa.hidinc.com/opiate.pdf|11/05/2013| 00054023863|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017| 00054023863|Opioid Clinical Policy (MME and days supply limits)|https://paxpress.txpa.hidinc.com/opc.pdf|09/01/2020| 00054024324|Opiate Overutilization|https://paxpress.txpa.hidinc.com/opiate.pdf|11/05/2013| 00054024324|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017| 00054024424|Opiate Overutilization|https://paxpress.txpa.hidinc.com/opiate.pdf|11/05/2013| 00054024424|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017| 00054024424|Opioid Clinical Policy (MME and days supply limits)|https://paxpress.txpa.hidinc.com/opc.pdf|09/01/2020| 00054024425|Opiate Overutilization|https://paxpress.txpa.hidinc.com/opiate.pdf|11/05/2013| 00054024425|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017| 00054024425|Opioid Clinical Policy (MME and days supply limits)|https://paxpress.txpa.hidinc.com/opc.pdf|09/01/2020| 00054024525|Opiate Overutilization|https://paxpress.txpa.hidinc.com/opiate.pdf|11/05/2013| 00054024525|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017| 00054024525|Opioid Clinical Policy (MME and days supply limits)|https://paxpress.txpa.hidinc.com/opc.pdf|09/01/2020| 00054025413|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 00054025422|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 00054025513|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 00054025522|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 00054027803|Antimigraine Agents Triptans|https://paxpress.txpa.hidinc.com/triptans.pdf|04/04/2023| 00054027903|Antimigraine Agents Triptans|https://paxpress.txpa.hidinc.com/triptans.pdf|04/04/2023| 00054028325|Opiate Overutilization|https://paxpress.txpa.hidinc.com/opiate.pdf|11/05/2013| 00054028325|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017| 00054028325|Opioid Clinical Policy (MME and days supply limits)|https://paxpress.txpa.hidinc.com/opc.pdf|09/01/2020| 00054028425|Opiate Overutilization|https://paxpress.txpa.hidinc.com/opiate.pdf|11/05/2013| 00054028425|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017| 00054028425|Opioid Clinical Policy (MME and days supply limits)|https://paxpress.txpa.hidinc.com/opc.pdf|09/01/2020| 00054032656|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 00054032756|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 00054038663|Opiate Overutilization|https://paxpress.txpa.hidinc.com/opiate.pdf|11/05/2013| 00054038663|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017| 00054038663|Opioid Clinical Policy (MME and days supply limits)|https://paxpress.txpa.hidinc.com/opc.pdf|09/01/2020| 00054039041|Opiate Overutilization|https://paxpress.txpa.hidinc.com/opiate.pdf|11/05/2013| 00054039041|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017| 00054039041|Opioid Clinical Policy (MME and days supply limits)|https://paxpress.txpa.hidinc.com/opc.pdf|09/01/2020| 00054039063|Opiate Overutilization|https://paxpress.txpa.hidinc.com/opiate.pdf|11/05/2013| 00054039063|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017| 00054039063|Opioid Clinical Policy (MME and days supply limits)|https://paxpress.txpa.hidinc.com/opc.pdf|09/01/2020| 00054039168|Opiate Overutilization|https://paxpress.txpa.hidinc.com/opiate.pdf|11/05/2013| 00054039168|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017| 00054039168|Opioid Clinical Policy (MME and days supply limits)|https://paxpress.txpa.hidinc.com/opc.pdf|09/01/2020| 00054039268|Opiate Overutilization|https://paxpress.txpa.hidinc.com/opiate.pdf|11/05/2013| 00054039268|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017| 00054039268|Opioid Clinical Policy (MME and days supply limits)|https://paxpress.txpa.hidinc.com/opc.pdf|09/01/2020| 00054050823|Omega 3 Fatty Acids|https://paxpress.txpa.hidinc.com/lovaza.pdf|03/21/2023| 00054051741|Opiate Overutilization|https://paxpress.txpa.hidinc.com/opiate.pdf|11/05/2013| 00054051741|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017| 00054051741|Opioid Clinical Policy (MME and days supply limits)|https://paxpress.txpa.hidinc.com/opc.pdf|09/01/2020| 00054051744|Opiate Overutilization|https://paxpress.txpa.hidinc.com/opiate.pdf|11/05/2013| 00054051744|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017| 00054051744|Opioid Clinical Policy (MME and days supply limits)|https://paxpress.txpa.hidinc.com/opc.pdf|09/01/2020| 00054051750|Opiate Overutilization|https://paxpress.txpa.hidinc.com/opiate.pdf|11/05/2013| 00054051750|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017| 00054051750|Opioid Clinical Policy (MME and days supply limits)|https://paxpress.txpa.hidinc.com/opc.pdf|09/01/2020| 00054062127|Omega 3 Fatty Acids|https://paxpress.txpa.hidinc.com/lovaza.pdf|03/21/2023| 00054065025|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017| 00054065025|Opioid Clinical Policy (MME and days supply limits)|https://paxpress.txpa.hidinc.com/opc.pdf|09/01/2020| 00054070920|Opiate Overutilization|https://paxpress.txpa.hidinc.com/opiate.pdf|11/05/2013| 00054070920|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017| 00054070920|Opioid Clinical Policy (MME and days supply limits)|https://paxpress.txpa.hidinc.com/opc.pdf|09/01/2020| 00054070925|Opiate Overutilization|https://paxpress.txpa.hidinc.com/opiate.pdf|11/05/2013| 00054070925|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017| 00054070925|Opioid Clinical Policy (MME and days supply limits)|https://paxpress.txpa.hidinc.com/opc.pdf|09/01/2020| 00054071020|Opiate Overutilization|https://paxpress.txpa.hidinc.com/opiate.pdf|11/05/2013| 00054071020|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017| 00054071020|Opioid Clinical Policy (MME and days supply limits)|https://paxpress.txpa.hidinc.com/opc.pdf|09/01/2020| 00054071025|Opiate Overutilization|https://paxpress.txpa.hidinc.com/opiate.pdf|11/05/2013| 00054071025|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017| 00054071025|Opioid Clinical Policy (MME and days supply limits)|https://paxpress.txpa.hidinc.com/opc.pdf|09/01/2020| 00054074287|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 00054300001|Opiate Overutilization|https://paxpress.txpa.hidinc.com/opiate.pdf|11/05/2013| 00054300001|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017| 00054300001|Opioid Clinical Policy (MME and days supply limits)|https://paxpress.txpa.hidinc.com/opc.pdf|09/01/2020| 00054306844|Anxiolytics and Sedative-Hypnotics|https://paxpress.txpa.hidinc.com/ash.pdf|05/28/2015| 00054306844|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017| 00054309036|Opiate Overutilization|https://paxpress.txpa.hidinc.com/opiate.pdf|11/05/2013| 00054309036|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017| 00054309036|Opioid Clinical Policy (MME and days supply limits)|https://paxpress.txpa.hidinc.com/opc.pdf|09/01/2020| 00054317644|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 00054317757|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 00054317763|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 00054318544|Anxiolytics and Sedative-Hypnotics|https://paxpress.txpa.hidinc.com/ash.pdf|01/31/2011| 00054318544|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017| 00054318863|Anxiolytics and Sedative-Hypnotics|https://paxpress.txpa.hidinc.com/ash.pdf|01/31/2011| 00054318863|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017| 00054353244|Anxiolytics and Sedative-Hypnotics|https://paxpress.txpa.hidinc.com/ash.pdf|01/31/2011| 00054353244|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017| 00054354563|Opiate Overutilization|https://paxpress.txpa.hidinc.com/opiate.pdf|11/05/2013| 00054354563|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017| 00054354563|Opioid Clinical Policy (MME and days supply limits)|https://paxpress.txpa.hidinc.com/opc.pdf|09/01/2020| 00054355344|Opiate Overutilization|https://paxpress.txpa.hidinc.com/opiate.pdf|11/05/2013| 00054355344|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017| 00054355344|Opioid Clinical Policy (MME and days supply limits)|https://paxpress.txpa.hidinc.com/opc.pdf|09/01/2020| 00054355563|Opiate Overutilization|https://paxpress.txpa.hidinc.com/opiate.pdf|11/05/2013| 00054355563|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017| 00054355563|Opioid Clinical Policy (MME and days supply limits)|https://paxpress.txpa.hidinc.com/opc.pdf|09/01/2020| 00054355663|Opiate Overutilization|https://paxpress.txpa.hidinc.com/opiate.pdf|11/05/2013| 00054355663|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017| 00054355663|Opioid Clinical Policy (MME and days supply limits)|https://paxpress.txpa.hidinc.com/opc.pdf|09/01/2020| 00054363063|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 00054372144|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 00054372250|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 00054372263|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 00054417925|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 00054418025|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 00054418125|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 00054418225|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 00054418325|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 00054418425|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 00054418625|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 00054453825|Opiate Overutilization|https://paxpress.txpa.hidinc.com/opiate.pdf|11/05/2013| 00054453825|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017| 00054453825|Opioid Clinical Policy (MME and days supply limits)|https://paxpress.txpa.hidinc.com/opc.pdf|09/01/2020| 00054472825|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 00054472831|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 00054474125|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 00054474131|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 00054474225|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 00054485825|Anxiolytics and Sedative-Hypnotics|https://paxpress.txpa.hidinc.com/ash.pdf|01/31/2011| 00054485825|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017| 00054485925|Anxiolytics and Sedative-Hypnotics|https://paxpress.txpa.hidinc.com/ash.pdf|01/31/2011| 00054485925|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017| 00054485929|Anxiolytics and Sedative-Hypnotics|https://paxpress.txpa.hidinc.com/ash.pdf|01/31/2011| 00054485929|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017| 00054817425|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 00054817525|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 00054817625|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 00054817925|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 00054818025|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 00054818125|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 00054818325|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 00054872425|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 00054873925|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 00054874025|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 00054962857|Xyrem|https://paxpress.txpa.hidinc.com/xyrem.pdf|02/17/2011| 00054981725|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 00054981729|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 00054982825|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 00054982831|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 00069019502|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 00069019602|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 00069020602|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 00069021702|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 00069022002|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 00069022302|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 00069022802|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 00069023201|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 00069023530|Cytokine and CAM Antagonists|https://paxpress.txpa.hidinc.com/cytokine.pdf|06/01/2023| 00069033530|Cytokine and CAM Antagonists|https://paxpress.txpa.hidinc.com/cytokine.pdf|06/01/2023| 00069033621|PDE5-Inhibitors|https://paxpress.txpa.hidinc.com/revatio.pdf|01/31/2011| 00069043530|Cytokine and CAM Antagonists|https://paxpress.txpa.hidinc.com/cytokine.pdf|06/01/2023| 00069050130|Cytokine and CAM Antagonists|https://paxpress.txpa.hidinc.com/cytokine.pdf|03/27/2018| 00069100101|Cytokine and CAM Antagonists|https://paxpress.txpa.hidinc.com/cytokine.pdf|03/27/2018| 00069100201|Cytokine and CAM Antagonists|https://paxpress.txpa.hidinc.com/cytokine.pdf|03/27/2018| 00069102902|Cytokine and CAM Antagonists|https://paxpress.txpa.hidinc.com/cytokine.pdf|11/30/2021| 00069130501|Erythropoiesis-Stimulating Proteins|https://paxpress.txpa.hidinc.com/esa.pdf|09/24/2013| 00069130510|Erythropoiesis-Stimulating Proteins|https://paxpress.txpa.hidinc.com/esa.pdf|09/24/2013| 00069130601|Erythropoiesis-Stimulating Proteins|https://paxpress.txpa.hidinc.com/esa.pdf|09/24/2013| 00069130610|Erythropoiesis-Stimulating Proteins|https://paxpress.txpa.hidinc.com/esa.pdf|09/24/2013| 00069130701|Erythropoiesis-Stimulating Proteins|https://paxpress.txpa.hidinc.com/esa.pdf|09/24/2013| 00069130710|Erythropoiesis-Stimulating Proteins|https://paxpress.txpa.hidinc.com/esa.pdf|09/24/2013| 00069130801|Erythropoiesis-Stimulating Proteins|https://paxpress.txpa.hidinc.com/esa.pdf|09/24/2013| 00069130810|Erythropoiesis-Stimulating Proteins|https://paxpress.txpa.hidinc.com/esa.pdf|09/24/2013| 00069130901|Erythropoiesis-Stimulating Proteins|https://paxpress.txpa.hidinc.com/esa.pdf|09/24/2013| 00069130904|Erythropoiesis-Stimulating Proteins|https://paxpress.txpa.hidinc.com/esa.pdf|09/24/2013| 00069215030|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|08/23/2023 00069217030|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|08/23/2023 00069218030|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|08/23/2023 00069219030|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|08/08/2024 00069225030|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|08/23/2023 00069226030|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|08/23/2023 00069227030|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|08/23/2023 00069322066|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 00069323066|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 00069419068|PDE5-Inhibitors|https://paxpress.txpa.hidinc.com/revatio.pdf|01/31/2011| 00069541066|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 00069542066|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 00071015523|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/04/2016| 00071015623|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/04/2016| 00071015723|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/04/2016| 00071015823|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/04/2016| 00071022323|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 00071040124|Gabapentin Agents|https://paxpress.txpa.hidinc.com/neurontin.pdf|01/31/2011| 00071080324|Gabapentin Agents|https://paxpress.txpa.hidinc.com/neurontin.pdf|01/31/2011| 00071080524|Gabapentin Agents|https://paxpress.txpa.hidinc.com/neurontin.pdf|01/31/2011| 00071080624|Gabapentin Agents|https://paxpress.txpa.hidinc.com/neurontin.pdf|01/31/2011| 00071201247|Gabapentin Agents|https://paxpress.txpa.hidinc.com/neurontin.pdf|01/31/2011| 00074006702|Cytokine and CAM Antagonists|https://paxpress.txpa.hidinc.com/cytokine.pdf|03/27/2018| 00074012402|Cytokine and CAM Antagonists|https://paxpress.txpa.hidinc.com/cytokine.pdf|03/27/2018| 00074012403|Cytokine and CAM Antagonists|https://paxpress.txpa.hidinc.com/cytokine.pdf|03/27/2018| 00074012404|Cytokine and CAM Antagonists|https://paxpress.txpa.hidinc.com/cytokine.pdf|03/27/2018| 00074024302|Cytokine and CAM Antagonists|https://paxpress.txpa.hidinc.com/cytokine.pdf|03/27/2018| 00074055402|Cytokine and CAM Antagonists|https://paxpress.txpa.hidinc.com/cytokine.pdf|03/27/2018| 00074061602|Cytokine and CAM Antagonists|https://paxpress.txpa.hidinc.com/cytokine.pdf|03/27/2018| 00074081702|Cytokine and CAM Antagonists|https://paxpress.txpa.hidinc.com/cytokine.pdf|03/27/2018| 00074104328|Cytokine and CAM Antagonists|https://paxpress.txpa.hidinc.com/cytokine.pdf|03/03/2020| 00074105001|Cytokine and CAM Antagonists|https://paxpress.txpa.hidinc.com/cytokine.pdf|11/04/2019| 00074106501|Cytokine and CAM Antagonists|https://paxpress.txpa.hidinc.com/cytokine.pdf|11/04/2019| 00074107001|Cytokine and CAM Antagonists|https://paxpress.txpa.hidinc.com/cytokine.pdf|11/04/2019| 00074153903|Cytokine and CAM Antagonists|https://paxpress.txpa.hidinc.com/cytokine.pdf|03/27/2018| 00074204202|Cytokine and CAM Antagonists|https://paxpress.txpa.hidinc.com/cytokine.pdf|11/04/2019|08/23/2023 00074210001|Cytokine and CAM Antagonists|https://paxpress.txpa.hidinc.com/cytokine.pdf|11/04/2019| 00074230630|Cytokine and CAM Antagonists|https://paxpress.txpa.hidinc.com/cytokine.pdf|03/03/2020| 00074231030|Cytokine and CAM Antagonists|https://paxpress.txpa.hidinc.com/cytokine.pdf|03/03/2020| 00074254003|Cytokine and CAM Antagonists|https://paxpress.txpa.hidinc.com/cytokine.pdf|03/27/2018| 00074379902|Cytokine and CAM Antagonists|https://paxpress.txpa.hidinc.com/cytokine.pdf|03/27/2018| 00074433902|Cytokine and CAM Antagonists|https://paxpress.txpa.hidinc.com/cytokine.pdf|03/27/2018| 00074433906|Cytokine and CAM Antagonists|https://paxpress.txpa.hidinc.com/cytokine.pdf|03/27/2018| 00074433907|Cytokine and CAM Antagonists|https://paxpress.txpa.hidinc.com/cytokine.pdf|03/27/2018| 00074709430|CGRP Agents Prophylaxis|https://paxpress.txpa.hidinc.com/cgrpchronic.pdf|11/22/2022| 00074709530|CGRP Agents Prophylaxis|https://paxpress.txpa.hidinc.com/cgrpchronic.pdf|11/22/2022| 00074709630|CGRP Agents Prophylaxis|https://paxpress.txpa.hidinc.com/cgrpchronic.pdf|11/22/2022| 00075062040|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 00075062160|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 00075062280|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 00075062300|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 00075062430|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 00075062603|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 00075291201|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 00075291501|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 00078031434|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 00078031534|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 00078034542|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 00078034642|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 00078035415|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/04/2016| 00078035834|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 00078035934|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 00078036034|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 00078037005|ADD/ADHD Agents|https://paxpress.txpa.hidinc.com/add_adhd_agents.pdf|02/13/2014| 00078037105|ADD/ADHD Agents|https://paxpress.txpa.hidinc.com/add_adhd_agents.pdf|02/13/2014| 00078037205|ADD/ADHD Agents|https://paxpress.txpa.hidinc.com/add_adhd_agents.pdf|02/13/2014| 00078038005|ADD/ADHD Agents|https://paxpress.txpa.hidinc.com/add_adhd_agents.pdf|02/13/2014| 00078038105|ADD/ADHD Agents|https://paxpress.txpa.hidinc.com/add_adhd_agents.pdf|02/13/2014| 00078038205|ADD/ADHD Agents|https://paxpress.txpa.hidinc.com/add_adhd_agents.pdf|02/13/2014| 00078038334|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 00078042315|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 00078042405|ADD/ADHD Agents|https://paxpress.txpa.hidinc.com/add_adhd_agents.pdf|02/13/2014| 00078043005|ADD/ADHD Agents|https://paxpress.txpa.hidinc.com/add_adhd_agents.pdf|02/13/2014| 00078043105|ADD/ADHD Agents|https://paxpress.txpa.hidinc.com/add_adhd_agents.pdf|02/13/2014| 00078043205|ADD/ADHD Agents|https://paxpress.txpa.hidinc.com/add_adhd_agents.pdf|02/13/2014| 00078043305|ADD/ADHD Agents|https://paxpress.txpa.hidinc.com/add_adhd_agents.pdf|02/13/2014| 00078043405|ADD/ADHD Agents|https://paxpress.txpa.hidinc.com/add_adhd_agents.pdf|02/13/2014| 00078043905|ADD/ADHD Agents|https://paxpress.txpa.hidinc.com/add_adhd_agents.pdf|02/13/2014| 00078044005|ADD/ADHD Agents|https://paxpress.txpa.hidinc.com/add_adhd_agents.pdf|02/13/2014| 00078044105|ADD/ADHD Agents|https://paxpress.txpa.hidinc.com/add_adhd_agents.pdf|02/13/2014| 00078047134|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 00078047234|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 00078048815|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 00078048915|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 00078049015|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 00078049115|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 00078049305|ADD/ADHD Agents|https://paxpress.txpa.hidinc.com/add_adhd_agents.pdf|02/13/2014| 00078060805|ADD/ADHD Agents|https://paxpress.txpa.hidinc.com/add_adhd_agents.pdf|02/13/2014| 00078060905|ADD/ADHD Agents|https://paxpress.txpa.hidinc.com/add_adhd_agents.pdf|02/13/2014| 00078063941|Cytokine and CAM Antagonists|https://paxpress.txpa.hidinc.com/cytokine.pdf|03/27/2018| 00078063968|Cytokine and CAM Antagonists|https://paxpress.txpa.hidinc.com/cytokine.pdf|03/27/2018| 00078063997|Cytokine and CAM Antagonists|https://paxpress.txpa.hidinc.com/cytokine.pdf|03/27/2018| 00078063998|Cytokine and CAM Antagonists|https://paxpress.txpa.hidinc.com/cytokine.pdf|03/27/2018| 00078065920|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 00078065967|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 00078066419|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/04/2016| 00078069620|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 00078069667|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 00078073461|Cytokine and CAM Antagonists|https://paxpress.txpa.hidinc.com/cytokine.pdf|03/27/2018| 00078077720|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 00078077767|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 00078105697|Cytokine and CAM Antagonists|https://paxpress.txpa.hidinc.com/cytokine.pdf|03/27/2018| 00085134102|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 00085433301|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|08/23/2023 00093005801|Opiate Overutilization|https://paxpress.txpa.hidinc.com/opiate.pdf|11/05/2013| 00093005801|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017| 00093005801|Opioid Clinical Policy (MME and days supply limits)|https://paxpress.txpa.hidinc.com/opc.pdf|09/01/2020| 00093005805|Opiate Overutilization|https://paxpress.txpa.hidinc.com/opiate.pdf|11/05/2013| 00093005805|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017| 00093005805|Opioid Clinical Policy (MME and days supply limits)|https://paxpress.txpa.hidinc.com/opc.pdf|09/01/2020| 00093007301|Anxiolytics and Sedative-Hypnotics|https://paxpress.txpa.hidinc.com/ash.pdf|01/31/2011| 00093007401|Anxiolytics and Sedative-Hypnotics|https://paxpress.txpa.hidinc.com/ash.pdf|01/31/2011| 00093030801|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 00093031401|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 00093031401|Ketorolac|https://paxpress.txpa.hidinc.com/ketorolac.pdf|05/25/2012| 00093057610|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/04/2016| 00093071101|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 00093071105|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 00093075601|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 00093075701|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 00093075705|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 00093077198|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/04/2016| 00093083201|Anxiolytics and Sedative-Hypnotics|https://paxpress.txpa.hidinc.com/ash.pdf|01/31/2011| 00093083201|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017| 00093083205|Anxiolytics and Sedative-Hypnotics|https://paxpress.txpa.hidinc.com/ash.pdf|01/31/2011| 00093083205|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017| 00093092401|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|08/23/2023 00093092405|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|08/23/2023 00093092606|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/04/2016| 00093092610|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/04/2016| 00093092810|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/04/2016| 00093094801|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 00093094805|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 00093100501|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 00093100505|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 00093100601|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 00093100605|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 00093111801|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 00093112201|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 00093171201|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 00093171210|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 00093171301|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 00093171310|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 00093171401|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 00093171410|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 00093171501|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 00093171601|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 00093171610|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 00093171801|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 00093172001|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 00093172101|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 00093172110|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 00093172301|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 00093192006|Cyclobenzaprine|https://paxpress.txpa.hidinc.com/cyclobenzaprine.pdf|01/31/2011| 00093192006|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017| 00093192106|Cyclobenzaprine|https://paxpress.txpa.hidinc.com/cyclobenzaprine.pdf|01/31/2011| 00093192106|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017| 00093201312|Antimigraine Agents Triptans|https://paxpress.txpa.hidinc.com/triptans.pdf|04/04/2023| 00093201412|Antimigraine Agents Triptans|https://paxpress.txpa.hidinc.com/triptans.pdf|04/04/2023| 00093206301|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016| 00093309056|CNS Stimulants|https://paxpress.txpa.hidinc.com/provigil.pdf|02/06/2018| 00093309256|CNS Stimulants|https://paxpress.txpa.hidinc.com/provigil.pdf|02/06/2018| 00093309356|CNS Stimulants|https://paxpress.txpa.hidinc.com/provigil.pdf|02/06/2018| 00093309456|CNS Stimulants|https://paxpress.txpa.hidinc.com/provigil.pdf|02/06/2018| 00093312242|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 00093312298|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 00093313331|Imiquimod|https://paxpress.txpa.hidinc.com/imiquimod.pdf|07/16/2012| 00093317431|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 00093321201|Anxiolytics and Sedative-Hypnotics|https://paxpress.txpa.hidinc.com/ash.pdf|01/31/2011| 00093321201|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017| 00093321205|Anxiolytics and Sedative-Hypnotics|https://paxpress.txpa.hidinc.com/ash.pdf|01/31/2011| 00093321205|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017| 00093321301|Anxiolytics and Sedative-Hypnotics|https://paxpress.txpa.hidinc.com/ash.pdf|01/31/2011| 00093321301|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017| 00093321305|Anxiolytics and Sedative-Hypnotics|https://paxpress.txpa.hidinc.com/ash.pdf|01/31/2011| 00093321305|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017| 00093322308|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 00093322397|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 00093323940|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017| 00093323940|Opioid Clinical Policy (MME and days supply limits)|https://paxpress.txpa.hidinc.com/opc.pdf|09/01/2020| 00093324101|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 00093324201|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 00093324356|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 00093333406|PDE5-Inhibitors|https://paxpress.txpa.hidinc.com/revatio.pdf|01/31/2011| 00093342001|Cyclobenzaprine|https://paxpress.txpa.hidinc.com/cyclobenzaprine.pdf|01/31/2011| 00093342001|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017| 00093342101|Cyclobenzaprine|https://paxpress.txpa.hidinc.com/cyclobenzaprine.pdf|01/31/2011| 00093342101|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017| 00093342201|Cyclobenzaprine|https://paxpress.txpa.hidinc.com/cyclobenzaprine.pdf|01/31/2011| 00093342201|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017| 00093342205|Cyclobenzaprine|https://paxpress.txpa.hidinc.com/cyclobenzaprine.pdf|01/31/2011| 00093342205|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017| 00093342210|Cyclobenzaprine|https://paxpress.txpa.hidinc.com/cyclobenzaprine.pdf|01/31/2011| 00093342210|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017| 00093342501|Anxiolytics and Sedative-Hypnotics|https://paxpress.txpa.hidinc.com/ash.pdf|01/31/2011| 00093342501|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017| 00093342505|Anxiolytics and Sedative-Hypnotics|https://paxpress.txpa.hidinc.com/ash.pdf|01/31/2011| 00093342505|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017| 00093342510|Anxiolytics and Sedative-Hypnotics|https://paxpress.txpa.hidinc.com/ash.pdf|01/31/2011| 00093342510|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017| 00093342601|Anxiolytics and Sedative-Hypnotics|https://paxpress.txpa.hidinc.com/ash.pdf|01/31/2011| 00093342601|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017| 00093342605|Anxiolytics and Sedative-Hypnotics|https://paxpress.txpa.hidinc.com/ash.pdf|01/31/2011| 00093342605|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017| 00093342610|Anxiolytics and Sedative-Hypnotics|https://paxpress.txpa.hidinc.com/ash.pdf|01/31/2011| 00093342610|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017| 00093342701|Anxiolytics and Sedative-Hypnotics|https://paxpress.txpa.hidinc.com/ash.pdf|01/31/2011| 00093342701|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017| 00093342705|Anxiolytics and Sedative-Hypnotics|https://paxpress.txpa.hidinc.com/ash.pdf|01/31/2011| 00093342705|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017| 00093342710|Anxiolytics and Sedative-Hypnotics|https://paxpress.txpa.hidinc.com/ash.pdf|01/31/2011| 00093342710|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017| 00093342810|Topical Immunomodulators|https://paxpress.txpa.hidinc.com/immunomodulators.pdf|01/31/2011| 00093342830|Topical Immunomodulators|https://paxpress.txpa.hidinc.com/immunomodulators.pdf|01/31/2011| 00093342892|Topical Immunomodulators|https://paxpress.txpa.hidinc.com/immunomodulators.pdf|01/31/2011| 00093342910|Topical Immunomodulators|https://paxpress.txpa.hidinc.com/immunomodulators.pdf|01/31/2011| 00093342930|Topical Immunomodulators|https://paxpress.txpa.hidinc.com/immunomodulators.pdf|01/31/2011| 00093342992|Topical Immunomodulators|https://paxpress.txpa.hidinc.com/immunomodulators.pdf|01/31/2011| 00093354143|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 00093354256|ADD/ADHD Agents|https://paxpress.txpa.hidinc.com/add_adhd_agents.pdf|02/13/2014| 00093354356|ADD/ADHD Agents|https://paxpress.txpa.hidinc.com/add_adhd_agents.pdf|02/13/2014| 00093354456|ADD/ADHD Agents|https://paxpress.txpa.hidinc.com/add_adhd_agents.pdf|02/13/2014| 00093354556|ADD/ADHD Agents|https://paxpress.txpa.hidinc.com/add_adhd_agents.pdf|02/13/2014| 00093354656|ADD/ADHD Agents|https://paxpress.txpa.hidinc.com/add_adhd_agents.pdf|02/13/2014| 00093354756|ADD/ADHD Agents|https://paxpress.txpa.hidinc.com/add_adhd_agents.pdf|02/13/2014| 00093354856|ADD/ADHD Agents|https://paxpress.txpa.hidinc.com/add_adhd_agents.pdf|02/13/2014| 00093360782|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 00093360882|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 00093360982|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 00093365640|Opiate Overutilization|https://paxpress.txpa.hidinc.com/opiate.pdf|11/05/2013| 00093365640|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017| 00093365640|Opioid Clinical Policy (MME and days supply limits)|https://paxpress.txpa.hidinc.com/opc.pdf|09/01/2020| 00093365740|Opiate Overutilization|https://paxpress.txpa.hidinc.com/opiate.pdf|11/05/2013| 00093365740|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017| 00093365740|Opioid Clinical Policy (MME and days supply limits)|https://paxpress.txpa.hidinc.com/opc.pdf|09/01/2020| 00093365840|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017| 00093365840|Opioid Clinical Policy (MME and days supply limits)|https://paxpress.txpa.hidinc.com/opc.pdf|09/01/2020| 00093365940|Opiate Overutilization|https://paxpress.txpa.hidinc.com/opiate.pdf|11/05/2013| 00093365940|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017| 00093365940|Opioid Clinical Policy (MME and days supply limits)|https://paxpress.txpa.hidinc.com/opc.pdf|09/01/2020| 00093372755|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 00093375028|Inhaled Antibiotics Clinical|https://paxpress.txpa.hidinc.com/inhaledantibiotics.pdf|05/02/2023| 00093375063|Inhaled Antibiotics Clinical|https://paxpress.txpa.hidinc.com/inhaledantibiotics.pdf|05/02/2023| 00093406106|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/04/2016| 00093406130|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/04/2016| 00093408563|Inhaled Antibiotics Clinical|https://paxpress.txpa.hidinc.com/inhaledantibiotics.pdf|05/02/2023| 00093414556|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 00093414656|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 00093414756|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 00093414856|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 00093500256|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 00093500356|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 00093500456|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 00093500556|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 00093500656|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 00093504501|ADD/ADHD Agents|https://paxpress.txpa.hidinc.com/add_adhd_agents.pdf|02/13/2014| 00093504601|ADD/ADHD Agents|https://paxpress.txpa.hidinc.com/add_adhd_agents.pdf|02/13/2014| 00093505610|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/04/2016| 00093505698|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/04/2016| 00093505705|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/04/2016| 00093505798|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/04/2016| 00093505810|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/04/2016| 00093505898|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/04/2016| 00093505910|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/04/2016| 00093505998|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/04/2016| 00093506001|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 00093506005|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 00093506101|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 00093506105|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 00093506110|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 00093506201|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 00093506205|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 00093524565|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016| 00093524665|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016| 00093524765|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016| 00093524865|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016| 00093526018|Antimigraine Agents Triptans|https://paxpress.txpa.hidinc.com/triptans.pdf|04/04/2023| 00093526129|Antimigraine Agents Triptans|https://paxpress.txpa.hidinc.com/triptans.pdf|04/04/2023| 00093529201|ADD/ADHD Agents|https://paxpress.txpa.hidinc.com/add_adhd_agents.pdf|02/13/2014| 00093529301|ADD/ADHD Agents|https://paxpress.txpa.hidinc.com/add_adhd_agents.pdf|02/13/2014| 00093529501|ADD/ADHD Agents|https://paxpress.txpa.hidinc.com/add_adhd_agents.pdf|02/13/2014| 00093529601|ADD/ADHD Agents|https://paxpress.txpa.hidinc.com/add_adhd_agents.pdf|02/13/2014| 00093529701|ADD/ADHD Agents|https://paxpress.txpa.hidinc.com/add_adhd_agents.pdf|02/13/2014| 00093529801|ADD/ADHD Agents|https://paxpress.txpa.hidinc.com/add_adhd_agents.pdf|02/13/2014| 00093534601|ADD/ADHD Agents|https://paxpress.txpa.hidinc.com/add_adhd_agents.pdf|02/13/2014| 00093534701|ADD/ADHD Agents|https://paxpress.txpa.hidinc.com/add_adhd_agents.pdf|02/13/2014| 00093534801|ADD/ADHD Agents|https://paxpress.txpa.hidinc.com/add_adhd_agents.pdf|02/13/2014| 00093537601|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016| 00093537701|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016| 00093541601|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016| 00093541701|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016| 00093541784|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016| 00093541901|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016| 00093541984|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016| 00093545528|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 00093545542|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 00093550356|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016| 00093550456|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016| 00093550556|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016| 00093550656|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016| 00093550756|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016| 00093551798|PDE5-Inhibitors|https://paxpress.txpa.hidinc.com/revatio.pdf|01/31/2011| 00093553756|Anxiolytics and Sedative-Hypnotics|https://paxpress.txpa.hidinc.com/ash.pdf|01/31/2011| 00093553801|Anxiolytics and Sedative-Hypnotics|https://paxpress.txpa.hidinc.com/ash.pdf|01/31/2011| 00093553901|Anxiolytics and Sedative-Hypnotics|https://paxpress.txpa.hidinc.com/ash.pdf|01/31/2011| 00093555001|ADD/ADHD Agents|https://paxpress.txpa.hidinc.com/add_adhd_agents.pdf|02/13/2014| 00093555101|ADD/ADHD Agents|https://paxpress.txpa.hidinc.com/add_adhd_agents.pdf|02/13/2014| 00093555201|ADD/ADHD Agents|https://paxpress.txpa.hidinc.com/add_adhd_agents.pdf|02/13/2014| 00093555301|ADD/ADHD Agents|https://paxpress.txpa.hidinc.com/add_adhd_agents.pdf|02/13/2014| 00093555401|ADD/ADHD Agents|https://paxpress.txpa.hidinc.com/add_adhd_agents.pdf|02/13/2014| 00093556201|ADD/ADHD Agents|https://paxpress.txpa.hidinc.com/add_adhd_agents.pdf|02/13/2014| 00093573101|Opiate Overutilization|https://paxpress.txpa.hidinc.com/opiate.pdf|11/05/2013|02/13/2024 00093573101|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017|02/13/2024 00093573101|Opioid Clinical Policy (MME and days supply limits)|https://paxpress.txpa.hidinc.com/opc.pdf|09/01/2020|02/13/2024 00093573101|Oxycontin / Narcotic Analgesic|https://paxpress.txpa.hidinc.com/oxycontin.pdf|01/31/2011|02/13/2024 00093573201|Opiate Overutilization|https://paxpress.txpa.hidinc.com/opiate.pdf|11/05/2013|02/13/2024 00093573201|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017|02/13/2024 00093573201|Opioid Clinical Policy (MME and days supply limits)|https://paxpress.txpa.hidinc.com/opc.pdf|09/01/2020|02/13/2024 00093573201|Oxycontin / Narcotic Analgesic|https://paxpress.txpa.hidinc.com/oxycontin.pdf|01/31/2011|02/13/2024 00093573301|Opiate Overutilization|https://paxpress.txpa.hidinc.com/opiate.pdf|11/05/2013|02/13/2024 00093573301|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017|02/13/2024 00093573301|Opioid Clinical Policy (MME and days supply limits)|https://paxpress.txpa.hidinc.com/opc.pdf|09/01/2020|02/13/2024 00093573301|Oxycontin / Narcotic Analgesic|https://paxpress.txpa.hidinc.com/oxycontin.pdf|01/31/2011|02/13/2024 00093573401|Opiate Overutilization|https://paxpress.txpa.hidinc.com/opiate.pdf|11/05/2013|02/13/2024 00093573401|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017|02/13/2024 00093573401|Opioid Clinical Policy (MME and days supply limits)|https://paxpress.txpa.hidinc.com/opc.pdf|09/01/2020|02/13/2024 00093573401|Oxycontin / Narcotic Analgesic|https://paxpress.txpa.hidinc.com/oxycontin.pdf|01/31/2011|02/13/2024 00093593898|Phosphate Binders|https://paxpress.txpa.hidinc.com/phosphate_binders.pdf|04/05/2022| 00093593998|Phosphate Binders|https://paxpress.txpa.hidinc.com/phosphate_binders.pdf|04/05/2022| 00093594098|Phosphate Binders|https://paxpress.txpa.hidinc.com/phosphate_binders.pdf|04/05/2022| 00093595506|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/04/2016| 00093595556|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/04/2016| 00093681555|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 00093681573|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 00093681655|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 00093681673|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 00093681773|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 00093716501|COX-2 Inhibitors|https://paxpress.txpa.hidinc.com/cox2.pdf|01/31/2011|07/28/2024 00093716501|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/04/2016|07/28/2024 00093716505|COX-2 Inhibitors|https://paxpress.txpa.hidinc.com/cox2.pdf|01/31/2011| 00093716505|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/04/2016| 00093716601|COX-2 Inhibitors|https://paxpress.txpa.hidinc.com/cox2.pdf|01/31/2011|07/28/2024 00093716601|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/04/2016|07/28/2024 00093716605|COX-2 Inhibitors|https://paxpress.txpa.hidinc.com/cox2.pdf|01/31/2011|07/28/2024 00093716605|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/04/2016|07/28/2024 00093717006|COX-2 Inhibitors|https://paxpress.txpa.hidinc.com/cox2.pdf|01/31/2011|07/28/2024 00093717006|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/04/2016|07/28/2024 00093717201|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 00093720110|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/04/2016| 00093720198|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/04/2016| 00093720210|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/04/2016| 00093720298|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/04/2016| 00093727010|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/04/2016|03/20/2024 00093727098|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/04/2016|02/09/2024 00093727105|Thiazolidinediones|https://paxpress.txpa.hidinc.com/thiazolidinediones.pdf|01/31/2011| 00093727156|Thiazolidinediones|https://paxpress.txpa.hidinc.com/thiazolidinediones.pdf|01/31/2011| 00093727198|Thiazolidinediones|https://paxpress.txpa.hidinc.com/thiazolidinediones.pdf|01/31/2011| 00093727205|Thiazolidinediones|https://paxpress.txpa.hidinc.com/thiazolidinediones.pdf|01/31/2011| 00093727256|Thiazolidinediones|https://paxpress.txpa.hidinc.com/thiazolidinediones.pdf|01/31/2011| 00093727298|Thiazolidinediones|https://paxpress.txpa.hidinc.com/thiazolidinediones.pdf|01/31/2011| 00093727305|Thiazolidinediones|https://paxpress.txpa.hidinc.com/thiazolidinediones.pdf|01/31/2011| 00093727356|Thiazolidinediones|https://paxpress.txpa.hidinc.com/thiazolidinediones.pdf|01/31/2011| 00093727398|Thiazolidinediones|https://paxpress.txpa.hidinc.com/thiazolidinediones.pdf|01/31/2011| 00093729001|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/04/2016| 00093729056|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/04/2016| 00093730606|COX-2 Inhibitors|https://paxpress.txpa.hidinc.com/cox2.pdf|01/31/2011|07/28/2024 00093730606|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/04/2016|07/28/2024 00093736710|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 00093736756|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 00093736798|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 00093736810|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 00093736856|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 00093736898|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 00093736910|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 00093736956|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 00093736998|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 00093744201|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/04/2016| 00093744256|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/04/2016| 00093744301|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/04/2016| 00093744356|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/04/2016| 00093744601|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/04/2016| 00093744656|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/04/2016| 00093747119|Antimigraine Agents Triptans|https://paxpress.txpa.hidinc.com/triptans.pdf|04/04/2023| 00093747143|Antimigraine Agents Triptans|https://paxpress.txpa.hidinc.com/triptans.pdf|04/04/2023| 00093747219|Antimigraine Agents Triptans|https://paxpress.txpa.hidinc.com/triptans.pdf|04/04/2023| 00093747243|Antimigraine Agents Triptans|https://paxpress.txpa.hidinc.com/triptans.pdf|04/04/2023| 00093748756|Leukotriene Modifiers|https://paxpress.txpa.hidinc.com/leukotriene.pdf|12/15/2015|08/23/2023 00093751631|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 00093751731|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 00093751831|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 00093770198|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 00093786565|Fentanyl Agents|https://paxpress.txpa.hidinc.com/fentanyl.pdf|01/31/2011| 00093786565|Opiate Overutilization|https://paxpress.txpa.hidinc.com/opiate.pdf|11/05/2013| 00093786565|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017| 00093786565|Opioid Clinical Policy (MME and days supply limits)|https://paxpress.txpa.hidinc.com/opc.pdf|09/01/2020| 00093786665|Fentanyl Agents|https://paxpress.txpa.hidinc.com/fentanyl.pdf|01/31/2011| 00093786665|Opiate Overutilization|https://paxpress.txpa.hidinc.com/opiate.pdf|11/05/2013| 00093786665|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017| 00093786665|Opioid Clinical Policy (MME and days supply limits)|https://paxpress.txpa.hidinc.com/opc.pdf|09/01/2020| 00093786765|Fentanyl Agents|https://paxpress.txpa.hidinc.com/fentanyl.pdf|01/31/2011| 00093786765|Opiate Overutilization|https://paxpress.txpa.hidinc.com/opiate.pdf|11/05/2013| 00093786765|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017| 00093786765|Opioid Clinical Policy (MME and days supply limits)|https://paxpress.txpa.hidinc.com/opc.pdf|09/01/2020| 00093786865|Fentanyl Agents|https://paxpress.txpa.hidinc.com/fentanyl.pdf|01/31/2011| 00093786865|Opiate Overutilization|https://paxpress.txpa.hidinc.com/opiate.pdf|11/05/2013| 00093786865|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017| 00093786865|Opioid Clinical Policy (MME and days supply limits)|https://paxpress.txpa.hidinc.com/opc.pdf|09/01/2020| 00093786965|Fentanyl Agents|https://paxpress.txpa.hidinc.com/fentanyl.pdf|01/31/2011| 00093786965|Opiate Overutilization|https://paxpress.txpa.hidinc.com/opiate.pdf|11/05/2013| 00093786965|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017| 00093786965|Opioid Clinical Policy (MME and days supply limits)|https://paxpress.txpa.hidinc.com/opc.pdf|09/01/2020| 00093787065|Fentanyl Agents|https://paxpress.txpa.hidinc.com/fentanyl.pdf|01/31/2011| 00093787065|Opiate Overutilization|https://paxpress.txpa.hidinc.com/opiate.pdf|11/05/2013| 00093787065|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017| 00093787065|Opioid Clinical Policy (MME and days supply limits)|https://paxpress.txpa.hidinc.com/opc.pdf|09/01/2020| 00093810798|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 00093816201|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016| 00093816301|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016| 00093816401|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016| 00093816501|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016| 00093816601|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016| 00093823256|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 00093823298|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 00093823856|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 00093823898|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 00093831018|Antimigraine Agents Triptans|https://paxpress.txpa.hidinc.com/triptans.pdf|04/04/2023| 00093831118|Antimigraine Agents Triptans|https://paxpress.txpa.hidinc.com/triptans.pdf|04/04/2023| 00093922201|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 00093922205|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 00093922206|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 00093929067|Anxiolytics and Sedative-Hypnotics|https://paxpress.txpa.hidinc.com/ash.pdf|01/31/2011| 00093929067|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017| 00093929167|Anxiolytics and Sedative-Hypnotics|https://paxpress.txpa.hidinc.com/ash.pdf|01/31/2011| 00093929167|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017| 00093929267|Anxiolytics and Sedative-Hypnotics|https://paxpress.txpa.hidinc.com/ash.pdf|01/31/2011| 00093929267|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017| 00093929367|Anxiolytics and Sedative-Hypnotics|https://paxpress.txpa.hidinc.com/ash.pdf|01/31/2011| 00093929367|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017| 00093929467|Anxiolytics and Sedative-Hypnotics|https://paxpress.txpa.hidinc.com/ash.pdf|01/31/2011| 00093929467|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017| 00113005705|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 00113016626|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 00113057826|Cough and Cold Agents|https://paxpress.txpa.hidinc.com/Cough%20&%20Cold.pdf|12/15/2015| 00113057826|Dextromethorphan Overutilization|https://paxpress.txpa.hidinc.com/dextro.pdf|07/16/2012| 00113060471|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 00113060478|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 00113060490|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 00113061239|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 00113061265|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 00113066026|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 00113089726|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 00113089734|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 00115136529|Phosphate Binders|https://paxpress.txpa.hidinc.com/phosphate_binders.pdf|01/31/2011| 00115136629|Phosphate Binders|https://paxpress.txpa.hidinc.com/phosphate_binders.pdf|01/31/2011| 00115143613|Cyclobenzaprine|https://paxpress.txpa.hidinc.com/cyclobenzaprine.pdf|01/31/2011| 00115143613|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017| 00115143713|Cyclobenzaprine|https://paxpress.txpa.hidinc.com/cyclobenzaprine.pdf|01/31/2011| 00115143713|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017| 00115148601|ADD/ADHD Agents|https://paxpress.txpa.hidinc.com/add_adhd_agents.pdf|02/13/2014| 00115148701|ADD/ADHD Agents|https://paxpress.txpa.hidinc.com/add_adhd_agents.pdf|02/13/2014| 00115148801|ADD/ADHD Agents|https://paxpress.txpa.hidinc.com/add_adhd_agents.pdf|02/13/2014| 00115148901|ADD/ADHD Agents|https://paxpress.txpa.hidinc.com/add_adhd_agents.pdf|02/13/2014| 00115149001|ADD/ADHD Agents|https://paxpress.txpa.hidinc.com/add_adhd_agents.pdf|02/13/2014| 00115149101|ADD/ADHD Agents|https://paxpress.txpa.hidinc.com/add_adhd_agents.pdf|02/13/2014| 00115168774|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|04/14/2024 00115168974|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|05/31/2024 00115169606|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 00115169701|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 00115170001|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 00115170901|ADD/ADHD Agents|https://paxpress.txpa.hidinc.com/add_adhd_agents.pdf|02/13/2014| 00115171001|ADD/ADHD Agents|https://paxpress.txpa.hidinc.com/add_adhd_agents.pdf|02/13/2014| 00115173601|ADD/ADHD Agents|https://paxpress.txpa.hidinc.com/add_adhd_agents.pdf|02/13/2014| 00115173701|ADD/ADHD Agents|https://paxpress.txpa.hidinc.com/add_adhd_agents.pdf|02/13/2014| 00115173801|ADD/ADHD Agents|https://paxpress.txpa.hidinc.com/add_adhd_agents.pdf|02/13/2014| 00115173901|ADD/ADHD Agents|https://paxpress.txpa.hidinc.com/add_adhd_agents.pdf|02/13/2014| 00115174001|ADD/ADHD Agents|https://paxpress.txpa.hidinc.com/add_adhd_agents.pdf|02/13/2014| 00115174101|ADD/ADHD Agents|https://paxpress.txpa.hidinc.com/add_adhd_agents.pdf|02/13/2014| 00115174501|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017| 00115174801|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017|04/11/2024 00115175701|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 00115180001|ADD/ADHD Agents|https://paxpress.txpa.hidinc.com/add_adhd_agents.pdf|02/13/2014| 00115180101|ADD/ADHD Agents|https://paxpress.txpa.hidinc.com/add_adhd_agents.pdf|02/13/2014| 00115180201|ADD/ADHD Agents|https://paxpress.txpa.hidinc.com/add_adhd_agents.pdf|02/13/2014| 00115180301|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 00115180302|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 00115180401|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 00115180402|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 00115991801|ADD/ADHD Agents|https://paxpress.txpa.hidinc.com/add_adhd_agents.pdf|02/13/2014| 00115991901|ADD/ADHD Agents|https://paxpress.txpa.hidinc.com/add_adhd_agents.pdf|02/13/2014| 00115992001|ADD/ADHD Agents|https://paxpress.txpa.hidinc.com/add_adhd_agents.pdf|02/13/2014| 00115992101|ADD/ADHD Agents|https://paxpress.txpa.hidinc.com/add_adhd_agents.pdf|02/13/2014| 00115992201|ADD/ADHD Agents|https://paxpress.txpa.hidinc.com/add_adhd_agents.pdf|02/13/2014| 00115993078|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 00115993178|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 00115993278|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 00121050404|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017|09/01/2024 00121050404|Opioid Clinical Policy (MME and days supply limits)|https://paxpress.txpa.hidinc.com/opc.pdf|09/01/2020|09/01/2024 00121050416|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017|08/01/2024 00121050416|Opioid Clinical Policy (MME and days supply limits)|https://paxpress.txpa.hidinc.com/opc.pdf|09/01/2020|08/01/2024 00121058104|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016| 00121065304|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016| 00121065402|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016| 00121065416|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016| 00121075908|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 00121077001|Anxiolytics and Sedative-Hypnotics|https://paxpress.txpa.hidinc.com/ash.pdf|01/31/2011| 00121077001|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017| 00121077204|Opiate Overutilization|https://paxpress.txpa.hidinc.com/opiate.pdf|11/05/2013| 00121077204|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017| 00121077204|Opioid Clinical Policy (MME and days supply limits)|https://paxpress.txpa.hidinc.com/opc.pdf|09/01/2020| 00121077216|Opiate Overutilization|https://paxpress.txpa.hidinc.com/opiate.pdf|11/05/2013| 00121077216|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017| 00121077216|Opioid Clinical Policy (MME and days supply limits)|https://paxpress.txpa.hidinc.com/opc.pdf|09/01/2020| 00121077308|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 00121077504|Cough and Cold Agents|https://paxpress.txpa.hidinc.com/Cough%20&%20Cold.pdf|12/15/2015| 00121077504|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017| 00121077504|Opioid Clinical Policy (MME and days supply limits)|https://paxpress.txpa.hidinc.com/opc.pdf|09/01/2020| 00121077508|Cough and Cold Agents|https://paxpress.txpa.hidinc.com/Cough%20&%20Cold.pdf|12/15/2015|08/01/2024 00121077508|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017|08/01/2024 00121077508|Opioid Clinical Policy (MME and days supply limits)|https://paxpress.txpa.hidinc.com/opc.pdf|09/01/2020|08/01/2024 00121077516|Cough and Cold Agents|https://paxpress.txpa.hidinc.com/Cough%20&%20Cold.pdf|12/15/2015| 00121077516|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017| 00121077516|Opioid Clinical Policy (MME and days supply limits)|https://paxpress.txpa.hidinc.com/opc.pdf|09/01/2020| 00121077708|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 00121082508|Opiate Overutilization|https://paxpress.txpa.hidinc.com/opiate.pdf|11/05/2013| 00121082508|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017| 00121082508|Opioid Clinical Policy (MME and days supply limits)|https://paxpress.txpa.hidinc.com/opc.pdf|09/01/2020| 00121092716|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|08/01/2024 00121092716|Promethazine Utilization|https://paxpress.txpa.hidinc.com/phenergan.pdf|01/31/2011|08/01/2024 00121093304|Cough and Cold Agents|https://paxpress.txpa.hidinc.com/Cough%20&%20Cold.pdf|12/15/2015| 00121093304|Dextromethorphan Overutilization|https://paxpress.txpa.hidinc.com/dextro.pdf|07/16/2012| 00121093304|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 00121101830|Buprenorphine Agents|https://paxpress.txpa.hidinc.com/buprenorphine_agents.pdf|04/23/2013| 00121101830|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017| 00121203630|Buprenorphine Agents|https://paxpress.txpa.hidinc.com/buprenorphine_agents.pdf|04/23/2013| 00121203630|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017| 00143928901|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 00168041630|Topical Immunomodulators|https://paxpress.txpa.hidinc.com/immunomodulators.pdf|01/31/2011| 00168041660|Topical Immunomodulators|https://paxpress.txpa.hidinc.com/immunomodulators.pdf|01/31/2011| 00168041699|Topical Immunomodulators|https://paxpress.txpa.hidinc.com/immunomodulators.pdf|01/31/2011| 00168041730|Topical Immunomodulators|https://paxpress.txpa.hidinc.com/immunomodulators.pdf|01/31/2011| 00168041760|Topical Immunomodulators|https://paxpress.txpa.hidinc.com/immunomodulators.pdf|01/31/2011| 00168041799|Topical Immunomodulators|https://paxpress.txpa.hidinc.com/immunomodulators.pdf|01/31/2011| 00169291115|DPP-4 Inhibitors|https://paxpress.txpa.hidinc.com/dpp4_inhibitor.pdf|09/25/2018| 00169406012|DPP-4 Inhibitors|https://paxpress.txpa.hidinc.com/dpp4_inhibitor.pdf|09/25/2018| 00169406013|DPP-4 Inhibitors|https://paxpress.txpa.hidinc.com/dpp4_inhibitor.pdf|09/25/2018| 00169517603|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 00169517604|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 00169770321|Growth Hormones|https://paxpress.txpa.hidinc.com/gh.pdf|01/31/2011| 00169770421|Growth Hormones|https://paxpress.txpa.hidinc.com/gh.pdf|01/31/2011| 00169770521|Growth Hormones|https://paxpress.txpa.hidinc.com/gh.pdf|01/31/2011| 00169770821|Growth Hormones|https://paxpress.txpa.hidinc.com/gh.pdf|01/31/2011| 00172208360|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 00172208380|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 00172208960|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 00172208980|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 00172392560|Anxiolytics and Sedative-Hypnotics|https://paxpress.txpa.hidinc.com/ash.pdf|01/31/2011| 00172392560|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017| 00172392570|Anxiolytics and Sedative-Hypnotics|https://paxpress.txpa.hidinc.com/ash.pdf|01/31/2011| 00172392570|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017| 00172392660|Anxiolytics and Sedative-Hypnotics|https://paxpress.txpa.hidinc.com/ash.pdf|01/31/2011| 00172392660|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017| 00172392670|Anxiolytics and Sedative-Hypnotics|https://paxpress.txpa.hidinc.com/ash.pdf|01/31/2011| 00172392670|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017| 00172392680|Anxiolytics and Sedative-Hypnotics|https://paxpress.txpa.hidinc.com/ash.pdf|01/31/2011| 00172392680|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017| 00172392760|Anxiolytics and Sedative-Hypnotics|https://paxpress.txpa.hidinc.com/ash.pdf|01/31/2011| 00172392760|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017| 00172392770|Anxiolytics and Sedative-Hypnotics|https://paxpress.txpa.hidinc.com/ash.pdf|01/31/2011| 00172392770|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017| 00172392780|Anxiolytics and Sedative-Hypnotics|https://paxpress.txpa.hidinc.com/ash.pdf|01/31/2011| 00172392780|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017| 00173047800|Antimigraine Agents Triptans|https://paxpress.txpa.hidinc.com/triptans.pdf|04/04/2023| 00173047900|Antimigraine Agents Triptans|https://paxpress.txpa.hidinc.com/triptans.pdf|04/04/2023| 00173051700|Pulmonary Hypertension Agents Clinical|https://paxpress.txpa.hidinc.com/pah.pdf|07/27/2023| 00173051900|Pulmonary Hypertension Agents Clinical|https://paxpress.txpa.hidinc.com/pah.pdf|07/27/2023| 00173052100|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/04/2016| 00173052300|Antimigraine Agents Triptans|https://paxpress.txpa.hidinc.com/triptans.pdf|04/04/2023| 00173052400|Antimigraine Agents Triptans|https://paxpress.txpa.hidinc.com/triptans.pdf|04/04/2023| 00173060002|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 00173060102|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 00173060202|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 00173068220|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 00173068224|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 00173069500|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 00173069600|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 00173069700|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 00173071520|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 00173071522|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 00173071620|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 00173071622|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 00173071720|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 00173071722|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 00173071820|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 00173071920|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 00173072020|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 00173073500|Antimigraine Agents Triptans|https://paxpress.txpa.hidinc.com/triptans.pdf|04/04/2023| 00173073601|Antimigraine Agents Triptans|https://paxpress.txpa.hidinc.com/triptans.pdf|04/04/2023| 00173073701|Antimigraine Agents Triptans|https://paxpress.txpa.hidinc.com/triptans.pdf|04/04/2023| 00173073900|Antimigraine Agents Triptans|https://paxpress.txpa.hidinc.com/triptans.pdf|04/04/2023| 00173073902|Antimigraine Agents Triptans|https://paxpress.txpa.hidinc.com/triptans.pdf|04/04/2023| 00173085910|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 00173085914|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 00173086910|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/04/2016| 00173087410|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 00173087610|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 00173088210|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 00173088710|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 00173088714|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 00173088810|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 00173089201|Monoclonal Antibody Agents (Fasenra and Nucala)|https://paxpress.txpa.hidinc.com/Monoclonal%20Antibodies.pdf|04/06/2021| 00173089242|Monoclonal Antibody Agents (Fasenra and Nucala)|https://paxpress.txpa.hidinc.com/Monoclonal%20Antibodies.pdf|04/06/2021| 00173089310|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 00173089314|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 00185002201|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017| 00185014101|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 00185021101|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 00185023601|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 00185027701|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 00185032501|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 00185044801|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017| 00185067401|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 00185067405|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 00185067501|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|07/31/2025 00185067510|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|03/31/2024 00185067601|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 00185067605|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 00185068701|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|12/31/2023 00185084201|ADD/ADHD Agents|https://paxpress.txpa.hidinc.com/add_adhd_agents.pdf|02/13/2014| 00185085301|ADD/ADHD Agents|https://paxpress.txpa.hidinc.com/add_adhd_agents.pdf|02/13/2014| 00185209801|ADD/ADHD Agents|https://paxpress.txpa.hidinc.com/add_adhd_agents.pdf|02/13/2014| 00185209901|ADD/ADHD Agents|https://paxpress.txpa.hidinc.com/add_adhd_agents.pdf|02/13/2014| 00186037020|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 00186037220|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 00186091612|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 00186091706|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 00186198804|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 00186198904|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 00186199004|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 00187000402|Cytokine and CAM Antagonists|https://paxpress.txpa.hidinc.com/cytokine.pdf|03/27/2018| 00187014601|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 00187065820|Anxiolytics and Sedative-Hypnotics|https://paxpress.txpa.hidinc.com/ash.pdf|01/31/2011| 00187065920|Anxiolytics and Sedative-Hypnotics|https://paxpress.txpa.hidinc.com/ash.pdf|01/31/2011| 00187510001|Topical Immunomodulators|https://paxpress.txpa.hidinc.com/immunomodulators.pdf|01/31/2011| 00187510102|Topical Immunomodulators|https://paxpress.txpa.hidinc.com/immunomodulators.pdf|01/31/2011| 00187510203|Topical Immunomodulators|https://paxpress.txpa.hidinc.com/immunomodulators.pdf|01/31/2011| 00228202710|Anxiolytics and Sedative-Hypnotics|https://paxpress.txpa.hidinc.com/ash.pdf|05/28/2015| 00228202710|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017| 00228202750|Anxiolytics and Sedative-Hypnotics|https://paxpress.txpa.hidinc.com/ash.pdf|05/28/2015| 00228202750|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017| 00228202796|Anxiolytics and Sedative-Hypnotics|https://paxpress.txpa.hidinc.com/ash.pdf|05/28/2015| 00228202796|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017| 00228202910|Anxiolytics and Sedative-Hypnotics|https://paxpress.txpa.hidinc.com/ash.pdf|05/28/2015| 00228202910|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017| 00228202950|Anxiolytics and Sedative-Hypnotics|https://paxpress.txpa.hidinc.com/ash.pdf|05/28/2015| 00228202950|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017| 00228202996|Anxiolytics and Sedative-Hypnotics|https://paxpress.txpa.hidinc.com/ash.pdf|05/28/2015| 00228202996|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017| 00228203110|Anxiolytics and Sedative-Hypnotics|https://paxpress.txpa.hidinc.com/ash.pdf|05/28/2015| 00228203110|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017| 00228203150|Anxiolytics and Sedative-Hypnotics|https://paxpress.txpa.hidinc.com/ash.pdf|05/28/2015| 00228203150|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017| 00228203196|Anxiolytics and Sedative-Hypnotics|https://paxpress.txpa.hidinc.com/ash.pdf|05/28/2015| 00228203196|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017| 00228203910|Anxiolytics and Sedative-Hypnotics|https://paxpress.txpa.hidinc.com/ash.pdf|05/28/2015| 00228203910|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017| 00228206710|Anxiolytics and Sedative-Hypnotics|https://paxpress.txpa.hidinc.com/ash.pdf|01/31/2011| 00228206710|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017| 00228206910|Anxiolytics and Sedative-Hypnotics|https://paxpress.txpa.hidinc.com/ash.pdf|01/31/2011| 00228206910|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017| 00228207310|Anxiolytics and Sedative-Hypnotics|https://paxpress.txpa.hidinc.com/ash.pdf|01/31/2011| 00228207310|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017| 00228207610|Anxiolytics and Sedative-Hypnotics|https://paxpress.txpa.hidinc.com/ash.pdf|01/31/2011| 00228207610|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017| 00228207650|Anxiolytics and Sedative-Hypnotics|https://paxpress.txpa.hidinc.com/ash.pdf|01/31/2011| 00228207650|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017| 00228207710|Anxiolytics and Sedative-Hypnotics|https://paxpress.txpa.hidinc.com/ash.pdf|01/31/2011| 00228207710|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017| 00228207750|Anxiolytics and Sedative-Hypnotics|https://paxpress.txpa.hidinc.com/ash.pdf|01/31/2011| 00228207750|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017| 00228234810|Propylthiouracil|https://paxpress.txpa.hidinc.com/ptu.pdf|04/18/2011| 00228255006|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 00228255011|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 00228255096|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 00228255106|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 00228255111|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 00228255196|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 00228263611|Gabapentin Agents|https://paxpress.txpa.hidinc.com/neurontin.pdf|01/31/2011| 00228263650|Gabapentin Agents|https://paxpress.txpa.hidinc.com/neurontin.pdf|01/31/2011| 00228263711|Gabapentin Agents|https://paxpress.txpa.hidinc.com/neurontin.pdf|01/31/2011| 00228263750|Gabapentin Agents|https://paxpress.txpa.hidinc.com/neurontin.pdf|01/31/2011| 00228282011|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 00228285011|ADD/ADHD Agents|https://paxpress.txpa.hidinc.com/add_adhd_agents.pdf|02/13/2014| 00228285111|ADD/ADHD Agents|https://paxpress.txpa.hidinc.com/add_adhd_agents.pdf|02/13/2014| 00228285311|ADD/ADHD Agents|https://paxpress.txpa.hidinc.com/add_adhd_agents.pdf|02/13/2014| 00228285511|ADD/ADHD Agents|https://paxpress.txpa.hidinc.com/add_adhd_agents.pdf|02/13/2014| 00228305911|ADD/ADHD Agents|https://paxpress.txpa.hidinc.com/add_adhd_agents.pdf|02/13/2014| 00228306011|ADD/ADHD Agents|https://paxpress.txpa.hidinc.com/add_adhd_agents.pdf|02/13/2014| 00228306111|ADD/ADHD Agents|https://paxpress.txpa.hidinc.com/add_adhd_agents.pdf|02/13/2014| 00228306211|ADD/ADHD Agents|https://paxpress.txpa.hidinc.com/add_adhd_agents.pdf|02/13/2014| 00228306311|ADD/ADHD Agents|https://paxpress.txpa.hidinc.com/add_adhd_agents.pdf|02/13/2014| 00228306411|ADD/ADHD Agents|https://paxpress.txpa.hidinc.com/add_adhd_agents.pdf|02/13/2014| 00228308306|Anxiolytics and Sedative-Hypnotics|https://paxpress.txpa.hidinc.com/ash.pdf|05/28/2015| 00228308306|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017| 00228308406|Anxiolytics and Sedative-Hypnotics|https://paxpress.txpa.hidinc.com/ash.pdf|05/28/2015| 00228308406|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017| 00228308606|Anxiolytics and Sedative-Hypnotics|https://paxpress.txpa.hidinc.com/ash.pdf|05/28/2015| 00228308606|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017| 00228308706|Anxiolytics and Sedative-Hypnotics|https://paxpress.txpa.hidinc.com/ash.pdf|05/28/2015| 00228308706|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017| 00228309011|Opiate Overutilization|https://paxpress.txpa.hidinc.com/opiate.pdf|11/05/2013| 00228309011|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017| 00228309011|Opioid Clinical Policy (MME and days supply limits)|https://paxpress.txpa.hidinc.com/opc.pdf|09/01/2020| 00228309111|Opiate Overutilization|https://paxpress.txpa.hidinc.com/opiate.pdf|11/05/2013| 00228309111|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017| 00228309111|Opioid Clinical Policy (MME and days supply limits)|https://paxpress.txpa.hidinc.com/opc.pdf|09/01/2020| 00228309211|Opiate Overutilization|https://paxpress.txpa.hidinc.com/opiate.pdf|11/05/2013| 00228309211|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017| 00228309211|Opioid Clinical Policy (MME and days supply limits)|https://paxpress.txpa.hidinc.com/opc.pdf|09/01/2020| 00228309311|Opiate Overutilization|https://paxpress.txpa.hidinc.com/opiate.pdf|11/05/2013| 00228309311|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017| 00228309311|Opioid Clinical Policy (MME and days supply limits)|https://paxpress.txpa.hidinc.com/opc.pdf|09/01/2020| 00228311611|Opiate Overutilization|https://paxpress.txpa.hidinc.com/opiate.pdf|11/05/2013| 00228311611|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017| 00228311611|Opioid Clinical Policy (MME and days supply limits)|https://paxpress.txpa.hidinc.com/opc.pdf|09/01/2020| 00228311711|Opiate Overutilization|https://paxpress.txpa.hidinc.com/opiate.pdf|11/05/2013| 00228311711|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017| 00228311711|Opioid Clinical Policy (MME and days supply limits)|https://paxpress.txpa.hidinc.com/opc.pdf|09/01/2020| 00228315303|Buprenorphine Agents|https://paxpress.txpa.hidinc.com/buprenorphine_agents.pdf|12/05/2014| 00228315303|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017| 00228315403|Buprenorphine Agents|https://paxpress.txpa.hidinc.com/buprenorphine_agents.pdf|04/23/2013| 00228315403|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017| 00228315503|Buprenorphine Agents|https://paxpress.txpa.hidinc.com/buprenorphine_agents.pdf|04/23/2013| 00228315503|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017| 00228315567|Buprenorphine Agents|https://paxpress.txpa.hidinc.com/buprenorphine_agents.pdf|04/23/2013| 00228315567|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017| 00228315603|Buprenorphine Agents|https://paxpress.txpa.hidinc.com/buprenorphine_agents.pdf|12/05/2014| 00228315603|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017| 00228401911|Anxiolytics and Sedative-Hypnotics|https://paxpress.txpa.hidinc.com/ash.pdf|05/28/2015| 00228401911|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017| 00228402211|Anxiolytics and Sedative-Hypnotics|https://paxpress.txpa.hidinc.com/ash.pdf|05/28/2015| 00228402211|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017| 00228402411|Anxiolytics and Sedative-Hypnotics|https://paxpress.txpa.hidinc.com/ash.pdf|05/28/2015| 00228402411|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017| 00228402511|Anxiolytics and Sedative-Hypnotics|https://paxpress.txpa.hidinc.com/ash.pdf|05/28/2015| 00228402511|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017| 00228424106|ADD/ADHD Agents|https://paxpress.txpa.hidinc.com/add_adhd_agents.pdf|02/13/2014| 00228427011|Opiate Overutilization|https://paxpress.txpa.hidinc.com/opiate.pdf|11/05/2013| 00228427011|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017| 00228427011|Opioid Clinical Policy (MME and days supply limits)|https://paxpress.txpa.hidinc.com/opc.pdf|09/01/2020| 00228427111|Opiate Overutilization|https://paxpress.txpa.hidinc.com/opiate.pdf|11/05/2013| 00228427111|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017| 00228427111|Opioid Clinical Policy (MME and days supply limits)|https://paxpress.txpa.hidinc.com/opc.pdf|09/01/2020| 00228431111|Opiate Overutilization|https://paxpress.txpa.hidinc.com/opiate.pdf|11/05/2013| 00228431111|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017| 00228431111|Opioid Clinical Policy (MME and days supply limits)|https://paxpress.txpa.hidinc.com/opc.pdf|09/01/2020| 00228432311|Opiate Overutilization|https://paxpress.txpa.hidinc.com/opiate.pdf|11/05/2013| 00228432311|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017| 00228432311|Opioid Clinical Policy (MME and days supply limits)|https://paxpress.txpa.hidinc.com/opc.pdf|09/01/2020| 00228434711|Opiate Overutilization|https://paxpress.txpa.hidinc.com/opiate.pdf|11/05/2013| 00228434711|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017| 00228434711|Opioid Clinical Policy (MME and days supply limits)|https://paxpress.txpa.hidinc.com/opc.pdf|09/01/2020| 00245080938|Antimigraine Agents Triptans|https://paxpress.txpa.hidinc.com/triptans.pdf|04/04/2023| 00245081261|Antimigraine Agents Triptans|https://paxpress.txpa.hidinc.com/triptans.pdf|04/04/2023| 00254200501|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017| 00254205301|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017| 00254302002|Enzymes|https://paxpress.txpa.hidinc.com/enzymes.pdf|11/20/2019| 00254302102|Enzymes|https://paxpress.txpa.hidinc.com/enzymes.pdf|11/20/2019| 00254302202|Enzymes|https://paxpress.txpa.hidinc.com/enzymes.pdf|11/20/2019| 00254302802|GI Motility Agents|https://paxpress.txpa.hidinc.com/GImotility.pdf|01/18/2017| 00254302902|GI Motility Agents|https://paxpress.txpa.hidinc.com/GImotility.pdf|01/18/2017| 00310027110|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016| 00310027210|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016| 00310027460|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016| 00310027510|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016| 00310027810|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016| 00310027910|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016| 00310028060|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016| 00310028160|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016| 00310028260|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016| 00310028360|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016| 00310028460|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016| 00310183030|Monoclonal Antibody Agents (Fasenra and Nucala)|https://paxpress.txpa.hidinc.com/Monoclonal%20Antibodies.pdf|04/06/2021| 00310460012|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/04/2016| 00310461612|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 00310461639|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 00310610030|DPP-4 Inhibitors|https://paxpress.txpa.hidinc.com/dpp4_inhibitor.pdf|09/25/2018| 00310610090|DPP-4 Inhibitors|https://paxpress.txpa.hidinc.com/dpp4_inhibitor.pdf|09/25/2018| 00310610530|DPP-4 Inhibitors|https://paxpress.txpa.hidinc.com/dpp4_inhibitor.pdf|09/25/2018| 00310610590|DPP-4 Inhibitors|https://paxpress.txpa.hidinc.com/dpp4_inhibitor.pdf|09/25/2018| 00310612560|DPP-4 Inhibitors|https://paxpress.txpa.hidinc.com/dpp4_inhibitor.pdf|09/25/2018| 00310613530|DPP-4 Inhibitors|https://paxpress.txpa.hidinc.com/dpp4_inhibitor.pdf|09/25/2018| 00310614530|DPP-4 Inhibitors|https://paxpress.txpa.hidinc.com/dpp4_inhibitor.pdf|09/25/2018| 00310620530|SGLT2 Inhibitors Clinical|https://paxpress.txpa.hidinc.com/SGLT2.pdf|05/23/2023| 00310621030|SGLT2 Inhibitors Clinical|https://paxpress.txpa.hidinc.com/SGLT2.pdf|05/23/2023| 00310625030|SGLT2 Inhibitors Clinical|https://paxpress.txpa.hidinc.com/SGLT2.pdf|05/23/2023| 00310626060|SGLT2 Inhibitors Clinical|https://paxpress.txpa.hidinc.com/SGLT2.pdf|05/23/2023| 00310627030|SGLT2 Inhibitors Clinical|https://paxpress.txpa.hidinc.com/SGLT2.pdf|05/23/2023| 00310628030|SGLT2 Inhibitors Clinical|https://paxpress.txpa.hidinc.com/SGLT2.pdf|05/23/2023| 00310654004|DPP-4 Inhibitors|https://paxpress.txpa.hidinc.com/dpp4_inhibitor.pdf|09/25/2018| 00310661502|Symlin|https://paxpress.txpa.hidinc.com/symlin.pdf|01/31/2011| 00310662702|Symlin|https://paxpress.txpa.hidinc.com/symlin.pdf|01/31/2011| 00310678030|DPP-4 Inhibitors|https://paxpress.txpa.hidinc.com/dpp4_inhibitor.pdf|09/25/2018| 00310737020|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 00310737220|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 00310756090|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/04/2016|04/30/2024 00310757090|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/04/2016|04/30/2024 00310758090|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/04/2016|04/30/2024 00310759030|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/04/2016|11/30/2023 00378004201|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016| 00378007301|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016| 00378021401|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016| 00378021410|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016| 00378025701|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016| 00378025710|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016| 00378027101|Anxiolytics and Sedative-Hypnotics|https://paxpress.txpa.hidinc.com/ash.pdf|01/31/2011| 00378027101|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017| 00378027105|Anxiolytics and Sedative-Hypnotics|https://paxpress.txpa.hidinc.com/ash.pdf|01/31/2011| 00378027105|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017| 00378032701|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016| 00378032710|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016| 00378033001|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016| 00378033401|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016| 00378033501|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016| 00378034501|Anxiolytics and Sedative-Hypnotics|https://paxpress.txpa.hidinc.com/ash.pdf|01/31/2011| 00378034501|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017| 00378034505|Anxiolytics and Sedative-Hypnotics|https://paxpress.txpa.hidinc.com/ash.pdf|01/31/2011| 00378034505|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017| 00378035101|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016| 00378035110|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016| 00378040301|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 00378042401|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 00378043401|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 00378044201|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016| 00378044501|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 00378046001|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|04/30/2024 00378046401|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|03/31/2024 00378047701|Anxiolytics and Sedative-Hypnotics|https://paxpress.txpa.hidinc.com/ash.pdf|01/31/2011| 00378047701|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017| 00378047705|Anxiolytics and Sedative-Hypnotics|https://paxpress.txpa.hidinc.com/ash.pdf|01/31/2011| 00378047705|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017| 00378057401|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016| 00378061201|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016| 00378061401|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016| 00378061601|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016| 00378061801|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016| 00378064001|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 00378064010|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 00378064101|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 00378064110|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 00378064201|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 00378064205|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 00378064210|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 00378082501|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016| 00378086001|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016| 00378086005|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016| 00378092393|Buprenorphine Agents|https://paxpress.txpa.hidinc.com/buprenorphine_agents.pdf|12/05/2014| 00378092393|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017| 00378092493|Buprenorphine Agents|https://paxpress.txpa.hidinc.com/buprenorphine_agents.pdf|12/05/2014| 00378092493|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017| 00378097201|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016| 00378097301|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016| 00378100101|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016|09/30/2023 00378107593|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 00378107693|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 00378107793|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 00378107893|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 00378113401|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 00378113401|Ketorolac|https://paxpress.txpa.hidinc.com/ketorolac.pdf|05/25/2012| 00378140496|Antimigraine Agents Triptans|https://paxpress.txpa.hidinc.com/triptans.pdf|04/04/2023| 00378165777|PDE5-Inhibitors|https://paxpress.txpa.hidinc.com/revatio.pdf|01/31/2011| 00378172193|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 00378172293|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 00378172393|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 00378172493|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 00378200201|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016|10/31/2023 00378215001|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 00378240101|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016| 00378240201|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016| 00378240501|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016| 00378241001|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016| 00378292093|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 00378300001|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 00378300177|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 00378300277|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 00378300377|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 00378300501|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016|10/31/2023 00378322477|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 00378322493|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 00378322577|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 00378322593|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 00378323177|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 00378323193|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 00378323277|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 00378323293|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 00378334999|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 00378335099|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 00378335199|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 00378335299|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 00378336099|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 00378336199|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 00378343193|CNS Stimulants|https://paxpress.txpa.hidinc.com/provigil.pdf|02/06/2018| 00378343293|CNS Stimulants|https://paxpress.txpa.hidinc.com/provigil.pdf|02/06/2018| 00378343393|CNS Stimulants|https://paxpress.txpa.hidinc.com/provigil.pdf|02/06/2018| 00378363501|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 00378363701|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 00378363705|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 00378395005|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/04/2016| 00378395077|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/04/2016| 00378395105|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/04/2016| 00378395177|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/04/2016| 00378395205|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/04/2016| 00378395277|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/04/2016| 00378395305|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/04/2016| 00378395377|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/04/2016| 00378397893|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016|04/14/2024 00378397993|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016|04/14/2024 00378398093|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016|04/14/2024 00378398193|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016|04/14/2024 00378427093|Pulmonary Hypertension Agents Clinical|https://paxpress.txpa.hidinc.com/pah.pdf|07/27/2023| 00378427193|Pulmonary Hypertension Agents Clinical|https://paxpress.txpa.hidinc.com/pah.pdf|07/27/2023| 00378428785|Antimigraine Agents Triptans|https://paxpress.txpa.hidinc.com/triptans.pdf|04/04/2023| 00378428808|Antimigraine Agents Triptans|https://paxpress.txpa.hidinc.com/triptans.pdf|04/04/2023| 00378428885|Antimigraine Agents Triptans|https://paxpress.txpa.hidinc.com/triptans.pdf|04/04/2023| 00378438591|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 00378438691|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 00378451493|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 00378451593|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 00378451793|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 00378451893|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 00378451993|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 00378461926|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 00378462026|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 00378462126|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 00378462226|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 00378462326|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 00378464026|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 00378464126|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 00378464226|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 00378464326|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 00378464426|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 00378501001|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016|10/31/2023 00378527001|Anxiolytics and Sedative-Hypnotics|https://paxpress.txpa.hidinc.com/ash.pdf|01/31/2011| 00378527101|Anxiolytics and Sedative-Hypnotics|https://paxpress.txpa.hidinc.com/ash.pdf|01/31/2011| 00378527201|Anxiolytics and Sedative-Hypnotics|https://paxpress.txpa.hidinc.com/ash.pdf|01/31/2011| 00378551093|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016| 00378551193|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016| 00378551293|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016| 00378551393|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016| 00378563059|Antimigraine Agents Triptans|https://paxpress.txpa.hidinc.com/triptans.pdf|04/04/2023| 00378563159|Antimigraine Agents Triptans|https://paxpress.txpa.hidinc.com/triptans.pdf|04/04/2023| 00378563259|Antimigraine Agents Triptans|https://paxpress.txpa.hidinc.com/triptans.pdf|04/04/2023| 00378580793|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 00378581377|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 00378581477|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 00378581577|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 00378632177|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 00378632277|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 00378632377|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 00378632477|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 00378632577|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 00378699152|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|10/07/2023 00378699252|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|10/07/2023 00378699393|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 00378705752|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 00378705852|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 00378729453|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 00378729553|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 00378802077|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/04/2016| 00378802093|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/04/2016| 00378802177|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/04/2016| 00378802193|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/04/2016| 00378820001|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 00378826093|ADD/ADHD Agents|https://paxpress.txpa.hidinc.com/add_adhd_agents.pdf|02/13/2014| 00378826193|ADD/ADHD Agents|https://paxpress.txpa.hidinc.com/add_adhd_agents.pdf|02/13/2014| 00378826293|ADD/ADHD Agents|https://paxpress.txpa.hidinc.com/add_adhd_agents.pdf|02/13/2014| 00378826393|ADD/ADHD Agents|https://paxpress.txpa.hidinc.com/add_adhd_agents.pdf|02/13/2014| 00378827052|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 00378827091|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 00378876516|Buprenorphine Agents|https://paxpress.txpa.hidinc.com/buprenorphine_agents.pdf|04/23/2013| 00378876516|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017| 00378876593|Buprenorphine Agents|https://paxpress.txpa.hidinc.com/buprenorphine_agents.pdf|04/23/2013| 00378876593|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017| 00378876616|Buprenorphine Agents|https://paxpress.txpa.hidinc.com/buprenorphine_agents.pdf|04/23/2013| 00378876616|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017| 00378876693|Buprenorphine Agents|https://paxpress.txpa.hidinc.com/buprenorphine_agents.pdf|04/23/2013| 00378876693|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017| 00378876716|Buprenorphine Agents|https://paxpress.txpa.hidinc.com/buprenorphine_agents.pdf|04/23/2013| 00378876716|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017| 00378876793|Buprenorphine Agents|https://paxpress.txpa.hidinc.com/buprenorphine_agents.pdf|04/23/2013| 00378876793|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017| 00378876816|Buprenorphine Agents|https://paxpress.txpa.hidinc.com/buprenorphine_agents.pdf|04/23/2013| 00378876816|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017| 00378876893|Buprenorphine Agents|https://paxpress.txpa.hidinc.com/buprenorphine_agents.pdf|04/23/2013| 00378876893|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017| 00378877035|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 00378911998|Fentanyl Agents|https://paxpress.txpa.hidinc.com/fentanyl.pdf|01/31/2011| 00378911998|Opiate Overutilization|https://paxpress.txpa.hidinc.com/opiate.pdf|11/05/2013| 00378911998|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017| 00378911998|Opioid Clinical Policy (MME and days supply limits)|https://paxpress.txpa.hidinc.com/opc.pdf|09/01/2020| 00378912198|Fentanyl Agents|https://paxpress.txpa.hidinc.com/fentanyl.pdf|01/31/2011| 00378912198|Opiate Overutilization|https://paxpress.txpa.hidinc.com/opiate.pdf|11/05/2013| 00378912198|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017| 00378912198|Opioid Clinical Policy (MME and days supply limits)|https://paxpress.txpa.hidinc.com/opc.pdf|09/01/2020| 00378912298|Fentanyl Agents|https://paxpress.txpa.hidinc.com/fentanyl.pdf|01/31/2011| 00378912298|Opiate Overutilization|https://paxpress.txpa.hidinc.com/opiate.pdf|11/05/2013| 00378912298|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017| 00378912298|Opioid Clinical Policy (MME and days supply limits)|https://paxpress.txpa.hidinc.com/opc.pdf|09/01/2020| 00378912398|Fentanyl Agents|https://paxpress.txpa.hidinc.com/fentanyl.pdf|01/31/2011| 00378912398|Opiate Overutilization|https://paxpress.txpa.hidinc.com/opiate.pdf|11/05/2013| 00378912398|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017| 00378912398|Opioid Clinical Policy (MME and days supply limits)|https://paxpress.txpa.hidinc.com/opc.pdf|09/01/2020| 00378912498|Fentanyl Agents|https://paxpress.txpa.hidinc.com/fentanyl.pdf|01/31/2011| 00378912498|Opiate Overutilization|https://paxpress.txpa.hidinc.com/opiate.pdf|11/05/2013| 00378912498|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017| 00378912498|Opioid Clinical Policy (MME and days supply limits)|https://paxpress.txpa.hidinc.com/opc.pdf|09/01/2020| 00378912598|Fentanyl Agents|https://paxpress.txpa.hidinc.com/fentanyl.pdf|01/31/2011| 00378912598|Opiate Overutilization|https://paxpress.txpa.hidinc.com/opiate.pdf|11/05/2013| 00378912598|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017| 00378912598|Opioid Clinical Policy (MME and days supply limits)|https://paxpress.txpa.hidinc.com/opc.pdf|09/01/2020| 00378912698|Fentanyl Agents|https://paxpress.txpa.hidinc.com/fentanyl.pdf|01/31/2011| 00378912698|Opiate Overutilization|https://paxpress.txpa.hidinc.com/opiate.pdf|11/05/2013| 00378912698|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017| 00378912698|Opioid Clinical Policy (MME and days supply limits)|https://paxpress.txpa.hidinc.com/opc.pdf|09/01/2020| 00378912798|Fentanyl Agents|https://paxpress.txpa.hidinc.com/fentanyl.pdf|01/31/2011| 00378912798|Opiate Overutilization|https://paxpress.txpa.hidinc.com/opiate.pdf|11/05/2013| 00378912798|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017| 00378912798|Opioid Clinical Policy (MME and days supply limits)|https://paxpress.txpa.hidinc.com/opc.pdf|09/01/2020| 00378932032|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 00378932132|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 00378932232|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 00378969052|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 00378969152|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 00378969252|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 00406012301|Opiate Overutilization|https://paxpress.txpa.hidinc.com/opiate.pdf|11/05/2013| 00406012301|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017| 00406012301|Opioid Clinical Policy (MME and days supply limits)|https://paxpress.txpa.hidinc.com/opc.pdf|09/01/2020| 00406012305|Opiate Overutilization|https://paxpress.txpa.hidinc.com/opiate.pdf|11/05/2013| 00406012305|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017| 00406012305|Opioid Clinical Policy (MME and days supply limits)|https://paxpress.txpa.hidinc.com/opc.pdf|09/01/2020| 00406012310|Opiate Overutilization|https://paxpress.txpa.hidinc.com/opiate.pdf|11/05/2013| 00406012310|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017| 00406012310|Opioid Clinical Policy (MME and days supply limits)|https://paxpress.txpa.hidinc.com/opc.pdf|09/01/2020| 00406012362|Opiate Overutilization|https://paxpress.txpa.hidinc.com/opiate.pdf|11/05/2013| 00406012362|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017| 00406012362|Opioid Clinical Policy (MME and days supply limits)|https://paxpress.txpa.hidinc.com/opc.pdf|09/01/2020| 00406012401|Opiate Overutilization|https://paxpress.txpa.hidinc.com/opiate.pdf|11/05/2013| 00406012401|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017| 00406012401|Opioid Clinical Policy (MME and days supply limits)|https://paxpress.txpa.hidinc.com/opc.pdf|09/01/2020| 00406012405|Opiate Overutilization|https://paxpress.txpa.hidinc.com/opiate.pdf|11/05/2013| 00406012405|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017| 00406012405|Opioid Clinical Policy (MME and days supply limits)|https://paxpress.txpa.hidinc.com/opc.pdf|09/01/2020| 00406012410|Opiate Overutilization|https://paxpress.txpa.hidinc.com/opiate.pdf|11/05/2013| 00406012410|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017| 00406012410|Opioid Clinical Policy (MME and days supply limits)|https://paxpress.txpa.hidinc.com/opc.pdf|09/01/2020| 00406012462|Opiate Overutilization|https://paxpress.txpa.hidinc.com/opiate.pdf|11/05/2013| 00406012462|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017| 00406012462|Opioid Clinical Policy (MME and days supply limits)|https://paxpress.txpa.hidinc.com/opc.pdf|09/01/2020| 00406012501|Opiate Overutilization|https://paxpress.txpa.hidinc.com/opiate.pdf|11/05/2013| 00406012501|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017| 00406012501|Opioid Clinical Policy (MME and days supply limits)|https://paxpress.txpa.hidinc.com/opc.pdf|09/01/2020| 00406012505|Opiate Overutilization|https://paxpress.txpa.hidinc.com/opiate.pdf|11/05/2013| 00406012505|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017| 00406012505|Opioid Clinical Policy (MME and days supply limits)|https://paxpress.txpa.hidinc.com/opc.pdf|09/01/2020| 00406012510|Opiate Overutilization|https://paxpress.txpa.hidinc.com/opiate.pdf|11/05/2013| 00406012510|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017| 00406012510|Opioid Clinical Policy (MME and days supply limits)|https://paxpress.txpa.hidinc.com/opc.pdf|09/01/2020| 00406012562|Opiate Overutilization|https://paxpress.txpa.hidinc.com/opiate.pdf|11/05/2013| 00406012562|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017| 00406012562|Opioid Clinical Policy (MME and days supply limits)|https://paxpress.txpa.hidinc.com/opc.pdf|09/01/2020| 00406012701|ADD/ADHD Agents|https://paxpress.txpa.hidinc.com/add_adhd_agents.pdf|02/13/2014| 00406013601|ADD/ADHD Agents|https://paxpress.txpa.hidinc.com/add_adhd_agents.pdf|02/13/2014| 00406015401|ADD/ADHD Agents|https://paxpress.txpa.hidinc.com/add_adhd_agents.pdf|02/13/2014| 00406037601|Opiate Overutilization|https://paxpress.txpa.hidinc.com/opiate.pdf|11/05/2013| 00406037601|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017| 00406037601|Opioid Clinical Policy (MME and days supply limits)|https://paxpress.txpa.hidinc.com/opc.pdf|09/01/2020| 00406037605|Opiate Overutilization|https://paxpress.txpa.hidinc.com/opiate.pdf|11/05/2013| 00406037605|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017| 00406037605|Opioid Clinical Policy (MME and days supply limits)|https://paxpress.txpa.hidinc.com/opc.pdf|09/01/2020| 00406037701|Opiate Overutilization|https://paxpress.txpa.hidinc.com/opiate.pdf|11/05/2013| 00406037701|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017| 00406037701|Opioid Clinical Policy (MME and days supply limits)|https://paxpress.txpa.hidinc.com/opc.pdf|09/01/2020| 00406037705|Opiate Overutilization|https://paxpress.txpa.hidinc.com/opiate.pdf|11/05/2013| 00406037705|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017| 00406037705|Opioid Clinical Policy (MME and days supply limits)|https://paxpress.txpa.hidinc.com/opc.pdf|09/01/2020| 00406037801|Opiate Overutilization|https://paxpress.txpa.hidinc.com/opiate.pdf|11/05/2013| 00406037801|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017| 00406037801|Opioid Clinical Policy (MME and days supply limits)|https://paxpress.txpa.hidinc.com/opc.pdf|09/01/2020| 00406037805|Opiate Overutilization|https://paxpress.txpa.hidinc.com/opiate.pdf|11/05/2013| 00406037805|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017| 00406037805|Opioid Clinical Policy (MME and days supply limits)|https://paxpress.txpa.hidinc.com/opc.pdf|09/01/2020| 00406048301|Opiate Overutilization|https://paxpress.txpa.hidinc.com/opiate.pdf|11/05/2013| 00406048301|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017| 00406048301|Opioid Clinical Policy (MME and days supply limits)|https://paxpress.txpa.hidinc.com/opc.pdf|09/01/2020| 00406048401|Opiate Overutilization|https://paxpress.txpa.hidinc.com/opiate.pdf|11/05/2013| 00406048401|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017| 00406048401|Opioid Clinical Policy (MME and days supply limits)|https://paxpress.txpa.hidinc.com/opc.pdf|09/01/2020| 00406048410|Opiate Overutilization|https://paxpress.txpa.hidinc.com/opiate.pdf|11/05/2013| 00406048410|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017| 00406048410|Opioid Clinical Policy (MME and days supply limits)|https://paxpress.txpa.hidinc.com/opc.pdf|09/01/2020| 00406048462|Opiate Overutilization|https://paxpress.txpa.hidinc.com/opiate.pdf|11/05/2013| 00406048462|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017| 00406048462|Opioid Clinical Policy (MME and days supply limits)|https://paxpress.txpa.hidinc.com/opc.pdf|09/01/2020| 00406048501|Opiate Overutilization|https://paxpress.txpa.hidinc.com/opiate.pdf|11/05/2013| 00406048501|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017| 00406048501|Opioid Clinical Policy (MME and days supply limits)|https://paxpress.txpa.hidinc.com/opc.pdf|09/01/2020| 00406048505|Opiate Overutilization|https://paxpress.txpa.hidinc.com/opiate.pdf|11/05/2013| 00406048505|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017| 00406048505|Opioid Clinical Policy (MME and days supply limits)|https://paxpress.txpa.hidinc.com/opc.pdf|09/01/2020| 00406051201|Opiate Overutilization|https://paxpress.txpa.hidinc.com/opiate.pdf|11/05/2013| 00406051201|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017| 00406051201|Opioid Clinical Policy (MME and days supply limits)|https://paxpress.txpa.hidinc.com/opc.pdf|09/01/2020| 00406051205|Opiate Overutilization|https://paxpress.txpa.hidinc.com/opiate.pdf|11/05/2013| 00406051205|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017| 00406051205|Opioid Clinical Policy (MME and days supply limits)|https://paxpress.txpa.hidinc.com/opc.pdf|09/01/2020| 00406052201|Opiate Overutilization|https://paxpress.txpa.hidinc.com/opiate.pdf|11/05/2013| 00406052201|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017| 00406052201|Opioid Clinical Policy (MME and days supply limits)|https://paxpress.txpa.hidinc.com/opc.pdf|09/01/2020| 00406052205|Opiate Overutilization|https://paxpress.txpa.hidinc.com/opiate.pdf|11/05/2013| 00406052205|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017| 00406052205|Opioid Clinical Policy (MME and days supply limits)|https://paxpress.txpa.hidinc.com/opc.pdf|09/01/2020| 00406052301|Opiate Overutilization|https://paxpress.txpa.hidinc.com/opiate.pdf|11/05/2013| 00406052301|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017| 00406052301|Opioid Clinical Policy (MME and days supply limits)|https://paxpress.txpa.hidinc.com/opc.pdf|09/01/2020| 00406052305|Opiate Overutilization|https://paxpress.txpa.hidinc.com/opiate.pdf|11/05/2013| 00406052305|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017| 00406052305|Opioid Clinical Policy (MME and days supply limits)|https://paxpress.txpa.hidinc.com/opc.pdf|09/01/2020| 00406052710|Opiate Overutilization|https://paxpress.txpa.hidinc.com/opiate.pdf|11/05/2013| 00406052710|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017| 00406052710|Opioid Clinical Policy (MME and days supply limits)|https://paxpress.txpa.hidinc.com/opc.pdf|09/01/2020| 00406054034|Opiate Overutilization|https://paxpress.txpa.hidinc.com/opiate.pdf|11/05/2013| 00406054034|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017| 00406054034|Opioid Clinical Policy (MME and days supply limits)|https://paxpress.txpa.hidinc.com/opc.pdf|09/01/2020| 00406055201|Opiate Overutilization|https://paxpress.txpa.hidinc.com/opiate.pdf|11/05/2013| 00406055201|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017| 00406055201|Opioid Clinical Policy (MME and days supply limits)|https://paxpress.txpa.hidinc.com/opc.pdf|09/01/2020| 00406114201|ADD/ADHD Agents|https://paxpress.txpa.hidinc.com/add_adhd_agents.pdf|02/13/2014| 00406114401|ADD/ADHD Agents|https://paxpress.txpa.hidinc.com/add_adhd_agents.pdf|02/13/2014| 00406114601|ADD/ADHD Agents|https://paxpress.txpa.hidinc.com/add_adhd_agents.pdf|02/13/2014| 00406144501|ADD/ADHD Agents|https://paxpress.txpa.hidinc.com/add_adhd_agents.pdf|02/13/2014| 00406147301|ADD/ADHD Agents|https://paxpress.txpa.hidinc.com/add_adhd_agents.pdf|02/13/2014| 00406181001|ADD/ADHD Agents|https://paxpress.txpa.hidinc.com/add_adhd_agents.pdf|02/13/2014| 00406182001|ADD/ADHD Agents|https://paxpress.txpa.hidinc.com/add_adhd_agents.pdf|02/13/2014| 00406183001|ADD/ADHD Agents|https://paxpress.txpa.hidinc.com/add_adhd_agents.pdf|02/13/2014| 00406184001|ADD/ADHD Agents|https://paxpress.txpa.hidinc.com/add_adhd_agents.pdf|02/13/2014| 00406185001|ADD/ADHD Agents|https://paxpress.txpa.hidinc.com/add_adhd_agents.pdf|02/13/2014| 00406186001|ADD/ADHD Agents|https://paxpress.txpa.hidinc.com/add_adhd_agents.pdf|02/13/2014| 00406192303|Buprenorphine Agents|https://paxpress.txpa.hidinc.com/buprenorphine_agents.pdf|04/23/2013| 00406192303|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017| 00406254001|Opiate Overutilization|https://paxpress.txpa.hidinc.com/opiate.pdf|11/05/2013| 00406254001|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017| 00406254001|Opioid Clinical Policy (MME and days supply limits)|https://paxpress.txpa.hidinc.com/opc.pdf|09/01/2020| 00406324301|Opiate Overutilization|https://paxpress.txpa.hidinc.com/opiate.pdf|11/05/2013| 00406324301|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017| 00406324301|Opioid Clinical Policy (MME and days supply limits)|https://paxpress.txpa.hidinc.com/opc.pdf|09/01/2020| 00406324401|Opiate Overutilization|https://paxpress.txpa.hidinc.com/opiate.pdf|11/05/2013| 00406324401|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017| 00406324401|Opioid Clinical Policy (MME and days supply limits)|https://paxpress.txpa.hidinc.com/opc.pdf|09/01/2020| 00406324901|Opiate Overutilization|https://paxpress.txpa.hidinc.com/opiate.pdf|11/05/2013| 00406324901|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017| 00406324901|Opioid Clinical Policy (MME and days supply limits)|https://paxpress.txpa.hidinc.com/opc.pdf|09/01/2020| 00406575501|Opiate Overutilization|https://paxpress.txpa.hidinc.com/opiate.pdf|11/05/2013| 00406575501|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017| 00406575501|Opioid Clinical Policy (MME and days supply limits)|https://paxpress.txpa.hidinc.com/opc.pdf|09/01/2020| 00406577101|Opiate Overutilization|https://paxpress.txpa.hidinc.com/opiate.pdf|11/05/2013| 00406577101|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017| 00406577101|Opioid Clinical Policy (MME and days supply limits)|https://paxpress.txpa.hidinc.com/opc.pdf|09/01/2020| 00406800312|Opiate Overutilization|https://paxpress.txpa.hidinc.com/opiate.pdf|11/05/2013| 00406800312|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017| 00406800312|Opioid Clinical Policy (MME and days supply limits)|https://paxpress.txpa.hidinc.com/opc.pdf|09/01/2020| 00406800315|Opiate Overutilization|https://paxpress.txpa.hidinc.com/opiate.pdf|11/05/2013| 00406800315|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017| 00406800315|Opioid Clinical Policy (MME and days supply limits)|https://paxpress.txpa.hidinc.com/opc.pdf|09/01/2020| 00406800324|Opiate Overutilization|https://paxpress.txpa.hidinc.com/opiate.pdf|11/05/2013| 00406800324|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017| 00406800324|Opioid Clinical Policy (MME and days supply limits)|https://paxpress.txpa.hidinc.com/opc.pdf|09/01/2020| 00406800330|Opiate Overutilization|https://paxpress.txpa.hidinc.com/opiate.pdf|11/05/2013| 00406800330|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017| 00406800330|Opioid Clinical Policy (MME and days supply limits)|https://paxpress.txpa.hidinc.com/opc.pdf|09/01/2020| 00406800503|Buprenorphine Agents|https://paxpress.txpa.hidinc.com/buprenorphine_agents.pdf|04/23/2013| 00406800503|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017| 00406802003|Buprenorphine Agents|https://paxpress.txpa.hidinc.com/buprenorphine_agents.pdf|04/23/2013| 00406802003|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017| 00406831501|Opiate Overutilization|https://paxpress.txpa.hidinc.com/opiate.pdf|11/05/2013| 00406831501|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017| 00406831501|Opioid Clinical Policy (MME and days supply limits)|https://paxpress.txpa.hidinc.com/opc.pdf|09/01/2020| 00406832001|Opiate Overutilization|https://paxpress.txpa.hidinc.com/opiate.pdf|11/05/2013| 00406832001|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017| 00406832001|Opioid Clinical Policy (MME and days supply limits)|https://paxpress.txpa.hidinc.com/opc.pdf|09/01/2020| 00406833001|Opiate Overutilization|https://paxpress.txpa.hidinc.com/opiate.pdf|11/05/2013| 00406833001|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017| 00406833001|Opioid Clinical Policy (MME and days supply limits)|https://paxpress.txpa.hidinc.com/opc.pdf|09/01/2020| 00406838001|Opiate Overutilization|https://paxpress.txpa.hidinc.com/opiate.pdf|11/05/2013| 00406838001|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017| 00406838001|Opioid Clinical Policy (MME and days supply limits)|https://paxpress.txpa.hidinc.com/opc.pdf|09/01/2020| 00406839001|Opiate Overutilization|https://paxpress.txpa.hidinc.com/opiate.pdf|11/05/2013| 00406839001|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017| 00406839001|Opioid Clinical Policy (MME and days supply limits)|https://paxpress.txpa.hidinc.com/opc.pdf|09/01/2020| 00406851501|Opiate Overutilization|https://paxpress.txpa.hidinc.com/opiate.pdf|11/05/2013| 00406851501|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017| 00406851501|Opioid Clinical Policy (MME and days supply limits)|https://paxpress.txpa.hidinc.com/opc.pdf|09/01/2020| 00406851562|Opiate Overutilization|https://paxpress.txpa.hidinc.com/opiate.pdf|11/05/2013| 00406851562|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017| 00406851562|Opioid Clinical Policy (MME and days supply limits)|https://paxpress.txpa.hidinc.com/opc.pdf|09/01/2020| 00406853001|Opiate Overutilization|https://paxpress.txpa.hidinc.com/opiate.pdf|11/05/2013| 00406853001|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017| 00406853001|Opioid Clinical Policy (MME and days supply limits)|https://paxpress.txpa.hidinc.com/opc.pdf|09/01/2020| 00406853062|Opiate Overutilization|https://paxpress.txpa.hidinc.com/opiate.pdf|11/05/2013| 00406853062|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017| 00406853062|Opioid Clinical Policy (MME and days supply limits)|https://paxpress.txpa.hidinc.com/opc.pdf|09/01/2020| 00406855605|Opiate Overutilization|https://paxpress.txpa.hidinc.com/opiate.pdf|11/05/2013| 00406855605|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017| 00406855605|Opioid Clinical Policy (MME and days supply limits)|https://paxpress.txpa.hidinc.com/opc.pdf|09/01/2020| 00406855730|Opiate Overutilization|https://paxpress.txpa.hidinc.com/opiate.pdf|11/05/2013| 00406855730|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017| 00406872510|Opiate Overutilization|https://paxpress.txpa.hidinc.com/opiate.pdf|11/05/2013| 00406872510|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017| 00406872510|Opioid Clinical Policy (MME and days supply limits)|https://paxpress.txpa.hidinc.com/opc.pdf|09/01/2020| 00406888401|ADD/ADHD Agents|https://paxpress.txpa.hidinc.com/add_adhd_agents.pdf|02/13/2014| 00406889301|ADD/ADHD Agents|https://paxpress.txpa.hidinc.com/add_adhd_agents.pdf|02/13/2014| 00406889401|ADD/ADHD Agents|https://paxpress.txpa.hidinc.com/add_adhd_agents.pdf|02/13/2014| 00406895101|ADD/ADHD Agents|https://paxpress.txpa.hidinc.com/add_adhd_agents.pdf|02/13/2014| 00406895201|ADD/ADHD Agents|https://paxpress.txpa.hidinc.com/add_adhd_agents.pdf|02/13/2014| 00406895301|ADD/ADHD Agents|https://paxpress.txpa.hidinc.com/add_adhd_agents.pdf|02/13/2014| 00406895401|ADD/ADHD Agents|https://paxpress.txpa.hidinc.com/add_adhd_agents.pdf|02/13/2014| 00406895501|ADD/ADHD Agents|https://paxpress.txpa.hidinc.com/add_adhd_agents.pdf|02/13/2014| 00406895601|ADD/ADHD Agents|https://paxpress.txpa.hidinc.com/add_adhd_agents.pdf|02/13/2014| 00406895801|ADD/ADHD Agents|https://paxpress.txpa.hidinc.com/add_adhd_agents.pdf|02/13/2014| 00406895901|ADD/ADHD Agents|https://paxpress.txpa.hidinc.com/add_adhd_agents.pdf|02/13/2014| 00406896001|ADD/ADHD Agents|https://paxpress.txpa.hidinc.com/add_adhd_agents.pdf|02/13/2014| 00406896101|ADD/ADHD Agents|https://paxpress.txpa.hidinc.com/add_adhd_agents.pdf|02/13/2014| 00406896201|ADD/ADHD Agents|https://paxpress.txpa.hidinc.com/add_adhd_agents.pdf|02/13/2014| 00406900076|Fentanyl Agents|https://paxpress.txpa.hidinc.com/fentanyl.pdf|01/31/2011|08/23/2023 00406900076|Opiate Overutilization|https://paxpress.txpa.hidinc.com/opiate.pdf|11/05/2013|08/23/2023 00406900076|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017|08/23/2023 00406900076|Opioid Clinical Policy (MME and days supply limits)|https://paxpress.txpa.hidinc.com/opc.pdf|09/01/2020|08/23/2023 00406901276|Fentanyl Agents|https://paxpress.txpa.hidinc.com/fentanyl.pdf|01/31/2011|08/23/2023 00406901276|Opiate Overutilization|https://paxpress.txpa.hidinc.com/opiate.pdf|11/05/2013|08/23/2023 00406901276|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017|08/23/2023 00406901276|Opioid Clinical Policy (MME and days supply limits)|https://paxpress.txpa.hidinc.com/opc.pdf|09/01/2020|08/23/2023 00406902576|Fentanyl Agents|https://paxpress.txpa.hidinc.com/fentanyl.pdf|01/31/2011|08/23/2023 00406902576|Opiate Overutilization|https://paxpress.txpa.hidinc.com/opiate.pdf|11/05/2013|08/23/2023 00406902576|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017|08/23/2023 00406902576|Opioid Clinical Policy (MME and days supply limits)|https://paxpress.txpa.hidinc.com/opc.pdf|09/01/2020|08/23/2023 00406905076|Fentanyl Agents|https://paxpress.txpa.hidinc.com/fentanyl.pdf|01/31/2011|08/23/2023 00406905076|Opiate Overutilization|https://paxpress.txpa.hidinc.com/opiate.pdf|11/05/2013|08/23/2023 00406905076|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017|08/23/2023 00406905076|Opioid Clinical Policy (MME and days supply limits)|https://paxpress.txpa.hidinc.com/opc.pdf|09/01/2020|08/23/2023 00406907576|Fentanyl Agents|https://paxpress.txpa.hidinc.com/fentanyl.pdf|01/31/2011|08/23/2023 00406907576|Opiate Overutilization|https://paxpress.txpa.hidinc.com/opiate.pdf|11/05/2013|08/23/2023 00406907576|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017|08/23/2023 00406907576|Opioid Clinical Policy (MME and days supply limits)|https://paxpress.txpa.hidinc.com/opc.pdf|09/01/2020|08/23/2023 00406920230|Fentanyl Agents|https://paxpress.txpa.hidinc.com/fentanyl.pdf|01/31/2011| 00406920230|Opiate Overutilization|https://paxpress.txpa.hidinc.com/opiate.pdf|11/05/2013| 00406920230|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017| 00406920230|Opioid Clinical Policy (MME and days supply limits)|https://paxpress.txpa.hidinc.com/opc.pdf|09/01/2020| 00406920430|Fentanyl Agents|https://paxpress.txpa.hidinc.com/fentanyl.pdf|01/31/2011| 00406920430|Opiate Overutilization|https://paxpress.txpa.hidinc.com/opiate.pdf|11/05/2013| 00406920430|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017| 00406920430|Opioid Clinical Policy (MME and days supply limits)|https://paxpress.txpa.hidinc.com/opc.pdf|09/01/2020| 00406920630|Fentanyl Agents|https://paxpress.txpa.hidinc.com/fentanyl.pdf|01/31/2011| 00406920630|Opiate Overutilization|https://paxpress.txpa.hidinc.com/opiate.pdf|11/05/2013| 00406920630|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017| 00406920630|Opioid Clinical Policy (MME and days supply limits)|https://paxpress.txpa.hidinc.com/opc.pdf|09/01/2020| 00406920830|Fentanyl Agents|https://paxpress.txpa.hidinc.com/fentanyl.pdf|01/31/2011| 00406920830|Opiate Overutilization|https://paxpress.txpa.hidinc.com/opiate.pdf|11/05/2013| 00406920830|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017| 00406920830|Opioid Clinical Policy (MME and days supply limits)|https://paxpress.txpa.hidinc.com/opc.pdf|09/01/2020| 00406921230|Fentanyl Agents|https://paxpress.txpa.hidinc.com/fentanyl.pdf|01/31/2011| 00406921230|Opiate Overutilization|https://paxpress.txpa.hidinc.com/opiate.pdf|11/05/2013| 00406921230|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017| 00406921230|Opioid Clinical Policy (MME and days supply limits)|https://paxpress.txpa.hidinc.com/opc.pdf|09/01/2020| 00406921630|Fentanyl Agents|https://paxpress.txpa.hidinc.com/fentanyl.pdf|01/31/2011| 00406921630|Opiate Overutilization|https://paxpress.txpa.hidinc.com/opiate.pdf|11/05/2013| 00406921630|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017| 00406921630|Opioid Clinical Policy (MME and days supply limits)|https://paxpress.txpa.hidinc.com/opc.pdf|09/01/2020| 00406991403|Anxiolytics and Sedative-Hypnotics|https://paxpress.txpa.hidinc.com/ash.pdf|01/31/2011| 00406991403|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017| 00406991501|Anxiolytics and Sedative-Hypnotics|https://paxpress.txpa.hidinc.com/ash.pdf|01/31/2011| 00406991501|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017| 00406991503|Anxiolytics and Sedative-Hypnotics|https://paxpress.txpa.hidinc.com/ash.pdf|01/31/2011| 00406991503|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017| 00406991601|Anxiolytics and Sedative-Hypnotics|https://paxpress.txpa.hidinc.com/ash.pdf|01/31/2011| 00406991601|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017| 00406991701|Anxiolytics and Sedative-Hypnotics|https://paxpress.txpa.hidinc.com/ash.pdf|01/31/2011| 00406991701|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017| 00406995903|Anxiolytics and Sedative-Hypnotics|https://paxpress.txpa.hidinc.com/ash.pdf|01/31/2011| 00406995903|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017| 00406996001|Anxiolytics and Sedative-Hypnotics|https://paxpress.txpa.hidinc.com/ash.pdf|01/31/2011| 00406996001|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017| 00409113403|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017| 00409113403|Opioid Clinical Policy (MME and days supply limits)|https://paxpress.txpa.hidinc.com/opc.pdf|09/01/2020| 00409113405|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017| 00409113405|Opioid Clinical Policy (MME and days supply limits)|https://paxpress.txpa.hidinc.com/opc.pdf|09/01/2020| 00409118130|Opiate Overutilization|https://paxpress.txpa.hidinc.com/opiate.pdf|11/05/2013| 00409118130|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017| 00409118130|Opioid Clinical Policy (MME and days supply limits)|https://paxpress.txpa.hidinc.com/opc.pdf|09/01/2020| 00409127303|Anxiolytics and Sedative-Hypnotics|https://paxpress.txpa.hidinc.com/ash.pdf|01/31/2011| 00409127332|Anxiolytics and Sedative-Hypnotics|https://paxpress.txpa.hidinc.com/ash.pdf|01/31/2011| 00409146301|Opiate Overutilization|https://paxpress.txpa.hidinc.com/opiate.pdf|11/05/2013| 00409146301|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017| 00409146301|Opioid Clinical Policy (MME and days supply limits)|https://paxpress.txpa.hidinc.com/opc.pdf|09/01/2020| 00409146701|Opiate Overutilization|https://paxpress.txpa.hidinc.com/opiate.pdf|11/05/2013| 00409146701|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017| 00409146701|Opioid Clinical Policy (MME and days supply limits)|https://paxpress.txpa.hidinc.com/opc.pdf|09/01/2020| 00409189001|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017| 00409189001|Opioid Clinical Policy (MME and days supply limits)|https://paxpress.txpa.hidinc.com/opc.pdf|09/01/2020| 00409189101|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017| 00409189101|Opioid Clinical Policy (MME and days supply limits)|https://paxpress.txpa.hidinc.com/opc.pdf|09/01/2020| 00409189201|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017| 00409189201|Opioid Clinical Policy (MME and days supply limits)|https://paxpress.txpa.hidinc.com/opc.pdf|09/01/2020| 00409189301|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017| 00409189301|Opioid Clinical Policy (MME and days supply limits)|https://paxpress.txpa.hidinc.com/opc.pdf|09/01/2020| 00409321311|Anxiolytics and Sedative-Hypnotics|https://paxpress.txpa.hidinc.com/ash.pdf|01/31/2011| 00409321312|Anxiolytics and Sedative-Hypnotics|https://paxpress.txpa.hidinc.com/ash.pdf|01/31/2011| 00409379601|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 00409379601|Ketorolac|https://paxpress.txpa.hidinc.com/ketorolac.pdf|05/25/2012| 00409677802|Anxiolytics and Sedative-Hypnotics|https://paxpress.txpa.hidinc.com/ash.pdf|01/31/2011| 00409677802|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017| 00430072024|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 00430072124|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 00430072224|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 00430375414|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 00456120130|GI Motility Agents|https://paxpress.txpa.hidinc.com/GImotility.pdf|01/18/2017| 00456120230|GI Motility Agents|https://paxpress.txpa.hidinc.com/GImotility.pdf|01/18/2017| 00456120330|GI Motility Agents|https://paxpress.txpa.hidinc.com/GImotility.pdf|01/18/2017| 00456240260|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016| 00456240560|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016| 00456241060|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016| 00472103016|Cough and Cold Agents|https://paxpress.txpa.hidinc.com/Cough%20&%20Cold.pdf|12/15/2015| 00472103016|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017| 00472103016|Opioid Clinical Policy (MME and days supply limits)|https://paxpress.txpa.hidinc.com/opc.pdf|09/01/2020| 00472178310|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 00472200294|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 00480012649|Omega 3 Fatty Acids|https://paxpress.txpa.hidinc.com/lovaza.pdf|03/21/2023| 00480012789|Omega 3 Fatty Acids|https://paxpress.txpa.hidinc.com/lovaza.pdf|03/21/2023| 00480095101|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 00480095258|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 00480095356|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 00480347906|GI Motility Agents|https://paxpress.txpa.hidinc.com/GImotility.pdf|01/18/2017| 00480413806|GI Motility Agents|https://paxpress.txpa.hidinc.com/GImotility.pdf|01/18/2017| 00480449056|Anxiolytics and Sedative-Hypnotics|https://paxpress.txpa.hidinc.com/ash.pdf|11/16/2021| 00480727010|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/04/2016| 00480727098|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/04/2016| 00480943589|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 00485008001|Cough and Cold Agents|https://paxpress.txpa.hidinc.com/Cough%20&%20Cold.pdf|12/15/2015| 00485008001|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 00485009816|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 00485015516|Cough and Cold Agents|https://paxpress.txpa.hidinc.com/Cough%20&%20Cold.pdf|12/15/2015| 00485015516|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 00485017116|Cough and Cold Agents|https://paxpress.txpa.hidinc.com/Cough%20&%20Cold.pdf|12/15/2015| 00485017116|Dextromethorphan Overutilization|https://paxpress.txpa.hidinc.com/dextro.pdf|07/16/2012| 00485017116|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 00485020216|Cough and Cold Agents|https://paxpress.txpa.hidinc.com/Cough%20&%20Cold.pdf|12/15/2015| 00485020216|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 00485020404|Cough and Cold Agents|https://paxpress.txpa.hidinc.com/Cough%20&%20Cold.pdf|12/15/2015| 00485020404|Dextromethorphan Overutilization|https://paxpress.txpa.hidinc.com/dextro.pdf|07/16/2012| 00485020404|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 00485020416|Cough and Cold Agents|https://paxpress.txpa.hidinc.com/Cough%20&%20Cold.pdf|12/15/2015| 00485020416|Dextromethorphan Overutilization|https://paxpress.txpa.hidinc.com/dextro.pdf|07/16/2012| 00485020416|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 00485020616|Cough and Cold Agents|https://paxpress.txpa.hidinc.com/Cough%20&%20Cold.pdf|12/15/2015| 00485020616|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 00485020816|Cough and Cold Agents|https://paxpress.txpa.hidinc.com/Cough%20&%20Cold.pdf|12/15/2015| 00485024001|Cough and Cold Agents|https://paxpress.txpa.hidinc.com/Cough%20&%20Cold.pdf|12/15/2015| 00485024001|Dextromethorphan Overutilization|https://paxpress.txpa.hidinc.com/dextro.pdf|07/16/2012| 00485024001|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 00485025401|Cough and Cold Agents|https://paxpress.txpa.hidinc.com/Cough%20&%20Cold.pdf|12/15/2015| 00485025401|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 00487020101|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/04/2016| 00487020103|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/04/2016| 00487020160|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/04/2016| 00487030101|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 00487950101|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 00487950103|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 00487950125|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 00487950160|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 00487990130|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 00487990401|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 00487990425|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 00517042001|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 00517044001|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 00517420125|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 00527131201|Opiate Overutilization|https://paxpress.txpa.hidinc.com/opiate.pdf|11/05/2013| 00527131201|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017| 00527131201|Opioid Clinical Policy (MME and days supply limits)|https://paxpress.txpa.hidinc.com/opc.pdf|09/01/2020| 00527135301|Opiate Overutilization|https://paxpress.txpa.hidinc.com/opiate.pdf|11/05/2013| 00527135301|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017| 00527135301|Opioid Clinical Policy (MME and days supply limits)|https://paxpress.txpa.hidinc.com/opc.pdf|09/01/2020| 00527135401|Opiate Overutilization|https://paxpress.txpa.hidinc.com/opiate.pdf|11/05/2013| 00527135401|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017| 00527135401|Opioid Clinical Policy (MME and days supply limits)|https://paxpress.txpa.hidinc.com/opc.pdf|09/01/2020| 00527135501|Opiate Overutilization|https://paxpress.txpa.hidinc.com/opiate.pdf|11/05/2013| 00527135501|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017| 00527135501|Opioid Clinical Policy (MME and days supply limits)|https://paxpress.txpa.hidinc.com/opc.pdf|09/01/2020| 00527139401|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016| 00527139501|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016| 00527139601|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016| 00527139701|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016| 00527143501|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017| 00527150037|ADD/ADHD Agents|https://paxpress.txpa.hidinc.com/add_adhd_agents.pdf|02/13/2014| 00527150137|ADD/ADHD Agents|https://paxpress.txpa.hidinc.com/add_adhd_agents.pdf|02/13/2014|04/24/2024 00527150237|ADD/ADHD Agents|https://paxpress.txpa.hidinc.com/add_adhd_agents.pdf|02/13/2014| 00527150337|ADD/ADHD Agents|https://paxpress.txpa.hidinc.com/add_adhd_agents.pdf|02/13/2014| 00527150437|ADD/ADHD Agents|https://paxpress.txpa.hidinc.com/add_adhd_agents.pdf|02/13/2014| 00527150537|ADD/ADHD Agents|https://paxpress.txpa.hidinc.com/add_adhd_agents.pdf|02/13/2014| 00527150637|ADD/ADHD Agents|https://paxpress.txpa.hidinc.com/add_adhd_agents.pdf|02/13/2014| 00527163201|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 00527163210|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 00527176836|Anxiolytics and Sedative-Hypnotics|https://paxpress.txpa.hidinc.com/ash.pdf|01/31/2011| 00527176836|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017| 00527178801|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016| 00527178901|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016| 00527179001|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016| 00527179005|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016| 00527179101|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016| 00527179105|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016| 00527181843|Antimigraine Agents Triptans|https://paxpress.txpa.hidinc.com/triptans.pdf|04/04/2023| 00527185943|Antimigraine Agents Triptans|https://paxpress.txpa.hidinc.com/triptans.pdf|04/04/2023| 00527194947|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 00527217037|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 00527293037|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 00527293043|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 00527293137|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 00527293237|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 00527293243|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 00527293337|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 00527293341|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 00527293437|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 00527293441|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 00527293537|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 00527331037|ADD/ADHD Agents|https://paxpress.txpa.hidinc.com/add_adhd_agents.pdf|02/13/2014|10/25/2023 00527331137|ADD/ADHD Agents|https://paxpress.txpa.hidinc.com/add_adhd_agents.pdf|02/13/2014|10/25/2023 00527331237|ADD/ADHD Agents|https://paxpress.txpa.hidinc.com/add_adhd_agents.pdf|02/13/2014|10/25/2023 00527331337|ADD/ADHD Agents|https://paxpress.txpa.hidinc.com/add_adhd_agents.pdf|02/13/2014|10/25/2023 00527457937|ADD/ADHD Agents|https://paxpress.txpa.hidinc.com/add_adhd_agents.pdf|02/13/2014| 00527458037|ADD/ADHD Agents|https://paxpress.txpa.hidinc.com/add_adhd_agents.pdf|02/13/2014| 00527458137|ADD/ADHD Agents|https://paxpress.txpa.hidinc.com/add_adhd_agents.pdf|02/13/2014| 00527458237|ADD/ADHD Agents|https://paxpress.txpa.hidinc.com/add_adhd_agents.pdf|02/13/2014| 00527458337|ADD/ADHD Agents|https://paxpress.txpa.hidinc.com/add_adhd_agents.pdf|02/13/2014| 00527458437|ADD/ADHD Agents|https://paxpress.txpa.hidinc.com/add_adhd_agents.pdf|02/13/2014| 00527530264|Cough and Cold Agents|https://paxpress.txpa.hidinc.com/Cough%20&%20Cold.pdf|12/15/2015| 00527530264|Dextromethorphan Overutilization|https://paxpress.txpa.hidinc.com/dextro.pdf|07/16/2012| 00527530264|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 00527530270|Cough and Cold Agents|https://paxpress.txpa.hidinc.com/Cough%20&%20Cold.pdf|12/15/2015| 00527530270|Dextromethorphan Overutilization|https://paxpress.txpa.hidinc.com/dextro.pdf|07/16/2012| 00527530270|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 00527551037|ADD/ADHD Agents|https://paxpress.txpa.hidinc.com/add_adhd_agents.pdf|02/13/2014| 00527551137|ADD/ADHD Agents|https://paxpress.txpa.hidinc.com/add_adhd_agents.pdf|02/13/2014| 00527551237|ADD/ADHD Agents|https://paxpress.txpa.hidinc.com/add_adhd_agents.pdf|02/13/2014|05/01/2024 00527551337|ADD/ADHD Agents|https://paxpress.txpa.hidinc.com/add_adhd_agents.pdf|02/13/2014|05/01/2024 00527551437|ADD/ADHD Agents|https://paxpress.txpa.hidinc.com/add_adhd_agents.pdf|02/13/2014|04/14/2024 00527551537|ADD/ADHD Agents|https://paxpress.txpa.hidinc.com/add_adhd_agents.pdf|02/13/2014| 00527810637|ADD/ADHD Agents|https://paxpress.txpa.hidinc.com/add_adhd_agents.pdf|02/13/2014| 00527810737|ADD/ADHD Agents|https://paxpress.txpa.hidinc.com/add_adhd_agents.pdf|02/13/2014| 00527810837|ADD/ADHD Agents|https://paxpress.txpa.hidinc.com/add_adhd_agents.pdf|02/13/2014| 00527810937|ADD/ADHD Agents|https://paxpress.txpa.hidinc.com/add_adhd_agents.pdf|02/13/2014| 00527811037|ADD/ADHD Agents|https://paxpress.txpa.hidinc.com/add_adhd_agents.pdf|02/13/2014| 00527811137|ADD/ADHD Agents|https://paxpress.txpa.hidinc.com/add_adhd_agents.pdf|02/13/2014| 00527811237|ADD/ADHD Agents|https://paxpress.txpa.hidinc.com/add_adhd_agents.pdf|02/13/2014| 00527811337|ADD/ADHD Agents|https://paxpress.txpa.hidinc.com/add_adhd_agents.pdf|02/13/2014| 00536100601|Cough and Cold Agents|https://paxpress.txpa.hidinc.com/Cough%20&%20Cold.pdf|12/15/2015| 00536100601|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 00536100610|Cough and Cold Agents|https://paxpress.txpa.hidinc.com/Cough%20&%20Cold.pdf|12/15/2015| 00536100610|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 00536101001|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|02/08/2024 00536109301|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|08/22/2023 00536109306|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 00536109401|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|11/30/2023 00536109411|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 00536114730|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 00536116134|Cough and Cold Agents|https://paxpress.txpa.hidinc.com/Cough%20&%20Cold.pdf|12/15/2015| 00536116134|Dextromethorphan Overutilization|https://paxpress.txpa.hidinc.com/dextro.pdf|07/16/2012| 00536116137|Cough and Cold Agents|https://paxpress.txpa.hidinc.com/Cough%20&%20Cold.pdf|12/15/2015| 00536116137|Dextromethorphan Overutilization|https://paxpress.txpa.hidinc.com/dextro.pdf|07/16/2012| 00536116361|Cough and Cold Agents|https://paxpress.txpa.hidinc.com/Cough%20&%20Cold.pdf|12/15/2015| 00536118297|Cough and Cold Agents|https://paxpress.txpa.hidinc.com/Cough%20&%20Cold.pdf|12/15/2015|06/01/2024 00536121388|Cough and Cold Agents|https://paxpress.txpa.hidinc.com/Cough%20&%20Cold.pdf|12/15/2015| 00536121388|Dextromethorphan Overutilization|https://paxpress.txpa.hidinc.com/dextro.pdf|07/16/2012| 00536121429|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 00536124207|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 00536125775|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|01/30/2024 00536127912|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 00536127935|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 00536129434|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 00536129497|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 00536129701|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 00536129710|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 00536129910|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 00536130907|Cough and Cold Agents|https://paxpress.txpa.hidinc.com/Cough%20&%20Cold.pdf|12/15/2015| 00536130908|Cough and Cold Agents|https://paxpress.txpa.hidinc.com/Cough%20&%20Cold.pdf|12/15/2015| 00536131108|Cough and Cold Agents|https://paxpress.txpa.hidinc.com/Cough%20&%20Cold.pdf|12/15/2015| 00536131208|Cough and Cold Agents|https://paxpress.txpa.hidinc.com/Cough%20&%20Cold.pdf|12/15/2015| 00536131208|Dextromethorphan Overutilization|https://paxpress.txpa.hidinc.com/dextro.pdf|07/16/2012| 00536131385|Cough and Cold Agents|https://paxpress.txpa.hidinc.com/Cough%20&%20Cold.pdf|12/15/2015| 00536131385|Dextromethorphan Overutilization|https://paxpress.txpa.hidinc.com/dextro.pdf|07/16/2012| 00536131485|Cough and Cold Agents|https://paxpress.txpa.hidinc.com/Cough%20&%20Cold.pdf|12/15/2015| 00536133321|Cough and Cold Agents|https://paxpress.txpa.hidinc.com/Cough%20&%20Cold.pdf|12/15/2015| 00536133336|Cough and Cold Agents|https://paxpress.txpa.hidinc.com/Cough%20&%20Cold.pdf|12/15/2015| 00536133434|Cough and Cold Agents|https://paxpress.txpa.hidinc.com/Cough%20&%20Cold.pdf|12/15/2015| 00536133434|Dextromethorphan Overutilization|https://paxpress.txpa.hidinc.com/dextro.pdf|07/16/2012| 00536136707|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 00548560100|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 00548560200|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 00548560300|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 00548560400|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 00548560500|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 00548560600|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 00548560700|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 00548560800|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 00555003302|Anxiolytics and Sedative-Hypnotics|https://paxpress.txpa.hidinc.com/ash.pdf|01/31/2011| 00555003302|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017| 00555003305|Anxiolytics and Sedative-Hypnotics|https://paxpress.txpa.hidinc.com/ash.pdf|01/31/2011| 00555003305|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017| 00555015802|Anxiolytics and Sedative-Hypnotics|https://paxpress.txpa.hidinc.com/ash.pdf|01/31/2011| 00555015802|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017| 00555015804|Anxiolytics and Sedative-Hypnotics|https://paxpress.txpa.hidinc.com/ash.pdf|01/31/2011| 00555015804|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017| 00555015902|Anxiolytics and Sedative-Hypnotics|https://paxpress.txpa.hidinc.com/ash.pdf|01/31/2011| 00555015902|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017| 00555015904|Anxiolytics and Sedative-Hypnotics|https://paxpress.txpa.hidinc.com/ash.pdf|01/31/2011| 00555015904|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017| 00555030202|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 00555030204|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 00555032302|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 00555032304|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 00555032402|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 00555048302|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 00555048305|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 00555077502|ADD/ADHD Agents|https://paxpress.txpa.hidinc.com/add_adhd_agents.pdf|02/13/2014| 00555077602|ADD/ADHD Agents|https://paxpress.txpa.hidinc.com/add_adhd_agents.pdf|02/13/2014| 00555077702|ADD/ADHD Agents|https://paxpress.txpa.hidinc.com/add_adhd_agents.pdf|02/13/2014| 00555088602|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 00555088604|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 00555088702|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 00555088704|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 00555089902|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 00555095202|ADD/ADHD Agents|https://paxpress.txpa.hidinc.com/add_adhd_agents.pdf|02/13/2014| 00555095302|ADD/ADHD Agents|https://paxpress.txpa.hidinc.com/add_adhd_agents.pdf|02/13/2014| 00555097102|ADD/ADHD Agents|https://paxpress.txpa.hidinc.com/add_adhd_agents.pdf|02/13/2014| 00555097202|ADD/ADHD Agents|https://paxpress.txpa.hidinc.com/add_adhd_agents.pdf|02/13/2014| 00555097302|ADD/ADHD Agents|https://paxpress.txpa.hidinc.com/add_adhd_agents.pdf|02/13/2014| 00555097402|ADD/ADHD Agents|https://paxpress.txpa.hidinc.com/add_adhd_agents.pdf|02/13/2014| 00574016712|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 00574022701|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 00574022801|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 00574022901|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 00574024001|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 00574024101|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 00574024201|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 00574110404|Cough and Cold Agents|https://paxpress.txpa.hidinc.com/Cough%20&%20Cold.pdf|12/15/2015| 00574110404|Dextromethorphan Overutilization|https://paxpress.txpa.hidinc.com/dextro.pdf|07/16/2012| 00574110404|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 00574110416|Cough and Cold Agents|https://paxpress.txpa.hidinc.com/Cough%20&%20Cold.pdf|12/15/2015| 00574110416|Dextromethorphan Overutilization|https://paxpress.txpa.hidinc.com/dextro.pdf|07/16/2012| 00574110416|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 00574206727|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 00574241065|ADD/ADHD Agents|https://paxpress.txpa.hidinc.com/add_adhd_agents.pdf|02/13/2014| 00574241565|ADD/ADHD Agents|https://paxpress.txpa.hidinc.com/add_adhd_agents.pdf|02/13/2014| 00574242065|ADD/ADHD Agents|https://paxpress.txpa.hidinc.com/add_adhd_agents.pdf|02/13/2014| 00574243065|ADD/ADHD Agents|https://paxpress.txpa.hidinc.com/add_adhd_agents.pdf|02/13/2014| 00574704012|Opiate Overutilization|https://paxpress.txpa.hidinc.com/opiate.pdf|11/05/2013| 00574704012|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017| 00574704012|Opioid Clinical Policy (MME and days supply limits)|https://paxpress.txpa.hidinc.com/opc.pdf|09/01/2020| 00574704512|Opiate Overutilization|https://paxpress.txpa.hidinc.com/opiate.pdf|11/05/2013| 00574704512|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017| 00574704512|Opioid Clinical Policy (MME and days supply limits)|https://paxpress.txpa.hidinc.com/opc.pdf|09/01/2020| 00574722406|Opiate Overutilization|https://paxpress.txpa.hidinc.com/opiate.pdf|11/05/2013| 00574722406|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017| 00574985510|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 00591034701|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 00591034705|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 00591034801|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 00591034805|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 00591034810|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 00591036901|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016| 00591037001|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016| 00591037101|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016| 00591037201|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016| 00591039501|Opiate Overutilization|https://paxpress.txpa.hidinc.com/opiate.pdf|11/05/2013| 00591039501|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017| 00591039501|Opioid Clinical Policy (MME and days supply limits)|https://paxpress.txpa.hidinc.com/opc.pdf|09/01/2020| 00591039719|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 00591039760|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 00591039860|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 00591042401|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 00591042405|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 00591074401|Anxiolytics and Sedative-Hypnotics|https://paxpress.txpa.hidinc.com/ash.pdf|01/31/2011| 00591074401|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017| 00591074501|Anxiolytics and Sedative-Hypnotics|https://paxpress.txpa.hidinc.com/ash.pdf|01/31/2011| 00591074501|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017| 00591086001|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 00591086005|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 00591086101|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 00591086105|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 00591086201|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 00591086205|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 00591219101|Anxiolytics and Sedative-Hypnotics|https://paxpress.txpa.hidinc.com/ash.pdf|01/31/2011| 00591219130|Anxiolytics and Sedative-Hypnotics|https://paxpress.txpa.hidinc.com/ash.pdf|01/31/2011| 00591234101|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017| 00591240530|Pulmonary Hypertension Agents Clinical|https://paxpress.txpa.hidinc.com/pah.pdf|07/27/2023| 00591240630|Pulmonary Hypertension Agents Clinical|https://paxpress.txpa.hidinc.com/pah.pdf|07/27/2023| 00591246401|Desmopressin|https://paxpress.txpa.hidinc.com/desmopressin.pdf|05/25/2012|08/31/2023 00591246501|Desmopressin|https://paxpress.txpa.hidinc.com/desmopressin.pdf|05/25/2012|01/31/2024 00591251160|Pulmonary Hypertension Agents Clinical|https://paxpress.txpa.hidinc.com/pah.pdf|07/27/2023| 00591251260|Pulmonary Hypertension Agents Clinical|https://paxpress.txpa.hidinc.com/pah.pdf|07/27/2023| 00591252001|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017| 00591252005|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017| 00591264101|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017| 00591264101|Opioid Clinical Policy (MME and days supply limits)|https://paxpress.txpa.hidinc.com/opc.pdf|09/01/2020| 00591269301|Opiate Overutilization|https://paxpress.txpa.hidinc.com/opiate.pdf|11/05/2013|08/23/2023 00591269301|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017|08/23/2023 00591269301|Opioid Clinical Policy (MME and days supply limits)|https://paxpress.txpa.hidinc.com/opc.pdf|09/01/2020|08/23/2023 00591269301|Oxycontin / Narcotic Analgesic|https://paxpress.txpa.hidinc.com/oxycontin.pdf|01/31/2011|08/23/2023 00591270801|Opiate Overutilization|https://paxpress.txpa.hidinc.com/opiate.pdf|11/05/2013|08/23/2023 00591270801|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017|08/23/2023 00591270801|Opioid Clinical Policy (MME and days supply limits)|https://paxpress.txpa.hidinc.com/opc.pdf|09/01/2020|08/23/2023 00591270801|Oxycontin / Narcotic Analgesic|https://paxpress.txpa.hidinc.com/oxycontin.pdf|01/31/2011|08/23/2023 00591292754|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 00591294430|Topical Immunomodulators|https://paxpress.txpa.hidinc.com/immunomodulators.pdf|01/31/2011| 00591294460|Topical Immunomodulators|https://paxpress.txpa.hidinc.com/immunomodulators.pdf|01/31/2011| 00591294487|Topical Immunomodulators|https://paxpress.txpa.hidinc.com/immunomodulators.pdf|01/31/2011| 00591322001|Opiate Overutilization|https://paxpress.txpa.hidinc.com/opiate.pdf|11/05/2013| 00591322001|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017| 00591322001|Opioid Clinical Policy (MME and days supply limits)|https://paxpress.txpa.hidinc.com/opc.pdf|09/01/2020| 00591335501|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 00591346753|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 00591346853|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 00591354601|Opiate Overutilization|https://paxpress.txpa.hidinc.com/opiate.pdf|11/05/2013|08/23/2023 00591354601|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017|08/23/2023 00591354601|Opioid Clinical Policy (MME and days supply limits)|https://paxpress.txpa.hidinc.com/opc.pdf|09/01/2020|08/23/2023 00591354605|Opiate Overutilization|https://paxpress.txpa.hidinc.com/opiate.pdf|11/05/2013|08/23/2023 00591354605|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017|08/23/2023 00591354605|Opioid Clinical Policy (MME and days supply limits)|https://paxpress.txpa.hidinc.com/opc.pdf|09/01/2020|08/23/2023 00591367001|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 00591367005|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 00591367101|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 00591367105|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 00591369230|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016| 00591369319|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016| 00591369330|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016| 00591369419|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016| 00591369430|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016| 00591369519|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016| 00591369530|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016| 00591385419|ADD/ADHD Agents|https://paxpress.txpa.hidinc.com/add_adhd_agents.pdf|02/13/2014| 00591386219|ADD/ADHD Agents|https://paxpress.txpa.hidinc.com/add_adhd_agents.pdf|02/13/2014| 00591386919|ADD/ADHD Agents|https://paxpress.txpa.hidinc.com/add_adhd_agents.pdf|02/13/2014| 00591387319|ADD/ADHD Agents|https://paxpress.txpa.hidinc.com/add_adhd_agents.pdf|02/13/2014| 00591389119|ADD/ADHD Agents|https://paxpress.txpa.hidinc.com/add_adhd_agents.pdf|02/13/2014| 00591389519|ADD/ADHD Agents|https://paxpress.txpa.hidinc.com/add_adhd_agents.pdf|02/13/2014| 00591390219|ADD/ADHD Agents|https://paxpress.txpa.hidinc.com/add_adhd_agents.pdf|02/13/2014| 00591398260|COX-2 Inhibitors|https://paxpress.txpa.hidinc.com/cox2.pdf|01/31/2011| 00591398260|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/04/2016| 00591398301|COX-2 Inhibitors|https://paxpress.txpa.hidinc.com/cox2.pdf|01/31/2011| 00591398301|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/04/2016| 00591398305|COX-2 Inhibitors|https://paxpress.txpa.hidinc.com/cox2.pdf|01/31/2011| 00591398305|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/04/2016| 00591398401|COX-2 Inhibitors|https://paxpress.txpa.hidinc.com/cox2.pdf|01/31/2011| 00591398401|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/04/2016| 00591398405|COX-2 Inhibitors|https://paxpress.txpa.hidinc.com/cox2.pdf|01/31/2011| 00591398405|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/04/2016| 00591405094|PDE5-Inhibitors|https://paxpress.txpa.hidinc.com/revatio.pdf|09/01/2015| 00591410101|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016| 00591410201|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016| 00591410301|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016| 00591410401|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016| 00591505201|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 00591505210|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 00591530701|Promethazine Utilization|https://paxpress.txpa.hidinc.com/phenergan.pdf|01/31/2011| 00591530710|Promethazine Utilization|https://paxpress.txpa.hidinc.com/phenergan.pdf|01/31/2011| 00591531901|Promethazine Utilization|https://paxpress.txpa.hidinc.com/phenergan.pdf|01/31/2011| 00591544201|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 00591544205|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 00591544210|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 00591544301|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 00591544305|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 00591544310|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 00591551301|Carisoprodol Overuse|https://paxpress.txpa.hidinc.com/soma.pdf|01/31/2011| 00591551301|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017| 00591551305|Carisoprodol Overuse|https://paxpress.txpa.hidinc.com/soma.pdf|01/31/2011| 00591551305|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017| 00591551310|Carisoprodol Overuse|https://paxpress.txpa.hidinc.com/soma.pdf|01/31/2011| 00591551310|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017| 00591566001|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 00591566005|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 00591566101|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 00591566105|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 00591578201|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 00591578301|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 00597002402|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/04/2016| 00597003937|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 00597004037|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 00597004137|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 00597004237|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 00597004337|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 00597004437|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 00597014030|DPP-4 Inhibitors|https://paxpress.txpa.hidinc.com/dpp4_inhibitor.pdf|09/25/2018| 00597014090|DPP-4 Inhibitors|https://paxpress.txpa.hidinc.com/dpp4_inhibitor.pdf|09/25/2018| 00597014618|DPP-4 Inhibitors|https://paxpress.txpa.hidinc.com/dpp4_inhibitor.pdf|09/25/2018| 00597014660|DPP-4 Inhibitors|https://paxpress.txpa.hidinc.com/dpp4_inhibitor.pdf|09/25/2018| 00597014718|DPP-4 Inhibitors|https://paxpress.txpa.hidinc.com/dpp4_inhibitor.pdf|09/25/2018| 00597014760|DPP-4 Inhibitors|https://paxpress.txpa.hidinc.com/dpp4_inhibitor.pdf|09/25/2018| 00597014818|DPP-4 Inhibitors|https://paxpress.txpa.hidinc.com/dpp4_inhibitor.pdf|09/25/2018| 00597014860|DPP-4 Inhibitors|https://paxpress.txpa.hidinc.com/dpp4_inhibitor.pdf|09/25/2018| 00597015230|SGLT2 Inhibitors Clinical|https://paxpress.txpa.hidinc.com/SGLT2.pdf|05/23/2023| 00597015237|SGLT2 Inhibitors Clinical|https://paxpress.txpa.hidinc.com/SGLT2.pdf|05/23/2023| 00597015290|SGLT2 Inhibitors Clinical|https://paxpress.txpa.hidinc.com/SGLT2.pdf|05/23/2023| 00597015330|SGLT2 Inhibitors Clinical|https://paxpress.txpa.hidinc.com/SGLT2.pdf|05/23/2023| 00597015337|SGLT2 Inhibitors Clinical|https://paxpress.txpa.hidinc.com/SGLT2.pdf|05/23/2023| 00597015390|SGLT2 Inhibitors Clinical|https://paxpress.txpa.hidinc.com/SGLT2.pdf|05/23/2023| 00597015561|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/04/2016| 00597015570|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/04/2016| 00597016430|DPP-4 Inhibitors|https://paxpress.txpa.hidinc.com/dpp4_inhibitor.pdf|09/25/2018| 00597016490|DPP-4 Inhibitors|https://paxpress.txpa.hidinc.com/dpp4_inhibitor.pdf|09/25/2018| 00597016818|SGLT2 Inhibitors Clinical|https://paxpress.txpa.hidinc.com/SGLT2.pdf|05/23/2023| 00597016860|SGLT2 Inhibitors Clinical|https://paxpress.txpa.hidinc.com/SGLT2.pdf|05/23/2023| 00597017518|SGLT2 Inhibitors Clinical|https://paxpress.txpa.hidinc.com/SGLT2.pdf|05/23/2023| 00597017560|SGLT2 Inhibitors Clinical|https://paxpress.txpa.hidinc.com/SGLT2.pdf|05/23/2023| 00597018018|SGLT2 Inhibitors Clinical|https://paxpress.txpa.hidinc.com/SGLT2.pdf|05/23/2023| 00597018060|SGLT2 Inhibitors Clinical|https://paxpress.txpa.hidinc.com/SGLT2.pdf|05/23/2023| 00597018230|DPP-4 Inhibitors|https://paxpress.txpa.hidinc.com/dpp4_inhibitor.pdf|09/25/2018| 00597018239|DPP-4 Inhibitors|https://paxpress.txpa.hidinc.com/dpp4_inhibitor.pdf|09/25/2018| 00597018290|DPP-4 Inhibitors|https://paxpress.txpa.hidinc.com/dpp4_inhibitor.pdf|09/25/2018| 00597019261|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/04/2016| 00597027073|DPP-4 Inhibitors|https://paxpress.txpa.hidinc.com/dpp4_inhibitor.pdf|09/25/2018| 00597027094|DPP-4 Inhibitors|https://paxpress.txpa.hidinc.com/dpp4_inhibitor.pdf|09/25/2018| 00597027533|DPP-4 Inhibitors|https://paxpress.txpa.hidinc.com/dpp4_inhibitor.pdf|09/25/2018| 00597027581|DPP-4 Inhibitors|https://paxpress.txpa.hidinc.com/dpp4_inhibitor.pdf|09/25/2018| 00597028073|SGLT2 Inhibitors Clinical|https://paxpress.txpa.hidinc.com/SGLT2.pdf|05/23/2023| 00597028090|SGLT2 Inhibitors Clinical|https://paxpress.txpa.hidinc.com/SGLT2.pdf|05/23/2023| 00597029059|SGLT2 Inhibitors Clinical|https://paxpress.txpa.hidinc.com/SGLT2.pdf|05/23/2023| 00597029074|SGLT2 Inhibitors Clinical|https://paxpress.txpa.hidinc.com/SGLT2.pdf|05/23/2023| 00597029578|SGLT2 Inhibitors Clinical|https://paxpress.txpa.hidinc.com/SGLT2.pdf|05/23/2023| 00597029588|SGLT2 Inhibitors Clinical|https://paxpress.txpa.hidinc.com/SGLT2.pdf|05/23/2023| 00597030045|SGLT2 Inhibitors Clinical|https://paxpress.txpa.hidinc.com/SGLT2.pdf|05/23/2023| 00597030093|SGLT2 Inhibitors Clinical|https://paxpress.txpa.hidinc.com/SGLT2.pdf|05/23/2023| 00597035509|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 00597035556|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 00597036055|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 00597036082|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 00603255321|Opiate Overutilization|https://paxpress.txpa.hidinc.com/opiate.pdf|11/05/2013|09/30/2023 00603255321|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017|09/30/2023 00603255321|Opioid Clinical Policy (MME and days supply limits)|https://paxpress.txpa.hidinc.com/opc.pdf|09/01/2020|09/30/2023 00603388728|Opiate Overutilization|https://paxpress.txpa.hidinc.com/opiate.pdf|11/05/2013|06/30/2024 00603388728|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017|06/30/2024 00603388728|Opioid Clinical Policy (MME and days supply limits)|https://paxpress.txpa.hidinc.com/opc.pdf|09/01/2020|06/30/2024 00603388732|Opiate Overutilization|https://paxpress.txpa.hidinc.com/opiate.pdf|11/05/2013| 00603388732|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017| 00603388732|Opioid Clinical Policy (MME and days supply limits)|https://paxpress.txpa.hidinc.com/opc.pdf|09/01/2020| 00603389028|Opiate Overutilization|https://paxpress.txpa.hidinc.com/opiate.pdf|11/05/2013|11/30/2023 00603389028|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017|11/30/2023 00603389028|Opioid Clinical Policy (MME and days supply limits)|https://paxpress.txpa.hidinc.com/opc.pdf|09/01/2020|11/30/2023 00603389032|Opiate Overutilization|https://paxpress.txpa.hidinc.com/opiate.pdf|11/05/2013|11/30/2023 00603389032|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017|11/30/2023 00603389032|Opioid Clinical Policy (MME and days supply limits)|https://paxpress.txpa.hidinc.com/opc.pdf|09/01/2020|11/30/2023 00603389128|Opiate Overutilization|https://paxpress.txpa.hidinc.com/opiate.pdf|11/05/2013|11/30/2023 00603389128|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017|11/30/2023 00603389128|Opioid Clinical Policy (MME and days supply limits)|https://paxpress.txpa.hidinc.com/opc.pdf|09/01/2020|11/30/2023 00603389132|Opiate Overutilization|https://paxpress.txpa.hidinc.com/opiate.pdf|11/05/2013|11/30/2023 00603389132|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017|11/30/2023 00603389132|Opioid Clinical Policy (MME and days supply limits)|https://paxpress.txpa.hidinc.com/opc.pdf|09/01/2020|11/30/2023 00603459315|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 00603459321|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 00603506021|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016| 00603506121|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016| 00603506128|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016| 00603506221|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016| 00603506228|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016| 00603506321|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016| 00603533521|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 00603533532|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 00603533621|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 00603533715|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 00603533721|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 00603533731|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 00603533732|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 00603533815|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 00603533821|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 00603533828|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 00603533831|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 00603533832|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 00603533921|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 00603533928|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 00603533932|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 00641092821|Promethazine Utilization|https://paxpress.txpa.hidinc.com/phenergan.pdf|01/31/2011| 00641092825|Promethazine Utilization|https://paxpress.txpa.hidinc.com/phenergan.pdf|01/31/2011| 00641092921|Promethazine Utilization|https://paxpress.txpa.hidinc.com/phenergan.pdf|01/31/2011| 00641092925|Promethazine Utilization|https://paxpress.txpa.hidinc.com/phenergan.pdf|01/31/2011| 00641094931|Promethazine Utilization|https://paxpress.txpa.hidinc.com/phenergan.pdf|01/31/2011| 00641094935|Promethazine Utilization|https://paxpress.txpa.hidinc.com/phenergan.pdf|01/31/2011| 00641139835|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016| 00641149535|Promethazine Utilization|https://paxpress.txpa.hidinc.com/phenergan.pdf|01/31/2011| 00641149635|Promethazine Utilization|https://paxpress.txpa.hidinc.com/phenergan.pdf|01/31/2011| 00641605225|Opiate Overutilization|https://paxpress.txpa.hidinc.com/opiate.pdf|11/05/2013| 00641605225|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017| 00641605225|Opioid Clinical Policy (MME and days supply limits)|https://paxpress.txpa.hidinc.com/opc.pdf|09/01/2020| 00641605325|Opiate Overutilization|https://paxpress.txpa.hidinc.com/opiate.pdf|11/05/2013| 00641605325|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017| 00641605325|Opioid Clinical Policy (MME and days supply limits)|https://paxpress.txpa.hidinc.com/opc.pdf|09/01/2020| 00641605425|Opiate Overutilization|https://paxpress.txpa.hidinc.com/opiate.pdf|11/05/2013| 00641605425|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017| 00641605425|Opioid Clinical Policy (MME and days supply limits)|https://paxpress.txpa.hidinc.com/opc.pdf|09/01/2020| 00641608425|Promethazine Utilization|https://paxpress.txpa.hidinc.com/phenergan.pdf|01/31/2011| 00641624310|Anxiolytics and Sedative-Hypnotics|https://paxpress.txpa.hidinc.com/ash.pdf|01/31/2011| 00703001801|Opiate Overutilization|https://paxpress.txpa.hidinc.com/opiate.pdf|11/05/2013| 00703001801|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017| 00703001801|Opioid Clinical Policy (MME and days supply limits)|https://paxpress.txpa.hidinc.com/opc.pdf|09/01/2020| 00703011003|Opiate Overutilization|https://paxpress.txpa.hidinc.com/opiate.pdf|11/05/2013| 00703011003|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017| 00703011003|Opioid Clinical Policy (MME and days supply limits)|https://paxpress.txpa.hidinc.com/opc.pdf|09/01/2020| 00703011303|Opiate Overutilization|https://paxpress.txpa.hidinc.com/opiate.pdf|11/05/2013| 00703011303|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017| 00703011303|Opioid Clinical Policy (MME and days supply limits)|https://paxpress.txpa.hidinc.com/opc.pdf|09/01/2020| 00703066601|Pulmonary Hypertension Agents Clinical|https://paxpress.txpa.hidinc.com/pah.pdf|07/27/2023| 00703067601|Pulmonary Hypertension Agents Clinical|https://paxpress.txpa.hidinc.com/pah.pdf|07/27/2023| 00703068601|Pulmonary Hypertension Agents Clinical|https://paxpress.txpa.hidinc.com/pah.pdf|07/27/2023| 00703069601|Pulmonary Hypertension Agents Clinical|https://paxpress.txpa.hidinc.com/pah.pdf|07/27/2023| 00703198501|Pulmonary Hypertension Agents Clinical|https://paxpress.txpa.hidinc.com/pah.pdf|07/27/2023|08/23/2023 00703199501|Pulmonary Hypertension Agents Clinical|https://paxpress.txpa.hidinc.com/pah.pdf|07/27/2023|08/23/2023 00703505103|Desmopressin|https://paxpress.txpa.hidinc.com/desmopressin.pdf|05/25/2012|08/23/2023 00703505401|Desmopressin|https://paxpress.txpa.hidinc.com/desmopressin.pdf|05/25/2012|08/23/2023 00713013212|Promethazine Utilization|https://paxpress.txpa.hidinc.com/phenergan.pdf|01/31/2011| 00713052612|Promethazine Utilization|https://paxpress.txpa.hidinc.com/phenergan.pdf|01/31/2011| 00713053612|Promethazine Utilization|https://paxpress.txpa.hidinc.com/phenergan.pdf|01/31/2011| 00781106101|Anxiolytics and Sedative-Hypnotics|https://paxpress.txpa.hidinc.com/ash.pdf|05/28/2015| 00781106101|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017| 00781106105|Anxiolytics and Sedative-Hypnotics|https://paxpress.txpa.hidinc.com/ash.pdf|05/28/2015| 00781106105|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017| 00781106110|Anxiolytics and Sedative-Hypnotics|https://paxpress.txpa.hidinc.com/ash.pdf|05/28/2015| 00781106110|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017| 00781107701|Anxiolytics and Sedative-Hypnotics|https://paxpress.txpa.hidinc.com/ash.pdf|05/28/2015| 00781107701|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017| 00781107705|Anxiolytics and Sedative-Hypnotics|https://paxpress.txpa.hidinc.com/ash.pdf|05/28/2015| 00781107705|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017| 00781107710|Anxiolytics and Sedative-Hypnotics|https://paxpress.txpa.hidinc.com/ash.pdf|05/28/2015| 00781107710|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017| 00781107901|Anxiolytics and Sedative-Hypnotics|https://paxpress.txpa.hidinc.com/ash.pdf|05/28/2015| 00781107901|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017| 00781107905|Anxiolytics and Sedative-Hypnotics|https://paxpress.txpa.hidinc.com/ash.pdf|05/28/2015| 00781107905|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017| 00781107910|Anxiolytics and Sedative-Hypnotics|https://paxpress.txpa.hidinc.com/ash.pdf|05/28/2015| 00781107910|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017| 00781108901|Anxiolytics and Sedative-Hypnotics|https://paxpress.txpa.hidinc.com/ash.pdf|05/28/2015| 00781108901|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017| 00781108905|Anxiolytics and Sedative-Hypnotics|https://paxpress.txpa.hidinc.com/ash.pdf|05/28/2015| 00781108905|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017| 00781183001|Promethazine Utilization|https://paxpress.txpa.hidinc.com/phenergan.pdf|01/31/2011|04/30/2024 00781183010|Promethazine Utilization|https://paxpress.txpa.hidinc.com/phenergan.pdf|01/31/2011|09/30/2024 00781183201|Promethazine Utilization|https://paxpress.txpa.hidinc.com/phenergan.pdf|01/31/2011|11/30/2023 00781207401|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 00781207410|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 00781208102|Phosphate Binders|https://paxpress.txpa.hidinc.com/phosphate_binders.pdf|01/31/2011| 00781216460|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016| 00781216660|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016| 00781216760|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016| 00781216860|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016| 00781232106|Antiemetic Agents|https://paxpress.txpa.hidinc.com/antiemetics.pdf|01/31/2011| 00781232151|Antiemetic Agents|https://paxpress.txpa.hidinc.com/antiemetics.pdf|01/31/2011| 00781232246|Antiemetic Agents|https://paxpress.txpa.hidinc.com/antiemetics.pdf|01/31/2011| 00781232268|Antiemetic Agents|https://paxpress.txpa.hidinc.com/antiemetics.pdf|01/31/2011| 00781232368|Antiemetic Agents|https://paxpress.txpa.hidinc.com/antiemetics.pdf|01/31/2011| 00781232901|ADD/ADHD Agents|https://paxpress.txpa.hidinc.com/add_adhd_agents.pdf|02/13/2014| 00781233501|ADD/ADHD Agents|https://paxpress.txpa.hidinc.com/add_adhd_agents.pdf|02/13/2014| 00781234301|ADD/ADHD Agents|https://paxpress.txpa.hidinc.com/add_adhd_agents.pdf|02/13/2014| 00781235201|ADD/ADHD Agents|https://paxpress.txpa.hidinc.com/add_adhd_agents.pdf|02/13/2014| 00781236101|ADD/ADHD Agents|https://paxpress.txpa.hidinc.com/add_adhd_agents.pdf|02/13/2014| 00781236201|ADD/ADHD Agents|https://paxpress.txpa.hidinc.com/add_adhd_agents.pdf|02/13/2014| 00781236301|ADD/ADHD Agents|https://paxpress.txpa.hidinc.com/add_adhd_agents.pdf|02/13/2014| 00781236401|ADD/ADHD Agents|https://paxpress.txpa.hidinc.com/add_adhd_agents.pdf|02/13/2014| 00781236801|ADD/ADHD Agents|https://paxpress.txpa.hidinc.com/add_adhd_agents.pdf|02/13/2014| 00781237101|ADD/ADHD Agents|https://paxpress.txpa.hidinc.com/add_adhd_agents.pdf|02/13/2014| 00781300107|Growth Hormones|https://paxpress.txpa.hidinc.com/gh.pdf|01/31/2011| 00781300407|Growth Hormones|https://paxpress.txpa.hidinc.com/gh.pdf|01/31/2011| 00781315972|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016| 00781323863|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 00781324664|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 00781325666|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 00781326268|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 00781326869|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 00781329868|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 00781329969|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 00781342080|Pulmonary Hypertension Agents Clinical|https://paxpress.txpa.hidinc.com/pah.pdf|07/27/2023| 00781342580|Pulmonary Hypertension Agents Clinical|https://paxpress.txpa.hidinc.com/pah.pdf|07/27/2023| 00781342780|Pulmonary Hypertension Agents Clinical|https://paxpress.txpa.hidinc.com/pah.pdf|07/27/2023| 00781343080|Pulmonary Hypertension Agents Clinical|https://paxpress.txpa.hidinc.com/pah.pdf|07/27/2023| 00781344395|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 00781345495|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 00781346595|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 00781347612|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|08/23/2023 00781347695|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 00781400436|Growth Hormones|https://paxpress.txpa.hidinc.com/gh.pdf|01/31/2011| 00781402753|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016| 00781402822|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016| 00781406336|Antiemetic Agents|https://paxpress.txpa.hidinc.com/antiemetics.pdf|01/31/2011| 00781502201|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|01/31/2024 00781502207|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 00781531501|Anxiolytics and Sedative-Hypnotics|https://paxpress.txpa.hidinc.com/ash.pdf|01/31/2011| 00781531601|Anxiolytics and Sedative-Hypnotics|https://paxpress.txpa.hidinc.com/ash.pdf|01/31/2011| 00781531701|Anxiolytics and Sedative-Hypnotics|https://paxpress.txpa.hidinc.com/ash.pdf|01/31/2011| 00781531710|Anxiolytics and Sedative-Hypnotics|https://paxpress.txpa.hidinc.com/ash.pdf|01/31/2011| 00781531801|Anxiolytics and Sedative-Hypnotics|https://paxpress.txpa.hidinc.com/ash.pdf|01/31/2011| 00781531810|Anxiolytics and Sedative-Hypnotics|https://paxpress.txpa.hidinc.com/ash.pdf|01/31/2011| 00781540092|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/04/2016|08/23/2023 00781540331|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/04/2016|08/23/2023 00781710454|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 00781711954|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 00781712254|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 00781712983|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 00781713354|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 00781713454|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 00781713654|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 00781713883|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 00781714483|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 00781715683|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 00781716783|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 00781721606|Buprenorphine Agents|https://paxpress.txpa.hidinc.com/buprenorphine_agents.pdf|04/23/2013| 00781721606|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017| 00781721664|Buprenorphine Agents|https://paxpress.txpa.hidinc.com/buprenorphine_agents.pdf|04/23/2013| 00781721664|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017| 00781722706|Buprenorphine Agents|https://paxpress.txpa.hidinc.com/buprenorphine_agents.pdf|04/23/2013| 00781722706|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017| 00781722764|Buprenorphine Agents|https://paxpress.txpa.hidinc.com/buprenorphine_agents.pdf|04/23/2013| 00781722764|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017| 00781723806|Buprenorphine Agents|https://paxpress.txpa.hidinc.com/buprenorphine_agents.pdf|04/23/2013| 00781723806|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017| 00781723864|Buprenorphine Agents|https://paxpress.txpa.hidinc.com/buprenorphine_agents.pdf|04/23/2013| 00781723864|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017| 00781724906|Buprenorphine Agents|https://paxpress.txpa.hidinc.com/buprenorphine_agents.pdf|04/23/2013| 00781724906|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017| 00781724964|Buprenorphine Agents|https://paxpress.txpa.hidinc.com/buprenorphine_agents.pdf|04/23/2013| 00781724964|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017| 00781729685|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 00781751587|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 00781751687|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 00781751787|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 00781801701|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/04/2016| 00781801731|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/04/2016| 00781802801|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016| 00781802931|CNS Stimulants|https://paxpress.txpa.hidinc.com/provigil.pdf|02/06/2018| 00781803201|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016| 00781803401|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016| 00781803601|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016| 00781803731|CNS Stimulants|https://paxpress.txpa.hidinc.com/provigil.pdf|02/06/2018| 00781804531|CNS Stimulants|https://paxpress.txpa.hidinc.com/provigil.pdf|02/06/2018| 00781804601|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016| 00781804701|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016| 00781804801|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016| 00781804901|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016| 00781805331|CNS Stimulants|https://paxpress.txpa.hidinc.com/provigil.pdf|02/06/2018| 00781910572|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016| 00832022500|Opiate Overutilization|https://paxpress.txpa.hidinc.com/opiate.pdf|11/05/2013| 00832022500|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017| 00832022500|Opioid Clinical Policy (MME and days supply limits)|https://paxpress.txpa.hidinc.com/opc.pdf|09/01/2020| 00832022600|Opiate Overutilization|https://paxpress.txpa.hidinc.com/opiate.pdf|11/05/2013| 00832022600|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017| 00832022600|Opioid Clinical Policy (MME and days supply limits)|https://paxpress.txpa.hidinc.com/opc.pdf|09/01/2020| 00832022700|Opiate Overutilization|https://paxpress.txpa.hidinc.com/opiate.pdf|11/05/2013| 00832022700|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017| 00832022700|Opioid Clinical Policy (MME and days supply limits)|https://paxpress.txpa.hidinc.com/opc.pdf|09/01/2020| 00832022800|Opiate Overutilization|https://paxpress.txpa.hidinc.com/opiate.pdf|11/05/2013| 00832022800|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017| 00832022800|Opioid Clinical Policy (MME and days supply limits)|https://paxpress.txpa.hidinc.com/opc.pdf|09/01/2020| 00832022900|Opiate Overutilization|https://paxpress.txpa.hidinc.com/opiate.pdf|11/05/2013| 00832022900|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017| 00832022900|Opioid Clinical Policy (MME and days supply limits)|https://paxpress.txpa.hidinc.com/opc.pdf|09/01/2020| 00832023000|Opiate Overutilization|https://paxpress.txpa.hidinc.com/opiate.pdf|11/05/2013| 00832023000|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017| 00832023000|Opioid Clinical Policy (MME and days supply limits)|https://paxpress.txpa.hidinc.com/opc.pdf|09/01/2020| 00832023300|Opiate Overutilization|https://paxpress.txpa.hidinc.com/opiate.pdf|11/05/2013| 00832023300|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017| 00832023300|Opioid Clinical Policy (MME and days supply limits)|https://paxpress.txpa.hidinc.com/opc.pdf|09/01/2020| 00832027311|Opiate Overutilization|https://paxpress.txpa.hidinc.com/opiate.pdf|11/05/2013| 00832027311|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017| 00832027311|Opioid Clinical Policy (MME and days supply limits)|https://paxpress.txpa.hidinc.com/opc.pdf|09/01/2020| 00832027411|Opiate Overutilization|https://paxpress.txpa.hidinc.com/opiate.pdf|11/05/2013| 00832027411|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017| 00832027411|Opioid Clinical Policy (MME and days supply limits)|https://paxpress.txpa.hidinc.com/opc.pdf|09/01/2020| 00832030000|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016|08/01/2024 00832030100|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016|08/01/2024 00832030110|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016|08/01/2024 00832030200|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016|08/01/2024 00832030210|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016|08/01/2024 00832030300|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016|08/01/2024 00832030310|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016|08/01/2024 00832030400|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016|08/01/2024 00832030410|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016|08/01/2024 00832105410|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017| 00832121100|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 00832121101|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 00832121110|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 00832121200|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 00832121201|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 00832121210|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 00832121300|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 00832121301|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 00832121310|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 00832121400|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 00832121401|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 00832121410|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 00832121500|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 00832121501|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 00832121510|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 00832121600|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 00832121601|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 00832121610|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 00832121700|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 00832121701|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 00832121710|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 00832121800|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 00832121801|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 00832121900|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 00832121901|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 00832151011|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016| 00832152011|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016| 00832153011|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016| 00832154011|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016| 00832155011|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016| 00832156011|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016| 00832601700|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016| 00832601800|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016| 00832601810|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016| 00832601901|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016| 00832602001|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016| 00832602101|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016| 00832602110|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016| 00904001280|Cough and Cold Agents|https://paxpress.txpa.hidinc.com/Cough%20&%20Cold.pdf|12/15/2015| 00904001280|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 00904025024|Cough and Cold Agents|https://paxpress.txpa.hidinc.com/Cough%20&%20Cold.pdf|12/15/2015|10/10/2023 00904025024|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|10/10/2023 00904025059|Cough and Cold Agents|https://paxpress.txpa.hidinc.com/Cough%20&%20Cold.pdf|12/15/2015|11/22/2023 00904025059|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|11/22/2023 00904530624|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 00904530660|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|10/27/2023 00904530680|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|01/31/2024 00904530760|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 00904530780|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 00904530909|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 00904530920|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 00904557720|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 00904578624|Dextromethorphan Overutilization|https://paxpress.txpa.hidinc.com/dextro.pdf|07/16/2012| 00904583315|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 00904583348|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 00904585340|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 00904585360|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 00904585440|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 00904585461|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 00904585540|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 00904585560|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 00904585561|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 00904589161|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/04/2016| 00904589261|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/04/2016| 00904589361|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/04/2016| 00904600760|Anxiolytics and Sedative-Hypnotics|https://paxpress.txpa.hidinc.com/ash.pdf|01/31/2011| 00904600760|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017| 00904600761|Anxiolytics and Sedative-Hypnotics|https://paxpress.txpa.hidinc.com/ash.pdf|01/31/2011| 00904600761|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017| 00904600860|Anxiolytics and Sedative-Hypnotics|https://paxpress.txpa.hidinc.com/ash.pdf|01/31/2011| 00904600860|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017| 00904600861|Anxiolytics and Sedative-Hypnotics|https://paxpress.txpa.hidinc.com/ash.pdf|01/31/2011| 00904600861|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017| 00904600960|Anxiolytics and Sedative-Hypnotics|https://paxpress.txpa.hidinc.com/ash.pdf|01/31/2011| 00904600960|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017| 00904600961|Anxiolytics and Sedative-Hypnotics|https://paxpress.txpa.hidinc.com/ash.pdf|01/31/2011| 00904600961|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017| 00904608261|Anxiolytics and Sedative-Hypnotics|https://paxpress.txpa.hidinc.com/ash.pdf|01/31/2011| 00904621740|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|08/23/2023 00904626908|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016| 00904627008|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016| 00904627108|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016| 00904627208|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016| 00904628361|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016| 00904628606|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016| 00904628661|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016| 00904628706|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016| 00904628761|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016| 00904629061|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/04/2016| 00904629161|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/04/2016| 00904629261|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/04/2016| 00904629304|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/04/2016| 00904631256|Cough and Cold Agents|https://paxpress.txpa.hidinc.com/Cough%20&%20Cold.pdf|12/15/2015| 00904631256|Dextromethorphan Overutilization|https://paxpress.txpa.hidinc.com/dextro.pdf|07/16/2012| 00904635761|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016|11/30/2023 00904635861|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016| 00904635961|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016| 00904636061|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016| 00904636161|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016| 00904636261|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016| 00904637661|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016| 00904637761|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016| 00904643604|Anxiolytics and Sedative-Hypnotics|https://paxpress.txpa.hidinc.com/ash.pdf|01/31/2011| 00904643604|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017| 00904646161|Promethazine Utilization|https://paxpress.txpa.hidinc.com/phenergan.pdf|01/31/2011|05/04/2024 00904646320|Cough and Cold Agents|https://paxpress.txpa.hidinc.com/Cough%20&%20Cold.pdf|12/15/2015| 00904646320|Dextromethorphan Overutilization|https://paxpress.txpa.hidinc.com/dextro.pdf|07/16/2012| 00904646320|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 00904650261|COX-2 Inhibitors|https://paxpress.txpa.hidinc.com/cox2.pdf|01/31/2011| 00904650261|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/04/2016| 00904650361|COX-2 Inhibitors|https://paxpress.txpa.hidinc.com/cox2.pdf|01/31/2011| 00904650361|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/04/2016| 00904650904|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016| 00904651006|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016| 00904651061|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016| 00904651106|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016| 00904651161|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016| 00904651204|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016| 00904651304|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016| 00904651404|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016| 00904651661|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 00904651761|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 00904653061|Opiate Overutilization|https://paxpress.txpa.hidinc.com/opiate.pdf|11/05/2013| 00904653061|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017| 00904653061|Opioid Clinical Policy (MME and days supply limits)|https://paxpress.txpa.hidinc.com/opc.pdf|09/01/2020| 00904653720|Cough and Cold Agents|https://paxpress.txpa.hidinc.com/Cough%20&%20Cold.pdf|12/15/2015| 00904653720|Dextromethorphan Overutilization|https://paxpress.txpa.hidinc.com/dextro.pdf|07/16/2012| 00904655761|Opiate Overutilization|https://paxpress.txpa.hidinc.com/opiate.pdf|11/05/2013| 00904655761|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017| 00904655761|Opioid Clinical Policy (MME and days supply limits)|https://paxpress.txpa.hidinc.com/opc.pdf|09/01/2020| 00904655861|Opiate Overutilization|https://paxpress.txpa.hidinc.com/opiate.pdf|11/05/2013| 00904655861|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017| 00904655861|Opioid Clinical Policy (MME and days supply limits)|https://paxpress.txpa.hidinc.com/opc.pdf|09/01/2020| 00904655961|Opiate Overutilization|https://paxpress.txpa.hidinc.com/opiate.pdf|11/05/2013| 00904655961|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017| 00904655961|Opioid Clinical Policy (MME and days supply limits)|https://paxpress.txpa.hidinc.com/opc.pdf|09/01/2020| 00904656061|Opiate Overutilization|https://paxpress.txpa.hidinc.com/opiate.pdf|11/05/2013| 00904656061|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017| 00904656061|Opioid Clinical Policy (MME and days supply limits)|https://paxpress.txpa.hidinc.com/opc.pdf|09/01/2020| 00904656460|Cough and Cold Agents|https://paxpress.txpa.hidinc.com/Cough%20&%20Cold.pdf|12/15/2015| 00904656461|Cough and Cold Agents|https://paxpress.txpa.hidinc.com/Cough%20&%20Cold.pdf|12/15/2015|12/27/2023 00904659961|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016| 00904660061|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016| 00904660161|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016| 00904661761|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 00904661861|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 00904663861|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016| 00904663961|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016| 00904664061|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016| 00904664161|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016| 00904664261|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016| 00904664361|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016| 00904665640|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016| 00904666561|Gabapentin Agents|https://paxpress.txpa.hidinc.com/neurontin.pdf|01/31/2011| 00904666661|Gabapentin Agents|https://paxpress.txpa.hidinc.com/neurontin.pdf|01/31/2011| 00904666761|Gabapentin Agents|https://paxpress.txpa.hidinc.com/neurontin.pdf|01/31/2011| 00904667104|PDE5-Inhibitors|https://paxpress.txpa.hidinc.com/revatio.pdf|01/31/2011| 00904667840|Opiate Overutilization|https://paxpress.txpa.hidinc.com/opiate.pdf|11/05/2013| 00904667840|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017| 00904667840|Opioid Clinical Policy (MME and days supply limits)|https://paxpress.txpa.hidinc.com/opc.pdf|09/01/2020| 00904671146|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 00904671740|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 00904671741|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 00904671743|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 00904671746|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 00904671760|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 00904671761|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 00904671772|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 00904671786|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 00904671839|Cough and Cold Agents|https://paxpress.txpa.hidinc.com/Cough%20&%20Cold.pdf|12/15/2015| 00904674724|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 00904674740|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 00904674751|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 00904674759|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 00904674770|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 00904674780|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 00904676130|Cough and Cold Agents|https://paxpress.txpa.hidinc.com/Cough%20&%20Cold.pdf|12/15/2015| 00904676320|Cough and Cold Agents|https://paxpress.txpa.hidinc.com/Cough%20&%20Cold.pdf|12/15/2015|05/02/2024 00904676520|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 00904676720|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 00904677861|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/04/2016| 00904678061|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/04/2016| 00904680361|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016| 00904680561|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016| 00904680861|Leukotriene Modifiers|https://paxpress.txpa.hidinc.com/leukotriene.pdf|12/15/2015| 00904683106|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017| 00904685207|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 00904685260|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 00904685261|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 00904685272|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 00904685289|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 00904690804|ADD/ADHD Agents|https://paxpress.txpa.hidinc.com/add_adhd_agents.pdf|02/13/2014| 00904698516|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 00904698520|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 00904698640|Cough and Cold Agents|https://paxpress.txpa.hidinc.com/Cough%20&%20Cold.pdf|12/15/2015| 00904699544|Dextromethorphan Overutilization|https://paxpress.txpa.hidinc.com/dextro.pdf|07/16/2012| 00904699644|Dextromethorphan Overutilization|https://paxpress.txpa.hidinc.com/dextro.pdf|07/16/2012| 00904700635|Cough and Cold Agents|https://paxpress.txpa.hidinc.com/Cough%20&%20Cold.pdf|12/15/2015| 00904700906|Buprenorphine Agents|https://paxpress.txpa.hidinc.com/buprenorphine_agents.pdf|04/23/2013| 00904700906|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017| 00904701006|Buprenorphine Agents|https://paxpress.txpa.hidinc.com/buprenorphine_agents.pdf|04/23/2013| 00904701006|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017| 00904705040|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 00904705060|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 00904715404|Buprenorphine Agents|https://paxpress.txpa.hidinc.com/buprenorphine_agents.pdf|12/05/2014| 00904715404|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017| 00904715504|Buprenorphine Agents|https://paxpress.txpa.hidinc.com/buprenorphine_agents.pdf|12/05/2014| 00904715504|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017| 00904719240|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 00904719260|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 00904722320|Cough and Cold Agents|https://paxpress.txpa.hidinc.com/Cough%20&%20Cold.pdf|12/15/2015| 00904722320|Dextromethorphan Overutilization|https://paxpress.txpa.hidinc.com/dextro.pdf|07/16/2012| 00904722359|Cough and Cold Agents|https://paxpress.txpa.hidinc.com/Cough%20&%20Cold.pdf|12/15/2015| 00904722359|Dextromethorphan Overutilization|https://paxpress.txpa.hidinc.com/dextro.pdf|07/16/2012| 00904723724|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 00904723760|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 00904723780|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 00904730224|Cough and Cold Agents|https://paxpress.txpa.hidinc.com/Cough%20&%20Cold.pdf|12/15/2015| 00904730224|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 00904730260|Cough and Cold Agents|https://paxpress.txpa.hidinc.com/Cough%20&%20Cold.pdf|12/15/2015| 00904730260|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 00904791251|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 00904791459|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 00944417910|Enzymes|https://paxpress.txpa.hidinc.com/enzymes.pdf|11/20/2019| 00955100310|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 00955100410|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 00955100610|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 00955100810|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 00955101010|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 00955101210|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 00955101510|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 00955101601|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 00955104090|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 00955104190|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 00955104290|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 00955104590|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 00955104690|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 00955104818|Phosphate Binders|https://paxpress.txpa.hidinc.com/phosphate_binders.pdf|01/31/2011| 00955105027|Phosphate Binders|https://paxpress.txpa.hidinc.com/phosphate_binders.pdf|01/31/2011| 00955105290|Phosphate Binders|https://paxpress.txpa.hidinc.com/phosphate_binders.pdf|01/31/2011| 00955105490|Phosphate Binders|https://paxpress.txpa.hidinc.com/phosphate_binders.pdf|01/31/2011| 00955170210|Anxiolytics and Sedative-Hypnotics|https://paxpress.txpa.hidinc.com/ash.pdf|01/31/2011| 00955170310|Anxiolytics and Sedative-Hypnotics|https://paxpress.txpa.hidinc.com/ash.pdf|01/31/2011| 10122010150|Cough and Cold Agents|https://paxpress.txpa.hidinc.com/Cough%20&%20Cold.pdf|12/15/2015| 10122050201|Enzymes|https://paxpress.txpa.hidinc.com/enzymes.pdf|11/20/2019| 10122082028|Inhaled Antibiotics Clinical|https://paxpress.txpa.hidinc.com/inhaledantibiotics.pdf|05/02/2023| 10122082056|Inhaled Antibiotics Clinical|https://paxpress.txpa.hidinc.com/inhaledantibiotics.pdf|05/02/2023| 10147068501|ADD/ADHD Agents|https://paxpress.txpa.hidinc.com/add_adhd_agents.pdf|02/13/2014|01/16/2024 10147068601|ADD/ADHD Agents|https://paxpress.txpa.hidinc.com/add_adhd_agents.pdf|02/13/2014|01/16/2024 10147068701|ADD/ADHD Agents|https://paxpress.txpa.hidinc.com/add_adhd_agents.pdf|02/13/2014|01/16/2024 10147068801|ADD/ADHD Agents|https://paxpress.txpa.hidinc.com/add_adhd_agents.pdf|02/13/2014|01/16/2024 10147095103|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016|01/16/2024 10147095203|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016|01/16/2024 10147095303|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016|01/16/2024 10147095403|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016|01/16/2024 10370011610|Anxiolytics and Sedative-Hypnotics|https://paxpress.txpa.hidinc.com/ash.pdf|01/31/2011|07/31/2024 10370011710|Anxiolytics and Sedative-Hypnotics|https://paxpress.txpa.hidinc.com/ash.pdf|01/31/2011|06/30/2024 10370025702|ADD/ADHD Agents|https://paxpress.txpa.hidinc.com/add_adhd_agents.pdf|02/13/2014|08/23/2023 10702000201|Promethazine Utilization|https://paxpress.txpa.hidinc.com/phenergan.pdf|01/31/2011| 10702000301|Promethazine Utilization|https://paxpress.txpa.hidinc.com/phenergan.pdf|01/31/2011| 10702000310|Promethazine Utilization|https://paxpress.txpa.hidinc.com/phenergan.pdf|01/31/2011| 10702000401|Promethazine Utilization|https://paxpress.txpa.hidinc.com/phenergan.pdf|01/31/2011| 10702000601|Cyclobenzaprine|https://paxpress.txpa.hidinc.com/cyclobenzaprine.pdf|01/31/2011| 10702000601|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017| 10702000610|Cyclobenzaprine|https://paxpress.txpa.hidinc.com/cyclobenzaprine.pdf|01/31/2011| 10702000610|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017| 10702000650|Cyclobenzaprine|https://paxpress.txpa.hidinc.com/cyclobenzaprine.pdf|01/31/2011| 10702000650|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017| 10702000701|Cyclobenzaprine|https://paxpress.txpa.hidinc.com/cyclobenzaprine.pdf|01/31/2011| 10702000701|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017| 10702000710|Cyclobenzaprine|https://paxpress.txpa.hidinc.com/cyclobenzaprine.pdf|01/31/2011| 10702000710|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017| 10702000750|Cyclobenzaprine|https://paxpress.txpa.hidinc.com/cyclobenzaprine.pdf|01/31/2011| 10702000750|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017| 10702000801|Opiate Overutilization|https://paxpress.txpa.hidinc.com/opiate.pdf|11/05/2013| 10702000801|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017| 10702000801|Opioid Clinical Policy (MME and days supply limits)|https://paxpress.txpa.hidinc.com/opc.pdf|09/01/2020| 10702000850|Opiate Overutilization|https://paxpress.txpa.hidinc.com/opiate.pdf|11/05/2013| 10702000850|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017| 10702000850|Opioid Clinical Policy (MME and days supply limits)|https://paxpress.txpa.hidinc.com/opc.pdf|09/01/2020| 10702000901|Opiate Overutilization|https://paxpress.txpa.hidinc.com/opiate.pdf|11/05/2013| 10702000901|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017| 10702000901|Opioid Clinical Policy (MME and days supply limits)|https://paxpress.txpa.hidinc.com/opc.pdf|09/01/2020| 10702000950|Opiate Overutilization|https://paxpress.txpa.hidinc.com/opiate.pdf|11/05/2013| 10702000950|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017| 10702000950|Opioid Clinical Policy (MME and days supply limits)|https://paxpress.txpa.hidinc.com/opc.pdf|09/01/2020| 10702001001|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 10702001050|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 10702001101|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 10702001110|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 10702001150|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 10702001201|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 10702001210|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 10702001250|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 10702001801|Opiate Overutilization|https://paxpress.txpa.hidinc.com/opiate.pdf|11/05/2013| 10702001801|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017| 10702001801|Opioid Clinical Policy (MME and days supply limits)|https://paxpress.txpa.hidinc.com/opc.pdf|09/01/2020| 10702001850|Opiate Overutilization|https://paxpress.txpa.hidinc.com/opiate.pdf|11/05/2013| 10702001850|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017| 10702001850|Opioid Clinical Policy (MME and days supply limits)|https://paxpress.txpa.hidinc.com/opc.pdf|09/01/2020| 10702002301|Opiate Overutilization|https://paxpress.txpa.hidinc.com/opiate.pdf|11/05/2013| 10702002301|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017| 10702002301|Opioid Clinical Policy (MME and days supply limits)|https://paxpress.txpa.hidinc.com/opc.pdf|09/01/2020| 10702005501|Cough and Cold Agents|https://paxpress.txpa.hidinc.com/Cough%20&%20Cold.pdf|12/15/2015| 10702005501|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017| 10702005501|Opioid Clinical Policy (MME and days supply limits)|https://paxpress.txpa.hidinc.com/opc.pdf|09/01/2020| 10702005503|Cough and Cold Agents|https://paxpress.txpa.hidinc.com/Cough%20&%20Cold.pdf|12/15/2015| 10702005503|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017| 10702005503|Opioid Clinical Policy (MME and days supply limits)|https://paxpress.txpa.hidinc.com/opc.pdf|09/01/2020| 10702005601|Opiate Overutilization|https://paxpress.txpa.hidinc.com/opiate.pdf|11/05/2013| 10702005601|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017| 10702005601|Opioid Clinical Policy (MME and days supply limits)|https://paxpress.txpa.hidinc.com/opc.pdf|09/01/2020| 10702005650|Opiate Overutilization|https://paxpress.txpa.hidinc.com/opiate.pdf|11/05/2013| 10702005650|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017| 10702005650|Opioid Clinical Policy (MME and days supply limits)|https://paxpress.txpa.hidinc.com/opc.pdf|09/01/2020| 10702005701|Opiate Overutilization|https://paxpress.txpa.hidinc.com/opiate.pdf|11/05/2013| 10702005701|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017| 10702005701|Opioid Clinical Policy (MME and days supply limits)|https://paxpress.txpa.hidinc.com/opc.pdf|09/01/2020| 10702005750|Opiate Overutilization|https://paxpress.txpa.hidinc.com/opiate.pdf|11/05/2013| 10702005750|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017| 10702005750|Opioid Clinical Policy (MME and days supply limits)|https://paxpress.txpa.hidinc.com/opc.pdf|09/01/2020| 10702006501|ADD/ADHD Agents|https://paxpress.txpa.hidinc.com/add_adhd_agents.pdf|02/13/2014| 10702006601|ADD/ADHD Agents|https://paxpress.txpa.hidinc.com/add_adhd_agents.pdf|02/13/2014| 10702007001|Opiate Overutilization|https://paxpress.txpa.hidinc.com/opiate.pdf|11/05/2013| 10702007001|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017| 10702007001|Opioid Clinical Policy (MME and days supply limits)|https://paxpress.txpa.hidinc.com/opc.pdf|09/01/2020| 10702007006|Opiate Overutilization|https://paxpress.txpa.hidinc.com/opiate.pdf|11/05/2013|08/23/2023 10702007006|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017|08/23/2023 10702007006|Opioid Clinical Policy (MME and days supply limits)|https://paxpress.txpa.hidinc.com/opc.pdf|09/01/2020|08/23/2023 10702007101|Opiate Overutilization|https://paxpress.txpa.hidinc.com/opiate.pdf|11/05/2013| 10702007101|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017| 10702007101|Opioid Clinical Policy (MME and days supply limits)|https://paxpress.txpa.hidinc.com/opc.pdf|09/01/2020| 10702007106|Opiate Overutilization|https://paxpress.txpa.hidinc.com/opiate.pdf|11/05/2013|08/23/2023 10702007106|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017|08/23/2023 10702007106|Opioid Clinical Policy (MME and days supply limits)|https://paxpress.txpa.hidinc.com/opc.pdf|09/01/2020|08/23/2023 10702007501|ADD/ADHD Agents|https://paxpress.txpa.hidinc.com/add_adhd_agents.pdf|02/13/2014| 10702007601|ADD/ADHD Agents|https://paxpress.txpa.hidinc.com/add_adhd_agents.pdf|02/13/2014| 10702010001|ADD/ADHD Agents|https://paxpress.txpa.hidinc.com/add_adhd_agents.pdf|02/13/2014| 10702010101|ADD/ADHD Agents|https://paxpress.txpa.hidinc.com/add_adhd_agents.pdf|02/13/2014| 10702010201|ADD/ADHD Agents|https://paxpress.txpa.hidinc.com/add_adhd_agents.pdf|02/13/2014| 10702010601|ADD/ADHD Agents|https://paxpress.txpa.hidinc.com/add_adhd_agents.pdf|02/13/2014| 10702010701|ADD/ADHD Agents|https://paxpress.txpa.hidinc.com/add_adhd_agents.pdf|02/13/2014| 10702010801|ADD/ADHD Agents|https://paxpress.txpa.hidinc.com/add_adhd_agents.pdf|02/13/2014| 10702015016|Cough and Cold Agents|https://paxpress.txpa.hidinc.com/Cough%20&%20Cold.pdf|12/15/2015| 10702015016|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017| 10702015016|Opioid Clinical Policy (MME and days supply limits)|https://paxpress.txpa.hidinc.com/opc.pdf|09/01/2020| 10702016350|ADD/ADHD Agents|https://paxpress.txpa.hidinc.com/add_adhd_agents.pdf|02/13/2014| 10702016450|ADD/ADHD Agents|https://paxpress.txpa.hidinc.com/add_adhd_agents.pdf|02/13/2014| 10702018401|Opiate Overutilization|https://paxpress.txpa.hidinc.com/opiate.pdf|11/05/2013| 10702018401|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017| 10702018401|Opioid Clinical Policy (MME and days supply limits)|https://paxpress.txpa.hidinc.com/opc.pdf|09/01/2020| 10702018501|Opiate Overutilization|https://paxpress.txpa.hidinc.com/opiate.pdf|11/05/2013| 10702018501|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017| 10702018501|Opioid Clinical Policy (MME and days supply limits)|https://paxpress.txpa.hidinc.com/opc.pdf|09/01/2020| 10702018601|Opiate Overutilization|https://paxpress.txpa.hidinc.com/opiate.pdf|11/05/2013| 10702018601|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017| 10702018601|Opioid Clinical Policy (MME and days supply limits)|https://paxpress.txpa.hidinc.com/opc.pdf|09/01/2020| 10702018701|Opiate Overutilization|https://paxpress.txpa.hidinc.com/opiate.pdf|11/05/2013| 10702018701|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017| 10702018701|Opioid Clinical Policy (MME and days supply limits)|https://paxpress.txpa.hidinc.com/opc.pdf|09/01/2020| 10702018750|Opiate Overutilization|https://paxpress.txpa.hidinc.com/opiate.pdf|11/05/2013| 10702018750|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017| 10702018750|Opioid Clinical Policy (MME and days supply limits)|https://paxpress.txpa.hidinc.com/opc.pdf|09/01/2020| 10702018910|Opiate Overutilization|https://paxpress.txpa.hidinc.com/opiate.pdf|11/05/2013| 10702018910|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017| 10702018910|Opioid Clinical Policy (MME and days supply limits)|https://paxpress.txpa.hidinc.com/opc.pdf|09/01/2020| 10702018950|Opiate Overutilization|https://paxpress.txpa.hidinc.com/opiate.pdf|11/05/2013| 10702018950|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017| 10702018950|Opioid Clinical Policy (MME and days supply limits)|https://paxpress.txpa.hidinc.com/opc.pdf|09/01/2020| 10702019001|Opiate Overutilization|https://paxpress.txpa.hidinc.com/opiate.pdf|11/05/2013| 10702019001|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017| 10702019001|Opioid Clinical Policy (MME and days supply limits)|https://paxpress.txpa.hidinc.com/opc.pdf|09/01/2020| 10702019010|Opiate Overutilization|https://paxpress.txpa.hidinc.com/opiate.pdf|11/05/2013| 10702019010|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017| 10702019010|Opioid Clinical Policy (MME and days supply limits)|https://paxpress.txpa.hidinc.com/opc.pdf|09/01/2020| 10702019050|Opiate Overutilization|https://paxpress.txpa.hidinc.com/opiate.pdf|11/05/2013| 10702019050|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017| 10702019050|Opioid Clinical Policy (MME and days supply limits)|https://paxpress.txpa.hidinc.com/opc.pdf|09/01/2020| 10702019101|Opiate Overutilization|https://paxpress.txpa.hidinc.com/opiate.pdf|11/05/2013| 10702019101|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017| 10702019101|Opioid Clinical Policy (MME and days supply limits)|https://paxpress.txpa.hidinc.com/opc.pdf|09/01/2020| 10702019150|Opiate Overutilization|https://paxpress.txpa.hidinc.com/opiate.pdf|11/05/2013| 10702019150|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017| 10702019150|Opioid Clinical Policy (MME and days supply limits)|https://paxpress.txpa.hidinc.com/opc.pdf|09/01/2020| 10702019201|Opiate Overutilization|https://paxpress.txpa.hidinc.com/opiate.pdf|11/05/2013| 10702019201|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017| 10702019201|Opioid Clinical Policy (MME and days supply limits)|https://paxpress.txpa.hidinc.com/opc.pdf|09/01/2020| 10702019301|Opiate Overutilization|https://paxpress.txpa.hidinc.com/opiate.pdf|11/05/2013| 10702019301|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017| 10702019301|Opioid Clinical Policy (MME and days supply limits)|https://paxpress.txpa.hidinc.com/opc.pdf|09/01/2020| 10702019401|Opiate Overutilization|https://paxpress.txpa.hidinc.com/opiate.pdf|11/05/2013| 10702019401|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017| 10702019401|Opioid Clinical Policy (MME and days supply limits)|https://paxpress.txpa.hidinc.com/opc.pdf|09/01/2020| 10702034301|Opiate Overutilization|https://paxpress.txpa.hidinc.com/opiate.pdf|11/05/2013|08/23/2023 10702034301|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017|08/23/2023 10702034301|Opioid Clinical Policy (MME and days supply limits)|https://paxpress.txpa.hidinc.com/opc.pdf|09/01/2020|08/23/2023 10702034401|Opiate Overutilization|https://paxpress.txpa.hidinc.com/opiate.pdf|11/05/2013|08/23/2023 10702034401|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017|08/23/2023 10702034401|Opioid Clinical Policy (MME and days supply limits)|https://paxpress.txpa.hidinc.com/opc.pdf|09/01/2020|08/23/2023 10702034501|Opiate Overutilization|https://paxpress.txpa.hidinc.com/opiate.pdf|11/05/2013|08/23/2023 10702034501|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017|08/23/2023 10702034501|Opioid Clinical Policy (MME and days supply limits)|https://paxpress.txpa.hidinc.com/opc.pdf|09/01/2020|08/23/2023 11534018801|ADD/ADHD Agents|https://paxpress.txpa.hidinc.com/add_adhd_agents.pdf|02/13/2014| 11534018901|ADD/ADHD Agents|https://paxpress.txpa.hidinc.com/add_adhd_agents.pdf|02/13/2014| 11534019001|ADD/ADHD Agents|https://paxpress.txpa.hidinc.com/add_adhd_agents.pdf|02/13/2014| 11534019101|ADD/ADHD Agents|https://paxpress.txpa.hidinc.com/add_adhd_agents.pdf|02/13/2014| 11534019201|ADD/ADHD Agents|https://paxpress.txpa.hidinc.com/add_adhd_agents.pdf|02/13/2014| 11534019301|ADD/ADHD Agents|https://paxpress.txpa.hidinc.com/add_adhd_agents.pdf|02/13/2014| 11534019401|ADD/ADHD Agents|https://paxpress.txpa.hidinc.com/add_adhd_agents.pdf|02/13/2014| 11534019501|ADD/ADHD Agents|https://paxpress.txpa.hidinc.com/add_adhd_agents.pdf|02/13/2014| 11534019601|ADD/ADHD Agents|https://paxpress.txpa.hidinc.com/add_adhd_agents.pdf|02/13/2014| 12496009001|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016| 12496012001|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016| 12496120201|Buprenorphine Agents|https://paxpress.txpa.hidinc.com/buprenorphine_agents.pdf|04/23/2013| 12496120201|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017| 12496120203|Buprenorphine Agents|https://paxpress.txpa.hidinc.com/buprenorphine_agents.pdf|04/23/2013| 12496120203|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017| 12496120401|Buprenorphine Agents|https://paxpress.txpa.hidinc.com/buprenorphine_agents.pdf|04/23/2013| 12496120401|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017| 12496120403|Buprenorphine Agents|https://paxpress.txpa.hidinc.com/buprenorphine_agents.pdf|04/23/2013| 12496120403|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017| 12496120801|Buprenorphine Agents|https://paxpress.txpa.hidinc.com/buprenorphine_agents.pdf|04/23/2013| 12496120801|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017| 12496120803|Buprenorphine Agents|https://paxpress.txpa.hidinc.com/buprenorphine_agents.pdf|04/23/2013| 12496120803|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017| 12496121201|Buprenorphine Agents|https://paxpress.txpa.hidinc.com/buprenorphine_agents.pdf|04/23/2013| 12496121201|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017| 12496121203|Buprenorphine Agents|https://paxpress.txpa.hidinc.com/buprenorphine_agents.pdf|04/23/2013| 12496121203|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017| 12830076216|Cough and Cold Agents|https://paxpress.txpa.hidinc.com/Cough%20&%20Cold.pdf|12/15/2015| 12830076216|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 12830081616|Cough and Cold Agents|https://paxpress.txpa.hidinc.com/Cough%20&%20Cold.pdf|12/15/2015| 12830081616|Dextromethorphan Overutilization|https://paxpress.txpa.hidinc.com/dextro.pdf|07/16/2012| 12830081616|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 13107000401|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 13107000401|Opiate Overutilization|https://paxpress.txpa.hidinc.com/opiate.pdf|11/05/2013| 13107000401|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017| 13107000401|Opioid Clinical Policy (MME and days supply limits)|https://paxpress.txpa.hidinc.com/opc.pdf|09/01/2020| 13107001901|Opiate Overutilization|https://paxpress.txpa.hidinc.com/opiate.pdf|11/05/2013| 13107001901|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017| 13107001901|Opioid Clinical Policy (MME and days supply limits)|https://paxpress.txpa.hidinc.com/opc.pdf|09/01/2020| 13107001905|Opiate Overutilization|https://paxpress.txpa.hidinc.com/opiate.pdf|11/05/2013| 13107001905|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017| 13107001905|Opioid Clinical Policy (MME and days supply limits)|https://paxpress.txpa.hidinc.com/opc.pdf|09/01/2020| 13107002001|Opiate Overutilization|https://paxpress.txpa.hidinc.com/opiate.pdf|11/05/2013| 13107002001|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017| 13107002001|Opioid Clinical Policy (MME and days supply limits)|https://paxpress.txpa.hidinc.com/opc.pdf|09/01/2020| 13107002005|Opiate Overutilization|https://paxpress.txpa.hidinc.com/opiate.pdf|11/05/2013| 13107002005|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017| 13107002005|Opioid Clinical Policy (MME and days supply limits)|https://paxpress.txpa.hidinc.com/opc.pdf|09/01/2020| 13107002101|Opiate Overutilization|https://paxpress.txpa.hidinc.com/opiate.pdf|11/05/2013| 13107002101|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017| 13107002101|Opioid Clinical Policy (MME and days supply limits)|https://paxpress.txpa.hidinc.com/opc.pdf|09/01/2020| 13107002105|Opiate Overutilization|https://paxpress.txpa.hidinc.com/opiate.pdf|11/05/2013| 13107002105|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017| 13107002105|Opioid Clinical Policy (MME and days supply limits)|https://paxpress.txpa.hidinc.com/opc.pdf|09/01/2020| 13107002199|Opiate Overutilization|https://paxpress.txpa.hidinc.com/opiate.pdf|11/05/2013| 13107002199|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017| 13107002199|Opioid Clinical Policy (MME and days supply limits)|https://paxpress.txpa.hidinc.com/opc.pdf|09/01/2020| 13107003501|ADD/ADHD Agents|https://paxpress.txpa.hidinc.com/add_adhd_agents.pdf|02/13/2014| 13107003601|ADD/ADHD Agents|https://paxpress.txpa.hidinc.com/add_adhd_agents.pdf|02/13/2014| 13107004401|Opiate Overutilization|https://paxpress.txpa.hidinc.com/opiate.pdf|11/05/2013| 13107004401|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017| 13107004401|Opioid Clinical Policy (MME and days supply limits)|https://paxpress.txpa.hidinc.com/opc.pdf|09/01/2020| 13107004405|Opiate Overutilization|https://paxpress.txpa.hidinc.com/opiate.pdf|11/05/2013| 13107004405|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017| 13107004405|Opioid Clinical Policy (MME and days supply limits)|https://paxpress.txpa.hidinc.com/opc.pdf|09/01/2020| 13107004501|Opiate Overutilization|https://paxpress.txpa.hidinc.com/opiate.pdf|11/05/2013| 13107004501|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017| 13107004501|Opioid Clinical Policy (MME and days supply limits)|https://paxpress.txpa.hidinc.com/opc.pdf|09/01/2020| 13107004505|Opiate Overutilization|https://paxpress.txpa.hidinc.com/opiate.pdf|11/05/2013| 13107004505|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017| 13107004505|Opioid Clinical Policy (MME and days supply limits)|https://paxpress.txpa.hidinc.com/opc.pdf|09/01/2020| 13107004601|Opiate Overutilization|https://paxpress.txpa.hidinc.com/opiate.pdf|11/05/2013| 13107004601|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017| 13107004601|Opioid Clinical Policy (MME and days supply limits)|https://paxpress.txpa.hidinc.com/opc.pdf|09/01/2020| 13107004605|Opiate Overutilization|https://paxpress.txpa.hidinc.com/opiate.pdf|11/05/2013| 13107004605|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017| 13107004605|Opioid Clinical Policy (MME and days supply limits)|https://paxpress.txpa.hidinc.com/opc.pdf|09/01/2020| 13107005501|Opiate Overutilization|https://paxpress.txpa.hidinc.com/opiate.pdf|11/05/2013| 13107005501|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017| 13107005501|Opioid Clinical Policy (MME and days supply limits)|https://paxpress.txpa.hidinc.com/opc.pdf|09/01/2020| 13107005601|Opiate Overutilization|https://paxpress.txpa.hidinc.com/opiate.pdf|11/05/2013| 13107005601|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017| 13107005601|Opioid Clinical Policy (MME and days supply limits)|https://paxpress.txpa.hidinc.com/opc.pdf|09/01/2020| 13107005701|Opiate Overutilization|https://paxpress.txpa.hidinc.com/opiate.pdf|11/05/2013| 13107005701|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017| 13107005701|Opioid Clinical Policy (MME and days supply limits)|https://paxpress.txpa.hidinc.com/opc.pdf|09/01/2020| 13107005801|Opiate Overutilization|https://paxpress.txpa.hidinc.com/opiate.pdf|11/05/2013| 13107005801|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017| 13107005801|Opioid Clinical Policy (MME and days supply limits)|https://paxpress.txpa.hidinc.com/opc.pdf|09/01/2020| 13107005901|Opiate Overutilization|https://paxpress.txpa.hidinc.com/opiate.pdf|11/05/2013| 13107005901|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017| 13107005901|Opioid Clinical Policy (MME and days supply limits)|https://paxpress.txpa.hidinc.com/opc.pdf|09/01/2020| 13107005999|Opiate Overutilization|https://paxpress.txpa.hidinc.com/opiate.pdf|11/05/2013| 13107005999|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017| 13107005999|Opioid Clinical Policy (MME and days supply limits)|https://paxpress.txpa.hidinc.com/opc.pdf|09/01/2020| 13107006001|Opiate Overutilization|https://paxpress.txpa.hidinc.com/opiate.pdf|11/05/2013| 13107006001|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017| 13107006001|Opioid Clinical Policy (MME and days supply limits)|https://paxpress.txpa.hidinc.com/opc.pdf|09/01/2020| 13107006005|Opiate Overutilization|https://paxpress.txpa.hidinc.com/opiate.pdf|11/05/2013| 13107006005|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017| 13107006005|Opioid Clinical Policy (MME and days supply limits)|https://paxpress.txpa.hidinc.com/opc.pdf|09/01/2020| 13107006099|Opiate Overutilization|https://paxpress.txpa.hidinc.com/opiate.pdf|11/05/2013| 13107006099|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017| 13107006099|Opioid Clinical Policy (MME and days supply limits)|https://paxpress.txpa.hidinc.com/opc.pdf|09/01/2020| 13107006801|ADD/ADHD Agents|https://paxpress.txpa.hidinc.com/add_adhd_agents.pdf|02/13/2014| 13107007001|ADD/ADHD Agents|https://paxpress.txpa.hidinc.com/add_adhd_agents.pdf|02/13/2014| 13107007201|ADD/ADHD Agents|https://paxpress.txpa.hidinc.com/add_adhd_agents.pdf|02/13/2014| 13107007301|ADD/ADHD Agents|https://paxpress.txpa.hidinc.com/add_adhd_agents.pdf|02/13/2014| 13107007401|ADD/ADHD Agents|https://paxpress.txpa.hidinc.com/add_adhd_agents.pdf|02/13/2014| 13107008301|Anxiolytics and Sedative-Hypnotics|https://paxpress.txpa.hidinc.com/ash.pdf|01/31/2011| 13107008301|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017| 13107008305|Anxiolytics and Sedative-Hypnotics|https://paxpress.txpa.hidinc.com/ash.pdf|01/31/2011| 13107008305|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017| 13107008401|Anxiolytics and Sedative-Hypnotics|https://paxpress.txpa.hidinc.com/ash.pdf|01/31/2011| 13107008401|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017| 13107008405|Anxiolytics and Sedative-Hypnotics|https://paxpress.txpa.hidinc.com/ash.pdf|01/31/2011| 13107008405|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017| 13107008499|Anxiolytics and Sedative-Hypnotics|https://paxpress.txpa.hidinc.com/ash.pdf|01/31/2011| 13107008499|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017| 13107008501|Anxiolytics and Sedative-Hypnotics|https://paxpress.txpa.hidinc.com/ash.pdf|01/31/2011| 13107008501|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017| 13107008801|Opiate Overutilization|https://paxpress.txpa.hidinc.com/opiate.pdf|11/05/2013| 13107008801|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017| 13107008801|Opioid Clinical Policy (MME and days supply limits)|https://paxpress.txpa.hidinc.com/opc.pdf|09/01/2020| 13107008901|Opiate Overutilization|https://paxpress.txpa.hidinc.com/opiate.pdf|11/05/2013| 13107008901|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017| 13107008901|Opioid Clinical Policy (MME and days supply limits)|https://paxpress.txpa.hidinc.com/opc.pdf|09/01/2020| 13107010301|Opiate Overutilization|https://paxpress.txpa.hidinc.com/opiate.pdf|11/05/2013| 13107010301|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017| 13107010301|Opioid Clinical Policy (MME and days supply limits)|https://paxpress.txpa.hidinc.com/opc.pdf|09/01/2020| 13107010401|Opiate Overutilization|https://paxpress.txpa.hidinc.com/opiate.pdf|11/05/2013| 13107010401|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017| 13107010401|Opioid Clinical Policy (MME and days supply limits)|https://paxpress.txpa.hidinc.com/opc.pdf|09/01/2020| 13107010701|Opiate Overutilization|https://paxpress.txpa.hidinc.com/opiate.pdf|11/05/2013| 13107010701|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017| 13107010701|Opioid Clinical Policy (MME and days supply limits)|https://paxpress.txpa.hidinc.com/opc.pdf|09/01/2020| 13107010801|Opiate Overutilization|https://paxpress.txpa.hidinc.com/opiate.pdf|11/05/2013| 13107010801|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017| 13107010801|Opioid Clinical Policy (MME and days supply limits)|https://paxpress.txpa.hidinc.com/opc.pdf|09/01/2020| 13107010901|Opiate Overutilization|https://paxpress.txpa.hidinc.com/opiate.pdf|11/05/2013| 13107010901|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017| 13107010901|Opioid Clinical Policy (MME and days supply limits)|https://paxpress.txpa.hidinc.com/opc.pdf|09/01/2020| 13107021101|Opiate Overutilization|https://paxpress.txpa.hidinc.com/opiate.pdf|11/05/2013| 13107021101|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017| 13107021101|Opioid Clinical Policy (MME and days supply limits)|https://paxpress.txpa.hidinc.com/opc.pdf|09/01/2020| 13107021105|Opiate Overutilization|https://paxpress.txpa.hidinc.com/opiate.pdf|11/05/2013| 13107021105|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017| 13107021105|Opioid Clinical Policy (MME and days supply limits)|https://paxpress.txpa.hidinc.com/opc.pdf|09/01/2020| 13107021201|Opiate Overutilization|https://paxpress.txpa.hidinc.com/opiate.pdf|11/05/2013| 13107021201|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017| 13107021201|Opioid Clinical Policy (MME and days supply limits)|https://paxpress.txpa.hidinc.com/opc.pdf|09/01/2020| 13107021205|Opiate Overutilization|https://paxpress.txpa.hidinc.com/opiate.pdf|11/05/2013| 13107021205|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017| 13107021205|Opioid Clinical Policy (MME and days supply limits)|https://paxpress.txpa.hidinc.com/opc.pdf|09/01/2020| 13107021301|Opiate Overutilization|https://paxpress.txpa.hidinc.com/opiate.pdf|11/05/2013| 13107021301|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017| 13107021301|Opioid Clinical Policy (MME and days supply limits)|https://paxpress.txpa.hidinc.com/opc.pdf|09/01/2020| 13107021305|Opiate Overutilization|https://paxpress.txpa.hidinc.com/opiate.pdf|11/05/2013| 13107021305|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017| 13107021305|Opioid Clinical Policy (MME and days supply limits)|https://paxpress.txpa.hidinc.com/opc.pdf|09/01/2020| 13107026947|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 13107031901|Anxiolytics and Sedative-Hypnotics|https://paxpress.txpa.hidinc.com/ash.pdf|01/31/2011| 13107031901|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017| 13107031905|Anxiolytics and Sedative-Hypnotics|https://paxpress.txpa.hidinc.com/ash.pdf|01/31/2011| 13107031905|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017| 13107032001|Anxiolytics and Sedative-Hypnotics|https://paxpress.txpa.hidinc.com/ash.pdf|01/31/2011| 13107032001|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017| 13107032005|Anxiolytics and Sedative-Hypnotics|https://paxpress.txpa.hidinc.com/ash.pdf|01/31/2011| 13107032005|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017| 13107032101|Anxiolytics and Sedative-Hypnotics|https://paxpress.txpa.hidinc.com/ash.pdf|01/31/2011| 13107032101|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017| 13668000701|Anxiolytics and Sedative-Hypnotics|https://paxpress.txpa.hidinc.com/ash.pdf|01/31/2011| 13668000705|Anxiolytics and Sedative-Hypnotics|https://paxpress.txpa.hidinc.com/ash.pdf|01/31/2011| 13668000710|Anxiolytics and Sedative-Hypnotics|https://paxpress.txpa.hidinc.com/ash.pdf|01/31/2011| 13668000801|Anxiolytics and Sedative-Hypnotics|https://paxpress.txpa.hidinc.com/ash.pdf|01/31/2011| 13668000805|Anxiolytics and Sedative-Hypnotics|https://paxpress.txpa.hidinc.com/ash.pdf|01/31/2011| 13668000810|Anxiolytics and Sedative-Hypnotics|https://paxpress.txpa.hidinc.com/ash.pdf|01/31/2011| 13668003505|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016| 13668003560|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016| 13668003605|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016| 13668003660|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016| 13668003705|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016| 13668003760|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016| 13668003805|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016| 13668003860|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016| 13668003905|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016| 13668003960|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016| 13668004005|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016| 13668004060|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016| 13668006730|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 13668006890|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 13668006990|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 13668007090|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 13668007905|Leukotriene Modifiers|https://paxpress.txpa.hidinc.com/leukotriene.pdf|12/15/2015| 13668007930|Leukotriene Modifiers|https://paxpress.txpa.hidinc.com/leukotriene.pdf|12/15/2015| 13668007990|Leukotriene Modifiers|https://paxpress.txpa.hidinc.com/leukotriene.pdf|12/15/2015| 13668008005|Leukotriene Modifiers|https://paxpress.txpa.hidinc.com/leukotriene.pdf|12/15/2015| 13668008030|Leukotriene Modifiers|https://paxpress.txpa.hidinc.com/leukotriene.pdf|12/15/2015| 13668008090|Leukotriene Modifiers|https://paxpress.txpa.hidinc.com/leukotriene.pdf|12/15/2015| 13668008190|Leukotriene Modifiers|https://paxpress.txpa.hidinc.com/leukotriene.pdf|12/15/2015| 13668008630|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016| 13668008830|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016| 13668008930|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016| 13668009030|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016| 13668011310|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 13668011390|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 13668011510|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 13668011530|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 13668011590|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 13668011610|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 13668011630|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 13668011690|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 13668011710|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 13668011730|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 13668011790|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 13668011810|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 13668011830|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 13668011905|Thiazolidinediones|https://paxpress.txpa.hidinc.com/thiazolidinediones.pdf|01/31/2011| 13668011930|Thiazolidinediones|https://paxpress.txpa.hidinc.com/thiazolidinediones.pdf|01/31/2011| 13668011990|Thiazolidinediones|https://paxpress.txpa.hidinc.com/thiazolidinediones.pdf|01/31/2011| 13668012005|Thiazolidinediones|https://paxpress.txpa.hidinc.com/thiazolidinediones.pdf|01/31/2011| 13668012030|Thiazolidinediones|https://paxpress.txpa.hidinc.com/thiazolidinediones.pdf|01/31/2011| 13668012090|Thiazolidinediones|https://paxpress.txpa.hidinc.com/thiazolidinediones.pdf|01/31/2011| 13668014005|Thiazolidinediones|https://paxpress.txpa.hidinc.com/thiazolidinediones.pdf|01/31/2011| 13668014030|Thiazolidinediones|https://paxpress.txpa.hidinc.com/thiazolidinediones.pdf|01/31/2011| 13668014090|Thiazolidinediones|https://paxpress.txpa.hidinc.com/thiazolidinediones.pdf|01/31/2011| 13668015630|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 13668015730|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 13668015830|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 13668015930|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 13668016030|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 13668016130|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 13668016630|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016| 13668016730|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016| 13668016830|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016| 13668016930|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016| 13668017030|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016| 13668017130|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016| 13668017905|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/04/2016| 13668017990|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/04/2016| 13668018090|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/04/2016| 13668018190|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/04/2016| 13668018205|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/04/2016| 13668018230|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/04/2016| 13668018590|PDE5-Inhibitors|https://paxpress.txpa.hidinc.com/revatio.pdf|01/31/2011| 13668021630|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016| 13668021690|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016| 13668021730|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016| 13668021790|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016| 13668021830|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016| 13668021890|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016| 13668021930|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016| 13668021990|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016| 13668022030|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016| 13668022090|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016| 13668022130|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016| 13668022190|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016| 13668024830|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 13668024890|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 13668024930|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 13668024990|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 13668025030|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 13668025090|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 13668025130|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 13668025190|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 13668025230|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 13668025290|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 13668025330|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 13668025390|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 13668028033|Thiazolidinediones|https://paxpress.txpa.hidinc.com/thiazolidinediones.pdf|01/31/2011| 13668028060|Thiazolidinediones|https://paxpress.txpa.hidinc.com/thiazolidinediones.pdf|01/31/2011| 13668028133|Thiazolidinediones|https://paxpress.txpa.hidinc.com/thiazolidinediones.pdf|01/31/2011| 13668028160|Thiazolidinediones|https://paxpress.txpa.hidinc.com/thiazolidinediones.pdf|01/31/2011| 13668031130|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 13668031190|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 13668031230|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 13668031290|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 13668031330|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 13668031390|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 13668032430|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 13668032490|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 13668034330|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 13668034430|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 13668034530|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 13668034630|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 13668038230|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 13668038530|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 13668038630|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 13668039730|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 13668040910|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 13668040930|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 13668040990|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 13668044101|COX-2 Inhibitors|https://paxpress.txpa.hidinc.com/cox2.pdf|01/31/2011| 13668044101|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/04/2016| 13668053194|Leukotriene Modifiers|https://paxpress.txpa.hidinc.com/leukotriene.pdf|12/15/2015| 13668057710|Cough and Cold Agents|https://paxpress.txpa.hidinc.com/Cough%20&%20Cold.pdf|12/15/2015| 13668057710|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017| 13668057710|Opioid Clinical Policy (MME and days supply limits)|https://paxpress.txpa.hidinc.com/opc.pdf|09/01/2020| 13668058130|PDE5-Inhibitors|https://paxpress.txpa.hidinc.com/revatio.pdf|01/31/2011| 13668058906|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016| 13668059607|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 13811068930|Opiate Overutilization|https://paxpress.txpa.hidinc.com/opiate.pdf|11/05/2013| 13811068930|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017| 13811068930|Opioid Clinical Policy (MME and days supply limits)|https://paxpress.txpa.hidinc.com/opc.pdf|09/01/2020| 13811069030|Opiate Overutilization|https://paxpress.txpa.hidinc.com/opiate.pdf|11/05/2013| 13811069030|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017| 13811069030|Opioid Clinical Policy (MME and days supply limits)|https://paxpress.txpa.hidinc.com/opc.pdf|09/01/2020| 13811069130|Opiate Overutilization|https://paxpress.txpa.hidinc.com/opiate.pdf|11/05/2013| 13811069130|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017| 13811069130|Opioid Clinical Policy (MME and days supply limits)|https://paxpress.txpa.hidinc.com/opc.pdf|09/01/2020| 13811070110|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017| 13811070110|Opioid Clinical Policy (MME and days supply limits)|https://paxpress.txpa.hidinc.com/opc.pdf|09/01/2020| 13811070210|Opiate Overutilization|https://paxpress.txpa.hidinc.com/opiate.pdf|11/05/2013| 13811070210|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017| 13811070210|Opioid Clinical Policy (MME and days supply limits)|https://paxpress.txpa.hidinc.com/opc.pdf|09/01/2020| 13811070310|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017| 13811070310|Opioid Clinical Policy (MME and days supply limits)|https://paxpress.txpa.hidinc.com/opc.pdf|09/01/2020| 13811070410|Opiate Overutilization|https://paxpress.txpa.hidinc.com/opiate.pdf|11/05/2013| 13811070410|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017| 13811070410|Opioid Clinical Policy (MME and days supply limits)|https://paxpress.txpa.hidinc.com/opc.pdf|09/01/2020| 13811070610|ADD/ADHD Agents|https://paxpress.txpa.hidinc.com/add_adhd_agents.pdf|02/13/2014| 13811070710|ADD/ADHD Agents|https://paxpress.txpa.hidinc.com/add_adhd_agents.pdf|02/13/2014| 13811070810|ADD/ADHD Agents|https://paxpress.txpa.hidinc.com/add_adhd_agents.pdf|02/13/2014| 13811070910|ADD/ADHD Agents|https://paxpress.txpa.hidinc.com/add_adhd_agents.pdf|02/13/2014| 13811071710|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017| 13811071810|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017| 13925016604|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 14539067301|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 14539067306|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 14539067401|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 14539067405|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 14539067501|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 14539067505|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 15054104005|Increlex|https://paxpress.txpa.hidinc.com/increlex.pdf|01/31/2011| 15370013010|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 15370017030|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 15370018060|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 16571020106|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 16571020110|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 16571020111|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 16571020150|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 16571020206|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 16571020210|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 16571020211|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 16571020310|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 16571040110|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 16571040210|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 16571040250|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 16571066001|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 16571066050|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 16571066101|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 16571066110|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 16571068809|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 16571071601|Opiate Overutilization|https://paxpress.txpa.hidinc.com/opiate.pdf|11/05/2013| 16571071601|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017| 16571071601|Opioid Clinical Policy (MME and days supply limits)|https://paxpress.txpa.hidinc.com/opc.pdf|09/01/2020| 16571071610|Opiate Overutilization|https://paxpress.txpa.hidinc.com/opiate.pdf|11/05/2013| 16571071610|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017| 16571071610|Opioid Clinical Policy (MME and days supply limits)|https://paxpress.txpa.hidinc.com/opc.pdf|09/01/2020| 16571071650|Opiate Overutilization|https://paxpress.txpa.hidinc.com/opiate.pdf|11/05/2013| 16571071650|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017| 16571071650|Opioid Clinical Policy (MME and days supply limits)|https://paxpress.txpa.hidinc.com/opc.pdf|09/01/2020| 16571071701|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016| 16571071710|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016| 16571071801|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016| 16571071810|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016| 16571071901|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016| 16571071910|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016| 16571072001|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016| 16571072010|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016| 16571072106|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016| 16571072110|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016| 16571072201|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016| 16571072250|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016| 16571072501|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017| 16571072601|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017| 16571072701|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017| 16571073927|Phosphate Binders|https://paxpress.txpa.hidinc.com/phosphate_binders.pdf|01/31/2011|11/29/2023 16571075809|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 16571075909|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 16571078001|Carisoprodol Overuse|https://paxpress.txpa.hidinc.com/soma.pdf|01/31/2011| 16571078001|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017| 16571078101|Carisoprodol Overuse|https://paxpress.txpa.hidinc.com/soma.pdf|01/31/2011| 16571078101|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017| 16571078110|Carisoprodol Overuse|https://paxpress.txpa.hidinc.com/soma.pdf|01/31/2011| 16571078110|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017| 16571078150|Carisoprodol Overuse|https://paxpress.txpa.hidinc.com/soma.pdf|01/31/2011| 16571078150|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017| 16571078201|Cyclobenzaprine|https://paxpress.txpa.hidinc.com/cyclobenzaprine.pdf|01/31/2011| 16571078201|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017| 16571078210|Cyclobenzaprine|https://paxpress.txpa.hidinc.com/cyclobenzaprine.pdf|01/31/2011| 16571078210|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017| 16571078250|Cyclobenzaprine|https://paxpress.txpa.hidinc.com/cyclobenzaprine.pdf|01/31/2011| 16571078250|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017| 16571078301|Cyclobenzaprine|https://paxpress.txpa.hidinc.com/cyclobenzaprine.pdf|01/31/2011| 16571078301|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017| 16571078310|Cyclobenzaprine|https://paxpress.txpa.hidinc.com/cyclobenzaprine.pdf|01/31/2011| 16571078310|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017| 16571078350|Cyclobenzaprine|https://paxpress.txpa.hidinc.com/cyclobenzaprine.pdf|01/31/2011| 16571078350|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017| 16571080316|Antimigraine Agents Triptans|https://paxpress.txpa.hidinc.com/triptans.pdf|04/04/2023| 16571080413|Antimigraine Agents Triptans|https://paxpress.txpa.hidinc.com/triptans.pdf|04/04/2023| 16571080501|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 16571081320|Phosphate Binders|https://paxpress.txpa.hidinc.com/phosphate_binders.pdf|01/31/2011| 16571082201|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 16571082203|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 16571082230|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 16714000610|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 16714001501|Desmopressin|https://paxpress.txpa.hidinc.com/desmopressin.pdf|05/25/2012|05/31/2024 16714001610|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 16714001830|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|12/31/2024 16714001930|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 16714002030|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 16714002610|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 16714003610|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 16714004002|Antimigraine Agents Triptans|https://paxpress.txpa.hidinc.com/triptans.pdf|04/04/2023| 16714004610|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 16714004701|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016| 16714004801|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016| 16714004901|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016| 16714005001|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016| 16714005101|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016| 16714005610|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 16714006610|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 16714008110|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 16714008111|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 16714008210|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 16714008211|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 16714008212|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 16714008310|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 16714008311|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 16714011903|Inhaled Antibiotics Clinical|https://paxpress.txpa.hidinc.com/inhaledantibiotics.pdf|05/02/2023| 16714014101|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016| 16714014201|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016| 16714014301|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016| 16714014401|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016| 16714014501|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016| 16714014601|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016| 16714017301|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/04/2016| 16714017302|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/04/2016| 16714017303|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/04/2016| 16714017401|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/04/2016| 16714017402|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/04/2016| 16714017403|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/04/2016| 16714017501|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/04/2016| 16714017502|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/04/2016| 16714017503|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/04/2016| 16714017601|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/04/2016| 16714017602|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/04/2016| 16714017603|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/04/2016| 16714019001|ADD/ADHD Agents|https://paxpress.txpa.hidinc.com/add_adhd_agents.pdf|02/13/2014| 16714019101|ADD/ADHD Agents|https://paxpress.txpa.hidinc.com/add_adhd_agents.pdf|02/13/2014| 16714019201|ADD/ADHD Agents|https://paxpress.txpa.hidinc.com/add_adhd_agents.pdf|02/13/2014| 16714019301|ADD/ADHD Agents|https://paxpress.txpa.hidinc.com/add_adhd_agents.pdf|02/13/2014| 16714021301|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/04/2016| 16714021302|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/04/2016| 16714021303|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/04/2016| 16714033001|Gabapentin Agents|https://paxpress.txpa.hidinc.com/neurontin.pdf|01/31/2011| 16714033002|Gabapentin Agents|https://paxpress.txpa.hidinc.com/neurontin.pdf|01/31/2011| 16714033201|Gabapentin Agents|https://paxpress.txpa.hidinc.com/neurontin.pdf|01/31/2011| 16714033202|Gabapentin Agents|https://paxpress.txpa.hidinc.com/neurontin.pdf|01/31/2011| 16714045201|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016| 16714045202|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016| 16714045301|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016| 16714045302|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016|05/01/2025 16714045401|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016| 16714045402|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016| 16714045501|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016|06/30/2025 16714045601|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016| 16714045701|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016| 16714049701|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 16714049702|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 16714049801|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 16714049802|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 16714049901|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 16714049902|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 16714051001|Carisoprodol Overuse|https://paxpress.txpa.hidinc.com/soma.pdf|01/31/2011|02/29/2024 16714051001|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017|02/29/2024 16714055801|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/04/2016| 16714055802|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/04/2016| 16714055901|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/04/2016| 16714055902|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/04/2016| 16714056001|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/04/2016| 16714056002|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/04/2016| 16714056201|ADD/ADHD Agents|https://paxpress.txpa.hidinc.com/add_adhd_agents.pdf|02/13/2014| 16714056301|ADD/ADHD Agents|https://paxpress.txpa.hidinc.com/add_adhd_agents.pdf|02/13/2014| 16714056401|ADD/ADHD Agents|https://paxpress.txpa.hidinc.com/add_adhd_agents.pdf|02/13/2014| 16714056501|ADD/ADHD Agents|https://paxpress.txpa.hidinc.com/add_adhd_agents.pdf|02/13/2014| 16714056601|ADD/ADHD Agents|https://paxpress.txpa.hidinc.com/add_adhd_agents.pdf|02/13/2014| 16714056701|ADD/ADHD Agents|https://paxpress.txpa.hidinc.com/add_adhd_agents.pdf|02/13/2014| 16714056801|ADD/ADHD Agents|https://paxpress.txpa.hidinc.com/add_adhd_agents.pdf|02/13/2014| 16714056901|ADD/ADHD Agents|https://paxpress.txpa.hidinc.com/add_adhd_agents.pdf|02/13/2014| 16714057001|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/04/2016| 16714057002|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/04/2016| 16714062101|Anxiolytics and Sedative-Hypnotics|https://paxpress.txpa.hidinc.com/ash.pdf|01/31/2011| 16714062102|Anxiolytics and Sedative-Hypnotics|https://paxpress.txpa.hidinc.com/ash.pdf|01/31/2011| 16714062201|Anxiolytics and Sedative-Hypnotics|https://paxpress.txpa.hidinc.com/ash.pdf|01/31/2011| 16714062202|Anxiolytics and Sedative-Hypnotics|https://paxpress.txpa.hidinc.com/ash.pdf|01/31/2011| 16714064501|Thiazolidinediones|https://paxpress.txpa.hidinc.com/thiazolidinediones.pdf|01/31/2011| 16714064502|Thiazolidinediones|https://paxpress.txpa.hidinc.com/thiazolidinediones.pdf|01/31/2011| 16714064503|Thiazolidinediones|https://paxpress.txpa.hidinc.com/thiazolidinediones.pdf|01/31/2011| 16714064601|Thiazolidinediones|https://paxpress.txpa.hidinc.com/thiazolidinediones.pdf|01/31/2011| 16714064602|Thiazolidinediones|https://paxpress.txpa.hidinc.com/thiazolidinediones.pdf|01/31/2011| 16714064603|Thiazolidinediones|https://paxpress.txpa.hidinc.com/thiazolidinediones.pdf|01/31/2011| 16714064701|Thiazolidinediones|https://paxpress.txpa.hidinc.com/thiazolidinediones.pdf|01/31/2011| 16714064702|Thiazolidinediones|https://paxpress.txpa.hidinc.com/thiazolidinediones.pdf|01/31/2011| 16714064703|Thiazolidinediones|https://paxpress.txpa.hidinc.com/thiazolidinediones.pdf|01/31/2011| 16714066101|Gabapentin Agents|https://paxpress.txpa.hidinc.com/neurontin.pdf|01/31/2011| 16714066102|Gabapentin Agents|https://paxpress.txpa.hidinc.com/neurontin.pdf|01/31/2011| 16714066201|Gabapentin Agents|https://paxpress.txpa.hidinc.com/neurontin.pdf|01/31/2011| 16714066202|Gabapentin Agents|https://paxpress.txpa.hidinc.com/neurontin.pdf|01/31/2011| 16714066302|Gabapentin Agents|https://paxpress.txpa.hidinc.com/neurontin.pdf|01/31/2011| 16714067201|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016|01/31/2024 16714067301|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016|01/31/2024 16714067401|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016|04/30/2024 16714067402|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016|12/31/2023 16714067501|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016|12/31/2023 16714067502|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016|12/31/2023 16714068101|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/04/2016| 16714068102|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/04/2016| 16714068201|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/04/2016| 16714068202|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/04/2016| 16714068203|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/04/2016| 16714068301|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/04/2016| 16714068302|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/04/2016| 16714068303|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/04/2016| 16714068401|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/04/2016| 16714068402|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/04/2016| 16714068403|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/04/2016| 16714068501|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/04/2016| 16714068502|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/04/2016| 16714068503|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/04/2016| 16714073101|COX-2 Inhibitors|https://paxpress.txpa.hidinc.com/cox2.pdf|01/31/2011| 16714073101|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/04/2016| 16714073201|COX-2 Inhibitors|https://paxpress.txpa.hidinc.com/cox2.pdf|01/31/2011| 16714073201|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/04/2016| 16714073202|COX-2 Inhibitors|https://paxpress.txpa.hidinc.com/cox2.pdf|01/31/2011| 16714073202|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/04/2016| 16714073301|COX-2 Inhibitors|https://paxpress.txpa.hidinc.com/cox2.pdf|01/31/2011| 16714073301|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/04/2016| 16714073302|COX-2 Inhibitors|https://paxpress.txpa.hidinc.com/cox2.pdf|01/31/2011| 16714073302|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/04/2016| 16714073401|COX-2 Inhibitors|https://paxpress.txpa.hidinc.com/cox2.pdf|01/31/2011| 16714073401|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/04/2016| 16714075501|ADD/ADHD Agents|https://paxpress.txpa.hidinc.com/add_adhd_agents.pdf|02/13/2014| 16714075601|ADD/ADHD Agents|https://paxpress.txpa.hidinc.com/add_adhd_agents.pdf|02/13/2014| 16714075701|ADD/ADHD Agents|https://paxpress.txpa.hidinc.com/add_adhd_agents.pdf|02/13/2014| 16714075801|ADD/ADHD Agents|https://paxpress.txpa.hidinc.com/add_adhd_agents.pdf|02/13/2014| 16714075901|ADD/ADHD Agents|https://paxpress.txpa.hidinc.com/add_adhd_agents.pdf|02/13/2014| 16714076001|ADD/ADHD Agents|https://paxpress.txpa.hidinc.com/add_adhd_agents.pdf|02/13/2014| 16714076101|ADD/ADHD Agents|https://paxpress.txpa.hidinc.com/add_adhd_agents.pdf|02/13/2014| 16714077801|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 16714077802|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 16714077901|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 16714077902|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 16714078001|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 16714078002|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 16714078101|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 16714078102|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 16714078501|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016|10/31/2023 16714079601|Antimigraine Agents Triptans|https://paxpress.txpa.hidinc.com/triptans.pdf|04/04/2023| 16714079701|Antimigraine Agents Triptans|https://paxpress.txpa.hidinc.com/triptans.pdf|04/04/2023| 16714079801|Antimigraine Agents Triptans|https://paxpress.txpa.hidinc.com/triptans.pdf|04/04/2023| 16714079901|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 16714079902|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 16714079903|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 16714079904|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 16714080501|ADD/ADHD Agents|https://paxpress.txpa.hidinc.com/add_adhd_agents.pdf|02/13/2014| 16714080801|ADD/ADHD Agents|https://paxpress.txpa.hidinc.com/add_adhd_agents.pdf|02/13/2014| 16714081401|Phosphate Binders|https://paxpress.txpa.hidinc.com/phosphate_binders.pdf|01/31/2011| 16714082101|ADD/ADHD Agents|https://paxpress.txpa.hidinc.com/add_adhd_agents.pdf|02/13/2014|06/30/2024 16714082201|ADD/ADHD Agents|https://paxpress.txpa.hidinc.com/add_adhd_agents.pdf|02/13/2014|04/30/2024 16714082301|ADD/ADHD Agents|https://paxpress.txpa.hidinc.com/add_adhd_agents.pdf|02/13/2014|04/30/2024 16714082901|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 16714083501|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016| 16714083601|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016| 16714083701|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016| 16714083801|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016| 16714086601|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016| 16714086701|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016| 16714086801|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016| 16714086901|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016| 16714088301|Desmopressin|https://paxpress.txpa.hidinc.com/desmopressin.pdf|05/25/2012| 16714088401|Desmopressin|https://paxpress.txpa.hidinc.com/desmopressin.pdf|05/25/2012| 16714089101|Antimigraine Agents Triptans|https://paxpress.txpa.hidinc.com/triptans.pdf|04/04/2023| 16714089101|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 16714089801|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 16714089802|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 16714089803|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 16714089901|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 16714089902|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 16714093601|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 16714093701|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 16714094801|ADD/ADHD Agents|https://paxpress.txpa.hidinc.com/add_adhd_agents.pdf|02/13/2014| 16714094901|ADD/ADHD Agents|https://paxpress.txpa.hidinc.com/add_adhd_agents.pdf|02/13/2014| 16714095001|ADD/ADHD Agents|https://paxpress.txpa.hidinc.com/add_adhd_agents.pdf|02/13/2014| 16714095201|ADD/ADHD Agents|https://paxpress.txpa.hidinc.com/add_adhd_agents.pdf|02/13/2014| 16714095301|ADD/ADHD Agents|https://paxpress.txpa.hidinc.com/add_adhd_agents.pdf|02/13/2014| 16714095401|ADD/ADHD Agents|https://paxpress.txpa.hidinc.com/add_adhd_agents.pdf|02/13/2014|12/31/2023 16714098801|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/04/2016| 16714098901|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/04/2016| 16714099001|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/04/2016| 16714099101|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/04/2016| 16729000415|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/04/2016| 16729000417|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/04/2016| 16729000515|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/04/2016| 16729000517|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/04/2016| 16729000615|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/04/2016| 16729000617|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/04/2016| 16729000715|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/04/2016| 16729000717|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/04/2016| 16729000815|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/04/2016| 16729000816|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/04/2016| 16729000915|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/04/2016| 16729000916|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/04/2016| 16729000917|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/04/2016| 16729001015|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/04/2016| 16729001016|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/04/2016| 16729001017|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/04/2016| 16729001115|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/04/2016| 16729001116|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/04/2016| 16729002015|Thiazolidinediones|https://paxpress.txpa.hidinc.com/thiazolidinediones.pdf|01/31/2011| 16729002016|Thiazolidinediones|https://paxpress.txpa.hidinc.com/thiazolidinediones.pdf|01/31/2011| 16729002115|Thiazolidinediones|https://paxpress.txpa.hidinc.com/thiazolidinediones.pdf|01/31/2011| 16729002116|Thiazolidinediones|https://paxpress.txpa.hidinc.com/thiazolidinediones.pdf|01/31/2011| 16729002215|Thiazolidinediones|https://paxpress.txpa.hidinc.com/thiazolidinediones.pdf|01/31/2011| 16729002216|Thiazolidinediones|https://paxpress.txpa.hidinc.com/thiazolidinediones.pdf|01/31/2011| 16729004415|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/04/2016| 16729004417|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/04/2016| 16729004515|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/04/2016| 16729004517|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/04/2016| 16729004615|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/04/2016| 16729004617|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/04/2016| 16729004715|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/04/2016| 16729004716|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/04/2016| 16729009512|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016| 16729009612|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016| 16729009712|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016| 16729010912|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016| 16729011910|Leukotriene Modifiers|https://paxpress.txpa.hidinc.com/leukotriene.pdf|12/15/2015| 16729011915|Leukotriene Modifiers|https://paxpress.txpa.hidinc.com/leukotriene.pdf|12/15/2015| 16729011917|Leukotriene Modifiers|https://paxpress.txpa.hidinc.com/leukotriene.pdf|12/15/2015| 16729013212|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016| 16729013600|Anxiolytics and Sedative-Hypnotics|https://paxpress.txpa.hidinc.com/ash.pdf|01/31/2011| 16729013600|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017| 16729013616|Anxiolytics and Sedative-Hypnotics|https://paxpress.txpa.hidinc.com/ash.pdf|01/31/2011| 16729013616|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017| 16729013700|Anxiolytics and Sedative-Hypnotics|https://paxpress.txpa.hidinc.com/ash.pdf|01/31/2011| 16729013700|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017| 16729013716|Anxiolytics and Sedative-Hypnotics|https://paxpress.txpa.hidinc.com/ash.pdf|01/31/2011| 16729013716|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017| 16729013800|Anxiolytics and Sedative-Hypnotics|https://paxpress.txpa.hidinc.com/ash.pdf|01/31/2011| 16729013800|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017| 16729013816|Anxiolytics and Sedative-Hypnotics|https://paxpress.txpa.hidinc.com/ash.pdf|01/31/2011| 16729013816|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017| 16729014101|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016| 16729014116|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016| 16729014201|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016| 16729014216|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016| 16729014501|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016| 16729014517|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016| 16729014601|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016| 16729014617|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016| 16729014701|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016| 16729014717|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016| 16729014801|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016| 16729014817|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016| 16729014912|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016| 16729014917|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016| 16729015001|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016| 16729015016|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016| 16729015615|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/04/2016| 16729018201|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 16729018217|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 16729018301|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 16729018317|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 16729018401|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 16729018417|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 16729027801|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016| 16729027810|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016| 16729027901|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016| 16729027910|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016| 16729028001|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016| 16729028010|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016| 16729028101|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016| 16729028110|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016| 16729028201|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016| 16729028210|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016| 16729028301|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016| 16729028310|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016| 16729028415|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/04/2016| 16729028417|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/04/2016| 16729028515|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/04/2016| 16729028517|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/04/2016| 16729028615|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/04/2016| 16729028617|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/04/2016| 16729028710|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/04/2016| 16729028715|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/04/2016| 16729028717|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/04/2016| 16729032110|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 16729032115|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 16729032117|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 16729032210|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 16729032215|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 16729032217|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 16729036615|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 16729036715|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 16729036815|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 16729042101|Topical Immunomodulators|https://paxpress.txpa.hidinc.com/immunomodulators.pdf|01/31/2011| 16729042110|Topical Immunomodulators|https://paxpress.txpa.hidinc.com/immunomodulators.pdf|01/31/2011| 16729042112|Topical Immunomodulators|https://paxpress.txpa.hidinc.com/immunomodulators.pdf|01/31/2011| 16729042201|Topical Immunomodulators|https://paxpress.txpa.hidinc.com/immunomodulators.pdf|01/31/2011| 16729042210|Topical Immunomodulators|https://paxpress.txpa.hidinc.com/immunomodulators.pdf|01/31/2011| 16729042212|Topical Immunomodulators|https://paxpress.txpa.hidinc.com/immunomodulators.pdf|01/31/2011| 16729047801|ADD/ADHD Agents|https://paxpress.txpa.hidinc.com/add_adhd_agents.pdf|02/13/2014| 16729047901|ADD/ADHD Agents|https://paxpress.txpa.hidinc.com/add_adhd_agents.pdf|02/13/2014| 16729048001|ADD/ADHD Agents|https://paxpress.txpa.hidinc.com/add_adhd_agents.pdf|02/13/2014| 16729054910|Buprenorphine Agents|https://paxpress.txpa.hidinc.com/buprenorphine_agents.pdf|04/23/2013| 16729054910|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017| 16729055010|Buprenorphine Agents|https://paxpress.txpa.hidinc.com/buprenorphine_agents.pdf|04/23/2013| 16729055010|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017| 17478017224|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|02/23/2024 17478017324|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|02/23/2024 17478017424|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|02/23/2024 17772013130|ADD/ADHD Agents|https://paxpress.txpa.hidinc.com/add_adhd_agents.pdf|10/26/2022| 17772013230|ADD/ADHD Agents|https://paxpress.txpa.hidinc.com/add_adhd_agents.pdf|10/26/2022| 17772013330|ADD/ADHD Agents|https://paxpress.txpa.hidinc.com/add_adhd_agents.pdf|10/26/2022| 21724070105|ADD/ADHD Agents|https://paxpress.txpa.hidinc.com/add_adhd_agents.pdf|02/13/2014| 21922000909|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 23155000810|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 23155000910|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 23155002101|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 23155002201|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 23155005419|Antimigraine Agents Triptans|https://paxpress.txpa.hidinc.com/triptans.pdf|04/04/2023| 23155005519|Antimigraine Agents Triptans|https://paxpress.txpa.hidinc.com/triptans.pdf|04/04/2023| 23155048901|Desmopressin|https://paxpress.txpa.hidinc.com/desmopressin.pdf|05/25/2012| 23155049001|Desmopressin|https://paxpress.txpa.hidinc.com/desmopressin.pdf|05/25/2012| 23155050001|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 23155050005|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 23155050010|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 23155050101|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 23155050105|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 23155050110|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 23155050201|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 23155050205|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 23155053102|Phosphate Binders|https://paxpress.txpa.hidinc.com/phosphate_binders.pdf|01/31/2011| 23155060403|CNS Stimulants|https://paxpress.txpa.hidinc.com/provigil.pdf|11/06/2012| 23155060409|CNS Stimulants|https://paxpress.txpa.hidinc.com/provigil.pdf|11/06/2012| 23155060503|CNS Stimulants|https://paxpress.txpa.hidinc.com/provigil.pdf|11/06/2012| 23155060509|CNS Stimulants|https://paxpress.txpa.hidinc.com/provigil.pdf|11/06/2012| 23155062102|Phosphate Binders|https://paxpress.txpa.hidinc.com/phosphate_binders.pdf|01/31/2011| 23155070301|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 23155079901|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016| 23155080001|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016| 23155080101|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016| 23155080201|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016| 23155080801|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017| 23155084012|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 23155084403|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 23155084409|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 23155084503|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 23155084509|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 23155084603|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 23155084609|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 23155084703|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 23155084709|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 23359003216|Cough and Cold Agents|https://paxpress.txpa.hidinc.com/Cough%20&%20Cold.pdf|12/15/2015| 23359003216|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 23594010105|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 23594050501|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|11/15/2023 23635058110|Opiate Overutilization|https://paxpress.txpa.hidinc.com/opiate.pdf|11/05/2013| 23635058110|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017| 23635058110|Opioid Clinical Policy (MME and days supply limits)|https://paxpress.txpa.hidinc.com/opc.pdf|09/01/2020| 23635058210|Opiate Overutilization|https://paxpress.txpa.hidinc.com/opiate.pdf|11/05/2013| 23635058210|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017| 23635058210|Opioid Clinical Policy (MME and days supply limits)|https://paxpress.txpa.hidinc.com/opc.pdf|09/01/2020| 24338003101|ADD/ADHD Agents|https://paxpress.txpa.hidinc.com/add_adhd_agents.pdf|12/18/2019| 24338003301|ADD/ADHD Agents|https://paxpress.txpa.hidinc.com/add_adhd_agents.pdf|12/18/2019| 24338003501|ADD/ADHD Agents|https://paxpress.txpa.hidinc.com/add_adhd_agents.pdf|12/18/2019| 24338003702|ADD/ADHD Agents|https://paxpress.txpa.hidinc.com/add_adhd_agents.pdf|12/18/2019| 24338085003|ADD/ADHD Agents|https://paxpress.txpa.hidinc.com/add_adhd_agents.pdf|02/13/2014| 24338085103|ADD/ADHD Agents|https://paxpress.txpa.hidinc.com/add_adhd_agents.pdf|02/13/2014| 24338085203|ADD/ADHD Agents|https://paxpress.txpa.hidinc.com/add_adhd_agents.pdf|02/13/2014| 24338085303|ADD/ADHD Agents|https://paxpress.txpa.hidinc.com/add_adhd_agents.pdf|02/13/2014| 24338085403|ADD/ADHD Agents|https://paxpress.txpa.hidinc.com/add_adhd_agents.pdf|02/13/2014| 24338085503|ADD/ADHD Agents|https://paxpress.txpa.hidinc.com/add_adhd_agents.pdf|02/13/2014| 24338085603|ADD/ADHD Agents|https://paxpress.txpa.hidinc.com/add_adhd_agents.pdf|02/13/2014| 24385035926|Cough and Cold Agents|https://paxpress.txpa.hidinc.com/Cough%20&%20Cold.pdf|12/15/2015|10/31/2023 24385035926|Dextromethorphan Overutilization|https://paxpress.txpa.hidinc.com/dextro.pdf|07/16/2012|10/31/2023 24385035934|Cough and Cold Agents|https://paxpress.txpa.hidinc.com/Cough%20&%20Cold.pdf|12/15/2015|08/23/2023 24385035934|Dextromethorphan Overutilization|https://paxpress.txpa.hidinc.com/dextro.pdf|07/16/2012|08/23/2023 24385047199|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 24385053126|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 24385060471|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 24385060478|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 24385064771|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 24385064778|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 24385099865|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 24385099875|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 24478007401|ADD/ADHD Agents|https://paxpress.txpa.hidinc.com/add_adhd_agents.pdf|02/13/2014| 24478007501|ADD/ADHD Agents|https://paxpress.txpa.hidinc.com/add_adhd_agents.pdf|02/13/2014| 24478007601|ADD/ADHD Agents|https://paxpress.txpa.hidinc.com/add_adhd_agents.pdf|02/13/2014| 24478010201|ADD/ADHD Agents|https://paxpress.txpa.hidinc.com/add_adhd_agents.pdf|01/26/2017| 24478032102|ADD/ADHD Agents|https://paxpress.txpa.hidinc.com/add_adhd_agents.pdf|02/13/2014| 24478032204|ADD/ADHD Agents|https://paxpress.txpa.hidinc.com/add_adhd_agents.pdf|02/13/2014| 24478032305|ADD/ADHD Agents|https://paxpress.txpa.hidinc.com/add_adhd_agents.pdf|02/13/2014| 24478032406|ADD/ADHD Agents|https://paxpress.txpa.hidinc.com/add_adhd_agents.pdf|02/13/2014| 24492085056|Inhaled Antibiotics Clinical|https://paxpress.txpa.hidinc.com/inhaledantibiotics.pdf|05/02/2023| 24510005010|Opiate Overutilization|https://paxpress.txpa.hidinc.com/opiate.pdf|11/05/2013| 24510005010|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017| 24510005010|Opioid Clinical Policy (MME and days supply limits)|https://paxpress.txpa.hidinc.com/opc.pdf|09/01/2020| 24510005860|Opiate Overutilization|https://paxpress.txpa.hidinc.com/opiate.pdf|11/05/2013| 24510005860|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017| 24510005860|Opioid Clinical Policy (MME and days supply limits)|https://paxpress.txpa.hidinc.com/opc.pdf|09/01/2020| 24510007510|Opiate Overutilization|https://paxpress.txpa.hidinc.com/opiate.pdf|11/05/2013| 24510007510|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017| 24510007510|Opioid Clinical Policy (MME and days supply limits)|https://paxpress.txpa.hidinc.com/opc.pdf|09/01/2020| 24510010010|Opiate Overutilization|https://paxpress.txpa.hidinc.com/opiate.pdf|11/05/2013| 24510010010|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017| 24510010010|Opioid Clinical Policy (MME and days supply limits)|https://paxpress.txpa.hidinc.com/opc.pdf|09/01/2020| 24510011010|Opiate Overutilization|https://paxpress.txpa.hidinc.com/opiate.pdf|11/05/2013| 24510011010|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017| 24510011010|Opioid Clinical Policy (MME and days supply limits)|https://paxpress.txpa.hidinc.com/opc.pdf|09/01/2020| 24510011010|Oxycontin / Narcotic Analgesic|https://paxpress.txpa.hidinc.com/oxycontin.pdf|01/31/2011| 24510011510|Opiate Overutilization|https://paxpress.txpa.hidinc.com/opiate.pdf|11/05/2013| 24510011510|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017| 24510011510|Opioid Clinical Policy (MME and days supply limits)|https://paxpress.txpa.hidinc.com/opc.pdf|09/01/2020| 24510011510|Oxycontin / Narcotic Analgesic|https://paxpress.txpa.hidinc.com/oxycontin.pdf|01/31/2011| 24510011660|Opiate Overutilization|https://paxpress.txpa.hidinc.com/opiate.pdf|11/05/2013| 24510011660|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017| 24510011660|Opioid Clinical Policy (MME and days supply limits)|https://paxpress.txpa.hidinc.com/opc.pdf|09/01/2020| 24510012010|Opiate Overutilization|https://paxpress.txpa.hidinc.com/opiate.pdf|11/05/2013| 24510012010|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017| 24510012010|Opioid Clinical Policy (MME and days supply limits)|https://paxpress.txpa.hidinc.com/opc.pdf|09/01/2020| 24510012010|Oxycontin / Narcotic Analgesic|https://paxpress.txpa.hidinc.com/oxycontin.pdf|01/31/2011| 24510013010|Opiate Overutilization|https://paxpress.txpa.hidinc.com/opiate.pdf|11/05/2013| 24510013010|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017| 24510013010|Opioid Clinical Policy (MME and days supply limits)|https://paxpress.txpa.hidinc.com/opc.pdf|09/01/2020| 24510013010|Oxycontin / Narcotic Analgesic|https://paxpress.txpa.hidinc.com/oxycontin.pdf|01/31/2011| 24510014010|Opiate Overutilization|https://paxpress.txpa.hidinc.com/opiate.pdf|11/05/2013| 24510014010|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017| 24510014010|Opioid Clinical Policy (MME and days supply limits)|https://paxpress.txpa.hidinc.com/opc.pdf|09/01/2020| 24510014010|Oxycontin / Narcotic Analgesic|https://paxpress.txpa.hidinc.com/oxycontin.pdf|01/31/2011| 24510017460|Opiate Overutilization|https://paxpress.txpa.hidinc.com/opiate.pdf|11/05/2013| 24510017460|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017| 24510017460|Opioid Clinical Policy (MME and days supply limits)|https://paxpress.txpa.hidinc.com/opc.pdf|09/01/2020| 24510023260|Opiate Overutilization|https://paxpress.txpa.hidinc.com/opiate.pdf|11/05/2013| 24510023260|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017| 24510023260|Opioid Clinical Policy (MME and days supply limits)|https://paxpress.txpa.hidinc.com/opc.pdf|09/01/2020| 24510029160|Opiate Overutilization|https://paxpress.txpa.hidinc.com/opiate.pdf|11/05/2013| 24510029160|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017| 24510029160|Opioid Clinical Policy (MME and days supply limits)|https://paxpress.txpa.hidinc.com/opc.pdf|09/01/2020| 24979003504|Cyclobenzaprine|https://paxpress.txpa.hidinc.com/cyclobenzaprine.pdf|01/31/2011| 24979003504|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017| 24979003604|Cyclobenzaprine|https://paxpress.txpa.hidinc.com/cyclobenzaprine.pdf|01/31/2011| 24979003604|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017| 24979013601|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016| 24979013701|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016| 24979013801|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016| 24979013901|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016| 24979018646|Phosphate Binders|https://paxpress.txpa.hidinc.com/phosphate_binders.pdf|01/31/2011| 24979053301|ADD/ADHD Agents|https://paxpress.txpa.hidinc.com/add_adhd_agents.pdf|02/13/2014| 24979053401|ADD/ADHD Agents|https://paxpress.txpa.hidinc.com/add_adhd_agents.pdf|02/13/2014| 24979053601|ADD/ADHD Agents|https://paxpress.txpa.hidinc.com/add_adhd_agents.pdf|02/13/2014| 24979053801|ADD/ADHD Agents|https://paxpress.txpa.hidinc.com/add_adhd_agents.pdf|02/13/2014| 25208020109|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/04/2016| 25208020209|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/04/2016| 25682001012|Enzymes|https://paxpress.txpa.hidinc.com/enzymes.pdf|06/30/2021| 25682001312|Enzymes|https://paxpress.txpa.hidinc.com/enzymes.pdf|06/30/2021| 25682001612|Enzymes|https://paxpress.txpa.hidinc.com/enzymes.pdf|06/30/2021| 25682001912|Enzymes|https://paxpress.txpa.hidinc.com/enzymes.pdf|06/30/2021| 27241000106|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016| 27241000150|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016| 27241000206|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016| 27241000250|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016| 27241000306|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016| 27241000350|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016| 27241000406|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016| 27241000450|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016| 27241000506|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016| 27241000550|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016| 27241000606|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016| 27241000650|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016| 27241001531|Leukotriene Modifiers|https://paxpress.txpa.hidinc.com/leukotriene.pdf|12/15/2015| 27241002168|Antimigraine Agents Triptans|https://paxpress.txpa.hidinc.com/triptans.pdf|04/04/2023| 27241002238|Antimigraine Agents Triptans|https://paxpress.txpa.hidinc.com/triptans.pdf|04/04/2023| 27241003911|Antimigraine Agents Triptans|https://paxpress.txpa.hidinc.com/triptans.pdf|04/04/2023| 27241004011|Antimigraine Agents Triptans|https://paxpress.txpa.hidinc.com/triptans.pdf|04/04/2023| 27241004021|Antimigraine Agents Triptans|https://paxpress.txpa.hidinc.com/triptans.pdf|04/04/2023| 27241004111|Antimigraine Agents Triptans|https://paxpress.txpa.hidinc.com/triptans.pdf|04/04/2023| 27241004221|Antimigraine Agents Triptans|https://paxpress.txpa.hidinc.com/triptans.pdf|04/04/2023| 27241005103|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016| 27241005108|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016| 27241005203|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016| 27241005208|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016| 27241005303|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016| 27241005308|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016| 27241005403|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016| 27241005408|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016| 27241005503|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016| 27241005508|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016| 27241005603|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016| 27241005608|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016| 27241008303|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 27241008309|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 27241008403|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 27241008409|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 27241008503|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 27241008509|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 27241008603|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 27241008609|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 27241010806|ADD/ADHD Agents|https://paxpress.txpa.hidinc.com/add_adhd_agents.pdf|02/13/2014| 27241011105|PDE5-Inhibitors|https://paxpress.txpa.hidinc.com/revatio.pdf|01/31/2011| 27241011205|PDE5-Inhibitors|https://paxpress.txpa.hidinc.com/revatio.pdf|11/04/2019| 27241011305|PDE5-Inhibitors|https://paxpress.txpa.hidinc.com/revatio.pdf|01/31/2011| 27241011405|PDE5-Inhibitors|https://paxpress.txpa.hidinc.com/revatio.pdf|01/31/2011| 27241012302|PDE5-Inhibitors|https://paxpress.txpa.hidinc.com/revatio.pdf|01/31/2011| 27241012403|PDE5-Inhibitors|https://paxpress.txpa.hidinc.com/revatio.pdf|01/31/2011| 27241012502|Ranexa|https://paxpress.txpa.hidinc.com/ranexa.pdf|05/25/2012| 27241012602|Ranexa|https://paxpress.txpa.hidinc.com/ranexa.pdf|05/25/2012| 27241017529|PDE5-Inhibitors|https://paxpress.txpa.hidinc.com/revatio.pdf|09/01/2015| 27241020260|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 27241020360|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 27808000201|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016| 27808003501|Opiate Overutilization|https://paxpress.txpa.hidinc.com/opiate.pdf|11/05/2013| 27808003501|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017| 27808003501|Opioid Clinical Policy (MME and days supply limits)|https://paxpress.txpa.hidinc.com/opc.pdf|09/01/2020| 27808003502|Opiate Overutilization|https://paxpress.txpa.hidinc.com/opiate.pdf|11/05/2013| 27808003502|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017| 27808003502|Opioid Clinical Policy (MME and days supply limits)|https://paxpress.txpa.hidinc.com/opc.pdf|09/01/2020| 27808003503|Opiate Overutilization|https://paxpress.txpa.hidinc.com/opiate.pdf|11/05/2013| 27808003503|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017| 27808003503|Opioid Clinical Policy (MME and days supply limits)|https://paxpress.txpa.hidinc.com/opc.pdf|09/01/2020| 27808003601|Opiate Overutilization|https://paxpress.txpa.hidinc.com/opiate.pdf|11/05/2013| 27808003601|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017| 27808003601|Opioid Clinical Policy (MME and days supply limits)|https://paxpress.txpa.hidinc.com/opc.pdf|09/01/2020| 27808003602|Opiate Overutilization|https://paxpress.txpa.hidinc.com/opiate.pdf|11/05/2013| 27808003602|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017| 27808003602|Opioid Clinical Policy (MME and days supply limits)|https://paxpress.txpa.hidinc.com/opc.pdf|09/01/2020| 27808003603|Opiate Overutilization|https://paxpress.txpa.hidinc.com/opiate.pdf|11/05/2013| 27808003603|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017| 27808003603|Opioid Clinical Policy (MME and days supply limits)|https://paxpress.txpa.hidinc.com/opc.pdf|09/01/2020| 27808003701|Opiate Overutilization|https://paxpress.txpa.hidinc.com/opiate.pdf|11/05/2013| 27808003701|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017| 27808003701|Opioid Clinical Policy (MME and days supply limits)|https://paxpress.txpa.hidinc.com/opc.pdf|09/01/2020| 27808003702|Opiate Overutilization|https://paxpress.txpa.hidinc.com/opiate.pdf|11/05/2013| 27808003702|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017| 27808003702|Opioid Clinical Policy (MME and days supply limits)|https://paxpress.txpa.hidinc.com/opc.pdf|09/01/2020| 27808003703|Opiate Overutilization|https://paxpress.txpa.hidinc.com/opiate.pdf|11/05/2013| 27808003703|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017| 27808003703|Opioid Clinical Policy (MME and days supply limits)|https://paxpress.txpa.hidinc.com/opc.pdf|09/01/2020| 27808005102|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 27808005102|Promethazine Utilization|https://paxpress.txpa.hidinc.com/phenergan.pdf|01/31/2011| 27808005701|Cough and Cold Agents|https://paxpress.txpa.hidinc.com/Cough%20&%20Cold.pdf|12/15/2015| 27808005701|Dextromethorphan Overutilization|https://paxpress.txpa.hidinc.com/dextro.pdf|07/16/2012| 27808005701|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 27808005701|Promethazine Utilization|https://paxpress.txpa.hidinc.com/phenergan.pdf|01/31/2011| 27808005801|ADD/ADHD Agents|https://paxpress.txpa.hidinc.com/add_adhd_agents.pdf|02/13/2014| 27808005901|ADD/ADHD Agents|https://paxpress.txpa.hidinc.com/add_adhd_agents.pdf|02/13/2014| 27808006502|Cough and Cold Agents|https://paxpress.txpa.hidinc.com/Cough%20&%20Cold.pdf|12/15/2015| 27808006502|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 27808006502|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017| 27808006502|Opioid Clinical Policy (MME and days supply limits)|https://paxpress.txpa.hidinc.com/opc.pdf|09/01/2020| 27808006502|Promethazine Utilization|https://paxpress.txpa.hidinc.com/phenergan.pdf|01/31/2011| 27808008201|Opiate Overutilization|https://paxpress.txpa.hidinc.com/opiate.pdf|11/05/2013| 27808008201|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017| 27808008201|Opioid Clinical Policy (MME and days supply limits)|https://paxpress.txpa.hidinc.com/opc.pdf|09/01/2020| 27808008202|Opiate Overutilization|https://paxpress.txpa.hidinc.com/opiate.pdf|11/05/2013| 27808008202|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017| 27808008202|Opioid Clinical Policy (MME and days supply limits)|https://paxpress.txpa.hidinc.com/opc.pdf|09/01/2020| 27808008501|ADD/ADHD Agents|https://paxpress.txpa.hidinc.com/add_adhd_agents.pdf|02/13/2014| 27808008601|Cough and Cold Agents|https://paxpress.txpa.hidinc.com/Cough%20&%20Cold.pdf|12/15/2015| 27808008601|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 27808008601|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017| 27808008601|Opioid Clinical Policy (MME and days supply limits)|https://paxpress.txpa.hidinc.com/opc.pdf|09/01/2020| 27808008602|Cough and Cold Agents|https://paxpress.txpa.hidinc.com/Cough%20&%20Cold.pdf|12/15/2015| 27808008602|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 27808008602|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017| 27808008602|Opioid Clinical Policy (MME and days supply limits)|https://paxpress.txpa.hidinc.com/opc.pdf|09/01/2020| 27808009101|ADD/ADHD Agents|https://paxpress.txpa.hidinc.com/add_adhd_agents.pdf|02/13/2014| 27808009201|ADD/ADHD Agents|https://paxpress.txpa.hidinc.com/add_adhd_agents.pdf|02/13/2014| 27808009301|ADD/ADHD Agents|https://paxpress.txpa.hidinc.com/add_adhd_agents.pdf|02/13/2014| 27808010201|ADD/ADHD Agents|https://paxpress.txpa.hidinc.com/add_adhd_agents.pdf|01/26/2017|09/19/2023 27808011401|Opiate Overutilization|https://paxpress.txpa.hidinc.com/opiate.pdf|11/05/2013| 27808011401|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017| 27808011401|Opioid Clinical Policy (MME and days supply limits)|https://paxpress.txpa.hidinc.com/opc.pdf|09/01/2020| 27808011402|Opiate Overutilization|https://paxpress.txpa.hidinc.com/opiate.pdf|11/05/2013|05/02/2024 27808011402|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017|05/02/2024 27808011402|Opioid Clinical Policy (MME and days supply limits)|https://paxpress.txpa.hidinc.com/opc.pdf|09/01/2020|05/02/2024 27808011501|Opiate Overutilization|https://paxpress.txpa.hidinc.com/opiate.pdf|11/05/2013| 27808011501|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017| 27808011501|Opioid Clinical Policy (MME and days supply limits)|https://paxpress.txpa.hidinc.com/opc.pdf|09/01/2020| 27808011502|Opiate Overutilization|https://paxpress.txpa.hidinc.com/opiate.pdf|11/05/2013|05/02/2024 27808011502|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017|05/02/2024 27808011502|Opioid Clinical Policy (MME and days supply limits)|https://paxpress.txpa.hidinc.com/opc.pdf|09/01/2020|05/02/2024 27808011601|Opiate Overutilization|https://paxpress.txpa.hidinc.com/opiate.pdf|11/05/2013| 27808011601|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017| 27808011601|Opioid Clinical Policy (MME and days supply limits)|https://paxpress.txpa.hidinc.com/opc.pdf|09/01/2020| 27808011602|Opiate Overutilization|https://paxpress.txpa.hidinc.com/opiate.pdf|11/05/2013|05/02/2024 27808011602|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017|05/02/2024 27808011602|Opioid Clinical Policy (MME and days supply limits)|https://paxpress.txpa.hidinc.com/opc.pdf|09/01/2020|05/02/2024 27808015501|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/04/2016| 27808015503|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/04/2016| 27808015601|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/04/2016| 27808015603|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/04/2016| 27808015701|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/04/2016| 27808015703|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/04/2016| 27808015801|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/04/2016| 27808015803|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/04/2016| 27808022201|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016| 27808022301|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016| 27808022401|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016| 27808022501|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016| 28595080130|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 28595080208|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 28595080316|Cough and Cold Agents|https://paxpress.txpa.hidinc.com/Cough%20&%20Cold.pdf|12/15/2015| 28595080316|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 28595080416|Cough and Cold Agents|https://paxpress.txpa.hidinc.com/Cough%20&%20Cold.pdf|12/15/2015| 28595080416|Dextromethorphan Overutilization|https://paxpress.txpa.hidinc.com/dextro.pdf|07/16/2012| 28595080416|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 28595090060|Cough and Cold Agents|https://paxpress.txpa.hidinc.com/Cough%20&%20Cold.pdf|12/15/2015| 28595090060|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 29033001201|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 29033001301|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 29033002602|Phosphate Binders|https://paxpress.txpa.hidinc.com/phosphate_binders.pdf|01/31/2011| 29033020701|Carisoprodol Overuse|https://paxpress.txpa.hidinc.com/soma.pdf|01/31/2011| 29033020701|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017| 29033040535|Opiate Overutilization|https://paxpress.txpa.hidinc.com/opiate.pdf|11/05/2013| 29033040535|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017| 29033040535|Opioid Clinical Policy (MME and days supply limits)|https://paxpress.txpa.hidinc.com/opc.pdf|09/01/2020| 29300012401|COX-2 Inhibitors|https://paxpress.txpa.hidinc.com/cox2.pdf|01/31/2011| 29300012401|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/04/2016| 29300012410|COX-2 Inhibitors|https://paxpress.txpa.hidinc.com/cox2.pdf|01/31/2011| 29300012410|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/04/2016| 29300012501|COX-2 Inhibitors|https://paxpress.txpa.hidinc.com/cox2.pdf|01/31/2011| 29300012501|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/04/2016| 29300012510|COX-2 Inhibitors|https://paxpress.txpa.hidinc.com/cox2.pdf|01/31/2011| 29300012510|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/04/2016| 29300012801|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 29300012810|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 29300012901|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 29300012910|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 29300013001|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 29300013005|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 29300013010|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 29300013101|Anxiolytics and Sedative-Hypnotics|https://paxpress.txpa.hidinc.com/ash.pdf|01/31/2011| 29300013201|Anxiolytics and Sedative-Hypnotics|https://paxpress.txpa.hidinc.com/ash.pdf|01/31/2011| 29300014519|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 29300014701|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016| 29300014710|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016| 29300014801|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016| 29300014810|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016| 29300014901|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016| 29300015001|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016| 29300015101|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016| 29300015116|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016| 29300015201|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016| 29300017513|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016| 29300017613|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016| 29300017713|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016| 29300017813|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016| 29300017913|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016| 29300018013|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016| 29300018701|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 29300018705|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 29300018713|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 29300018801|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 29300018805|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 29300018813|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 29300018901|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 29300018905|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 29300018913|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 29300019010|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 29300019019|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 29300019110|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 29300019119|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 29300019210|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 29300019219|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 29300022010|Leukotriene Modifiers|https://paxpress.txpa.hidinc.com/leukotriene.pdf|12/15/2015| 29300022013|Leukotriene Modifiers|https://paxpress.txpa.hidinc.com/leukotriene.pdf|12/15/2015| 29300022019|Leukotriene Modifiers|https://paxpress.txpa.hidinc.com/leukotriene.pdf|12/15/2015| 29300022110|Leukotriene Modifiers|https://paxpress.txpa.hidinc.com/leukotriene.pdf|12/15/2015| 29300022113|Leukotriene Modifiers|https://paxpress.txpa.hidinc.com/leukotriene.pdf|12/15/2015| 29300022119|Leukotriene Modifiers|https://paxpress.txpa.hidinc.com/leukotriene.pdf|12/15/2015| 29300022210|Leukotriene Modifiers|https://paxpress.txpa.hidinc.com/leukotriene.pdf|12/15/2015| 29300022213|Leukotriene Modifiers|https://paxpress.txpa.hidinc.com/leukotriene.pdf|12/15/2015| 29300022219|Leukotriene Modifiers|https://paxpress.txpa.hidinc.com/leukotriene.pdf|12/15/2015| 29300025501|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 29300025601|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 29300026881|Antimigraine Agents Triptans|https://paxpress.txpa.hidinc.com/triptans.pdf|04/04/2023| 29300026981|Antimigraine Agents Triptans|https://paxpress.txpa.hidinc.com/triptans.pdf|04/04/2023| 29300028613|PDE5-Inhibitors|https://paxpress.txpa.hidinc.com/revatio.pdf|01/31/2011| 29300028705|PDE5-Inhibitors|https://paxpress.txpa.hidinc.com/revatio.pdf|11/04/2019| 29300028713|PDE5-Inhibitors|https://paxpress.txpa.hidinc.com/revatio.pdf|11/04/2019| 29300028813|PDE5-Inhibitors|https://paxpress.txpa.hidinc.com/revatio.pdf|01/31/2011| 29300028913|PDE5-Inhibitors|https://paxpress.txpa.hidinc.com/revatio.pdf|01/31/2011| 29300030816|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016| 29300030916|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016| 29300031016|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016| 29300031116|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016| 29300031216|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016| 29300035501|Opiate Overutilization|https://paxpress.txpa.hidinc.com/opiate.pdf|11/05/2013| 29300035501|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017| 29300035501|Opioid Clinical Policy (MME and days supply limits)|https://paxpress.txpa.hidinc.com/opc.pdf|09/01/2020| 29300035505|Opiate Overutilization|https://paxpress.txpa.hidinc.com/opiate.pdf|11/05/2013| 29300035505|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017| 29300035505|Opioid Clinical Policy (MME and days supply limits)|https://paxpress.txpa.hidinc.com/opc.pdf|09/01/2020| 29300035510|Opiate Overutilization|https://paxpress.txpa.hidinc.com/opiate.pdf|11/05/2013| 29300035510|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017| 29300035510|Opioid Clinical Policy (MME and days supply limits)|https://paxpress.txpa.hidinc.com/opc.pdf|09/01/2020| 29300040001|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 29300040101|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 29300041301|Cyclobenzaprine|https://paxpress.txpa.hidinc.com/cyclobenzaprine.pdf|01/31/2011| 29300041301|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017| 29300041305|Cyclobenzaprine|https://paxpress.txpa.hidinc.com/cyclobenzaprine.pdf|01/31/2011| 29300041305|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017| 29300041319|Cyclobenzaprine|https://paxpress.txpa.hidinc.com/cyclobenzaprine.pdf|01/31/2011| 29300041319|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017| 29300041401|Cyclobenzaprine|https://paxpress.txpa.hidinc.com/cyclobenzaprine.pdf|01/31/2011| 29300041401|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017| 29300041501|Cyclobenzaprine|https://paxpress.txpa.hidinc.com/cyclobenzaprine.pdf|01/31/2011| 29300041501|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017| 29300041510|Cyclobenzaprine|https://paxpress.txpa.hidinc.com/cyclobenzaprine.pdf|01/31/2011| 29300041510|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017| 29300041519|Cyclobenzaprine|https://paxpress.txpa.hidinc.com/cyclobenzaprine.pdf|01/31/2011| 29300041519|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017| 31722000760|Leukotriene Modifiers|https://paxpress.txpa.hidinc.com/leukotriene.pdf|12/15/2015| 31722000860|Leukotriene Modifiers|https://paxpress.txpa.hidinc.com/leukotriene.pdf|12/15/2015| 31722004031|Promethazine Utilization|https://paxpress.txpa.hidinc.com/phenergan.pdf|01/31/2011| 31722004131|Promethazine Utilization|https://paxpress.txpa.hidinc.com/phenergan.pdf|01/31/2011| 31722004412|Leukotriene Modifiers|https://paxpress.txpa.hidinc.com/leukotriene.pdf|12/15/2015| 31722010901|Opiate Overutilization|https://paxpress.txpa.hidinc.com/opiate.pdf|11/05/2013| 31722010901|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017| 31722010901|Opioid Clinical Policy (MME and days supply limits)|https://paxpress.txpa.hidinc.com/opc.pdf|09/01/2020| 31722010901|Oxycontin / Narcotic Analgesic|https://paxpress.txpa.hidinc.com/oxycontin.pdf|01/31/2011| 31722011001|Opiate Overutilization|https://paxpress.txpa.hidinc.com/opiate.pdf|11/05/2013| 31722011001|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017| 31722011001|Opioid Clinical Policy (MME and days supply limits)|https://paxpress.txpa.hidinc.com/opc.pdf|09/01/2020| 31722011001|Oxycontin / Narcotic Analgesic|https://paxpress.txpa.hidinc.com/oxycontin.pdf|01/31/2011| 31722011101|Opiate Overutilization|https://paxpress.txpa.hidinc.com/opiate.pdf|11/05/2013| 31722011101|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017| 31722011101|Opioid Clinical Policy (MME and days supply limits)|https://paxpress.txpa.hidinc.com/opc.pdf|09/01/2020| 31722011101|Oxycontin / Narcotic Analgesic|https://paxpress.txpa.hidinc.com/oxycontin.pdf|01/31/2011| 31722011901|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017| 31722011901|Opioid Clinical Policy (MME and days supply limits)|https://paxpress.txpa.hidinc.com/opc.pdf|09/01/2020| 31722012001|Opiate Overutilization|https://paxpress.txpa.hidinc.com/opiate.pdf|11/05/2013| 31722012001|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017| 31722012001|Opioid Clinical Policy (MME and days supply limits)|https://paxpress.txpa.hidinc.com/opc.pdf|09/01/2020| 31722012101|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017| 31722012101|Opioid Clinical Policy (MME and days supply limits)|https://paxpress.txpa.hidinc.com/opc.pdf|09/01/2020| 31722012201|Opiate Overutilization|https://paxpress.txpa.hidinc.com/opiate.pdf|11/05/2013| 31722012201|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017| 31722012201|Opioid Clinical Policy (MME and days supply limits)|https://paxpress.txpa.hidinc.com/opc.pdf|09/01/2020| 31722013631|PDE5-Inhibitors|https://paxpress.txpa.hidinc.com/revatio.pdf|09/01/2015| 31722015130|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 31722015290|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 31722015390|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 31722015490|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 31722015501|ADD/ADHD Agents|https://paxpress.txpa.hidinc.com/add_adhd_agents.pdf|02/13/2014| 31722015601|ADD/ADHD Agents|https://paxpress.txpa.hidinc.com/add_adhd_agents.pdf|02/13/2014| 31722015701|ADD/ADHD Agents|https://paxpress.txpa.hidinc.com/add_adhd_agents.pdf|02/13/2014| 31722015801|ADD/ADHD Agents|https://paxpress.txpa.hidinc.com/add_adhd_agents.pdf|02/13/2014| 31722015901|ADD/ADHD Agents|https://paxpress.txpa.hidinc.com/add_adhd_agents.pdf|02/13/2014| 31722016301|ADD/ADHD Agents|https://paxpress.txpa.hidinc.com/add_adhd_agents.pdf|02/13/2014| 31722016401|ADD/ADHD Agents|https://paxpress.txpa.hidinc.com/add_adhd_agents.pdf|02/13/2014| 31722016601|Gabapentin Agents|https://paxpress.txpa.hidinc.com/neurontin.pdf|01/31/2011| 31722016605|Gabapentin Agents|https://paxpress.txpa.hidinc.com/neurontin.pdf|01/31/2011| 31722016701|Gabapentin Agents|https://paxpress.txpa.hidinc.com/neurontin.pdf|01/31/2011| 31722016705|Gabapentin Agents|https://paxpress.txpa.hidinc.com/neurontin.pdf|01/31/2011| 31722017301|ADD/ADHD Agents|https://paxpress.txpa.hidinc.com/add_adhd_agents.pdf|02/13/2014| 31722017401|ADD/ADHD Agents|https://paxpress.txpa.hidinc.com/add_adhd_agents.pdf|02/13/2014| 31722017501|ADD/ADHD Agents|https://paxpress.txpa.hidinc.com/add_adhd_agents.pdf|02/13/2014| 31722018501|ADD/ADHD Agents|https://paxpress.txpa.hidinc.com/add_adhd_agents.pdf|02/13/2014| 31722018601|ADD/ADHD Agents|https://paxpress.txpa.hidinc.com/add_adhd_agents.pdf|02/13/2014| 31722018701|ADD/ADHD Agents|https://paxpress.txpa.hidinc.com/add_adhd_agents.pdf|02/13/2014| 31722018801|ADD/ADHD Agents|https://paxpress.txpa.hidinc.com/add_adhd_agents.pdf|02/13/2014| 31722018901|ADD/ADHD Agents|https://paxpress.txpa.hidinc.com/add_adhd_agents.pdf|02/13/2014| 31722019205|Opiate Overutilization|https://paxpress.txpa.hidinc.com/opiate.pdf|11/05/2013| 31722019205|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017| 31722019205|Opioid Clinical Policy (MME and days supply limits)|https://paxpress.txpa.hidinc.com/opc.pdf|09/01/2020| 31722019301|Opiate Overutilization|https://paxpress.txpa.hidinc.com/opiate.pdf|11/05/2013| 31722019301|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017| 31722019301|Opioid Clinical Policy (MME and days supply limits)|https://paxpress.txpa.hidinc.com/opc.pdf|09/01/2020| 31722019305|Opiate Overutilization|https://paxpress.txpa.hidinc.com/opiate.pdf|11/05/2013| 31722019305|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017| 31722019305|Opioid Clinical Policy (MME and days supply limits)|https://paxpress.txpa.hidinc.com/opc.pdf|09/01/2020| 31722019401|Opiate Overutilization|https://paxpress.txpa.hidinc.com/opiate.pdf|11/05/2013| 31722019401|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017| 31722019401|Opioid Clinical Policy (MME and days supply limits)|https://paxpress.txpa.hidinc.com/opc.pdf|09/01/2020| 31722019501|ADD/ADHD Agents|https://paxpress.txpa.hidinc.com/add_adhd_agents.pdf|02/13/2014| 31722022901|ADD/ADHD Agents|https://paxpress.txpa.hidinc.com/add_adhd_agents.pdf|02/13/2014| 31722023001|ADD/ADHD Agents|https://paxpress.txpa.hidinc.com/add_adhd_agents.pdf|02/13/2014| 31722023101|ADD/ADHD Agents|https://paxpress.txpa.hidinc.com/add_adhd_agents.pdf|02/13/2014| 31722023201|ADD/ADHD Agents|https://paxpress.txpa.hidinc.com/add_adhd_agents.pdf|02/13/2014| 31722023301|ADD/ADHD Agents|https://paxpress.txpa.hidinc.com/add_adhd_agents.pdf|02/13/2014| 31722023401|ADD/ADHD Agents|https://paxpress.txpa.hidinc.com/add_adhd_agents.pdf|02/13/2014| 31722023501|ADD/ADHD Agents|https://paxpress.txpa.hidinc.com/add_adhd_agents.pdf|02/13/2014| 31722023601|ADD/ADHD Agents|https://paxpress.txpa.hidinc.com/add_adhd_agents.pdf|02/13/2014| 31722053301|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017| 31722053305|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017| 31722053401|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017| 31722053405|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017| 31722054201|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 31722054301|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 31722055190|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 31722056501|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 31722056560|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 31722062160|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 31722062260|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 31722064730|PDE5-Inhibitors|https://paxpress.txpa.hidinc.com/revatio.pdf|01/31/2011| 31722065931|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 31722066860|Ranexa|https://paxpress.txpa.hidinc.com/ranexa.pdf|05/25/2012| 31722066960|Ranexa|https://paxpress.txpa.hidinc.com/ranexa.pdf|05/25/2012| 31722068205|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 31722070005|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 31722070010|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 31722070090|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 31722070110|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 31722070130|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 31722070190|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 31722070210|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 31722070230|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 31722070290|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 31722071430|ADD/ADHD Agents|https://paxpress.txpa.hidinc.com/add_adhd_agents.pdf|02/13/2014| 31722071530|ADD/ADHD Agents|https://paxpress.txpa.hidinc.com/add_adhd_agents.pdf|02/13/2014| 31722071630|ADD/ADHD Agents|https://paxpress.txpa.hidinc.com/add_adhd_agents.pdf|02/13/2014| 31722071730|ADD/ADHD Agents|https://paxpress.txpa.hidinc.com/add_adhd_agents.pdf|02/13/2014| 31722071830|ADD/ADHD Agents|https://paxpress.txpa.hidinc.com/add_adhd_agents.pdf|02/13/2014| 31722071930|ADD/ADHD Agents|https://paxpress.txpa.hidinc.com/add_adhd_agents.pdf|02/13/2014| 31722072030|ADD/ADHD Agents|https://paxpress.txpa.hidinc.com/add_adhd_agents.pdf|02/13/2014| 31722072610|Leukotriene Modifiers|https://paxpress.txpa.hidinc.com/leukotriene.pdf|12/15/2015| 31722072630|Leukotriene Modifiers|https://paxpress.txpa.hidinc.com/leukotriene.pdf|12/15/2015| 31722072690|Leukotriene Modifiers|https://paxpress.txpa.hidinc.com/leukotriene.pdf|12/15/2015| 31722072730|Leukotriene Modifiers|https://paxpress.txpa.hidinc.com/leukotriene.pdf|12/15/2015| 31722072790|Leukotriene Modifiers|https://paxpress.txpa.hidinc.com/leukotriene.pdf|12/15/2015| 31722072830|Leukotriene Modifiers|https://paxpress.txpa.hidinc.com/leukotriene.pdf|12/15/2015| 31722072890|Leukotriene Modifiers|https://paxpress.txpa.hidinc.com/leukotriene.pdf|12/15/2015| 31722072930|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 31722072990|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 31722073030|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 31722073090|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 31722073130|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 31722073190|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 31722074530|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 31722074690|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 31722074790|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 31722074890|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 31722077605|PDE5-Inhibitors|https://paxpress.txpa.hidinc.com/revatio.pdf|01/31/2011| 31722077690|PDE5-Inhibitors|https://paxpress.txpa.hidinc.com/revatio.pdf|01/31/2011| 31722081930|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016| 31722082030|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016| 31722082111|VMAT2 Inhibitors|https://paxpress.txpa.hidinc.com/vmat2_inhibitor.pdf|09/25/2018| 31722082211|VMAT2 Inhibitors|https://paxpress.txpa.hidinc.com/vmat2_inhibitor.pdf|09/25/2018| 31722082730|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016| 31722082830|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016| 31722082930|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016| 31722083030|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016| 31722088290|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/04/2016| 31722088390|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/04/2016| 31722088490|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/04/2016| 31722088530|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/04/2016| 31722091701|Opiate Overutilization|https://paxpress.txpa.hidinc.com/opiate.pdf|11/05/2013| 31722091701|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017| 31722091701|Opioid Clinical Policy (MME and days supply limits)|https://paxpress.txpa.hidinc.com/opc.pdf|09/01/2020| 31722091705|Opiate Overutilization|https://paxpress.txpa.hidinc.com/opiate.pdf|11/05/2013| 31722091705|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017| 31722091705|Opioid Clinical Policy (MME and days supply limits)|https://paxpress.txpa.hidinc.com/opc.pdf|09/01/2020| 31722091801|Opiate Overutilization|https://paxpress.txpa.hidinc.com/opiate.pdf|11/05/2013| 31722091801|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017| 31722091801|Opioid Clinical Policy (MME and days supply limits)|https://paxpress.txpa.hidinc.com/opc.pdf|09/01/2020| 31722091805|Opiate Overutilization|https://paxpress.txpa.hidinc.com/opiate.pdf|11/05/2013| 31722091805|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017| 31722091805|Opioid Clinical Policy (MME and days supply limits)|https://paxpress.txpa.hidinc.com/opc.pdf|09/01/2020| 31722092601|ADD/ADHD Agents|https://paxpress.txpa.hidinc.com/add_adhd_agents.pdf|02/13/2014| 31722092701|ADD/ADHD Agents|https://paxpress.txpa.hidinc.com/add_adhd_agents.pdf|02/13/2014| 31722092801|ADD/ADHD Agents|https://paxpress.txpa.hidinc.com/add_adhd_agents.pdf|02/13/2014| 31722092901|Opiate Overutilization|https://paxpress.txpa.hidinc.com/opiate.pdf|11/05/2013| 31722092901|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017| 31722092901|Opioid Clinical Policy (MME and days supply limits)|https://paxpress.txpa.hidinc.com/opc.pdf|09/01/2020| 31722093001|Opiate Overutilization|https://paxpress.txpa.hidinc.com/opiate.pdf|11/05/2013| 31722093001|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017| 31722093001|Opioid Clinical Policy (MME and days supply limits)|https://paxpress.txpa.hidinc.com/opc.pdf|09/01/2020| 31722093612|Lovaza|https://paxpress.txpa.hidinc.com/lovaza.pdf|07/16/2012| 31722094101|Opiate Overutilization|https://paxpress.txpa.hidinc.com/opiate.pdf|11/05/2013| 31722094101|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017| 31722094101|Opioid Clinical Policy (MME and days supply limits)|https://paxpress.txpa.hidinc.com/opc.pdf|09/01/2020| 31722094105|Opiate Overutilization|https://paxpress.txpa.hidinc.com/opiate.pdf|11/05/2013| 31722094105|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017| 31722094105|Opioid Clinical Policy (MME and days supply limits)|https://paxpress.txpa.hidinc.com/opc.pdf|09/01/2020| 31722094201|Opiate Overutilization|https://paxpress.txpa.hidinc.com/opiate.pdf|11/05/2013| 31722094201|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017| 31722094201|Opioid Clinical Policy (MME and days supply limits)|https://paxpress.txpa.hidinc.com/opc.pdf|09/01/2020| 31722094205|Opiate Overutilization|https://paxpress.txpa.hidinc.com/opiate.pdf|11/05/2013| 31722094205|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017| 31722094205|Opioid Clinical Policy (MME and days supply limits)|https://paxpress.txpa.hidinc.com/opc.pdf|09/01/2020| 31722094301|Opiate Overutilization|https://paxpress.txpa.hidinc.com/opiate.pdf|11/05/2013| 31722094301|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017| 31722094301|Opioid Clinical Policy (MME and days supply limits)|https://paxpress.txpa.hidinc.com/opc.pdf|09/01/2020| 31722094305|Opiate Overutilization|https://paxpress.txpa.hidinc.com/opiate.pdf|11/05/2013| 31722094305|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017| 31722094305|Opioid Clinical Policy (MME and days supply limits)|https://paxpress.txpa.hidinc.com/opc.pdf|09/01/2020| 31722094601|Opiate Overutilization|https://paxpress.txpa.hidinc.com/opiate.pdf|11/05/2013| 31722094601|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017| 31722094601|Opioid Clinical Policy (MME and days supply limits)|https://paxpress.txpa.hidinc.com/opc.pdf|09/01/2020| 31722094701|Opiate Overutilization|https://paxpress.txpa.hidinc.com/opiate.pdf|11/05/2013| 31722094701|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017| 31722094701|Opioid Clinical Policy (MME and days supply limits)|https://paxpress.txpa.hidinc.com/opc.pdf|09/01/2020| 31722094801|Opiate Overutilization|https://paxpress.txpa.hidinc.com/opiate.pdf|11/05/2013| 31722094801|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017| 31722094801|Opioid Clinical Policy (MME and days supply limits)|https://paxpress.txpa.hidinc.com/opc.pdf|09/01/2020| 31722094901|Opiate Overutilization|https://paxpress.txpa.hidinc.com/opiate.pdf|11/05/2013| 31722094901|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017| 31722094901|Opioid Clinical Policy (MME and days supply limits)|https://paxpress.txpa.hidinc.com/opc.pdf|09/01/2020| 31722095005|Opiate Overutilization|https://paxpress.txpa.hidinc.com/opiate.pdf|11/05/2013| 31722095005|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017| 31722095005|Opioid Clinical Policy (MME and days supply limits)|https://paxpress.txpa.hidinc.com/opc.pdf|09/01/2020| 31722095101|Opiate Overutilization|https://paxpress.txpa.hidinc.com/opiate.pdf|11/05/2013| 31722095101|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017| 31722095101|Opioid Clinical Policy (MME and days supply limits)|https://paxpress.txpa.hidinc.com/opc.pdf|09/01/2020| 31722095105|Opiate Overutilization|https://paxpress.txpa.hidinc.com/opiate.pdf|11/05/2013| 31722095105|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017| 31722095105|Opioid Clinical Policy (MME and days supply limits)|https://paxpress.txpa.hidinc.com/opc.pdf|09/01/2020| 31722095201|ADD/ADHD Agents|https://paxpress.txpa.hidinc.com/add_adhd_agents.pdf|02/13/2014| 31722095301|ADD/ADHD Agents|https://paxpress.txpa.hidinc.com/add_adhd_agents.pdf|02/13/2014| 31722095401|ADD/ADHD Agents|https://paxpress.txpa.hidinc.com/add_adhd_agents.pdf|02/13/2014| 31722095501|ADD/ADHD Agents|https://paxpress.txpa.hidinc.com/add_adhd_agents.pdf|02/13/2014| 31722095801|Cough and Cold Agents|https://paxpress.txpa.hidinc.com/Cough%20&%20Cold.pdf|12/15/2015| 31722099601|Opiate Overutilization|https://paxpress.txpa.hidinc.com/opiate.pdf|11/05/2013| 31722099601|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017| 31722099601|Opioid Clinical Policy (MME and days supply limits)|https://paxpress.txpa.hidinc.com/opc.pdf|09/01/2020| 31722099605|Opiate Overutilization|https://paxpress.txpa.hidinc.com/opiate.pdf|11/05/2013| 31722099605|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017| 31722099605|Opioid Clinical Policy (MME and days supply limits)|https://paxpress.txpa.hidinc.com/opc.pdf|09/01/2020| 31722099701|Opiate Overutilization|https://paxpress.txpa.hidinc.com/opiate.pdf|11/05/2013| 31722099701|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017| 31722099701|Opioid Clinical Policy (MME and days supply limits)|https://paxpress.txpa.hidinc.com/opc.pdf|09/01/2020| 31722099705|Opiate Overutilization|https://paxpress.txpa.hidinc.com/opiate.pdf|11/05/2013| 31722099705|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017| 31722099705|Opioid Clinical Policy (MME and days supply limits)|https://paxpress.txpa.hidinc.com/opc.pdf|09/01/2020| 33342004707|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 33342004710|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 33342004807|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 33342004810|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 33342004907|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 33342004910|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 33342005007|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 33342005044|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 33342005107|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 33342005144|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 33342005207|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 33342005407|Thiazolidinediones|https://paxpress.txpa.hidinc.com/thiazolidinediones.pdf|01/31/2011| 33342005410|Thiazolidinediones|https://paxpress.txpa.hidinc.com/thiazolidinediones.pdf|01/31/2011| 33342005415|Thiazolidinediones|https://paxpress.txpa.hidinc.com/thiazolidinediones.pdf|01/31/2011| 33342005507|Thiazolidinediones|https://paxpress.txpa.hidinc.com/thiazolidinediones.pdf|01/31/2011| 33342005510|Thiazolidinediones|https://paxpress.txpa.hidinc.com/thiazolidinediones.pdf|01/31/2011| 33342005515|Thiazolidinediones|https://paxpress.txpa.hidinc.com/thiazolidinediones.pdf|01/31/2011| 33342005607|Thiazolidinediones|https://paxpress.txpa.hidinc.com/thiazolidinediones.pdf|01/31/2011| 33342005610|Thiazolidinediones|https://paxpress.txpa.hidinc.com/thiazolidinediones.pdf|01/31/2011| 33342005615|Thiazolidinediones|https://paxpress.txpa.hidinc.com/thiazolidinediones.pdf|01/31/2011| 33342005707|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 33342005710|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 33342005807|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 33342005810|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 33342006207|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 33342006310|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 33342006410|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 33342006510|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 33342006707|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016| 33342006744|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016| 33342006807|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016| 33342006844|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016| 33342006907|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016| 33342006944|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016| 33342007007|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016| 33342007015|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016| 33342007107|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016| 33342007115|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016| 33342007207|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016| 33342007215|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016| 33342007410|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 33342007444|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 33342007510|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 33342007515|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 33342007610|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 33342007615|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 33342007710|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 33342007715|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 33342007810|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 33342007815|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 33342008307|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016| 33342008311|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016| 33342008407|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016| 33342008411|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016| 33342008507|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016| 33342008511|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016| 33342008607|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016| 33342008611|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016| 33342008741|Antimigraine Agents Triptans|https://paxpress.txpa.hidinc.com/triptans.pdf|04/04/2023| 33342008745|Antimigraine Agents Triptans|https://paxpress.txpa.hidinc.com/triptans.pdf|04/04/2023| 33342008750|Antimigraine Agents Triptans|https://paxpress.txpa.hidinc.com/triptans.pdf|04/04/2023| 33342008772|Antimigraine Agents Triptans|https://paxpress.txpa.hidinc.com/triptans.pdf|04/04/2023| 33342008841|Antimigraine Agents Triptans|https://paxpress.txpa.hidinc.com/triptans.pdf|04/04/2023| 33342008850|Antimigraine Agents Triptans|https://paxpress.txpa.hidinc.com/triptans.pdf|04/04/2023| 33342008872|Antimigraine Agents Triptans|https://paxpress.txpa.hidinc.com/triptans.pdf|04/04/2023| 33342009911|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016| 33342010011|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016| 33342010111|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016| 33342010207|Leukotriene Modifiers|https://paxpress.txpa.hidinc.com/leukotriene.pdf|12/15/2015| 33342010210|Leukotriene Modifiers|https://paxpress.txpa.hidinc.com/leukotriene.pdf|12/15/2015| 33342010215|Leukotriene Modifiers|https://paxpress.txpa.hidinc.com/leukotriene.pdf|12/15/2015| 33342010311|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016| 33342010511|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016| 33342011007|Leukotriene Modifiers|https://paxpress.txpa.hidinc.com/leukotriene.pdf|12/15/2015| 33342011010|Leukotriene Modifiers|https://paxpress.txpa.hidinc.com/leukotriene.pdf|12/15/2015| 33342011107|Leukotriene Modifiers|https://paxpress.txpa.hidinc.com/leukotriene.pdf|12/15/2015| 33342011110|Leukotriene Modifiers|https://paxpress.txpa.hidinc.com/leukotriene.pdf|12/15/2015| 33342011407|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 33342011507|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 33342011607|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 33342011610|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 33342011707|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 33342011710|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 33342012110|PDE5-Inhibitors|https://paxpress.txpa.hidinc.com/revatio.pdf|01/31/2011| 33342012207|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016| 33342012307|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016| 33342012407|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016| 33342012507|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016| 33342012607|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016| 33342012707|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016| 33342013110|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 33342013115|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 33342013210|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 33342013215|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 33342013310|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 33342013315|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 33342014409|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016| 33342014509|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016| 33342014609|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016| 33342014709|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016| 33342015509|COX-2 Inhibitors|https://paxpress.txpa.hidinc.com/cox2.pdf|01/31/2011| 33342015509|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/04/2016| 33342015711|COX-2 Inhibitors|https://paxpress.txpa.hidinc.com/cox2.pdf|01/31/2011| 33342015711|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/04/2016| 33342015715|COX-2 Inhibitors|https://paxpress.txpa.hidinc.com/cox2.pdf|01/31/2011| 33342015715|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/04/2016| 33342015809|COX-2 Inhibitors|https://paxpress.txpa.hidinc.com/cox2.pdf|01/31/2011| 33342015809|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/04/2016| 33342017609|Thiazolidinediones|https://paxpress.txpa.hidinc.com/thiazolidinediones.pdf|01/31/2011| 33342017657|Thiazolidinediones|https://paxpress.txpa.hidinc.com/thiazolidinediones.pdf|01/31/2011| 33342017709|Thiazolidinediones|https://paxpress.txpa.hidinc.com/thiazolidinediones.pdf|01/31/2011| 33342017757|Thiazolidinediones|https://paxpress.txpa.hidinc.com/thiazolidinediones.pdf|01/31/2011| 33342017807|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 33342017907|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 33342017910|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 33342018007|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 33342018010|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 33342019007|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 33342019010|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 33342019107|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 33342019110|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 33342019207|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 33342019210|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 33342019307|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 33342019310|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 33342020010|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 33342020144|Opiate Overutilization|https://paxpress.txpa.hidinc.com/opiate.pdf|11/05/2013| 33342020144|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017| 33342020144|Opioid Clinical Policy (MME and days supply limits)|https://paxpress.txpa.hidinc.com/opc.pdf|09/01/2020| 33342029907|Anxiolytics and Sedative-Hypnotics|https://paxpress.txpa.hidinc.com/ash.pdf|01/31/2011| 33342030011|Anxiolytics and Sedative-Hypnotics|https://paxpress.txpa.hidinc.com/ash.pdf|01/31/2011| 33342030111|Anxiolytics and Sedative-Hypnotics|https://paxpress.txpa.hidinc.com/ash.pdf|01/31/2011| 35356055630|Buprenorphine Agents|https://paxpress.txpa.hidinc.com/buprenorphine_agents.pdf|12/05/2014| 35356055630|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017| 35573041302|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017| 35573041304|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017| 35573041530|ADD/ADHD Agents|https://paxpress.txpa.hidinc.com/add_adhd_agents.pdf|02/13/2014| 35573041630|ADD/ADHD Agents|https://paxpress.txpa.hidinc.com/add_adhd_agents.pdf|02/13/2014| 35573041730|ADD/ADHD Agents|https://paxpress.txpa.hidinc.com/add_adhd_agents.pdf|02/13/2014| 35573041830|ADD/ADHD Agents|https://paxpress.txpa.hidinc.com/add_adhd_agents.pdf|02/13/2014| 35573041930|ADD/ADHD Agents|https://paxpress.txpa.hidinc.com/add_adhd_agents.pdf|02/13/2014| 35573042030|ADD/ADHD Agents|https://paxpress.txpa.hidinc.com/add_adhd_agents.pdf|02/13/2014| 35573042130|ADD/ADHD Agents|https://paxpress.txpa.hidinc.com/add_adhd_agents.pdf|02/13/2014| 35573043602|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016| 35573043702|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016| 35573043802|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016| 35573043902|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016| 35573044002|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016| 35573044102|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016| 35573044202|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016| 35573044325|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 35573044425|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 35573044525|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 35573045002|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 35573045002|Ketorolac|https://paxpress.txpa.hidinc.com/ketorolac.pdf|05/25/2012| 35573046038|PDE5-Inhibitors|https://paxpress.txpa.hidinc.com/revatio.pdf|01/31/2011| 35573046130|PDE5-Inhibitors|https://paxpress.txpa.hidinc.com/revatio.pdf|11/04/2019| 35573046230|PDE5-Inhibitors|https://paxpress.txpa.hidinc.com/revatio.pdf|01/31/2011| 35573046330|PDE5-Inhibitors|https://paxpress.txpa.hidinc.com/revatio.pdf|01/31/2011| 42023011001|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 42023011101|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 42023011201|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 42192060704|Cough and Cold Agents|https://paxpress.txpa.hidinc.com/Cough%20&%20Cold.pdf|12/15/2015| 42192060704|Dextromethorphan Overutilization|https://paxpress.txpa.hidinc.com/dextro.pdf|07/16/2012| 42192060704|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 42192060716|Cough and Cold Agents|https://paxpress.txpa.hidinc.com/Cough%20&%20Cold.pdf|12/15/2015| 42192060716|Dextromethorphan Overutilization|https://paxpress.txpa.hidinc.com/dextro.pdf|07/16/2012| 42192060716|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 42192060816|Gabapentin Agents|https://paxpress.txpa.hidinc.com/neurontin.pdf|01/31/2011| 42192061701|Cough and Cold Agents|https://paxpress.txpa.hidinc.com/Cough%20&%20Cold.pdf|12/15/2015| 42192061705|Cough and Cold Agents|https://paxpress.txpa.hidinc.com/Cough%20&%20Cold.pdf|12/15/2015| 42192061805|Cough and Cold Agents|https://paxpress.txpa.hidinc.com/Cough%20&%20Cold.pdf|12/15/2015| 42192061916|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 42195010090|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|08/05/2030 42195012106|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 42195015110|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 42195030809|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|12/05/2030 42195047101|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 42195084010|Opiate Overutilization|https://paxpress.txpa.hidinc.com/opiate.pdf|11/05/2013|08/15/2045 42195084010|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017|08/15/2045 42195084010|Opioid Clinical Policy (MME and days supply limits)|https://paxpress.txpa.hidinc.com/opc.pdf|09/01/2020|08/15/2045 42227008301|HAE Agents Clinical|https://paxpress.txpa.hidinc.com/HAE.pdf|03/21/2023| 42291017430|Buprenorphine Agents|https://paxpress.txpa.hidinc.com/buprenorphine_agents.pdf|04/23/2013| 42291017430|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017| 42291017530|Buprenorphine Agents|https://paxpress.txpa.hidinc.com/buprenorphine_agents.pdf|04/23/2013| 42291017530|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017| 42292002620|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016|11/30/2023 42292002720|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016|09/30/2023 42385096360|Ranexa|https://paxpress.txpa.hidinc.com/ranexa.pdf|05/25/2012| 42385096460|Ranexa|https://paxpress.txpa.hidinc.com/ranexa.pdf|05/25/2012| 42494040901|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017| 42494042510|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017| 42494042810|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017| 42543014050|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 42543014101|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 42543014201|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 42543096407|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 42543096507|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 42543096607|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 42571011010|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 42571011110|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 42571011210|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 42571011901|Opiate Overutilization|https://paxpress.txpa.hidinc.com/opiate.pdf|11/05/2013| 42571011901|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017| 42571011901|Opioid Clinical Policy (MME and days supply limits)|https://paxpress.txpa.hidinc.com/opc.pdf|09/01/2020| 42571011905|Opiate Overutilization|https://paxpress.txpa.hidinc.com/opiate.pdf|11/05/2013| 42571011905|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017| 42571011905|Opioid Clinical Policy (MME and days supply limits)|https://paxpress.txpa.hidinc.com/opc.pdf|09/01/2020| 42571012290|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 42571013360|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 42571013460|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 42571014260|COX-2 Inhibitors|https://paxpress.txpa.hidinc.com/cox2.pdf|01/31/2011| 42571014260|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/04/2016| 42571014301|COX-2 Inhibitors|https://paxpress.txpa.hidinc.com/cox2.pdf|01/31/2011| 42571014301|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/04/2016| 42571014305|COX-2 Inhibitors|https://paxpress.txpa.hidinc.com/cox2.pdf|01/31/2011| 42571014305|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/04/2016| 42571014401|COX-2 Inhibitors|https://paxpress.txpa.hidinc.com/cox2.pdf|01/31/2011| 42571014401|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/04/2016| 42571014405|COX-2 Inhibitors|https://paxpress.txpa.hidinc.com/cox2.pdf|01/31/2011| 42571014405|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/04/2016| 42571014560|COX-2 Inhibitors|https://paxpress.txpa.hidinc.com/cox2.pdf|01/31/2011| 42571014560|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/04/2016| 42571017210|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/04/2016| 42571017290|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/04/2016| 42571017310|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/04/2016| 42571017390|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/04/2016| 42571017410|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/04/2016| 42571017490|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/04/2016| 42571017510|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/04/2016| 42571017590|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/04/2016| 42571017601|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 42571017701|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 42571020230|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 42571020290|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 42571020330|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 42571020390|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 42571022630|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 42571022730|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 42571022830|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 42571023530|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 42571023590|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 42571023630|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 42571023690|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 42571023730|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 42571023790|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 42571023830|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 42571023890|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 42571025830|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 42747072601|Antiemetic Agents|https://paxpress.txpa.hidinc.com/antiemetics.pdf|01/31/2011| 42794001610|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016| 42794001710|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016| 42794005108|Pulmonary Hypertension Agents Clinical|https://paxpress.txpa.hidinc.com/pah.pdf|07/27/2023| 42794005208|Pulmonary Hypertension Agents Clinical|https://paxpress.txpa.hidinc.com/pah.pdf|07/27/2023| 42799011101|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 42799011201|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 42799021701|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017| 42799021701|Opioid Clinical Policy (MME and days supply limits)|https://paxpress.txpa.hidinc.com/opc.pdf|09/01/2020| 42799021702|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017| 42799021702|Opioid Clinical Policy (MME and days supply limits)|https://paxpress.txpa.hidinc.com/opc.pdf|09/01/2020| 42799081201|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 42799081301|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 42799092001|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 42799092002|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 42799092030|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 42799092101|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 42799092102|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 42799092130|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 42799092201|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 42799092202|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 42799092230|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 42806000501|Opiate Overutilization|https://paxpress.txpa.hidinc.com/opiate.pdf|11/05/2013| 42806000501|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017| 42806000501|Opioid Clinical Policy (MME and days supply limits)|https://paxpress.txpa.hidinc.com/opc.pdf|09/01/2020| 42806000601|Opiate Overutilization|https://paxpress.txpa.hidinc.com/opiate.pdf|11/05/2013| 42806000601|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017| 42806000601|Opioid Clinical Policy (MME and days supply limits)|https://paxpress.txpa.hidinc.com/opc.pdf|09/01/2020| 42806000701|Opiate Overutilization|https://paxpress.txpa.hidinc.com/opiate.pdf|11/05/2013| 42806000701|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017| 42806000701|Opioid Clinical Policy (MME and days supply limits)|https://paxpress.txpa.hidinc.com/opc.pdf|09/01/2020| 42806000801|Opiate Overutilization|https://paxpress.txpa.hidinc.com/opiate.pdf|11/05/2013| 42806000801|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017| 42806000801|Opioid Clinical Policy (MME and days supply limits)|https://paxpress.txpa.hidinc.com/opc.pdf|09/01/2020| 42806000901|Opiate Overutilization|https://paxpress.txpa.hidinc.com/opiate.pdf|11/05/2013| 42806000901|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017| 42806000901|Opioid Clinical Policy (MME and days supply limits)|https://paxpress.txpa.hidinc.com/opc.pdf|09/01/2020| 42806001101|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 42806001105|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 42806001201|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 42806001210|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 42806001401|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 42806001410|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 42806001801|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 42806001805|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 42806005030|Opiate Overutilization|https://paxpress.txpa.hidinc.com/opiate.pdf|11/05/2013| 42806005030|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017| 42806005030|Opioid Clinical Policy (MME and days supply limits)|https://paxpress.txpa.hidinc.com/opc.pdf|09/01/2020| 42806008701|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 42806008705|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 42806008801|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 42806008805|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 42806008901|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 42806008905|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 42806015901|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 42806015905|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 42806015910|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 42806016001|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 42806016005|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 42806016010|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 42806016101|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 42806016105|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 42806016110|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 42806033601|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016| 42806033701|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016|08/23/2023 42806033801|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016| 42806033901|ADD/ADHD Agents|https://paxpress.txpa.hidinc.com/add_adhd_agents.pdf|02/13/2014| 42806034101|ADD/ADHD Agents|https://paxpress.txpa.hidinc.com/add_adhd_agents.pdf|02/13/2014| 42806034301|ADD/ADHD Agents|https://paxpress.txpa.hidinc.com/add_adhd_agents.pdf|02/13/2014| 42806034401|ADD/ADHD Agents|https://paxpress.txpa.hidinc.com/add_adhd_agents.pdf|02/13/2014| 42806034501|ADD/ADHD Agents|https://paxpress.txpa.hidinc.com/add_adhd_agents.pdf|02/13/2014| 42806040001|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 42806055212|Lovaza|https://paxpress.txpa.hidinc.com/lovaza.pdf|07/16/2012| 42806056401|Anxiolytics and Sedative-Hypnotics|https://paxpress.txpa.hidinc.com/ash.pdf|01/31/2011| 42806056401|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017| 42806064810|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|08/23/2023 42806064910|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|08/23/2023 42806071401|Cough and Cold Agents|https://paxpress.txpa.hidinc.com/Cough%20&%20Cold.pdf|12/15/2015| 42806071405|Cough and Cold Agents|https://paxpress.txpa.hidinc.com/Cough%20&%20Cold.pdf|12/15/2015| 42806071501|Cough and Cold Agents|https://paxpress.txpa.hidinc.com/Cough%20&%20Cold.pdf|12/15/2015| 42806071505|Cough and Cold Agents|https://paxpress.txpa.hidinc.com/Cough%20&%20Cold.pdf|12/15/2015| 42806072060|COX-2 Inhibitors|https://paxpress.txpa.hidinc.com/cox2.pdf|01/31/2011| 42806072060|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/04/2016| 42806072101|COX-2 Inhibitors|https://paxpress.txpa.hidinc.com/cox2.pdf|01/31/2011| 42806072101|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/04/2016| 42806072105|COX-2 Inhibitors|https://paxpress.txpa.hidinc.com/cox2.pdf|01/31/2011| 42806072105|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/04/2016| 42806072201|COX-2 Inhibitors|https://paxpress.txpa.hidinc.com/cox2.pdf|01/31/2011| 42806072201|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/04/2016| 42806072205|COX-2 Inhibitors|https://paxpress.txpa.hidinc.com/cox2.pdf|01/31/2011| 42806072205|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/04/2016| 42806072360|COX-2 Inhibitors|https://paxpress.txpa.hidinc.com/cox2.pdf|01/31/2011| 42806072360|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/04/2016| 42858000101|Opiate Overutilization|https://paxpress.txpa.hidinc.com/opiate.pdf|11/05/2013| 42858000101|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017| 42858000101|Opioid Clinical Policy (MME and days supply limits)|https://paxpress.txpa.hidinc.com/opc.pdf|09/01/2020| 42858000201|Opiate Overutilization|https://paxpress.txpa.hidinc.com/opiate.pdf|11/05/2013| 42858000201|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017| 42858000201|Opioid Clinical Policy (MME and days supply limits)|https://paxpress.txpa.hidinc.com/opc.pdf|09/01/2020| 42858000301|Opiate Overutilization|https://paxpress.txpa.hidinc.com/opiate.pdf|11/05/2013| 42858000301|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017| 42858000301|Opioid Clinical Policy (MME and days supply limits)|https://paxpress.txpa.hidinc.com/opc.pdf|09/01/2020| 42858000401|Opiate Overutilization|https://paxpress.txpa.hidinc.com/opiate.pdf|11/05/2013| 42858000401|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017| 42858000401|Opioid Clinical Policy (MME and days supply limits)|https://paxpress.txpa.hidinc.com/opc.pdf|09/01/2020| 42858000501|Opiate Overutilization|https://paxpress.txpa.hidinc.com/opiate.pdf|11/05/2013| 42858000501|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017| 42858000501|Opioid Clinical Policy (MME and days supply limits)|https://paxpress.txpa.hidinc.com/opc.pdf|09/01/2020| 42858001101|ADD/ADHD Agents|https://paxpress.txpa.hidinc.com/add_adhd_agents.pdf|02/13/2014| 42858004001|Opiate Overutilization|https://paxpress.txpa.hidinc.com/opiate.pdf|11/05/2013| 42858004001|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017| 42858004001|Opioid Clinical Policy (MME and days supply limits)|https://paxpress.txpa.hidinc.com/opc.pdf|09/01/2020| 42858005501|ADD/ADHD Agents|https://paxpress.txpa.hidinc.com/add_adhd_agents.pdf|02/13/2014| 42858007545|ADD/ADHD Agents|https://paxpress.txpa.hidinc.com/add_adhd_agents.pdf|02/13/2014| 42858007645|ADD/ADHD Agents|https://paxpress.txpa.hidinc.com/add_adhd_agents.pdf|02/13/2014| 42858007745|ADD/ADHD Agents|https://paxpress.txpa.hidinc.com/add_adhd_agents.pdf|02/13/2014| 42858007845|ADD/ADHD Agents|https://paxpress.txpa.hidinc.com/add_adhd_agents.pdf|02/13/2014| 42858007945|ADD/ADHD Agents|https://paxpress.txpa.hidinc.com/add_adhd_agents.pdf|02/13/2014| 42858008045|ADD/ADHD Agents|https://paxpress.txpa.hidinc.com/add_adhd_agents.pdf|02/13/2014| 42858008145|ADD/ADHD Agents|https://paxpress.txpa.hidinc.com/add_adhd_agents.pdf|02/13/2014| 42858010201|Opiate Overutilization|https://paxpress.txpa.hidinc.com/opiate.pdf|11/05/2013| 42858010201|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017| 42858010201|Opioid Clinical Policy (MME and days supply limits)|https://paxpress.txpa.hidinc.com/opc.pdf|09/01/2020| 42858010250|Opiate Overutilization|https://paxpress.txpa.hidinc.com/opiate.pdf|11/05/2013| 42858010250|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017| 42858010250|Opioid Clinical Policy (MME and days supply limits)|https://paxpress.txpa.hidinc.com/opc.pdf|09/01/2020| 42858010301|Opiate Overutilization|https://paxpress.txpa.hidinc.com/opiate.pdf|11/05/2013| 42858010301|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017| 42858010301|Opioid Clinical Policy (MME and days supply limits)|https://paxpress.txpa.hidinc.com/opc.pdf|09/01/2020| 42858010350|Opiate Overutilization|https://paxpress.txpa.hidinc.com/opiate.pdf|11/05/2013| 42858010350|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017| 42858010350|Opioid Clinical Policy (MME and days supply limits)|https://paxpress.txpa.hidinc.com/opc.pdf|09/01/2020| 42858010401|Opiate Overutilization|https://paxpress.txpa.hidinc.com/opiate.pdf|11/05/2013| 42858010401|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017| 42858010401|Opioid Clinical Policy (MME and days supply limits)|https://paxpress.txpa.hidinc.com/opc.pdf|09/01/2020| 42858010450|Opiate Overutilization|https://paxpress.txpa.hidinc.com/opiate.pdf|11/05/2013| 42858010450|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017| 42858010450|Opioid Clinical Policy (MME and days supply limits)|https://paxpress.txpa.hidinc.com/opc.pdf|09/01/2020| 42858012201|Opiate Overutilization|https://paxpress.txpa.hidinc.com/opiate.pdf|11/05/2013| 42858012201|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017| 42858012201|Opioid Clinical Policy (MME and days supply limits)|https://paxpress.txpa.hidinc.com/opc.pdf|09/01/2020| 42858013901|Opiate Overutilization|https://paxpress.txpa.hidinc.com/opiate.pdf|11/05/2013| 42858013901|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017| 42858013901|Opioid Clinical Policy (MME and days supply limits)|https://paxpress.txpa.hidinc.com/opc.pdf|09/01/2020| 42858020101|Opiate Overutilization|https://paxpress.txpa.hidinc.com/opiate.pdf|11/05/2013| 42858020101|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017| 42858020101|Opioid Clinical Policy (MME and days supply limits)|https://paxpress.txpa.hidinc.com/opc.pdf|09/01/2020| 42858020150|Opiate Overutilization|https://paxpress.txpa.hidinc.com/opiate.pdf|11/05/2013| 42858020150|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017| 42858020150|Opioid Clinical Policy (MME and days supply limits)|https://paxpress.txpa.hidinc.com/opc.pdf|09/01/2020| 42858020201|Opiate Overutilization|https://paxpress.txpa.hidinc.com/opiate.pdf|11/05/2013| 42858020201|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017| 42858020201|Opioid Clinical Policy (MME and days supply limits)|https://paxpress.txpa.hidinc.com/opc.pdf|09/01/2020| 42858020301|Opiate Overutilization|https://paxpress.txpa.hidinc.com/opiate.pdf|11/05/2013| 42858020301|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017| 42858020301|Opioid Clinical Policy (MME and days supply limits)|https://paxpress.txpa.hidinc.com/opc.pdf|09/01/2020| 42858020350|Opiate Overutilization|https://paxpress.txpa.hidinc.com/opiate.pdf|11/05/2013| 42858020350|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017| 42858020350|Opioid Clinical Policy (MME and days supply limits)|https://paxpress.txpa.hidinc.com/opc.pdf|09/01/2020| 42858021501|ADD/ADHD Agents|https://paxpress.txpa.hidinc.com/add_adhd_agents.pdf|02/13/2014| 42858022501|ADD/ADHD Agents|https://paxpress.txpa.hidinc.com/add_adhd_agents.pdf|02/13/2014| 42858023401|Opiate Overutilization|https://paxpress.txpa.hidinc.com/opiate.pdf|11/05/2013| 42858023401|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017| 42858023401|Opioid Clinical Policy (MME and days supply limits)|https://paxpress.txpa.hidinc.com/opc.pdf|09/01/2020| 42858023450|Opiate Overutilization|https://paxpress.txpa.hidinc.com/opiate.pdf|11/05/2013| 42858023450|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017| 42858023450|Opioid Clinical Policy (MME and days supply limits)|https://paxpress.txpa.hidinc.com/opc.pdf|09/01/2020| 42858023801|Opiate Overutilization|https://paxpress.txpa.hidinc.com/opiate.pdf|11/05/2013| 42858023801|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017| 42858023801|Opioid Clinical Policy (MME and days supply limits)|https://paxpress.txpa.hidinc.com/opc.pdf|09/01/2020| 42858030101|Opiate Overutilization|https://paxpress.txpa.hidinc.com/opiate.pdf|11/05/2013| 42858030101|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017| 42858030101|Opioid Clinical Policy (MME and days supply limits)|https://paxpress.txpa.hidinc.com/opc.pdf|09/01/2020| 42858030201|Opiate Overutilization|https://paxpress.txpa.hidinc.com/opiate.pdf|11/05/2013| 42858030201|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017| 42858030201|Opioid Clinical Policy (MME and days supply limits)|https://paxpress.txpa.hidinc.com/opc.pdf|09/01/2020| 42858030250|Opiate Overutilization|https://paxpress.txpa.hidinc.com/opiate.pdf|11/05/2013| 42858030250|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017| 42858030250|Opioid Clinical Policy (MME and days supply limits)|https://paxpress.txpa.hidinc.com/opc.pdf|09/01/2020| 42858030301|Opiate Overutilization|https://paxpress.txpa.hidinc.com/opiate.pdf|11/05/2013| 42858030301|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017| 42858030301|Opioid Clinical Policy (MME and days supply limits)|https://paxpress.txpa.hidinc.com/opc.pdf|09/01/2020| 42858030416|Opiate Overutilization|https://paxpress.txpa.hidinc.com/opiate.pdf|11/05/2013| 42858030416|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017| 42858030416|Opioid Clinical Policy (MME and days supply limits)|https://paxpress.txpa.hidinc.com/opc.pdf|09/01/2020| 42858032501|ADD/ADHD Agents|https://paxpress.txpa.hidinc.com/add_adhd_agents.pdf|02/13/2014| 42858033801|Opiate Overutilization|https://paxpress.txpa.hidinc.com/opiate.pdf|11/05/2013| 42858033801|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017| 42858033801|Opioid Clinical Policy (MME and days supply limits)|https://paxpress.txpa.hidinc.com/opc.pdf|09/01/2020| 42858035340|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017| 42858035340|Opioid Clinical Policy (MME and days supply limits)|https://paxpress.txpa.hidinc.com/opc.pdf|09/01/2020| 42858040145|ADD/ADHD Agents|https://paxpress.txpa.hidinc.com/add_adhd_agents.pdf|02/13/2014| 42858040245|ADD/ADHD Agents|https://paxpress.txpa.hidinc.com/add_adhd_agents.pdf|02/13/2014| 42858040345|ADD/ADHD Agents|https://paxpress.txpa.hidinc.com/add_adhd_agents.pdf|02/13/2014| 42858040445|ADD/ADHD Agents|https://paxpress.txpa.hidinc.com/add_adhd_agents.pdf|02/13/2014| 42858040545|ADD/ADHD Agents|https://paxpress.txpa.hidinc.com/add_adhd_agents.pdf|02/13/2014| 42858040645|ADD/ADHD Agents|https://paxpress.txpa.hidinc.com/add_adhd_agents.pdf|02/13/2014| 42858040745|ADD/ADHD Agents|https://paxpress.txpa.hidinc.com/add_adhd_agents.pdf|02/13/2014| 42858041001|ADD/ADHD Agents|https://paxpress.txpa.hidinc.com/add_adhd_agents.pdf|02/13/2014| 42858041616|Opiate Overutilization|https://paxpress.txpa.hidinc.com/opiate.pdf|11/05/2013| 42858041616|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017| 42858041616|Opioid Clinical Policy (MME and days supply limits)|https://paxpress.txpa.hidinc.com/opc.pdf|09/01/2020| 42858049340|Opiate Overutilization|https://paxpress.txpa.hidinc.com/opiate.pdf|11/05/2013| 42858049340|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017| 42858049340|Opioid Clinical Policy (MME and days supply limits)|https://paxpress.txpa.hidinc.com/opc.pdf|09/01/2020| 42858050103|Buprenorphine Agents|https://paxpress.txpa.hidinc.com/buprenorphine_agents.pdf|12/05/2014| 42858050103|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017| 42858050203|Buprenorphine Agents|https://paxpress.txpa.hidinc.com/buprenorphine_agents.pdf|12/05/2014| 42858050203|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017| 42858051501|Opiate Overutilization|https://paxpress.txpa.hidinc.com/opiate.pdf|11/05/2013| 42858051501|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017| 42858051501|Opioid Clinical Policy (MME and days supply limits)|https://paxpress.txpa.hidinc.com/opc.pdf|09/01/2020| 42858058640|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017| 42858058640|Opioid Clinical Policy (MME and days supply limits)|https://paxpress.txpa.hidinc.com/opc.pdf|09/01/2020| 42858060103|Buprenorphine Agents|https://paxpress.txpa.hidinc.com/buprenorphine_agents.pdf|04/23/2013| 42858060103|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017| 42858060203|Buprenorphine Agents|https://paxpress.txpa.hidinc.com/buprenorphine_agents.pdf|04/23/2013| 42858060203|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017| 42858061001|ADD/ADHD Agents|https://paxpress.txpa.hidinc.com/add_adhd_agents.pdf|02/13/2014| 42858063101|Opiate Overutilization|https://paxpress.txpa.hidinc.com/opiate.pdf|11/05/2013| 42858063101|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017| 42858063101|Opioid Clinical Policy (MME and days supply limits)|https://paxpress.txpa.hidinc.com/opc.pdf|09/01/2020| 42858072001|ADD/ADHD Agents|https://paxpress.txpa.hidinc.com/add_adhd_agents.pdf|02/13/2014| 42858072101|ADD/ADHD Agents|https://paxpress.txpa.hidinc.com/add_adhd_agents.pdf|02/13/2014| 42858072201|ADD/ADHD Agents|https://paxpress.txpa.hidinc.com/add_adhd_agents.pdf|02/13/2014| 42858072301|ADD/ADHD Agents|https://paxpress.txpa.hidinc.com/add_adhd_agents.pdf|02/13/2014| 42858072401|ADD/ADHD Agents|https://paxpress.txpa.hidinc.com/add_adhd_agents.pdf|02/13/2014| 42858072501|ADD/ADHD Agents|https://paxpress.txpa.hidinc.com/add_adhd_agents.pdf|02/13/2014| 42858072601|ADD/ADHD Agents|https://paxpress.txpa.hidinc.com/add_adhd_agents.pdf|02/13/2014| 42858072701|ADD/ADHD Agents|https://paxpress.txpa.hidinc.com/add_adhd_agents.pdf|02/13/2014| 42858075040|Opiate Overutilization|https://paxpress.txpa.hidinc.com/opiate.pdf|11/05/2013| 42858075040|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017| 42858075040|Opioid Clinical Policy (MME and days supply limits)|https://paxpress.txpa.hidinc.com/opc.pdf|09/01/2020| 42858076001|Opiate Overutilization|https://paxpress.txpa.hidinc.com/opiate.pdf|11/05/2013| 42858076001|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017| 42858076001|Opioid Clinical Policy (MME and days supply limits)|https://paxpress.txpa.hidinc.com/opc.pdf|09/01/2020| 42858079901|Opiate Overutilization|https://paxpress.txpa.hidinc.com/opiate.pdf|11/05/2013| 42858079901|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017| 42858079901|Opioid Clinical Policy (MME and days supply limits)|https://paxpress.txpa.hidinc.com/opc.pdf|09/01/2020| 42858080101|Opiate Overutilization|https://paxpress.txpa.hidinc.com/opiate.pdf|11/05/2013| 42858080101|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017| 42858080101|Opioid Clinical Policy (MME and days supply limits)|https://paxpress.txpa.hidinc.com/opc.pdf|09/01/2020| 42858080201|Opiate Overutilization|https://paxpress.txpa.hidinc.com/opiate.pdf|11/05/2013| 42858080201|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017| 42858080201|Opioid Clinical Policy (MME and days supply limits)|https://paxpress.txpa.hidinc.com/opc.pdf|09/01/2020| 42858080301|Opiate Overutilization|https://paxpress.txpa.hidinc.com/opiate.pdf|11/05/2013| 42858080301|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017| 42858080301|Opioid Clinical Policy (MME and days supply limits)|https://paxpress.txpa.hidinc.com/opc.pdf|09/01/2020| 42858080401|Opiate Overutilization|https://paxpress.txpa.hidinc.com/opiate.pdf|11/05/2013| 42858080401|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017| 42858080401|Opioid Clinical Policy (MME and days supply limits)|https://paxpress.txpa.hidinc.com/opc.pdf|09/01/2020| 42858080501|Opiate Overutilization|https://paxpress.txpa.hidinc.com/opiate.pdf|11/05/2013| 42858080501|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017| 42858080501|Opioid Clinical Policy (MME and days supply limits)|https://paxpress.txpa.hidinc.com/opc.pdf|09/01/2020| 42858083940|Opiate Overutilization|https://paxpress.txpa.hidinc.com/opiate.pdf|11/05/2013| 42858083940|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017| 42858083940|Opioid Clinical Policy (MME and days supply limits)|https://paxpress.txpa.hidinc.com/opc.pdf|09/01/2020| 42858090001|Opiate Overutilization|https://paxpress.txpa.hidinc.com/opiate.pdf|11/05/2013| 42858090001|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017| 42858090001|Opioid Clinical Policy (MME and days supply limits)|https://paxpress.txpa.hidinc.com/opc.pdf|09/01/2020| 42858093001|ADD/ADHD Agents|https://paxpress.txpa.hidinc.com/add_adhd_agents.pdf|02/13/2014| 43068010102|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016| 43068010202|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016| 43068010402|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016| 43068010602|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016| 43068010802|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016| 43068011002|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016| 43068011202|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016| 43068011304|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016| 43068022001|Anxiolytics and Sedative-Hypnotics|https://paxpress.txpa.hidinc.com/ash.pdf|11/16/2021| 43068030402|Anxiolytics and Sedative-Hypnotics|https://paxpress.txpa.hidinc.com/ash.pdf|11/16/2021| 43068030406|Anxiolytics and Sedative-Hypnotics|https://paxpress.txpa.hidinc.com/ash.pdf|11/16/2021| 43386035101|Opiate Overutilization|https://paxpress.txpa.hidinc.com/opiate.pdf|11/05/2013| 43386035101|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017| 43386035101|Opioid Clinical Policy (MME and days supply limits)|https://paxpress.txpa.hidinc.com/opc.pdf|09/01/2020| 43386035105|Opiate Overutilization|https://paxpress.txpa.hidinc.com/opiate.pdf|11/05/2013| 43386035105|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017| 43386035105|Opioid Clinical Policy (MME and days supply limits)|https://paxpress.txpa.hidinc.com/opc.pdf|09/01/2020| 43386035201|Opiate Overutilization|https://paxpress.txpa.hidinc.com/opiate.pdf|11/05/2013| 43386035201|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017| 43386035201|Opioid Clinical Policy (MME and days supply limits)|https://paxpress.txpa.hidinc.com/opc.pdf|09/01/2020| 43386035205|Opiate Overutilization|https://paxpress.txpa.hidinc.com/opiate.pdf|11/05/2013| 43386035205|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017| 43386035205|Opioid Clinical Policy (MME and days supply limits)|https://paxpress.txpa.hidinc.com/opc.pdf|09/01/2020| 43386035301|Opiate Overutilization|https://paxpress.txpa.hidinc.com/opiate.pdf|11/05/2013| 43386035301|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017| 43386035301|Opioid Clinical Policy (MME and days supply limits)|https://paxpress.txpa.hidinc.com/opc.pdf|09/01/2020| 43386035305|Opiate Overutilization|https://paxpress.txpa.hidinc.com/opiate.pdf|11/05/2013| 43386035305|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017| 43386035305|Opioid Clinical Policy (MME and days supply limits)|https://paxpress.txpa.hidinc.com/opc.pdf|09/01/2020| 43386035601|Opiate Overutilization|https://paxpress.txpa.hidinc.com/opiate.pdf|11/05/2013| 43386035601|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017| 43386035601|Opioid Clinical Policy (MME and days supply limits)|https://paxpress.txpa.hidinc.com/opc.pdf|09/01/2020| 43386035610|Opiate Overutilization|https://paxpress.txpa.hidinc.com/opiate.pdf|11/05/2013| 43386035610|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017| 43386035610|Opioid Clinical Policy (MME and days supply limits)|https://paxpress.txpa.hidinc.com/opc.pdf|09/01/2020| 43386035701|Opiate Overutilization|https://paxpress.txpa.hidinc.com/opiate.pdf|11/05/2013| 43386035701|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017| 43386035701|Opioid Clinical Policy (MME and days supply limits)|https://paxpress.txpa.hidinc.com/opc.pdf|09/01/2020| 43386035801|Opiate Overutilization|https://paxpress.txpa.hidinc.com/opiate.pdf|11/05/2013| 43386035801|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017| 43386035801|Opioid Clinical Policy (MME and days supply limits)|https://paxpress.txpa.hidinc.com/opc.pdf|09/01/2020| 43386035810|Opiate Overutilization|https://paxpress.txpa.hidinc.com/opiate.pdf|11/05/2013| 43386035810|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017| 43386035810|Opioid Clinical Policy (MME and days supply limits)|https://paxpress.txpa.hidinc.com/opc.pdf|09/01/2020| 43386040503|Nitazoxanide|https://paxpress.txpa.hidinc.com/alinia.pdf|01/31/2011| 43386040512|Nitazoxanide|https://paxpress.txpa.hidinc.com/alinia.pdf|01/31/2011| 43386048024|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017| 43386048026|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017| 43386048028|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017| 43386068001|Opiate Overutilization|https://paxpress.txpa.hidinc.com/opiate.pdf|11/05/2013| 43386068001|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017| 43386068001|Opioid Clinical Policy (MME and days supply limits)|https://paxpress.txpa.hidinc.com/opc.pdf|09/01/2020| 43547004703|PDE5-Inhibitors|https://paxpress.txpa.hidinc.com/revatio.pdf|01/31/2011| 43547004903|PDE5-Inhibitors|https://paxpress.txpa.hidinc.com/revatio.pdf|11/04/2019| 43547005003|PDE5-Inhibitors|https://paxpress.txpa.hidinc.com/revatio.pdf|01/31/2011| 43547005103|PDE5-Inhibitors|https://paxpress.txpa.hidinc.com/revatio.pdf|01/31/2011| 43547022610|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017| 43547022650|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017| 43547025110|Anxiolytics and Sedative-Hypnotics|https://paxpress.txpa.hidinc.com/ash.pdf|01/31/2011| 43547025110|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017| 43547025210|Anxiolytics and Sedative-Hypnotics|https://paxpress.txpa.hidinc.com/ash.pdf|01/31/2011| 43547025210|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017| 43547025310|Anxiolytics and Sedative-Hypnotics|https://paxpress.txpa.hidinc.com/ash.pdf|01/31/2011| 43547025310|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017| 43547026510|Gabapentin Agents|https://paxpress.txpa.hidinc.com/neurontin.pdf|01/31/2011| 43547026550|Gabapentin Agents|https://paxpress.txpa.hidinc.com/neurontin.pdf|01/31/2011| 43547026610|Gabapentin Agents|https://paxpress.txpa.hidinc.com/neurontin.pdf|01/31/2011| 43547026650|Gabapentin Agents|https://paxpress.txpa.hidinc.com/neurontin.pdf|01/31/2011| 43547026710|Gabapentin Agents|https://paxpress.txpa.hidinc.com/neurontin.pdf|01/31/2011| 43547026750|Gabapentin Agents|https://paxpress.txpa.hidinc.com/neurontin.pdf|01/31/2011| 43547027703|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 43547028303|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 43547028403|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 43547028503|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 43547030203|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016| 43547030303|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016| 43547030403|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016| 43547030503|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016| 43547030603|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016| 43547030703|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016| 43547031109|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 43547031209|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 43547031309|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 43547031409|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 43547031509|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 43547033003|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 43547033009|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 43547033103|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 43547033109|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 43547033906|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016| 43547033950|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016| 43547034006|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016| 43547034050|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016| 43547034106|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016| 43547034150|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016| 43547034206|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016| 43547034250|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016| 43547034306|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016| 43547034350|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016| 43547034406|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016| 43547034450|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016| 43547036009|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 43547036011|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 43547036050|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 43547036103|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 43547036109|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 43547036111|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 43547036203|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 43547036209|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 43547036211|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 43547036703|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 43547036709|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 43547036809|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 43547036909|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 43547037009|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 43547037310|Opiate Overutilization|https://paxpress.txpa.hidinc.com/opiate.pdf|11/05/2013| 43547037310|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017| 43547037310|Opioid Clinical Policy (MME and days supply limits)|https://paxpress.txpa.hidinc.com/opc.pdf|09/01/2020| 43547037403|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 43547037409|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 43547037503|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 43547037509|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 43547037550|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 43547037603|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 43547037609|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 43547038450|Gabapentin Agents|https://paxpress.txpa.hidinc.com/neurontin.pdf|01/31/2011| 43547038510|Gabapentin Agents|https://paxpress.txpa.hidinc.com/neurontin.pdf|01/31/2011| 43547038550|Gabapentin Agents|https://paxpress.txpa.hidinc.com/neurontin.pdf|01/31/2011| 43547038950|Gabapentin Agents|https://paxpress.txpa.hidinc.com/neurontin.pdf|01/31/2011| 43547039050|Gabapentin Agents|https://paxpress.txpa.hidinc.com/neurontin.pdf|01/31/2011| 43547039103|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 43547039109|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 43547039203|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 43547039209|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 43547039303|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 43547039309|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 43547039710|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 43547039711|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 43547039810|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 43547039811|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 43547039910|Cyclobenzaprine|https://paxpress.txpa.hidinc.com/cyclobenzaprine.pdf|01/31/2011| 43547039910|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017| 43547039950|Cyclobenzaprine|https://paxpress.txpa.hidinc.com/cyclobenzaprine.pdf|01/31/2011| 43547039950|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017| 43547040010|Cyclobenzaprine|https://paxpress.txpa.hidinc.com/cyclobenzaprine.pdf|01/31/2011| 43547040010|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017| 43547040011|Cyclobenzaprine|https://paxpress.txpa.hidinc.com/cyclobenzaprine.pdf|01/31/2011| 43547040011|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017| 43547040050|Cyclobenzaprine|https://paxpress.txpa.hidinc.com/cyclobenzaprine.pdf|01/31/2011| 43547040050|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017| 43547040510|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017| 43547040550|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017| 43547040610|Anxiolytics and Sedative-Hypnotics|https://paxpress.txpa.hidinc.com/ash.pdf|01/31/2011| 43547040610|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017| 43547040611|Anxiolytics and Sedative-Hypnotics|https://paxpress.txpa.hidinc.com/ash.pdf|01/31/2011| 43547040611|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017| 43547040710|Anxiolytics and Sedative-Hypnotics|https://paxpress.txpa.hidinc.com/ash.pdf|01/31/2011| 43547040710|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017| 43547040711|Anxiolytics and Sedative-Hypnotics|https://paxpress.txpa.hidinc.com/ash.pdf|01/31/2011| 43547040711|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017| 43547040810|Anxiolytics and Sedative-Hypnotics|https://paxpress.txpa.hidinc.com/ash.pdf|01/31/2011| 43547040810|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017| 43547040850|Anxiolytics and Sedative-Hypnotics|https://paxpress.txpa.hidinc.com/ash.pdf|01/31/2011| 43547040850|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017| 43547042010|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 43547042050|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 43547042110|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 43547042150|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 43547042210|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 43547042250|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 43547042303|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 43547042309|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 43547042311|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 43547042403|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 43547042409|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 43547042411|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 43547042503|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 43547042509|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 43547042511|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 43547043506|ADD/ADHD Agents|https://paxpress.txpa.hidinc.com/add_adhd_agents.pdf|02/13/2014| 43547044103|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 43547044203|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 43547044303|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 43547046009|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 43547046109|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 43547048610|ADD/ADHD Agents|https://paxpress.txpa.hidinc.com/add_adhd_agents.pdf|02/13/2014| 43547048710|ADD/ADHD Agents|https://paxpress.txpa.hidinc.com/add_adhd_agents.pdf|02/13/2014| 43547048810|ADD/ADHD Agents|https://paxpress.txpa.hidinc.com/add_adhd_agents.pdf|02/13/2014| 43547061110|Anxiolytics and Sedative-Hypnotics|https://paxpress.txpa.hidinc.com/ash.pdf|01/31/2011| 43547061110|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017| 43547061210|Anxiolytics and Sedative-Hypnotics|https://paxpress.txpa.hidinc.com/ash.pdf|01/31/2011| 43547061210|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017| 43547061250|Anxiolytics and Sedative-Hypnotics|https://paxpress.txpa.hidinc.com/ash.pdf|01/31/2011| 43547061250|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017| 43547061303|Anxiolytics and Sedative-Hypnotics|https://paxpress.txpa.hidinc.com/ash.pdf|01/31/2011| 43547061303|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017| 43547061410|Anxiolytics and Sedative-Hypnotics|https://paxpress.txpa.hidinc.com/ash.pdf|01/31/2011| 43547061410|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017| 43547061450|Anxiolytics and Sedative-Hypnotics|https://paxpress.txpa.hidinc.com/ash.pdf|01/31/2011| 43547061450|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017| 43598003401|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016| 43598003501|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016| 43598003601|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016| 43598003701|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016| 43598005311|Desmopressin|https://paxpress.txpa.hidinc.com/desmopressin.pdf|05/25/2012| 43598013901|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 43598013901|Ketorolac|https://paxpress.txpa.hidinc.com/ketorolac.pdf|05/25/2012| 43598016360|GI Motility Agents|https://paxpress.txpa.hidinc.com/GImotility.pdf|01/18/2017| 43598016405|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016| 43598016430|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016| 43598016505|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016| 43598016530|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016| 43598016605|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016| 43598016630|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016| 43598016860|GI Motility Agents|https://paxpress.txpa.hidinc.com/GImotility.pdf|01/18/2017| 43598026704|Omega 3 Fatty Acids|https://paxpress.txpa.hidinc.com/lovaza.pdf|03/21/2023| 43598031330|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|11/30/2023 43598031430|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|12/31/2023 43598031530|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|01/31/2024 43598031590|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|01/31/2024 43598031630|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|12/31/2023 43598031690|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|12/31/2023 43598031730|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|12/31/2023 43598031830|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|10/31/2023 43598031890|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|10/31/2023 43598031930|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|11/30/2023 43598031990|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|11/30/2023 43598032030|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|12/31/2023 43598032130|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|09/30/2023 43598032190|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|09/30/2023 43598032230|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|11/30/2023 43598032290|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|11/30/2023 43598032330|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|11/30/2023 43598035130|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016| 43598035230|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016| 43598035330|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016| 43598035430|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016| 43598035530|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016| 43598039467|VMAT2 Inhibitors|https://paxpress.txpa.hidinc.com/vmat2_inhibitor.pdf|09/25/2018| 43598039567|VMAT2 Inhibitors|https://paxpress.txpa.hidinc.com/vmat2_inhibitor.pdf|09/25/2018| 43598043801|ADD/ADHD Agents|https://paxpress.txpa.hidinc.com/add_adhd_agents.pdf|02/13/2014| 43598043901|ADD/ADHD Agents|https://paxpress.txpa.hidinc.com/add_adhd_agents.pdf|02/13/2014| 43598044001|ADD/ADHD Agents|https://paxpress.txpa.hidinc.com/add_adhd_agents.pdf|02/13/2014| 43598044101|ADD/ADHD Agents|https://paxpress.txpa.hidinc.com/add_adhd_agents.pdf|02/13/2014| 43598047890|Phosphate Binders|https://paxpress.txpa.hidinc.com/phosphate_binders.pdf|01/31/2011| 43598047990|Phosphate Binders|https://paxpress.txpa.hidinc.com/phosphate_binders.pdf|01/31/2011| 43598049401|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 43598049501|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 43598049505|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 43598050501|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/04/2016| 43598050510|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/04/2016| 43598050530|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/04/2016| 43598055430|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016| 43598055530|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016| 43598055630|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016| 43598055730|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016| 43598055830|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016| 43598055930|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016| 43598057860|PDE5-Inhibitors|https://paxpress.txpa.hidinc.com/revatio.pdf|01/31/2011| 43598057901|Buprenorphine Agents|https://paxpress.txpa.hidinc.com/buprenorphine_agents.pdf|04/23/2013| 43598057901|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017| 43598057930|Buprenorphine Agents|https://paxpress.txpa.hidinc.com/buprenorphine_agents.pdf|04/23/2013| 43598057930|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017| 43598058001|Buprenorphine Agents|https://paxpress.txpa.hidinc.com/buprenorphine_agents.pdf|04/23/2013| 43598058001|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017| 43598058030|Buprenorphine Agents|https://paxpress.txpa.hidinc.com/buprenorphine_agents.pdf|04/23/2013| 43598058030|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017| 43598058101|Buprenorphine Agents|https://paxpress.txpa.hidinc.com/buprenorphine_agents.pdf|04/23/2013| 43598058101|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017| 43598058130|Buprenorphine Agents|https://paxpress.txpa.hidinc.com/buprenorphine_agents.pdf|04/23/2013| 43598058130|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017| 43598058201|Buprenorphine Agents|https://paxpress.txpa.hidinc.com/buprenorphine_agents.pdf|04/23/2013| 43598058201|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017| 43598058230|Buprenorphine Agents|https://paxpress.txpa.hidinc.com/buprenorphine_agents.pdf|04/23/2013| 43598058230|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017| 43598058310|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 43598058330|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 43598058390|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 43598058410|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 43598058430|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 43598058490|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 43598058510|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 43598058530|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 43598058590|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 43598058610|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 43598058630|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 43598058690|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 43598060556|Inhaled Antibiotics Clinical|https://paxpress.txpa.hidinc.com/inhaledantibiotics.pdf|05/02/2023| 43598060558|Inhaled Antibiotics Clinical|https://paxpress.txpa.hidinc.com/inhaledantibiotics.pdf|05/02/2023| 43598064611|Pulmonary Hypertension Agents Clinical|https://paxpress.txpa.hidinc.com/pah.pdf|07/27/2023| 43598064711|Pulmonary Hypertension Agents Clinical|https://paxpress.txpa.hidinc.com/pah.pdf|07/27/2023| 43598064911|Pulmonary Hypertension Agents Clinical|https://paxpress.txpa.hidinc.com/pah.pdf|07/27/2023| 43598070601|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017| 43598073330|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016| 43598073430|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016| 43598074101|Anxiolytics and Sedative-Hypnotics|https://paxpress.txpa.hidinc.com/ash.pdf|01/31/2011| 43598074130|Anxiolytics and Sedative-Hypnotics|https://paxpress.txpa.hidinc.com/ash.pdf|01/31/2011| 43598074210|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 43598074230|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 43598074290|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 43598074305|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 43598074330|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 43598074390|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 43598074410|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 43598074430|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 43598074490|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 43598074530|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 43598074590|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 43598074672|Omega 3 Fatty Acids|https://paxpress.txpa.hidinc.com/lovaza.pdf|03/21/2023| 43598081112|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 43598081115|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 43598082314|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 43598082331|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 43598082335|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 43598083005|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/04/2016| 43598083105|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/04/2016| 43598083190|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/04/2016| 43598083205|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/04/2016| 43598083290|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/04/2016| 43598083305|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/04/2016| 43598083390|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/04/2016| 43598084858|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016| 43598089701|ADD/ADHD Agents|https://paxpress.txpa.hidinc.com/add_adhd_agents.pdf|12/18/2019| 43598089801|ADD/ADHD Agents|https://paxpress.txpa.hidinc.com/add_adhd_agents.pdf|12/18/2019| 43598093109|Desmopressin|https://paxpress.txpa.hidinc.com/desmopressin.pdf|05/25/2012| 43598093111|Desmopressin|https://paxpress.txpa.hidinc.com/desmopressin.pdf|05/25/2012| 43598096530|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016| 43598096630|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016| 43598096730|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016| 43598096830|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016| 43598096930|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016| 43598097030|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016| 43598097710|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 43975027710|ADD/ADHD Agents|https://paxpress.txpa.hidinc.com/add_adhd_agents.pdf|02/13/2014| 43975027810|ADD/ADHD Agents|https://paxpress.txpa.hidinc.com/add_adhd_agents.pdf|02/13/2014| 43975027910|ADD/ADHD Agents|https://paxpress.txpa.hidinc.com/add_adhd_agents.pdf|02/13/2014| 43975028010|ADD/ADHD Agents|https://paxpress.txpa.hidinc.com/add_adhd_agents.pdf|02/13/2014| 43975028110|ADD/ADHD Agents|https://paxpress.txpa.hidinc.com/add_adhd_agents.pdf|02/13/2014| 43975028210|ADD/ADHD Agents|https://paxpress.txpa.hidinc.com/add_adhd_agents.pdf|02/13/2014| 43975034903|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016| 43975035003|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016| 43975035103|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016| 43975035203|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016| 44087000407|Growth Hormones|https://paxpress.txpa.hidinc.com/gh.pdf|01/31/2011| 44087000507|Growth Hormones|https://paxpress.txpa.hidinc.com/gh.pdf|01/31/2011| 44087000607|Growth Hormones|https://paxpress.txpa.hidinc.com/gh.pdf|01/31/2011| 44087100502|Growth Hormones|https://paxpress.txpa.hidinc.com/gh.pdf|01/31/2011|12/31/2023 44087108801|Growth Hormones|https://paxpress.txpa.hidinc.com/gh.pdf|01/31/2011|12/31/2023 45802002683|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 45802005705|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 45802008765|DPP-4 Inhibitors|https://paxpress.txpa.hidinc.com/dpp4_inhibitor.pdf|09/25/2018| 45802008801|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 45802009735|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 45802010365|DPP-4 Inhibitors|https://paxpress.txpa.hidinc.com/dpp4_inhibitor.pdf|09/25/2018| 45802011101|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 45802012246|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 45802012260|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 45802012265|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 45802013326|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 45802014026|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 45802014753|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 45802014762|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 45802015065|DPP-4 Inhibitors|https://paxpress.txpa.hidinc.com/dpp4_inhibitor.pdf|09/25/2018| 45802016972|DPP-4 Inhibitors|https://paxpress.txpa.hidinc.com/dpp4_inhibitor.pdf|09/25/2018| 45802021172|DPP-4 Inhibitors|https://paxpress.txpa.hidinc.com/dpp4_inhibitor.pdf|09/25/2018| 45802026065|DPP-4 Inhibitors|https://paxpress.txpa.hidinc.com/dpp4_inhibitor.pdf|09/25/2018| 45802035165|DPP-4 Inhibitors|https://paxpress.txpa.hidinc.com/dpp4_inhibitor.pdf|09/25/2018| 45802036853|Imiquimod|https://paxpress.txpa.hidinc.com/imiquimod.pdf|07/16/2012| 45802036862|Imiquimod|https://paxpress.txpa.hidinc.com/imiquimod.pdf|07/16/2012| 45802039000|Topical Immunomodulators|https://paxpress.txpa.hidinc.com/immunomodulators.pdf|01/31/2011| 45802039001|Topical Immunomodulators|https://paxpress.txpa.hidinc.com/immunomodulators.pdf|01/31/2011| 45802039002|Topical Immunomodulators|https://paxpress.txpa.hidinc.com/immunomodulators.pdf|01/31/2011| 45802040265|DPP-4 Inhibitors|https://paxpress.txpa.hidinc.com/dpp4_inhibitor.pdf|09/25/2018| 45802041059|Cough and Cold Agents|https://paxpress.txpa.hidinc.com/Cough%20&%20Cold.pdf|12/15/2015| 45802043321|Cough and Cold Agents|https://paxpress.txpa.hidinc.com/Cough%20&%20Cold.pdf|12/15/2015| 45802043321|Dextromethorphan Overutilization|https://paxpress.txpa.hidinc.com/dextro.pdf|07/16/2012| 45802049075|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 45802049078|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|11/30/2023 45802049965|DPP-4 Inhibitors|https://paxpress.txpa.hidinc.com/dpp4_inhibitor.pdf|09/25/2018| 45802059806|Antimigraine Agents Triptans|https://paxpress.txpa.hidinc.com/triptans.pdf|04/04/2023| 45802061906|Antimigraine Agents Triptans|https://paxpress.txpa.hidinc.com/triptans.pdf|04/04/2023| 45802062626|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 45802065065|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 45802065078|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 45802065087|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 45802068028|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 45802070000|Topical Immunomodulators|https://paxpress.txpa.hidinc.com/immunomodulators.pdf|01/31/2011| 45802070001|Topical Immunomodulators|https://paxpress.txpa.hidinc.com/immunomodulators.pdf|01/31/2011| 45802070002|Topical Immunomodulators|https://paxpress.txpa.hidinc.com/immunomodulators.pdf|01/31/2011| 45802071191|Antimigraine Agents Triptans|https://paxpress.txpa.hidinc.com/triptans.pdf|04/04/2023| 45802075830|Promethazine Utilization|https://paxpress.txpa.hidinc.com/phenergan.pdf|01/31/2011| 45802075930|Promethazine Utilization|https://paxpress.txpa.hidinc.com/phenergan.pdf|01/31/2011| 45802084778|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|07/01/2024 45802089726|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 45802089734|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 45802091939|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 45802091987|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 45802095226|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 45802095243|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 45802095301|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 45802097426|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 45963030309|ADD/ADHD Agents|https://paxpress.txpa.hidinc.com/add_adhd_agents.pdf|02/13/2014| 45963030409|ADD/ADHD Agents|https://paxpress.txpa.hidinc.com/add_adhd_agents.pdf|02/13/2014| 45963030509|ADD/ADHD Agents|https://paxpress.txpa.hidinc.com/add_adhd_agents.pdf|02/13/2014| 45963041806|Ranexa|https://paxpress.txpa.hidinc.com/ranexa.pdf|05/25/2012| 45963041906|Ranexa|https://paxpress.txpa.hidinc.com/ranexa.pdf|05/25/2012| 45963047903|GI Motility Agents|https://paxpress.txpa.hidinc.com/GImotility.pdf|01/18/2017| 45963048003|GI Motility Agents|https://paxpress.txpa.hidinc.com/GImotility.pdf|01/18/2017| 45963055511|Gabapentin Agents|https://paxpress.txpa.hidinc.com/neurontin.pdf|01/31/2011| 45963055550|Gabapentin Agents|https://paxpress.txpa.hidinc.com/neurontin.pdf|01/31/2011| 45963055611|Gabapentin Agents|https://paxpress.txpa.hidinc.com/neurontin.pdf|01/31/2011| 45963055650|Gabapentin Agents|https://paxpress.txpa.hidinc.com/neurontin.pdf|01/31/2011| 45963055711|Gabapentin Agents|https://paxpress.txpa.hidinc.com/neurontin.pdf|01/31/2011| 45963055750|Gabapentin Agents|https://paxpress.txpa.hidinc.com/neurontin.pdf|01/31/2011| 45963056508|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 45963056530|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 45963056608|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 45963056630|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 45963056708|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 45963056730|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 45963056808|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 45963056830|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 46287004515|PDE5-Inhibitors|https://paxpress.txpa.hidinc.com/revatio.pdf|09/01/2015| 47335001083|PDE5-Inhibitors|https://paxpress.txpa.hidinc.com/revatio.pdf|11/04/2019| 47335003886|Pulmonary Hypertension Agents Clinical|https://paxpress.txpa.hidinc.com/pah.pdf|07/27/2023| 47335003986|Pulmonary Hypertension Agents Clinical|https://paxpress.txpa.hidinc.com/pah.pdf|07/27/2023| 47335017149|Inhaled Antibiotics Clinical|https://paxpress.txpa.hidinc.com/inhaledantibiotics.pdf|05/02/2023| 47335017795|Cytokine and CAM Antagonists|https://paxpress.txpa.hidinc.com/cytokine.pdf|06/25/2019| 47335017923|VMAT2 Inhibitors|https://paxpress.txpa.hidinc.com/vmat2_inhibitor.pdf|09/25/2018| 47335023683|Pulmonary Hypertension Agents Clinical|https://paxpress.txpa.hidinc.com/pah.pdf|07/27/2023| 47335023783|Pulmonary Hypertension Agents Clinical|https://paxpress.txpa.hidinc.com/pah.pdf|07/27/2023| 47335027641|Antimigraine Agents Triptans|https://paxpress.txpa.hidinc.com/triptans.pdf|04/04/2023| 47335027723|VMAT2 Inhibitors|https://paxpress.txpa.hidinc.com/vmat2_inhibitor.pdf|09/25/2018| 47335030888|Anxiolytics and Sedative-Hypnotics|https://paxpress.txpa.hidinc.com/ash.pdf|01/31/2011| 47335034383|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 47335034483|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 47335053183|Opiate Overutilization|https://paxpress.txpa.hidinc.com/opiate.pdf|11/05/2013| 47335053183|Opioid Clinical Policy (MME and days supply limits)|https://paxpress.txpa.hidinc.com/opc.pdf|09/01/2020| 47335053188|Opiate Overutilization|https://paxpress.txpa.hidinc.com/opiate.pdf|11/05/2013| 47335053188|Opioid Clinical Policy (MME and days supply limits)|https://paxpress.txpa.hidinc.com/opc.pdf|09/01/2020| 47335053383|Opiate Overutilization|https://paxpress.txpa.hidinc.com/opiate.pdf|11/05/2013| 47335053383|Opioid Clinical Policy (MME and days supply limits)|https://paxpress.txpa.hidinc.com/opc.pdf|09/01/2020| 47335053388|Opiate Overutilization|https://paxpress.txpa.hidinc.com/opiate.pdf|11/05/2013| 47335053388|Opioid Clinical Policy (MME and days supply limits)|https://paxpress.txpa.hidinc.com/opc.pdf|09/01/2020| 47335053783|Opiate Overutilization|https://paxpress.txpa.hidinc.com/opiate.pdf|11/05/2013| 47335053783|Opioid Clinical Policy (MME and days supply limits)|https://paxpress.txpa.hidinc.com/opc.pdf|09/01/2020| 47335053788|Opiate Overutilization|https://paxpress.txpa.hidinc.com/opiate.pdf|11/05/2013| 47335053788|Opioid Clinical Policy (MME and days supply limits)|https://paxpress.txpa.hidinc.com/opc.pdf|09/01/2020| 47335058281|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/04/2016| 47335058381|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/04/2016| 47335058481|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/04/2016| 47335058583|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/04/2016| 47335060313|Anxiolytics and Sedative-Hypnotics|https://paxpress.txpa.hidinc.com/ash.pdf|05/28/2015| 47335060313|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017| 47335060318|Anxiolytics and Sedative-Hypnotics|https://paxpress.txpa.hidinc.com/ash.pdf|05/28/2015| 47335060318|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017| 47335060388|Anxiolytics and Sedative-Hypnotics|https://paxpress.txpa.hidinc.com/ash.pdf|05/28/2015| 47335060388|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017| 47335060413|Anxiolytics and Sedative-Hypnotics|https://paxpress.txpa.hidinc.com/ash.pdf|05/28/2015| 47335060413|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017| 47335060418|Anxiolytics and Sedative-Hypnotics|https://paxpress.txpa.hidinc.com/ash.pdf|05/28/2015| 47335060418|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017| 47335060513|Anxiolytics and Sedative-Hypnotics|https://paxpress.txpa.hidinc.com/ash.pdf|05/28/2015| 47335060513|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017| 47335060588|Anxiolytics and Sedative-Hypnotics|https://paxpress.txpa.hidinc.com/ash.pdf|05/28/2015| 47335060588|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017| 47335060688|Anxiolytics and Sedative-Hypnotics|https://paxpress.txpa.hidinc.com/ash.pdf|05/28/2015| 47335060688|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017| 47335063149|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 47335063249|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 47335063349|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 47335070349|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 47335070352|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 47335070354|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 47335074349|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 47335074649|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 47335075349|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 47335075649|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/04/2016| 47335075652|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/04/2016| 47335076783|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016| 47335077991|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 47335085983|Opiate Overutilization|https://paxpress.txpa.hidinc.com/opiate.pdf|11/05/2013| 47335085983|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017| 47335085983|Opioid Clinical Policy (MME and days supply limits)|https://paxpress.txpa.hidinc.com/opc.pdf|09/01/2020| 47335086083|Opiate Overutilization|https://paxpress.txpa.hidinc.com/opiate.pdf|11/05/2013| 47335086083|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017| 47335086083|Opioid Clinical Policy (MME and days supply limits)|https://paxpress.txpa.hidinc.com/opc.pdf|09/01/2020| 47335086183|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017| 47335090218|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016| 47335090288|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016| 47335090318|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016| 47335090388|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016| 47335090418|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016| 47335090488|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016| 47335090518|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016| 47335090588|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016| 47335090618|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016| 47335090686|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016| 47335090688|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016| 47335090718|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016| 47335090788|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016| 47335097863|Antimigraine Agents Triptans|https://paxpress.txpa.hidinc.com/triptans.pdf|04/04/2023| 47335097967|Antimigraine Agents Triptans|https://paxpress.txpa.hidinc.com/triptans.pdf|04/04/2023| 47781010444|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 47781015301|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 47781015475|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 47781018001|ADD/ADHD Agents|https://paxpress.txpa.hidinc.com/add_adhd_agents.pdf|02/13/2014| 47781019601|Opiate Overutilization|https://paxpress.txpa.hidinc.com/opiate.pdf|11/05/2013| 47781019601|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017| 47781019601|Opioid Clinical Policy (MME and days supply limits)|https://paxpress.txpa.hidinc.com/opc.pdf|09/01/2020| 47781019605|Opiate Overutilization|https://paxpress.txpa.hidinc.com/opiate.pdf|11/05/2013| 47781019605|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017| 47781019605|Opioid Clinical Policy (MME and days supply limits)|https://paxpress.txpa.hidinc.com/opc.pdf|09/01/2020| 47781022901|Opiate Overutilization|https://paxpress.txpa.hidinc.com/opiate.pdf|11/05/2013| 47781022901|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017| 47781022901|Opioid Clinical Policy (MME and days supply limits)|https://paxpress.txpa.hidinc.com/opc.pdf|09/01/2020| 47781022905|Opiate Overutilization|https://paxpress.txpa.hidinc.com/opiate.pdf|11/05/2013| 47781022905|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017| 47781022905|Opioid Clinical Policy (MME and days supply limits)|https://paxpress.txpa.hidinc.com/opc.pdf|09/01/2020| 47781023001|Opiate Overutilization|https://paxpress.txpa.hidinc.com/opiate.pdf|11/05/2013| 47781023001|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017| 47781023001|Opioid Clinical Policy (MME and days supply limits)|https://paxpress.txpa.hidinc.com/opc.pdf|09/01/2020| 47781023005|Opiate Overutilization|https://paxpress.txpa.hidinc.com/opiate.pdf|11/05/2013| 47781023005|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017| 47781023005|Opioid Clinical Policy (MME and days supply limits)|https://paxpress.txpa.hidinc.com/opc.pdf|09/01/2020| 47781023063|Opiate Overutilization|https://paxpress.txpa.hidinc.com/opiate.pdf|11/05/2013| 47781023063|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017| 47781023063|Opioid Clinical Policy (MME and days supply limits)|https://paxpress.txpa.hidinc.com/opc.pdf|09/01/2020| 47781026301|Opiate Overutilization|https://paxpress.txpa.hidinc.com/opiate.pdf|11/05/2013| 47781026301|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017| 47781026301|Opioid Clinical Policy (MME and days supply limits)|https://paxpress.txpa.hidinc.com/opc.pdf|09/01/2020| 47781026305|Opiate Overutilization|https://paxpress.txpa.hidinc.com/opiate.pdf|11/05/2013| 47781026305|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017| 47781026305|Opioid Clinical Policy (MME and days supply limits)|https://paxpress.txpa.hidinc.com/opc.pdf|09/01/2020| 47781026401|Opiate Overutilization|https://paxpress.txpa.hidinc.com/opiate.pdf|11/05/2013| 47781026401|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017| 47781026401|Opioid Clinical Policy (MME and days supply limits)|https://paxpress.txpa.hidinc.com/opc.pdf|09/01/2020| 47781026405|Opiate Overutilization|https://paxpress.txpa.hidinc.com/opiate.pdf|11/05/2013| 47781026405|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017| 47781026405|Opioid Clinical Policy (MME and days supply limits)|https://paxpress.txpa.hidinc.com/opc.pdf|09/01/2020| 47781026501|Opiate Overutilization|https://paxpress.txpa.hidinc.com/opiate.pdf|11/05/2013| 47781026501|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017| 47781026501|Opioid Clinical Policy (MME and days supply limits)|https://paxpress.txpa.hidinc.com/opc.pdf|09/01/2020| 47781026505|Opiate Overutilization|https://paxpress.txpa.hidinc.com/opiate.pdf|11/05/2013| 47781026505|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017| 47781026505|Opioid Clinical Policy (MME and days supply limits)|https://paxpress.txpa.hidinc.com/opc.pdf|09/01/2020| 47781035503|Buprenorphine Agents|https://paxpress.txpa.hidinc.com/buprenorphine_agents.pdf|04/23/2013| 47781035503|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017| 47781035511|Buprenorphine Agents|https://paxpress.txpa.hidinc.com/buprenorphine_agents.pdf|04/23/2013| 47781035511|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017| 47781035603|Buprenorphine Agents|https://paxpress.txpa.hidinc.com/buprenorphine_agents.pdf|04/23/2013| 47781035603|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017| 47781035611|Buprenorphine Agents|https://paxpress.txpa.hidinc.com/buprenorphine_agents.pdf|04/23/2013| 47781035611|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017| 47781035703|Buprenorphine Agents|https://paxpress.txpa.hidinc.com/buprenorphine_agents.pdf|04/23/2013| 47781035703|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017| 47781035711|Buprenorphine Agents|https://paxpress.txpa.hidinc.com/buprenorphine_agents.pdf|04/23/2013| 47781035711|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017| 47781035803|Buprenorphine Agents|https://paxpress.txpa.hidinc.com/buprenorphine_agents.pdf|04/23/2013| 47781035803|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017| 47781035811|Buprenorphine Agents|https://paxpress.txpa.hidinc.com/buprenorphine_agents.pdf|04/23/2013| 47781035811|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017| 47781039260|Opiate Overutilization|https://paxpress.txpa.hidinc.com/opiate.pdf|11/05/2013| 47781039260|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017| 47781039260|Opioid Clinical Policy (MME and days supply limits)|https://paxpress.txpa.hidinc.com/opc.pdf|09/01/2020| 47781039360|Opiate Overutilization|https://paxpress.txpa.hidinc.com/opiate.pdf|11/05/2013| 47781039360|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017| 47781039360|Opioid Clinical Policy (MME and days supply limits)|https://paxpress.txpa.hidinc.com/opc.pdf|09/01/2020| 47781039460|Opiate Overutilization|https://paxpress.txpa.hidinc.com/opiate.pdf|11/05/2013| 47781039460|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017| 47781039460|Opioid Clinical Policy (MME and days supply limits)|https://paxpress.txpa.hidinc.com/opc.pdf|09/01/2020| 47781039560|Opiate Overutilization|https://paxpress.txpa.hidinc.com/opiate.pdf|11/05/2013| 47781039560|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017| 47781039560|Opioid Clinical Policy (MME and days supply limits)|https://paxpress.txpa.hidinc.com/opc.pdf|09/01/2020| 47781039660|Opiate Overutilization|https://paxpress.txpa.hidinc.com/opiate.pdf|11/05/2013| 47781039660|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017| 47781039660|Opioid Clinical Policy (MME and days supply limits)|https://paxpress.txpa.hidinc.com/opc.pdf|09/01/2020| 47781039760|Opiate Overutilization|https://paxpress.txpa.hidinc.com/opiate.pdf|11/05/2013| 47781039760|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017| 47781039760|Opioid Clinical Policy (MME and days supply limits)|https://paxpress.txpa.hidinc.com/opc.pdf|09/01/2020| 47781039860|Opiate Overutilization|https://paxpress.txpa.hidinc.com/opiate.pdf|11/05/2013| 47781039860|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017| 47781039860|Opioid Clinical Policy (MME and days supply limits)|https://paxpress.txpa.hidinc.com/opc.pdf|09/01/2020| 47781042347|Fentanyl Agents|https://paxpress.txpa.hidinc.com/fentanyl.pdf|01/31/2011| 47781042347|Opiate Overutilization|https://paxpress.txpa.hidinc.com/opiate.pdf|11/05/2013| 47781042347|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017| 47781042347|Opioid Clinical Policy (MME and days supply limits)|https://paxpress.txpa.hidinc.com/opc.pdf|09/01/2020| 47781042447|Fentanyl Agents|https://paxpress.txpa.hidinc.com/fentanyl.pdf|01/31/2011| 47781042447|Opiate Overutilization|https://paxpress.txpa.hidinc.com/opiate.pdf|11/05/2013| 47781042447|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017| 47781042447|Opioid Clinical Policy (MME and days supply limits)|https://paxpress.txpa.hidinc.com/opc.pdf|09/01/2020| 47781042647|Fentanyl Agents|https://paxpress.txpa.hidinc.com/fentanyl.pdf|01/31/2011| 47781042647|Opiate Overutilization|https://paxpress.txpa.hidinc.com/opiate.pdf|11/05/2013| 47781042647|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017| 47781042647|Opioid Clinical Policy (MME and days supply limits)|https://paxpress.txpa.hidinc.com/opc.pdf|09/01/2020| 47781042747|Fentanyl Agents|https://paxpress.txpa.hidinc.com/fentanyl.pdf|01/31/2011| 47781042747|Opiate Overutilization|https://paxpress.txpa.hidinc.com/opiate.pdf|11/05/2013| 47781042747|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017| 47781042747|Opioid Clinical Policy (MME and days supply limits)|https://paxpress.txpa.hidinc.com/opc.pdf|09/01/2020| 47781042847|Fentanyl Agents|https://paxpress.txpa.hidinc.com/fentanyl.pdf|01/31/2011| 47781042847|Opiate Overutilization|https://paxpress.txpa.hidinc.com/opiate.pdf|11/05/2013| 47781042847|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017| 47781042847|Opioid Clinical Policy (MME and days supply limits)|https://paxpress.txpa.hidinc.com/opc.pdf|09/01/2020| 47781056301|ADD/ADHD Agents|https://paxpress.txpa.hidinc.com/add_adhd_agents.pdf|02/13/2014| 47781056401|ADD/ADHD Agents|https://paxpress.txpa.hidinc.com/add_adhd_agents.pdf|02/13/2014| 47781056501|ADD/ADHD Agents|https://paxpress.txpa.hidinc.com/add_adhd_agents.pdf|02/13/2014| 47781056601|ADD/ADHD Agents|https://paxpress.txpa.hidinc.com/add_adhd_agents.pdf|02/13/2014| 47781056701|ADD/ADHD Agents|https://paxpress.txpa.hidinc.com/add_adhd_agents.pdf|02/13/2014| 47781056801|ADD/ADHD Agents|https://paxpress.txpa.hidinc.com/add_adhd_agents.pdf|02/13/2014| 47781058568|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 47781058568|Ketorolac|https://paxpress.txpa.hidinc.com/ketorolac.pdf|05/25/2012| 47781091401|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 47781091451|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 47781091601|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 47783010101|HAE Agents Clinical|https://paxpress.txpa.hidinc.com/HAE.pdf|03/21/2023| 47783064401|HAE Agents Clinical|https://paxpress.txpa.hidinc.com/HAE.pdf|03/21/2023| 47783064501|HAE Agents Clinical|https://paxpress.txpa.hidinc.com/HAE.pdf|03/21/2023| 47783064601|HAE Agents Clinical|https://paxpress.txpa.hidinc.com/HAE.pdf|03/21/2023| 49230064331|Phosphate Binders|https://paxpress.txpa.hidinc.com/phosphate_binders.pdf|01/31/2011|10/31/2023 49230064551|Phosphate Binders|https://paxpress.txpa.hidinc.com/phosphate_binders.pdf|01/31/2011| 49348001737|Cough and Cold Agents|https://paxpress.txpa.hidinc.com/Cough%20&%20Cold.pdf|12/15/2015|04/30/2024 49348001737|Dextromethorphan Overutilization|https://paxpress.txpa.hidinc.com/dextro.pdf|07/16/2012|04/30/2024 49348002827|Cough and Cold Agents|https://paxpress.txpa.hidinc.com/Cough%20&%20Cold.pdf|12/15/2015| 49348004534|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 49348019609|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 49348054301|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 49348063634|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 49348070609|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 49348070610|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 49348086134|Cough and Cold Agents|https://paxpress.txpa.hidinc.com/Cough%20&%20Cold.pdf|12/15/2015| 49348086134|Dextromethorphan Overutilization|https://paxpress.txpa.hidinc.com/dextro.pdf|07/16/2012| 49502040124|Inhaled Antibiotics Clinical|https://paxpress.txpa.hidinc.com/inhaledantibiotics.pdf|05/02/2023| 49502060561|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/04/2016| 49884004801|ADD/ADHD Agents|https://paxpress.txpa.hidinc.com/add_adhd_agents.pdf|02/13/2014| 49884004901|ADD/ADHD Agents|https://paxpress.txpa.hidinc.com/add_adhd_agents.pdf|02/13/2014| 49884005802|Pulmonary Hypertension Agents Clinical|https://paxpress.txpa.hidinc.com/pah.pdf|07/27/2023| 49884005902|Pulmonary Hypertension Agents Clinical|https://paxpress.txpa.hidinc.com/pah.pdf|07/27/2023| 49884011074|Anxiolytics and Sedative-Hypnotics|https://paxpress.txpa.hidinc.com/ash.pdf|05/28/2015| 49884011074|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017| 49884011174|Anxiolytics and Sedative-Hypnotics|https://paxpress.txpa.hidinc.com/ash.pdf|05/28/2015| 49884011174|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017| 49884018601|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 49884021255|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016| 49884021374|Anxiolytics and Sedative-Hypnotics|https://paxpress.txpa.hidinc.com/ash.pdf|05/28/2015| 49884021374|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017| 49884021474|Anxiolytics and Sedative-Hypnotics|https://paxpress.txpa.hidinc.com/ash.pdf|05/28/2015| 49884021474|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017| 49884024801|ADD/ADHD Agents|https://paxpress.txpa.hidinc.com/add_adhd_agents.pdf|02/13/2014| 49884025011|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016| 49884025111|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016| 49884025211|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016| 49884025311|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016| 49884027711|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016| 49884030602|Anxiolytics and Sedative-Hypnotics|https://paxpress.txpa.hidinc.com/ash.pdf|01/31/2011| 49884030602|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017| 49884030702|Anxiolytics and Sedative-Hypnotics|https://paxpress.txpa.hidinc.com/ash.pdf|01/31/2011| 49884030702|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017| 49884030802|Anxiolytics and Sedative-Hypnotics|https://paxpress.txpa.hidinc.com/ash.pdf|01/31/2011| 49884030802|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017| 49884030902|Anxiolytics and Sedative-Hypnotics|https://paxpress.txpa.hidinc.com/ash.pdf|01/31/2011| 49884030902|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017| 49884031002|Anxiolytics and Sedative-Hypnotics|https://paxpress.txpa.hidinc.com/ash.pdf|01/31/2011| 49884031002|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017| 49884031155|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016| 49884031191|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016| 49884031555|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016| 49884031591|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016| 49884032055|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016|07/31/2024 49884032155|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016| 49884032255|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016| 49884032355|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016| 49884033301|ADD/ADHD Agents|https://paxpress.txpa.hidinc.com/add_adhd_agents.pdf|02/13/2014| 49884033901|ADD/ADHD Agents|https://paxpress.txpa.hidinc.com/add_adhd_agents.pdf|02/13/2014| 49884034701|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016| 49884034801|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016| 49884035311|Pulmonary Hypertension Agents Clinical|https://paxpress.txpa.hidinc.com/pah.pdf|07/27/2023|08/23/2023 49884035362|Pulmonary Hypertension Agents Clinical|https://paxpress.txpa.hidinc.com/pah.pdf|07/27/2023|08/23/2023 49884035411|Pulmonary Hypertension Agents Clinical|https://paxpress.txpa.hidinc.com/pah.pdf|07/27/2023|08/23/2023 49884035462|Pulmonary Hypertension Agents Clinical|https://paxpress.txpa.hidinc.com/pah.pdf|07/27/2023|08/23/2023 49884040191|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016| 49884040291|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016| 49884040391|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016| 49884042411|Aliskiren Containing Agents|https://paxpress.txpa.hidinc.com/aliskiren.pdf|07/16/2012| 49884042511|Aliskiren Containing Agents|https://paxpress.txpa.hidinc.com/aliskiren.pdf|07/16/2012| 49884042801|ADD/ADHD Agents|https://paxpress.txpa.hidinc.com/add_adhd_agents.pdf|02/13/2014| 49884043001|ADD/ADHD Agents|https://paxpress.txpa.hidinc.com/add_adhd_agents.pdf|02/13/2014| 49884054601|ADD/ADHD Agents|https://paxpress.txpa.hidinc.com/add_adhd_agents.pdf|02/13/2014| 49884054902|Leukotriene Modifiers|https://paxpress.txpa.hidinc.com/leukotriene.pdf|12/15/2015| 49884055402|Leukotriene Modifiers|https://paxpress.txpa.hidinc.com/leukotriene.pdf|12/15/2015|04/30/2024 49884065809|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 49884065909|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 49884066009|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 49884066109|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 49884072308|Leukotriene Modifiers|https://paxpress.txpa.hidinc.com/leukotriene.pdf|12/15/2015| 49884078609|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 49884078611|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 49884078709|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 49884078711|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 49884078809|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 49884078811|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 49884078911|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 49884079009|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 49884079011|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 49884081911|GI Motility Agents|https://paxpress.txpa.hidinc.com/GImotility.pdf|01/18/2017|08/23/2023 49884082011|GI Motility Agents|https://paxpress.txpa.hidinc.com/GImotility.pdf|01/18/2017|08/23/2023 49884083901|ADD/ADHD Agents|https://paxpress.txpa.hidinc.com/add_adhd_agents.pdf|02/13/2014| 49884084001|ADD/ADHD Agents|https://paxpress.txpa.hidinc.com/add_adhd_agents.pdf|02/13/2014| 49884084101|ADD/ADHD Agents|https://paxpress.txpa.hidinc.com/add_adhd_agents.pdf|02/13/2014| 49884084201|ADD/ADHD Agents|https://paxpress.txpa.hidinc.com/add_adhd_agents.pdf|02/13/2014| 49884084301|ADD/ADHD Agents|https://paxpress.txpa.hidinc.com/add_adhd_agents.pdf|02/13/2014| 49884084401|ADD/ADHD Agents|https://paxpress.txpa.hidinc.com/add_adhd_agents.pdf|02/13/2014| 49884089811|Anxiolytics and Sedative-Hypnotics|https://paxpress.txpa.hidinc.com/ash.pdf|01/31/2011| 49884089911|Anxiolytics and Sedative-Hypnotics|https://paxpress.txpa.hidinc.com/ash.pdf|01/31/2011| 49884098401|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 49884098501|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 50222020310|Topical Immunomodulators|https://paxpress.txpa.hidinc.com/immunomodulators.pdf|01/31/2011|05/18/2024 50222020330|Topical Immunomodulators|https://paxpress.txpa.hidinc.com/immunomodulators.pdf|01/31/2011|05/18/2024 50222020360|Topical Immunomodulators|https://paxpress.txpa.hidinc.com/immunomodulators.pdf|01/31/2011|05/18/2024 50222021110|Topical Immunomodulators|https://paxpress.txpa.hidinc.com/immunomodulators.pdf|01/31/2011|05/18/2024 50222021130|Topical Immunomodulators|https://paxpress.txpa.hidinc.com/immunomodulators.pdf|01/31/2011|05/18/2024 50222021160|Topical Immunomodulators|https://paxpress.txpa.hidinc.com/immunomodulators.pdf|01/31/2011|05/18/2024 50228010901|Carisoprodol Overuse|https://paxpress.txpa.hidinc.com/soma.pdf|01/31/2011| 50228010901|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017| 50228010905|Carisoprodol Overuse|https://paxpress.txpa.hidinc.com/soma.pdf|01/31/2011| 50228010905|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017| 50228010910|Carisoprodol Overuse|https://paxpress.txpa.hidinc.com/soma.pdf|01/31/2011| 50228010910|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017| 50228013630|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 50228013690|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 50228014601|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 50228014605|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 50228014610|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 50228015660|COX-2 Inhibitors|https://paxpress.txpa.hidinc.com/cox2.pdf|01/31/2011| 50228015660|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/04/2016| 50228015701|COX-2 Inhibitors|https://paxpress.txpa.hidinc.com/cox2.pdf|01/31/2011| 50228015701|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/04/2016| 50228015705|COX-2 Inhibitors|https://paxpress.txpa.hidinc.com/cox2.pdf|01/31/2011| 50228015705|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/04/2016| 50228015801|COX-2 Inhibitors|https://paxpress.txpa.hidinc.com/cox2.pdf|01/31/2011| 50228015801|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/04/2016| 50228015805|COX-2 Inhibitors|https://paxpress.txpa.hidinc.com/cox2.pdf|01/31/2011| 50228015805|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/04/2016| 50228015960|COX-2 Inhibitors|https://paxpress.txpa.hidinc.com/cox2.pdf|01/31/2011| 50228015960|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/04/2016| 50228017701|Gabapentin Agents|https://paxpress.txpa.hidinc.com/neurontin.pdf|01/31/2011| 50228017705|Gabapentin Agents|https://paxpress.txpa.hidinc.com/neurontin.pdf|01/31/2011| 50228017801|Gabapentin Agents|https://paxpress.txpa.hidinc.com/neurontin.pdf|01/31/2011| 50228017805|Gabapentin Agents|https://paxpress.txpa.hidinc.com/neurontin.pdf|01/31/2011| 50228017901|Gabapentin Agents|https://paxpress.txpa.hidinc.com/neurontin.pdf|01/31/2011| 50228017905|Gabapentin Agents|https://paxpress.txpa.hidinc.com/neurontin.pdf|01/31/2011| 50228017910|Gabapentin Agents|https://paxpress.txpa.hidinc.com/neurontin.pdf|01/31/2011| 50228018001|Gabapentin Agents|https://paxpress.txpa.hidinc.com/neurontin.pdf|01/31/2011| 50228018005|Gabapentin Agents|https://paxpress.txpa.hidinc.com/neurontin.pdf|01/31/2011| 50228018010|Gabapentin Agents|https://paxpress.txpa.hidinc.com/neurontin.pdf|01/31/2011| 50228018101|Gabapentin Agents|https://paxpress.txpa.hidinc.com/neurontin.pdf|01/31/2011| 50228018105|Gabapentin Agents|https://paxpress.txpa.hidinc.com/neurontin.pdf|01/31/2011| 50228032301|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017| 50228032305|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017| 50228033910|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 50228033930|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 50228033990|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 50228034010|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 50228034030|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 50228034090|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 50228034110|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 50228034130|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 50228034190|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 50228038060|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016| 50228038160|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016| 50228038260|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016| 50228038360|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016| 50228038460|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016| 50228042360|Ranexa|https://paxpress.txpa.hidinc.com/ranexa.pdf|05/25/2012| 50228042460|Ranexa|https://paxpress.txpa.hidinc.com/ranexa.pdf|05/25/2012| 50228043201|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 50228043205|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 50228043301|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 50228043305|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 50228043401|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 50228043405|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 50228043501|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 50228043505|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 50228043601|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 50228043605|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 50228045110|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/04/2016| 50228045190|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/04/2016| 50228045205|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/04/2016| 50228045290|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/04/2016| 50228045310|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/04/2016| 50228045390|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/04/2016| 50228045405|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/04/2016| 50228045490|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/04/2016| 50228046501|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 50228046505|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 50228046601|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 50228046605|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 50242000701|Cytokine and CAM Antagonists|https://paxpress.txpa.hidinc.com/cytokine.pdf|04/05/2022| 50242007401|Growth Hormones|https://paxpress.txpa.hidinc.com/gh.pdf|01/31/2011| 50242007501|Growth Hormones|https://paxpress.txpa.hidinc.com/gh.pdf|01/31/2011| 50242007601|Growth Hormones|https://paxpress.txpa.hidinc.com/gh.pdf|01/31/2011| 50242009002|Zelboraf|https://paxpress.txpa.hidinc.com/zelboraf.pdf|05/23/2023| 50242013801|Cytokine and CAM Antagonists|https://paxpress.txpa.hidinc.com/cytokine.pdf|03/27/2018| 50242014301|Cytokine and CAM Antagonists|https://paxpress.txpa.hidinc.com/cytokine.pdf|03/27/2018| 50268014411|Buprenorphine Agents|https://paxpress.txpa.hidinc.com/buprenorphine_agents.pdf|04/23/2013| 50268014411|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017| 50268014415|Buprenorphine Agents|https://paxpress.txpa.hidinc.com/buprenorphine_agents.pdf|04/23/2013| 50268014415|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017| 50268014511|Buprenorphine Agents|https://paxpress.txpa.hidinc.com/buprenorphine_agents.pdf|04/23/2013| 50268014511|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017| 50268014515|Buprenorphine Agents|https://paxpress.txpa.hidinc.com/buprenorphine_agents.pdf|04/23/2013| 50268014515|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017| 50268019115|Cyclobenzaprine|https://paxpress.txpa.hidinc.com/cyclobenzaprine.pdf|01/31/2011| 50268019115|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017| 50268036615|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016| 50268036715|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016| 50268036815|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016| 50268036915|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016| 50268040415|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 50268055615|Leukotriene Modifiers|https://paxpress.txpa.hidinc.com/leukotriene.pdf|12/15/2015| 50268066515|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/04/2016| 50268066715|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/04/2016| 50268067611|Lovaza|https://paxpress.txpa.hidinc.com/lovaza.pdf|07/16/2012| 50268067612|Lovaza|https://paxpress.txpa.hidinc.com/lovaza.pdf|07/16/2012| 50268072215|Ranexa|https://paxpress.txpa.hidinc.com/ranexa.pdf|05/25/2012| 50268072313|Ranexa|https://paxpress.txpa.hidinc.com/ranexa.pdf|05/25/2012| 50383004004|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|02/23/2024 50383004224|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|02/23/2024 50383004248|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|02/23/2024 50383004316|Cough and Cold Agents|https://paxpress.txpa.hidinc.com/Cough%20&%20Cold.pdf|12/15/2015|02/23/2024 50383004316|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017|02/23/2024 50383004316|Opioid Clinical Policy (MME and days supply limits)|https://paxpress.txpa.hidinc.com/opc.pdf|09/01/2020|02/23/2024 50383007916|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017|02/23/2024 50383007916|Opioid Clinical Policy (MME and days supply limits)|https://paxpress.txpa.hidinc.com/opc.pdf|09/01/2020|02/23/2024 50383008704|Cough and Cold Agents|https://paxpress.txpa.hidinc.com/Cough%20&%20Cold.pdf|12/15/2015|02/23/2024 50383008704|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017|02/23/2024 50383008704|Opioid Clinical Policy (MME and days supply limits)|https://paxpress.txpa.hidinc.com/opc.pdf|09/01/2020|02/23/2024 50383008716|Cough and Cold Agents|https://paxpress.txpa.hidinc.com/Cough%20&%20Cold.pdf|12/15/2015|02/23/2024 50383008716|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017|02/23/2024 50383008716|Opioid Clinical Policy (MME and days supply limits)|https://paxpress.txpa.hidinc.com/opc.pdf|09/01/2020|02/23/2024 50383028793|Buprenorphine Agents|https://paxpress.txpa.hidinc.com/buprenorphine_agents.pdf|04/23/2013| 50383028793|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017| 50383029493|Buprenorphine Agents|https://paxpress.txpa.hidinc.com/buprenorphine_agents.pdf|04/23/2013| 50383029493|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017| 50383031147|Gabapentin Agents|https://paxpress.txpa.hidinc.com/neurontin.pdf|01/31/2011|02/23/2024 50383070530|Anxiolytics and Sedative-Hypnotics|https://paxpress.txpa.hidinc.com/ash.pdf|01/31/2011|02/23/2024 50383070530|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017|02/23/2024 50383074120|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|02/23/2024 50383080116|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|02/23/2024 50383080116|Promethazine Utilization|https://paxpress.txpa.hidinc.com/phenergan.pdf|01/31/2011|02/23/2024 50383080416|Cough and Cold Agents|https://paxpress.txpa.hidinc.com/Cough%20&%20Cold.pdf|12/15/2015|02/23/2024 50383080416|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|02/23/2024 50383080416|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017|02/23/2024 50383080416|Opioid Clinical Policy (MME and days supply limits)|https://paxpress.txpa.hidinc.com/opc.pdf|09/01/2020|02/23/2024 50383080416|Promethazine Utilization|https://paxpress.txpa.hidinc.com/phenergan.pdf|01/31/2011|02/23/2024 50383092493|Buprenorphine Agents|https://paxpress.txpa.hidinc.com/buprenorphine_agents.pdf|12/05/2014| 50383092493|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017| 50383093093|Buprenorphine Agents|https://paxpress.txpa.hidinc.com/buprenorphine_agents.pdf|12/05/2014| 50383093093|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017| 50383096134|Opiate Overutilization|https://paxpress.txpa.hidinc.com/opiate.pdf|11/05/2013|02/23/2024 50383096134|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017|02/23/2024 50383096134|Opioid Clinical Policy (MME and days supply limits)|https://paxpress.txpa.hidinc.com/opc.pdf|09/01/2020|02/23/2024 50383096430|Opiate Overutilization|https://paxpress.txpa.hidinc.com/opiate.pdf|11/05/2013|02/23/2024 50383096430|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017|02/23/2024 50383096504|Opiate Overutilization|https://paxpress.txpa.hidinc.com/opiate.pdf|11/05/2013|02/23/2024 50383096504|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017|02/23/2024 50383096504|Opioid Clinical Policy (MME and days supply limits)|https://paxpress.txpa.hidinc.com/opc.pdf|09/01/2020|02/23/2024 50383096530|Opiate Overutilization|https://paxpress.txpa.hidinc.com/opiate.pdf|11/05/2013|02/23/2024 50383096530|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017|02/23/2024 50383096530|Opioid Clinical Policy (MME and days supply limits)|https://paxpress.txpa.hidinc.com/opc.pdf|09/01/2020|02/23/2024 50419025001|Pulmonary Hypertension Agents Clinical|https://paxpress.txpa.hidinc.com/pah.pdf|07/27/2023| 50419025101|Pulmonary Hypertension Agents Clinical|https://paxpress.txpa.hidinc.com/pah.pdf|07/27/2023| 50419025201|Pulmonary Hypertension Agents Clinical|https://paxpress.txpa.hidinc.com/pah.pdf|07/27/2023| 50419025301|Pulmonary Hypertension Agents Clinical|https://paxpress.txpa.hidinc.com/pah.pdf|07/27/2023| 50419025401|Pulmonary Hypertension Agents Clinical|https://paxpress.txpa.hidinc.com/pah.pdf|07/27/2023| 50419045104|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 50419045204|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 50419045304|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 50419045404|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 50419045504|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 50419045604|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 50419045904|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 50419048303|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 50419049104|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 50458014030|SGLT2 Inhibitors Clinical|https://paxpress.txpa.hidinc.com/SGLT2.pdf|05/23/2023| 50458014090|SGLT2 Inhibitors Clinical|https://paxpress.txpa.hidinc.com/SGLT2.pdf|05/23/2023| 50458014130|SGLT2 Inhibitors Clinical|https://paxpress.txpa.hidinc.com/SGLT2.pdf|05/23/2023| 50458014190|SGLT2 Inhibitors Clinical|https://paxpress.txpa.hidinc.com/SGLT2.pdf|05/23/2023| 50458030001|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016| 50458030006|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016| 50458030206|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016| 50458030503|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016| 50458030611|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016| 50458030711|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016| 50458030811|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016| 50458030911|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016| 50458032001|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016| 50458032006|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016| 50458033001|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016| 50458033006|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016| 50458035001|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016| 50458035006|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016| 50458054060|SGLT2 Inhibitors Clinical|https://paxpress.txpa.hidinc.com/SGLT2.pdf|05/23/2023| 50458054160|SGLT2 Inhibitors Clinical|https://paxpress.txpa.hidinc.com/SGLT2.pdf|05/23/2023| 50458054260|SGLT2 Inhibitors Clinical|https://paxpress.txpa.hidinc.com/SGLT2.pdf|05/23/2023| 50458054360|SGLT2 Inhibitors Clinical|https://paxpress.txpa.hidinc.com/SGLT2.pdf|05/23/2023| 50458055001|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016| 50458055101|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016| 50458055201|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016| 50458055401|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016| 50458056001|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016| 50458056101|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016| 50458056201|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016| 50458056301|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016| 50458056401|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016| 50458057501|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 50458057710|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 50458057718|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 50458057760|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 50458057810|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 50458057830|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 50458057890|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 50458057910|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 50458057930|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 50458057989|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 50458057990|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 50458058010|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 50458058030|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 50458058090|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 50458058451|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 50458058501|ADD/ADHD Agents|https://paxpress.txpa.hidinc.com/add_adhd_agents.pdf|02/13/2014| 50458058601|ADD/ADHD Agents|https://paxpress.txpa.hidinc.com/add_adhd_agents.pdf|02/13/2014| 50458058701|ADD/ADHD Agents|https://paxpress.txpa.hidinc.com/add_adhd_agents.pdf|02/13/2014| 50458058801|ADD/ADHD Agents|https://paxpress.txpa.hidinc.com/add_adhd_agents.pdf|02/13/2014| 50458059601|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016| 50458060601|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016| 50458060701|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016| 50458060801|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016| 50458060901|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016| 50458061101|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016| 50458061201|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016| 50458094001|SGLT2 Inhibitors Clinical|https://paxpress.txpa.hidinc.com/SGLT2.pdf|05/23/2023| 50458094101|SGLT2 Inhibitors Clinical|https://paxpress.txpa.hidinc.com/SGLT2.pdf|05/23/2023| 50458094201|SGLT2 Inhibitors Clinical|https://paxpress.txpa.hidinc.com/SGLT2.pdf|05/23/2023| 50458094301|SGLT2 Inhibitors Clinical|https://paxpress.txpa.hidinc.com/SGLT2.pdf|05/23/2023| 50474071079|Cytokine and CAM Antagonists|https://paxpress.txpa.hidinc.com/cytokine.pdf|03/27/2018| 50474071081|Cytokine and CAM Antagonists|https://paxpress.txpa.hidinc.com/cytokine.pdf|03/27/2018| 50742018921|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 50742019001|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 50742019010|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 50742024760|ADD/ADHD Agents|https://paxpress.txpa.hidinc.com/add_adhd_agents.pdf|02/13/2014| 50742025601|Carisoprodol Overuse|https://paxpress.txpa.hidinc.com/soma.pdf|01/31/2011| 50742025601|Opiate Overutilization|https://paxpress.txpa.hidinc.com/opiate.pdf|11/05/2013| 50742025601|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017| 50742025601|Opioid Clinical Policy (MME and days supply limits)|https://paxpress.txpa.hidinc.com/opc.pdf|09/01/2020| 50742027801|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 50742027901|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 50742029909|Antimigraine Agents Triptans|https://paxpress.txpa.hidinc.com/triptans.pdf|04/04/2023| 50742063560|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016| 50742063660|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016| 50742063760|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016| 50742063860|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016| 50742063960|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016| 50742064501|Anxiolytics and Sedative-Hypnotics|https://paxpress.txpa.hidinc.com/ash.pdf|01/31/2011| 50742064501|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017| 50742064601|Anxiolytics and Sedative-Hypnotics|https://paxpress.txpa.hidinc.com/ash.pdf|01/31/2011| 50742064601|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017| 50742065601|Carisoprodol Overuse|https://paxpress.txpa.hidinc.com/soma.pdf|01/31/2011| 50742065601|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017| 50742065728|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 50742065784|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 50742065828|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 50742065884|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 50991012116|Cough and Cold Agents|https://paxpress.txpa.hidinc.com/Cough%20&%20Cold.pdf|12/15/2015| 50991012116|Dextromethorphan Overutilization|https://paxpress.txpa.hidinc.com/dextro.pdf|07/16/2012| 50991021201|Cough and Cold Agents|https://paxpress.txpa.hidinc.com/Cough%20&%20Cold.pdf|12/15/2015| 50991021401|Cough and Cold Agents|https://paxpress.txpa.hidinc.com/Cough%20&%20Cold.pdf|12/15/2015| 50991021401|Dextromethorphan Overutilization|https://paxpress.txpa.hidinc.com/dextro.pdf|07/16/2012| 50991022016|Cough and Cold Agents|https://paxpress.txpa.hidinc.com/Cough%20&%20Cold.pdf|12/15/2015| 50991022016|Dextromethorphan Overutilization|https://paxpress.txpa.hidinc.com/dextro.pdf|07/16/2012| 50991022016|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 50991062601|Cough and Cold Agents|https://paxpress.txpa.hidinc.com/Cough%20&%20Cold.pdf|12/15/2015| 50991062601|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 50991073690|Cough and Cold Agents|https://paxpress.txpa.hidinc.com/Cough%20&%20Cold.pdf|12/15/2015| 50991074001|Cough and Cold Agents|https://paxpress.txpa.hidinc.com/Cough%20&%20Cold.pdf|12/15/2015| 50991074001|Dextromethorphan Overutilization|https://paxpress.txpa.hidinc.com/dextro.pdf|07/16/2012| 50991078360|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 50991078490|Cough and Cold Agents|https://paxpress.txpa.hidinc.com/Cough%20&%20Cold.pdf|12/15/2015| 50991082616|Cough and Cold Agents|https://paxpress.txpa.hidinc.com/Cough%20&%20Cold.pdf|12/15/2015| 50991082616|Dextromethorphan Overutilization|https://paxpress.txpa.hidinc.com/dextro.pdf|07/16/2012| 51079020820|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/04/2016| 51079020920|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/04/2016| 51079021020|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/04/2016| 51079021103|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/04/2016| 51079028804|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016| 51079043120|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016| 51079045820|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/04/2016| 51079057220|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016| 51079057320|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016| 51079057420|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016| 51079057520|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016| 51079059720|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 51079073320|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016| 51079073420|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016| 51079073520|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016| 51079073620|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016| 51079074920|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016| 51079078220|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/04/2016| 51079092120|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016| 51079092220|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016| 51167010602|Cystic Fibrosis Agents|https://paxpress.txpa.hidinc.com/cystic_fibrosis_agents.pdf|02/24/2020| 51167011301|Cystic Fibrosis Agents|https://paxpress.txpa.hidinc.com/cystic_fibrosis_agents.pdf|07/17/2018| 51167012201|Cystic Fibrosis Agents|https://paxpress.txpa.hidinc.com/cystic_fibrosis_agents.pdf|12/04/2016| 51167020001|Cystic Fibrosis Agents|https://paxpress.txpa.hidinc.com/cystic_fibrosis_agents.pdf|04/29/2013| 51167030001|Cystic Fibrosis Agents|https://paxpress.txpa.hidinc.com/cystic_fibrosis_agents.pdf|04/29/2013| 51167033101|Cystic Fibrosis Agents|https://paxpress.txpa.hidinc.com/cystic_fibrosis_agents.pdf|02/24/2020| 51167040001|Cystic Fibrosis Agents|https://paxpress.txpa.hidinc.com/cystic_fibrosis_agents.pdf|04/29/2013| 51167044501|Cystic Fibrosis Agents|https://paxpress.txpa.hidinc.com/cystic_fibrosis_agents.pdf|02/24/2020| 51167044601|Cystic Fibrosis Agents|https://paxpress.txpa.hidinc.com/cystic_fibrosis_agents.pdf|02/24/2020| 51167050002|Cystic Fibrosis Agents|https://paxpress.txpa.hidinc.com/cystic_fibrosis_agents.pdf|12/04/2016| 51167060001|Cystic Fibrosis Agents|https://paxpress.txpa.hidinc.com/cystic_fibrosis_agents.pdf|04/29/2013| 51167066101|Cystic Fibrosis Agents|https://paxpress.txpa.hidinc.com/cystic_fibrosis_agents.pdf|07/17/2018| 51167070002|Cystic Fibrosis Agents|https://paxpress.txpa.hidinc.com/cystic_fibrosis_agents.pdf|12/04/2016| 51167080901|Cystic Fibrosis Agents|https://paxpress.txpa.hidinc.com/cystic_fibrosis_agents.pdf|01/05/2016| 51167090001|Cystic Fibrosis Agents|https://paxpress.txpa.hidinc.com/cystic_fibrosis_agents.pdf|12/04/2016| 51224000150|Cough and Cold Agents|https://paxpress.txpa.hidinc.com/Cough%20&%20Cold.pdf|12/15/2015| 51224000160|Cough and Cold Agents|https://paxpress.txpa.hidinc.com/Cough%20&%20Cold.pdf|12/15/2015| 51224001050|Cough and Cold Agents|https://paxpress.txpa.hidinc.com/Cough%20&%20Cold.pdf|12/15/2015| 51224001060|Cough and Cold Agents|https://paxpress.txpa.hidinc.com/Cough%20&%20Cold.pdf|12/15/2015| 51224002150|Gabapentin Agents|https://paxpress.txpa.hidinc.com/neurontin.pdf|01/31/2011| 51224002160|Gabapentin Agents|https://paxpress.txpa.hidinc.com/neurontin.pdf|01/31/2011| 51224012150|Gabapentin Agents|https://paxpress.txpa.hidinc.com/neurontin.pdf|01/31/2011| 51224012160|Gabapentin Agents|https://paxpress.txpa.hidinc.com/neurontin.pdf|01/31/2011| 51224042510|VMAT2 Inhibitors|https://paxpress.txpa.hidinc.com/vmat2_inhibitor.pdf|09/25/2018| 51224042610|VMAT2 Inhibitors|https://paxpress.txpa.hidinc.com/vmat2_inhibitor.pdf|09/25/2018| 51285004001|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|09/04/2024 51285004702|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|09/04/2024 51285005002|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|09/04/2024 51285006390|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|09/04/2024 51293069601|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017| 51525590101|Carisoprodol Overuse|https://paxpress.txpa.hidinc.com/soma.pdf|01/31/2011| 51525590101|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017| 51660014030|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 51660014190|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 51660014290|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 51660014390|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 51672136307|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 51672138508|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 51672138509|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 51672207308|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 51672209208|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 51672210208|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 51672213008|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 51672213108|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 51672401601|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 51672401701|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 51672401801|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 51672402701|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 51672402703|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 51672402801|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 51672402803|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 51672402901|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 51672402903|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 51672403001|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 51672403003|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 51672403101|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 51672403103|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 51672403201|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 51672403203|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 51672403301|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 51672403303|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 51672403401|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 51672403403|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 51672403501|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 51672403503|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 51672403601|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 51672404201|Anxiolytics and Sedative-Hypnotics|https://paxpress.txpa.hidinc.com/ash.pdf|01/31/2011| 51672404201|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017| 51672404202|Anxiolytics and Sedative-Hypnotics|https://paxpress.txpa.hidinc.com/ash.pdf|01/31/2011| 51672404202|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017| 51672404301|Anxiolytics and Sedative-Hypnotics|https://paxpress.txpa.hidinc.com/ash.pdf|01/31/2011| 51672404301|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017| 51672404302|Anxiolytics and Sedative-Hypnotics|https://paxpress.txpa.hidinc.com/ash.pdf|01/31/2011| 51672404302|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017| 51672404401|Anxiolytics and Sedative-Hypnotics|https://paxpress.txpa.hidinc.com/ash.pdf|01/31/2011| 51672404401|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017| 51672404501|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 51672404601|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 51672405101|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 51672405104|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 51672405201|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 51672405204|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 51672405301|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 51672405304|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 51672407008|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 51672416108|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 51672529601|Promethazine Utilization|https://paxpress.txpa.hidinc.com/phenergan.pdf|01/31/2011| 51672529701|Promethazine Utilization|https://paxpress.txpa.hidinc.com/phenergan.pdf|01/31/2011| 51759020210|CGRP Agents Prophylaxis|https://paxpress.txpa.hidinc.com/cgrpchronic.pdf|11/22/2022| 51759020410|CGRP Agents Prophylaxis|https://paxpress.txpa.hidinc.com/cgrpchronic.pdf|11/22/2022| 51862007301|Anxiolytics and Sedative-Hypnotics|https://paxpress.txpa.hidinc.com/ash.pdf|01/31/2011| 51862007301|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017| 51862007401|Anxiolytics and Sedative-Hypnotics|https://paxpress.txpa.hidinc.com/ash.pdf|01/31/2011| 51862007401|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017| 51862018501|Opiate Overutilization|https://paxpress.txpa.hidinc.com/opiate.pdf|11/05/2013| 51862018501|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017| 51862018501|Opioid Clinical Policy (MME and days supply limits)|https://paxpress.txpa.hidinc.com/opc.pdf|09/01/2020| 51862018601|Opiate Overutilization|https://paxpress.txpa.hidinc.com/opiate.pdf|11/05/2013| 51862018601|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017| 51862018601|Opioid Clinical Policy (MME and days supply limits)|https://paxpress.txpa.hidinc.com/opc.pdf|09/01/2020| 51862018701|Opiate Overutilization|https://paxpress.txpa.hidinc.com/opiate.pdf|11/05/2013| 51862018701|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017| 51862018701|Opioid Clinical Policy (MME and days supply limits)|https://paxpress.txpa.hidinc.com/opc.pdf|09/01/2020| 51862018801|Opiate Overutilization|https://paxpress.txpa.hidinc.com/opiate.pdf|11/05/2013| 51862018801|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017| 51862018801|Opioid Clinical Policy (MME and days supply limits)|https://paxpress.txpa.hidinc.com/opc.pdf|09/01/2020| 51862033201|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 51862033301|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 51862033305|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 51862033401|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 51862033405|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 51862034490|ADD/ADHD Agents|https://paxpress.txpa.hidinc.com/add_adhd_agents.pdf|02/13/2014| 51862034590|ADD/ADHD Agents|https://paxpress.txpa.hidinc.com/add_adhd_agents.pdf|02/13/2014| 51862034690|ADD/ADHD Agents|https://paxpress.txpa.hidinc.com/add_adhd_agents.pdf|02/13/2014| 51862058001|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 51862060830|Buprenorphine Agents|https://paxpress.txpa.hidinc.com/buprenorphine_agents.pdf|04/23/2013| 51862060830|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017| 51862060901|ADD/ADHD Agents|https://paxpress.txpa.hidinc.com/add_adhd_agents.pdf|02/13/2014| 51862061001|ADD/ADHD Agents|https://paxpress.txpa.hidinc.com/add_adhd_agents.pdf|02/13/2014| 51862061101|ADD/ADHD Agents|https://paxpress.txpa.hidinc.com/add_adhd_agents.pdf|02/13/2014| 51862061201|ADD/ADHD Agents|https://paxpress.txpa.hidinc.com/add_adhd_agents.pdf|02/13/2014| 51862061430|ADD/ADHD Agents|https://paxpress.txpa.hidinc.com/add_adhd_agents.pdf|02/13/2014| 51862063428|Fentanyl Agents|https://paxpress.txpa.hidinc.com/fentanyl.pdf|09/24/2017| 51862063428|Opiate Overutilization|https://paxpress.txpa.hidinc.com/opiate.pdf|11/05/2013| 51862063428|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017| 51862063428|Opioid Clinical Policy (MME and days supply limits)|https://paxpress.txpa.hidinc.com/opc.pdf|09/01/2020| 51862063528|Fentanyl Agents|https://paxpress.txpa.hidinc.com/fentanyl.pdf|09/24/2017| 51862063528|Opiate Overutilization|https://paxpress.txpa.hidinc.com/opiate.pdf|11/05/2013| 51862063528|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017| 51862063528|Opioid Clinical Policy (MME and days supply limits)|https://paxpress.txpa.hidinc.com/opc.pdf|09/01/2020| 51862063628|Fentanyl Agents|https://paxpress.txpa.hidinc.com/fentanyl.pdf|09/24/2017| 51862063628|Opiate Overutilization|https://paxpress.txpa.hidinc.com/opiate.pdf|11/05/2013| 51862063628|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017| 51862063628|Opioid Clinical Policy (MME and days supply limits)|https://paxpress.txpa.hidinc.com/opc.pdf|09/01/2020| 51862063728|Fentanyl Agents|https://paxpress.txpa.hidinc.com/fentanyl.pdf|09/24/2017| 51862063728|Opiate Overutilization|https://paxpress.txpa.hidinc.com/opiate.pdf|11/05/2013| 51862063728|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017| 51862063728|Opioid Clinical Policy (MME and days supply limits)|https://paxpress.txpa.hidinc.com/opc.pdf|09/01/2020| 51862063828|Fentanyl Agents|https://paxpress.txpa.hidinc.com/fentanyl.pdf|09/24/2017| 51862063828|Opiate Overutilization|https://paxpress.txpa.hidinc.com/opiate.pdf|11/05/2013| 51862063828|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017| 51862063828|Opioid Clinical Policy (MME and days supply limits)|https://paxpress.txpa.hidinc.com/opc.pdf|09/01/2020| 51862090001|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016| 51862090005|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016| 51862090101|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016| 51862090105|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016| 51862090201|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016| 51862090205|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016| 51862090301|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016| 51862090305|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016| 51862094101|Anxiolytics and Sedative-Hypnotics|https://paxpress.txpa.hidinc.com/ash.pdf|01/31/2011| 51862094101|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017| 51862094105|Anxiolytics and Sedative-Hypnotics|https://paxpress.txpa.hidinc.com/ash.pdf|01/31/2011| 51862094105|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017| 51862094201|Anxiolytics and Sedative-Hypnotics|https://paxpress.txpa.hidinc.com/ash.pdf|01/31/2011| 51862094201|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017| 51862094205|Anxiolytics and Sedative-Hypnotics|https://paxpress.txpa.hidinc.com/ash.pdf|01/31/2011| 51862094205|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017| 51862094301|Anxiolytics and Sedative-Hypnotics|https://paxpress.txpa.hidinc.com/ash.pdf|01/31/2011| 51862094301|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017| 51862094305|Anxiolytics and Sedative-Hypnotics|https://paxpress.txpa.hidinc.com/ash.pdf|01/31/2011| 51862094305|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017| 51991007301|Opiate Overutilization|https://paxpress.txpa.hidinc.com/opiate.pdf|11/05/2013| 51991007301|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017| 51991007301|Opioid Clinical Policy (MME and days supply limits)|https://paxpress.txpa.hidinc.com/opc.pdf|09/01/2020| 51991007401|Opiate Overutilization|https://paxpress.txpa.hidinc.com/opiate.pdf|11/05/2013| 51991007401|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017| 51991007401|Opioid Clinical Policy (MME and days supply limits)|https://paxpress.txpa.hidinc.com/opc.pdf|09/01/2020| 51991007405|Opiate Overutilization|https://paxpress.txpa.hidinc.com/opiate.pdf|11/05/2013| 51991007405|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017| 51991007405|Opioid Clinical Policy (MME and days supply limits)|https://paxpress.txpa.hidinc.com/opc.pdf|09/01/2020| 51991033301|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 51991033404|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 51991035478|Antimigraine Agents Triptans|https://paxpress.txpa.hidinc.com/triptans.pdf|04/04/2023| 51991035578|Antimigraine Agents Triptans|https://paxpress.txpa.hidinc.com/triptans.pdf|04/04/2023| 51991035860|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016| 51991036060|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016| 51991036278|Antimigraine Agents Triptans|https://paxpress.txpa.hidinc.com/triptans.pdf|04/04/2023| 51991036378|Antimigraine Agents Triptans|https://paxpress.txpa.hidinc.com/triptans.pdf|04/04/2023| 51991047428|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 51991061150|ADD/ADHD Agents|https://paxpress.txpa.hidinc.com/add_adhd_agents.pdf|02/13/2014| 51991061250|ADD/ADHD Agents|https://paxpress.txpa.hidinc.com/add_adhd_agents.pdf|02/13/2014| 51991062328|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 51991070401|Anxiolytics and Sedative-Hypnotics|https://paxpress.txpa.hidinc.com/ash.pdf|05/28/2015| 51991070401|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017| 51991070405|Anxiolytics and Sedative-Hypnotics|https://paxpress.txpa.hidinc.com/ash.pdf|05/28/2015| 51991070405|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017| 51991070410|Anxiolytics and Sedative-Hypnotics|https://paxpress.txpa.hidinc.com/ash.pdf|05/28/2015| 51991070410|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017| 51991070501|Anxiolytics and Sedative-Hypnotics|https://paxpress.txpa.hidinc.com/ash.pdf|05/28/2015| 51991070501|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017| 51991070505|Anxiolytics and Sedative-Hypnotics|https://paxpress.txpa.hidinc.com/ash.pdf|05/28/2015| 51991070505|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017| 51991070510|Anxiolytics and Sedative-Hypnotics|https://paxpress.txpa.hidinc.com/ash.pdf|05/28/2015| 51991070510|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017| 51991070601|Anxiolytics and Sedative-Hypnotics|https://paxpress.txpa.hidinc.com/ash.pdf|05/28/2015| 51991070601|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017| 51991070605|Anxiolytics and Sedative-Hypnotics|https://paxpress.txpa.hidinc.com/ash.pdf|05/28/2015| 51991070605|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017| 51991070610|Anxiolytics and Sedative-Hypnotics|https://paxpress.txpa.hidinc.com/ash.pdf|05/28/2015| 51991070610|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017| 51991070701|Anxiolytics and Sedative-Hypnotics|https://paxpress.txpa.hidinc.com/ash.pdf|05/28/2015| 51991070701|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017| 51991070705|Anxiolytics and Sedative-Hypnotics|https://paxpress.txpa.hidinc.com/ash.pdf|05/28/2015| 51991070705|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017| 51991073520|Antiemetic Agents|https://paxpress.txpa.hidinc.com/antiemetics.pdf|01/31/2011| 51991073532|Antiemetic Agents|https://paxpress.txpa.hidinc.com/antiemetics.pdf|01/31/2011| 51991081403|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 51991083704|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 51991083716|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 51991083801|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 51991083810|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 51991092860|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016| 51991098101|Anxiolytics and Sedative-Hypnotics|https://paxpress.txpa.hidinc.com/ash.pdf|01/31/2011| 51991098201|Anxiolytics and Sedative-Hypnotics|https://paxpress.txpa.hidinc.com/ash.pdf|01/31/2011| 52427038290|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 52427038390|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 52427043690|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 52427043790|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 52427069203|Buprenorphine Agents|https://paxpress.txpa.hidinc.com/buprenorphine_agents.pdf|04/23/2013| 52427069203|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017| 52427069211|Buprenorphine Agents|https://paxpress.txpa.hidinc.com/buprenorphine_agents.pdf|04/23/2013| 52427069211|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017| 52427069403|Buprenorphine Agents|https://paxpress.txpa.hidinc.com/buprenorphine_agents.pdf|04/23/2013| 52427069403|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017| 52427069411|Buprenorphine Agents|https://paxpress.txpa.hidinc.com/buprenorphine_agents.pdf|04/23/2013| 52427069411|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017| 52427069803|Buprenorphine Agents|https://paxpress.txpa.hidinc.com/buprenorphine_agents.pdf|04/23/2013| 52427069803|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017| 52427069811|Buprenorphine Agents|https://paxpress.txpa.hidinc.com/buprenorphine_agents.pdf|04/23/2013| 52427069811|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017| 52427071203|Buprenorphine Agents|https://paxpress.txpa.hidinc.com/buprenorphine_agents.pdf|04/23/2013| 52427071203|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017| 52427071211|Buprenorphine Agents|https://paxpress.txpa.hidinc.com/buprenorphine_agents.pdf|04/23/2013| 52427071211|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017| 52427080390|Gabapentin Agents|https://paxpress.txpa.hidinc.com/neurontin.pdf|02/06/2018| 52427080690|Gabapentin Agents|https://paxpress.txpa.hidinc.com/neurontin.pdf|02/06/2018| 52536016201|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016| 52536016401|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016| 52536016801|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016| 52536017001|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016| 52709150103|Allergen Extracts|https://paxpress.txpa.hidinc.com/allergen_extracts.pdf|09/01/2015| 52709160103|Allergen Extracts|https://paxpress.txpa.hidinc.com/allergen_extracts.pdf|09/01/2015| 52817019610|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017| 52817021010|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 52817021050|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 52817023510|Anxiolytics and Sedative-Hypnotics|https://paxpress.txpa.hidinc.com/ash.pdf|01/31/2011| 52817023530|Anxiolytics and Sedative-Hypnotics|https://paxpress.txpa.hidinc.com/ash.pdf|01/31/2011| 52817029010|Anxiolytics and Sedative-Hypnotics|https://paxpress.txpa.hidinc.com/ash.pdf|01/31/2011| 52817029010|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017| 52817029110|Anxiolytics and Sedative-Hypnotics|https://paxpress.txpa.hidinc.com/ash.pdf|01/31/2011| 52817029110|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017| 52817029210|Anxiolytics and Sedative-Hypnotics|https://paxpress.txpa.hidinc.com/ash.pdf|01/31/2011| 52817029210|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017| 52817029590|PDE5-Inhibitors|https://paxpress.txpa.hidinc.com/revatio.pdf|01/31/2011|09/30/2024 52817033010|Cyclobenzaprine|https://paxpress.txpa.hidinc.com/cyclobenzaprine.pdf|01/31/2011| 52817033010|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017| 52817033050|Cyclobenzaprine|https://paxpress.txpa.hidinc.com/cyclobenzaprine.pdf|01/31/2011| 52817033050|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017| 52817033110|Cyclobenzaprine|https://paxpress.txpa.hidinc.com/cyclobenzaprine.pdf|01/31/2011| 52817033110|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017| 52817033200|Cyclobenzaprine|https://paxpress.txpa.hidinc.com/cyclobenzaprine.pdf|01/31/2011| 52817033200|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017| 52817033250|Cyclobenzaprine|https://paxpress.txpa.hidinc.com/cyclobenzaprine.pdf|01/31/2011| 52817033250|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017| 52856050101|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 52856050101|Emflaza|https://paxpress.txpa.hidinc.com/emflaza.pdf|09/24/2017| 52856050203|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 52856050203|Emflaza|https://paxpress.txpa.hidinc.com/emflaza.pdf|09/24/2017| 52856050303|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 52856050303|Emflaza|https://paxpress.txpa.hidinc.com/emflaza.pdf|09/24/2017| 52856050403|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 52856050403|Emflaza|https://paxpress.txpa.hidinc.com/emflaza.pdf|09/24/2017| 52856050522|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 52856050522|Emflaza|https://paxpress.txpa.hidinc.com/emflaza.pdf|09/24/2017| 52937000120|Omega 3 Fatty Acids|https://paxpress.txpa.hidinc.com/lovaza.pdf|03/21/2023| 53451010101|Gabapentin Agents|https://paxpress.txpa.hidinc.com/neurontin.pdf|02/06/2018| 53451010301|Gabapentin Agents|https://paxpress.txpa.hidinc.com/neurontin.pdf|02/06/2018| 53489014401|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 53489014405|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 53489014410|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 53489014801|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016| 53489014810|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016| 53489014901|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016| 53489014910|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016| 53489015001|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016| 53489015010|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016| 53489047801|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 53489047805|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 53489047901|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 53489047905|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 53489050001|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016| 53489050601|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|11/08/2023 53489064801|Anxiolytics and Sedative-Hypnotics|https://paxpress.txpa.hidinc.com/ash.pdf|01/31/2011| 53489064801|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017| 53489065007|Anxiolytics and Sedative-Hypnotics|https://paxpress.txpa.hidinc.com/ash.pdf|01/31/2011| 53489065007|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017| 53746010901|Opiate Overutilization|https://paxpress.txpa.hidinc.com/opiate.pdf|11/05/2013| 53746010901|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017| 53746010901|Opioid Clinical Policy (MME and days supply limits)|https://paxpress.txpa.hidinc.com/opc.pdf|09/01/2020| 53746010905|Opiate Overutilization|https://paxpress.txpa.hidinc.com/opiate.pdf|11/05/2013| 53746010905|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017| 53746010905|Opioid Clinical Policy (MME and days supply limits)|https://paxpress.txpa.hidinc.com/opc.pdf|09/01/2020| 53746011001|Opiate Overutilization|https://paxpress.txpa.hidinc.com/opiate.pdf|11/05/2013| 53746011001|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017| 53746011001|Opioid Clinical Policy (MME and days supply limits)|https://paxpress.txpa.hidinc.com/opc.pdf|09/01/2020| 53746011005|Opiate Overutilization|https://paxpress.txpa.hidinc.com/opiate.pdf|11/05/2013| 53746011005|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017| 53746011005|Opioid Clinical Policy (MME and days supply limits)|https://paxpress.txpa.hidinc.com/opc.pdf|09/01/2020| 53746011701|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 53746011701|Opiate Overutilization|https://paxpress.txpa.hidinc.com/opiate.pdf|11/05/2013| 53746011701|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017| 53746011701|Opioid Clinical Policy (MME and days supply limits)|https://paxpress.txpa.hidinc.com/opc.pdf|09/01/2020| 53746014501|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 53746014501|Opiate Overutilization|https://paxpress.txpa.hidinc.com/opiate.pdf|11/05/2013| 53746014501|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017| 53746014501|Opioid Clinical Policy (MME and days supply limits)|https://paxpress.txpa.hidinc.com/opc.pdf|09/01/2020| 53746014601|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 53746014601|Opiate Overutilization|https://paxpress.txpa.hidinc.com/opiate.pdf|11/05/2013| 53746014601|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017| 53746014601|Opioid Clinical Policy (MME and days supply limits)|https://paxpress.txpa.hidinc.com/opc.pdf|09/01/2020| 53746019301|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 53746019401|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 53746019405|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 53746020301|Opiate Overutilization|https://paxpress.txpa.hidinc.com/opiate.pdf|11/05/2013| 53746020301|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017| 53746020301|Opioid Clinical Policy (MME and days supply limits)|https://paxpress.txpa.hidinc.com/opc.pdf|09/01/2020| 53746020305|Opiate Overutilization|https://paxpress.txpa.hidinc.com/opiate.pdf|11/05/2013| 53746020305|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017| 53746020305|Opioid Clinical Policy (MME and days supply limits)|https://paxpress.txpa.hidinc.com/opc.pdf|09/01/2020| 53746020401|Opiate Overutilization|https://paxpress.txpa.hidinc.com/opiate.pdf|11/05/2013| 53746020401|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017| 53746020401|Opioid Clinical Policy (MME and days supply limits)|https://paxpress.txpa.hidinc.com/opc.pdf|09/01/2020| 53746020405|Opiate Overutilization|https://paxpress.txpa.hidinc.com/opiate.pdf|11/05/2013| 53746020405|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017| 53746020405|Opioid Clinical Policy (MME and days supply limits)|https://paxpress.txpa.hidinc.com/opc.pdf|09/01/2020| 53746044101|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 53746044110|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 53746044201|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 53746044210|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 53746052101|Promethazine Utilization|https://paxpress.txpa.hidinc.com/phenergan.pdf|01/31/2011| 53746052110|Promethazine Utilization|https://paxpress.txpa.hidinc.com/phenergan.pdf|01/31/2011| 53746052201|Promethazine Utilization|https://paxpress.txpa.hidinc.com/phenergan.pdf|01/31/2011| 53746061701|Opiate Overutilization|https://paxpress.txpa.hidinc.com/opiate.pdf|11/05/2013| 53746061701|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017| 53746061701|Opioid Clinical Policy (MME and days supply limits)|https://paxpress.txpa.hidinc.com/opc.pdf|09/01/2020| 53746061705|Opiate Overutilization|https://paxpress.txpa.hidinc.com/opiate.pdf|11/05/2013| 53746061705|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017| 53746061705|Opioid Clinical Policy (MME and days supply limits)|https://paxpress.txpa.hidinc.com/opc.pdf|09/01/2020| 53746061710|Opiate Overutilization|https://paxpress.txpa.hidinc.com/opiate.pdf|11/05/2013| 53746061710|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017| 53746061710|Opioid Clinical Policy (MME and days supply limits)|https://paxpress.txpa.hidinc.com/opc.pdf|09/01/2020| 53746074501|Promethazine Utilization|https://paxpress.txpa.hidinc.com/phenergan.pdf|01/31/2011| 54092025290|Phosphate Binders|https://paxpress.txpa.hidinc.com/phosphate_binders.pdf|01/31/2011| 54092025390|Phosphate Binders|https://paxpress.txpa.hidinc.com/phosphate_binders.pdf|01/31/2011| 54092025490|Phosphate Binders|https://paxpress.txpa.hidinc.com/phosphate_binders.pdf|01/31/2011| 54092025602|Phosphate Binders|https://paxpress.txpa.hidinc.com/phosphate_binders.pdf|01/31/2011| 54092025702|Phosphate Binders|https://paxpress.txpa.hidinc.com/phosphate_binders.pdf|01/31/2011| 54092038101|ADD/ADHD Agents|https://paxpress.txpa.hidinc.com/add_adhd_agents.pdf|02/13/2014| 54092038301|ADD/ADHD Agents|https://paxpress.txpa.hidinc.com/add_adhd_agents.pdf|02/13/2014| 54092038501|ADD/ADHD Agents|https://paxpress.txpa.hidinc.com/add_adhd_agents.pdf|02/13/2014| 54092038701|ADD/ADHD Agents|https://paxpress.txpa.hidinc.com/add_adhd_agents.pdf|02/13/2014| 54092038901|ADD/ADHD Agents|https://paxpress.txpa.hidinc.com/add_adhd_agents.pdf|02/13/2014| 54092039101|ADD/ADHD Agents|https://paxpress.txpa.hidinc.com/add_adhd_agents.pdf|02/13/2014| 54092046801|ADD/ADHD Agents|https://paxpress.txpa.hidinc.com/add_adhd_agents.pdf|09/24/2017| 54092047101|ADD/ADHD Agents|https://paxpress.txpa.hidinc.com/add_adhd_agents.pdf|09/24/2017| 54092047401|ADD/ADHD Agents|https://paxpress.txpa.hidinc.com/add_adhd_agents.pdf|09/24/2017| 54092047701|ADD/ADHD Agents|https://paxpress.txpa.hidinc.com/add_adhd_agents.pdf|09/24/2017| 54092051302|ADD/ADHD Agents|https://paxpress.txpa.hidinc.com/add_adhd_agents.pdf|02/13/2014| 54092051502|ADD/ADHD Agents|https://paxpress.txpa.hidinc.com/add_adhd_agents.pdf|02/13/2014| 54092051702|ADD/ADHD Agents|https://paxpress.txpa.hidinc.com/add_adhd_agents.pdf|02/13/2014| 54092051902|ADD/ADHD Agents|https://paxpress.txpa.hidinc.com/add_adhd_agents.pdf|02/13/2014| 54092070001|Enzymes|https://paxpress.txpa.hidinc.com/enzymes.pdf|11/20/2019| 54092070202|HAE Agents Clinical|https://paxpress.txpa.hidinc.com/HAE.pdf|03/21/2023| 54092070203|HAE Agents Clinical|https://paxpress.txpa.hidinc.com/HAE.pdf|03/21/2023| 54123011430|Buprenorphine Agents|https://paxpress.txpa.hidinc.com/buprenorphine_agents.pdf|04/23/2013| 54123090730|Buprenorphine Agents|https://paxpress.txpa.hidinc.com/buprenorphine_agents.pdf|04/23/2013| 54123091430|Buprenorphine Agents|https://paxpress.txpa.hidinc.com/buprenorphine_agents.pdf|04/23/2013| 54123091430|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017| 54123092930|Buprenorphine Agents|https://paxpress.txpa.hidinc.com/buprenorphine_agents.pdf|04/23/2013| 54123095730|Buprenorphine Agents|https://paxpress.txpa.hidinc.com/buprenorphine_agents.pdf|04/23/2013| 54123095730|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017| 54123098630|Buprenorphine Agents|https://paxpress.txpa.hidinc.com/buprenorphine_agents.pdf|04/23/2013| 54569639900|Buprenorphine Agents|https://paxpress.txpa.hidinc.com/buprenorphine_agents.pdf|04/23/2013| 54569639900|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017| 54766089403|GI Motility Agents|https://paxpress.txpa.hidinc.com/GImotility.pdf|01/18/2017| 54766089503|GI Motility Agents|https://paxpress.txpa.hidinc.com/GImotility.pdf|01/18/2017| 54838011540|Cough and Cold Agents|https://paxpress.txpa.hidinc.com/Cough%20&%20Cold.pdf|12/15/2015| 54838011540|Dextromethorphan Overutilization|https://paxpress.txpa.hidinc.com/dextro.pdf|07/16/2012| 54838011540|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 54838013340|Cough and Cold Agents|https://paxpress.txpa.hidinc.com/Cough%20&%20Cold.pdf|12/15/2015| 54838013340|Dextromethorphan Overutilization|https://paxpress.txpa.hidinc.com/dextro.pdf|07/16/2012| 54838013640|Cough and Cold Agents|https://paxpress.txpa.hidinc.com/Cough%20&%20Cold.pdf|12/15/2015| 54838013640|Dextromethorphan Overutilization|https://paxpress.txpa.hidinc.com/dextro.pdf|07/16/2012| 54838013640|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 54838013670|Cough and Cold Agents|https://paxpress.txpa.hidinc.com/Cough%20&%20Cold.pdf|12/15/2015| 54838013670|Dextromethorphan Overutilization|https://paxpress.txpa.hidinc.com/dextro.pdf|07/16/2012| 54838013670|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 54838050140|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016| 54838050280|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 54838055840|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 54838057059|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016| 54879000308|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 55111012105|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/04/2016| 55111012190|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/04/2016| 55111012205|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/04/2016| 55111012290|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/04/2016| 55111012305|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/04/2016| 55111012390|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/04/2016| 55111012405|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/04/2016| 55111012490|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/04/2016| 55111016305|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016| 55111016330|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016| 55111016705|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016| 55111016730|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016| 55111016805|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016| 55111016830|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016| 55111017001|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 55111017005|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 55111019705|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/04/2016| 55111019730|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/04/2016| 55111019790|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/04/2016| 55111019805|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/04/2016| 55111019830|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/04/2016| 55111019890|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/04/2016| 55111019905|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/04/2016| 55111019930|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/04/2016| 55111019990|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/04/2016| 55111020005|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/04/2016| 55111020030|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/04/2016| 55111020090|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/04/2016| 55111022905|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/04/2016| 55111022990|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/04/2016| 55111023005|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/04/2016| 55111023090|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/04/2016| 55111023105|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/04/2016| 55111023190|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/04/2016| 55111025660|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016| 55111025760|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016| 55111025860|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016| 55111025960|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016| 55111026281|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016| 55111026381|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016| 55111026481|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016| 55111026581|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016| 55111026805|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/04/2016| 55111026830|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/04/2016| 55111026890|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/04/2016| 55111027405|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/04/2016| 55111027490|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/04/2016| 55111028960|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 55111029109|Antimigraine Agents Triptans|https://paxpress.txpa.hidinc.com/triptans.pdf|04/04/2023|08/31/2023 55111029136|Antimigraine Agents Triptans|https://paxpress.txpa.hidinc.com/triptans.pdf|04/04/2023| 55111029190|Antimigraine Agents Triptans|https://paxpress.txpa.hidinc.com/triptans.pdf|04/04/2023| 55111029198|Antimigraine Agents Triptans|https://paxpress.txpa.hidinc.com/triptans.pdf|04/04/2023| 55111029209|Antimigraine Agents Triptans|https://paxpress.txpa.hidinc.com/triptans.pdf|04/04/2023|09/30/2023 55111029236|Antimigraine Agents Triptans|https://paxpress.txpa.hidinc.com/triptans.pdf|04/04/2023| 55111029290|Antimigraine Agents Triptans|https://paxpress.txpa.hidinc.com/triptans.pdf|04/04/2023| 55111029298|Antimigraine Agents Triptans|https://paxpress.txpa.hidinc.com/triptans.pdf|04/04/2023| 55111029309|Antimigraine Agents Triptans|https://paxpress.txpa.hidinc.com/triptans.pdf|04/04/2023|08/31/2023 55111029336|Antimigraine Agents Triptans|https://paxpress.txpa.hidinc.com/triptans.pdf|04/04/2023| 55111029390|Antimigraine Agents Triptans|https://paxpress.txpa.hidinc.com/triptans.pdf|04/04/2023| 55111029398|Antimigraine Agents Triptans|https://paxpress.txpa.hidinc.com/triptans.pdf|04/04/2023| 55111032890|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 55111032990|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 55111036031|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 55111047801|Anxiolytics and Sedative-Hypnotics|https://paxpress.txpa.hidinc.com/ash.pdf|01/31/2011| 55111047901|Anxiolytics and Sedative-Hypnotics|https://paxpress.txpa.hidinc.com/ash.pdf|01/31/2011| 55111051930|ADD/ADHD Agents|https://paxpress.txpa.hidinc.com/add_adhd_agents.pdf|02/13/2014| 55111052030|ADD/ADHD Agents|https://paxpress.txpa.hidinc.com/add_adhd_agents.pdf|02/13/2014| 55111052130|ADD/ADHD Agents|https://paxpress.txpa.hidinc.com/add_adhd_agents.pdf|02/13/2014| 55111052230|ADD/ADHD Agents|https://paxpress.txpa.hidinc.com/add_adhd_agents.pdf|02/13/2014| 55111052830|ADD/ADHD Agents|https://paxpress.txpa.hidinc.com/add_adhd_agents.pdf|02/13/2014| 55111055131|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 55111056330|ADD/ADHD Agents|https://paxpress.txpa.hidinc.com/add_adhd_agents.pdf|02/13/2014| 55111056430|ADD/ADHD Agents|https://paxpress.txpa.hidinc.com/add_adhd_agents.pdf|02/13/2014| 55111061701|Anxiolytics and Sedative-Hypnotics|https://paxpress.txpa.hidinc.com/ash.pdf|01/31/2011| 55111061901|Anxiolytics and Sedative-Hypnotics|https://paxpress.txpa.hidinc.com/ash.pdf|01/31/2011| 55111062560|Leukotriene Modifiers|https://paxpress.txpa.hidinc.com/leukotriene.pdf|12/15/2015| 55111062660|Leukotriene Modifiers|https://paxpress.txpa.hidinc.com/leukotriene.pdf|12/15/2015| 55111062930|Anxiolytics and Sedative-Hypnotics|https://paxpress.txpa.hidinc.com/ash.pdf|01/31/2011| 55111065001|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017| 55111067802|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 55111067810|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 55111067902|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 55111067910|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 55111068002|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 55111068010|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 55111068102|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 55111068110|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 55111068201|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 55111068205|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 55111068301|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 55111068305|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 55111068401|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 55111068405|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 55111069312|Antimigraine Agents Triptans|https://paxpress.txpa.hidinc.com/triptans.pdf|04/04/2023| 55111069990|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 55111070160|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 55111072510|Leukotriene Modifiers|https://paxpress.txpa.hidinc.com/leukotriene.pdf|12/15/2015| 55111072530|Leukotriene Modifiers|https://paxpress.txpa.hidinc.com/leukotriene.pdf|12/15/2015| 55111072590|Leukotriene Modifiers|https://paxpress.txpa.hidinc.com/leukotriene.pdf|12/15/2015| 55111073130|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 55111073190|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 55111073290|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 55111073390|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 55111073490|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 55111076303|Leukotriene Modifiers|https://paxpress.txpa.hidinc.com/leukotriene.pdf|12/15/2015| 55111078301|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 55111078401|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 55111078911|Phosphate Binders|https://paxpress.txpa.hidinc.com/phosphate_binders.pdf|01/31/2011| 55111078927|Phosphate Binders|https://paxpress.txpa.hidinc.com/phosphate_binders.pdf|01/31/2011| 55111079818|Cough and Cold Agents|https://paxpress.txpa.hidinc.com/Cough%20&%20Cold.pdf|12/15/2015| 55111079835|Cough and Cold Agents|https://paxpress.txpa.hidinc.com/Cough%20&%20Cold.pdf|12/15/2015| 55111079836|Cough and Cold Agents|https://paxpress.txpa.hidinc.com/Cough%20&%20Cold.pdf|12/15/2015| 55111079841|Cough and Cold Agents|https://paxpress.txpa.hidinc.com/Cough%20&%20Cold.pdf|12/15/2015| 55111079924|Cough and Cold Agents|https://paxpress.txpa.hidinc.com/Cough%20&%20Cold.pdf|12/15/2015| 55253080130|CNS Stimulants|https://paxpress.txpa.hidinc.com/provigil.pdf|11/06/2012| 55253080190|CNS Stimulants|https://paxpress.txpa.hidinc.com/provigil.pdf|11/06/2012| 55253080230|CNS Stimulants|https://paxpress.txpa.hidinc.com/provigil.pdf|11/06/2012| 55253080290|CNS Stimulants|https://paxpress.txpa.hidinc.com/provigil.pdf|11/06/2012| 55292010401|ADD/ADHD Agents|https://paxpress.txpa.hidinc.com/add_adhd_agents.pdf|02/13/2014|02/01/2024 55513000204|Erythropoiesis-Stimulating Proteins|https://paxpress.txpa.hidinc.com/esa.pdf|09/24/2013| 55513000304|Erythropoiesis-Stimulating Proteins|https://paxpress.txpa.hidinc.com/esa.pdf|09/24/2013| 55513000404|Erythropoiesis-Stimulating Proteins|https://paxpress.txpa.hidinc.com/esa.pdf|09/24/2013| 55513000504|Erythropoiesis-Stimulating Proteins|https://paxpress.txpa.hidinc.com/esa.pdf|09/24/2013| 55513000601|Erythropoiesis-Stimulating Proteins|https://paxpress.txpa.hidinc.com/esa.pdf|09/24/2013| 55513002104|Erythropoiesis-Stimulating Proteins|https://paxpress.txpa.hidinc.com/esa.pdf|09/24/2013| 55513002304|Erythropoiesis-Stimulating Proteins|https://paxpress.txpa.hidinc.com/esa.pdf|09/24/2013| 55513002504|Erythropoiesis-Stimulating Proteins|https://paxpress.txpa.hidinc.com/esa.pdf|09/24/2013| 55513002704|Erythropoiesis-Stimulating Proteins|https://paxpress.txpa.hidinc.com/esa.pdf|09/24/2013| 55513002801|Erythropoiesis-Stimulating Proteins|https://paxpress.txpa.hidinc.com/esa.pdf|09/24/2013| 55513003201|Erythropoiesis-Stimulating Proteins|https://paxpress.txpa.hidinc.com/esa.pdf|09/24/2013| 55513005704|Erythropoiesis-Stimulating Proteins|https://paxpress.txpa.hidinc.com/esa.pdf|09/24/2013| 55513011101|Erythropoiesis-Stimulating Proteins|https://paxpress.txpa.hidinc.com/esa.pdf|09/24/2013| 55513012601|Erythropoiesis-Stimulating Proteins|https://paxpress.txpa.hidinc.com/esa.pdf|09/24/2013| 55513012610|Erythropoiesis-Stimulating Proteins|https://paxpress.txpa.hidinc.com/esa.pdf|09/24/2013| 55513013760|Cytokine and CAM Antagonists|https://paxpress.txpa.hidinc.com/cytokine.pdf|03/27/2018| 55513014401|Erythropoiesis-Stimulating Proteins|https://paxpress.txpa.hidinc.com/esa.pdf|09/24/2013| 55513014410|Erythropoiesis-Stimulating Proteins|https://paxpress.txpa.hidinc.com/esa.pdf|09/24/2013| 55513014801|Erythropoiesis-Stimulating Proteins|https://paxpress.txpa.hidinc.com/esa.pdf|09/24/2013| 55513014810|Erythropoiesis-Stimulating Proteins|https://paxpress.txpa.hidinc.com/esa.pdf|09/24/2013| 55513026701|Erythropoiesis-Stimulating Proteins|https://paxpress.txpa.hidinc.com/esa.pdf|09/24/2013| 55513026710|Erythropoiesis-Stimulating Proteins|https://paxpress.txpa.hidinc.com/esa.pdf|09/24/2013| 55513028301|Erythropoiesis-Stimulating Proteins|https://paxpress.txpa.hidinc.com/esa.pdf|09/24/2013| 55513028310|Erythropoiesis-Stimulating Proteins|https://paxpress.txpa.hidinc.com/esa.pdf|09/24/2013| 55513036955|Cytokine and CAM Antagonists|https://paxpress.txpa.hidinc.com/cytokine.pdf|03/27/2018| 55513047801|Erythropoiesis-Stimulating Proteins|https://paxpress.txpa.hidinc.com/esa.pdf|09/24/2013| 55513047810|Erythropoiesis-Stimulating Proteins|https://paxpress.txpa.hidinc.com/esa.pdf|09/24/2013| 55513084101|CGRP Agents Prophylaxis|https://paxpress.txpa.hidinc.com/cgrpchronic.pdf|11/22/2022| 55513084301|CGRP Agents Prophylaxis|https://paxpress.txpa.hidinc.com/cgrpchronic.pdf|11/22/2022| 55566220000|Desmopressin|https://paxpress.txpa.hidinc.com/desmopressin.pdf|05/25/2012| 55566230000|Desmopressin|https://paxpress.txpa.hidinc.com/desmopressin.pdf|05/25/2012| 55566260000|Desmopressin|https://paxpress.txpa.hidinc.com/desmopressin.pdf|05/25/2012| 55566270000|Desmopressin|https://paxpress.txpa.hidinc.com/desmopressin.pdf|05/25/2012| 55700014730|Buprenorphine Agents|https://paxpress.txpa.hidinc.com/buprenorphine_agents.pdf|04/23/2013| 55700014730|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017| 55700030230|Buprenorphine Agents|https://paxpress.txpa.hidinc.com/buprenorphine_agents.pdf|12/05/2014| 55700030230|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017| 55700030330|Buprenorphine Agents|https://paxpress.txpa.hidinc.com/buprenorphine_agents.pdf|12/05/2014| 55700030330|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017| 55724021121|Topical Immunomodulators|https://paxpress.txpa.hidinc.com/immunomodulators.pdf|06/06/2017| 57237000201|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 57237000205|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 57237000299|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 57237008563|Antimigraine Agents Triptans|https://paxpress.txpa.hidinc.com/triptans.pdf|04/04/2023| 57237008663|Antimigraine Agents Triptans|https://paxpress.txpa.hidinc.com/triptans.pdf|04/04/2023| 57237008734|Antimigraine Agents Triptans|https://paxpress.txpa.hidinc.com/triptans.pdf|04/04/2023| 57237008763|Antimigraine Agents Triptans|https://paxpress.txpa.hidinc.com/triptans.pdf|04/04/2023| 57237008834|Antimigraine Agents Triptans|https://paxpress.txpa.hidinc.com/triptans.pdf|04/04/2023| 57237008863|Antimigraine Agents Triptans|https://paxpress.txpa.hidinc.com/triptans.pdf|04/04/2023| 57237011901|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 57237011999|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 57237012001|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 57237012099|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 57237012101|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 57237012199|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 57237012201|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 57237012299|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 57237012301|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 57237012399|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 57237012401|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 57237012499|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 57237012501|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 57237012601|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 57237012701|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 57237015430|CNS Stimulants|https://paxpress.txpa.hidinc.com/provigil.pdf|11/06/2012| 57237015490|CNS Stimulants|https://paxpress.txpa.hidinc.com/provigil.pdf|11/06/2012| 57237015530|CNS Stimulants|https://paxpress.txpa.hidinc.com/provigil.pdf|11/06/2012| 57237015590|CNS Stimulants|https://paxpress.txpa.hidinc.com/provigil.pdf|11/06/2012| 57237015701|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 57237015801|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 57237015901|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 57237016805|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/04/2016| 57237016890|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/04/2016| 57237016990|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/04/2016| 57237016999|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/04/2016| 57237017090|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/04/2016| 57237017099|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/04/2016| 57237017105|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/04/2016| 57237017130|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/04/2016| 57237017190|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/04/2016| 57237021230|Leukotriene Modifiers|https://paxpress.txpa.hidinc.com/leukotriene.pdf|12/15/2015| 57237021290|Leukotriene Modifiers|https://paxpress.txpa.hidinc.com/leukotriene.pdf|12/15/2015| 57237021330|Leukotriene Modifiers|https://paxpress.txpa.hidinc.com/leukotriene.pdf|12/15/2015| 57237021390|Leukotriene Modifiers|https://paxpress.txpa.hidinc.com/leukotriene.pdf|12/15/2015| 57237021760|Thiazolidinediones|https://paxpress.txpa.hidinc.com/thiazolidinediones.pdf|01/31/2011| 57237021860|Thiazolidinediones|https://paxpress.txpa.hidinc.com/thiazolidinediones.pdf|01/31/2011| 57237021905|Thiazolidinediones|https://paxpress.txpa.hidinc.com/thiazolidinediones.pdf|01/31/2011| 57237021930|Thiazolidinediones|https://paxpress.txpa.hidinc.com/thiazolidinediones.pdf|01/31/2011| 57237021990|Thiazolidinediones|https://paxpress.txpa.hidinc.com/thiazolidinediones.pdf|01/31/2011| 57237022005|Thiazolidinediones|https://paxpress.txpa.hidinc.com/thiazolidinediones.pdf|01/31/2011| 57237022030|Thiazolidinediones|https://paxpress.txpa.hidinc.com/thiazolidinediones.pdf|01/31/2011| 57237022090|Thiazolidinediones|https://paxpress.txpa.hidinc.com/thiazolidinediones.pdf|01/31/2011| 57237022105|Thiazolidinediones|https://paxpress.txpa.hidinc.com/thiazolidinediones.pdf|01/31/2011| 57237022130|Thiazolidinediones|https://paxpress.txpa.hidinc.com/thiazolidinediones.pdf|01/31/2011| 57237022190|Thiazolidinediones|https://paxpress.txpa.hidinc.com/thiazolidinediones.pdf|01/31/2011| 57237023901|Anxiolytics and Sedative-Hypnotics|https://paxpress.txpa.hidinc.com/ash.pdf|01/31/2011| 57237024001|Anxiolytics and Sedative-Hypnotics|https://paxpress.txpa.hidinc.com/ash.pdf|01/31/2011| 57237026601|Cyclobenzaprine|https://paxpress.txpa.hidinc.com/cyclobenzaprine.pdf|01/31/2011| 57237026601|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017| 57664010788|Promethazine Utilization|https://paxpress.txpa.hidinc.com/phenergan.pdf|01/31/2011| 57664010818|Promethazine Utilization|https://paxpress.txpa.hidinc.com/phenergan.pdf|01/31/2011| 57664010888|Promethazine Utilization|https://paxpress.txpa.hidinc.com/phenergan.pdf|01/31/2011| 57664010988|Promethazine Utilization|https://paxpress.txpa.hidinc.com/phenergan.pdf|01/31/2011| 57664012613|Opiate Overutilization|https://paxpress.txpa.hidinc.com/opiate.pdf|11/05/2013| 57664012613|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017| 57664012613|Opioid Clinical Policy (MME and days supply limits)|https://paxpress.txpa.hidinc.com/opc.pdf|09/01/2020| 57664012688|Opiate Overutilization|https://paxpress.txpa.hidinc.com/opiate.pdf|11/05/2013| 57664012688|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017| 57664012688|Opioid Clinical Policy (MME and days supply limits)|https://paxpress.txpa.hidinc.com/opc.pdf|09/01/2020| 57664013388|Cough and Cold Agents|https://paxpress.txpa.hidinc.com/Cough%20&%20Cold.pdf|12/15/2015| 57664013488|Cough and Cold Agents|https://paxpress.txpa.hidinc.com/Cough%20&%20Cold.pdf|12/15/2015| 57664017013|Opiate Overutilization|https://paxpress.txpa.hidinc.com/opiate.pdf|11/05/2013| 57664017013|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017| 57664017013|Opioid Clinical Policy (MME and days supply limits)|https://paxpress.txpa.hidinc.com/opc.pdf|09/01/2020| 57664017088|Opiate Overutilization|https://paxpress.txpa.hidinc.com/opiate.pdf|11/05/2013| 57664017088|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017| 57664017088|Opioid Clinical Policy (MME and days supply limits)|https://paxpress.txpa.hidinc.com/opc.pdf|09/01/2020| 57664017613|Opiate Overutilization|https://paxpress.txpa.hidinc.com/opiate.pdf|11/05/2013| 57664017613|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017| 57664017613|Opioid Clinical Policy (MME and days supply limits)|https://paxpress.txpa.hidinc.com/opc.pdf|09/01/2020| 57664017688|Opiate Overutilization|https://paxpress.txpa.hidinc.com/opiate.pdf|11/05/2013| 57664017688|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017| 57664017688|Opioid Clinical Policy (MME and days supply limits)|https://paxpress.txpa.hidinc.com/opc.pdf|09/01/2020| 57664018788|Opiate Overutilization|https://paxpress.txpa.hidinc.com/opiate.pdf|11/05/2013| 57664018788|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017| 57664018788|Opioid Clinical Policy (MME and days supply limits)|https://paxpress.txpa.hidinc.com/opc.pdf|09/01/2020| 57664021188|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016| 57664022388|Opiate Overutilization|https://paxpress.txpa.hidinc.com/opiate.pdf|11/05/2013| 57664022388|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017| 57664022388|Opioid Clinical Policy (MME and days supply limits)|https://paxpress.txpa.hidinc.com/opc.pdf|09/01/2020| 57664022488|Opiate Overutilization|https://paxpress.txpa.hidinc.com/opiate.pdf|11/05/2013| 57664022488|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017| 57664022488|Opioid Clinical Policy (MME and days supply limits)|https://paxpress.txpa.hidinc.com/opc.pdf|09/01/2020| 57664022888|ADD/ADHD Agents|https://paxpress.txpa.hidinc.com/add_adhd_agents.pdf|02/13/2014| 57664022988|ADD/ADHD Agents|https://paxpress.txpa.hidinc.com/add_adhd_agents.pdf|02/13/2014| 57664023088|ADD/ADHD Agents|https://paxpress.txpa.hidinc.com/add_adhd_agents.pdf|02/13/2014| 57664024188|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016| 57664033688|ADD/ADHD Agents|https://paxpress.txpa.hidinc.com/add_adhd_agents.pdf|02/13/2014| 57664033788|ADD/ADHD Agents|https://paxpress.txpa.hidinc.com/add_adhd_agents.pdf|02/13/2014| 57664033888|ADD/ADHD Agents|https://paxpress.txpa.hidinc.com/add_adhd_agents.pdf|02/13/2014| 57664033988|ADD/ADHD Agents|https://paxpress.txpa.hidinc.com/add_adhd_agents.pdf|02/13/2014| 57664034088|ADD/ADHD Agents|https://paxpress.txpa.hidinc.com/add_adhd_agents.pdf|02/13/2014| 57664034188|ADD/ADHD Agents|https://paxpress.txpa.hidinc.com/add_adhd_agents.pdf|02/13/2014| 57664034588|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016| 57664034713|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016| 57664034788|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016| 57664037688|ADD/ADHD Agents|https://paxpress.txpa.hidinc.com/add_adhd_agents.pdf|02/13/2014| 57664037708|Opiate Overutilization|https://paxpress.txpa.hidinc.com/opiate.pdf|11/05/2013| 57664037708|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017| 57664037708|Opioid Clinical Policy (MME and days supply limits)|https://paxpress.txpa.hidinc.com/opc.pdf|09/01/2020| 57664037713|Opiate Overutilization|https://paxpress.txpa.hidinc.com/opiate.pdf|11/05/2013| 57664037713|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017| 57664037713|Opioid Clinical Policy (MME and days supply limits)|https://paxpress.txpa.hidinc.com/opc.pdf|09/01/2020| 57664037718|Opiate Overutilization|https://paxpress.txpa.hidinc.com/opiate.pdf|11/05/2013| 57664037718|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017| 57664037718|Opioid Clinical Policy (MME and days supply limits)|https://paxpress.txpa.hidinc.com/opc.pdf|09/01/2020| 57664037888|ADD/ADHD Agents|https://paxpress.txpa.hidinc.com/add_adhd_agents.pdf|02/13/2014| 57664037988|ADD/ADHD Agents|https://paxpress.txpa.hidinc.com/add_adhd_agents.pdf|02/13/2014| 57664053713|Opiate Overutilization|https://paxpress.txpa.hidinc.com/opiate.pdf|11/05/2013| 57664053713|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017| 57664053713|Opioid Clinical Policy (MME and days supply limits)|https://paxpress.txpa.hidinc.com/opc.pdf|09/01/2020| 57664053718|Opiate Overutilization|https://paxpress.txpa.hidinc.com/opiate.pdf|11/05/2013| 57664053718|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017| 57664053718|Opioid Clinical Policy (MME and days supply limits)|https://paxpress.txpa.hidinc.com/opc.pdf|09/01/2020| 57664053788|Opiate Overutilization|https://paxpress.txpa.hidinc.com/opiate.pdf|11/05/2013| 57664053788|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017| 57664053788|Opioid Clinical Policy (MME and days supply limits)|https://paxpress.txpa.hidinc.com/opc.pdf|09/01/2020| 57664060688|ADD/ADHD Agents|https://paxpress.txpa.hidinc.com/add_adhd_agents.pdf|02/13/2014| 57664060788|ADD/ADHD Agents|https://paxpress.txpa.hidinc.com/add_adhd_agents.pdf|02/13/2014| 57664060888|ADD/ADHD Agents|https://paxpress.txpa.hidinc.com/add_adhd_agents.pdf|02/13/2014| 57664060988|ADD/ADHD Agents|https://paxpress.txpa.hidinc.com/add_adhd_agents.pdf|02/13/2014| 57664062188|ADD/ADHD Agents|https://paxpress.txpa.hidinc.com/add_adhd_agents.pdf|02/13/2014| 57664062288|ADD/ADHD Agents|https://paxpress.txpa.hidinc.com/add_adhd_agents.pdf|02/13/2014| 57664062388|ADD/ADHD Agents|https://paxpress.txpa.hidinc.com/add_adhd_agents.pdf|02/13/2014| 57664062588|ADD/ADHD Agents|https://paxpress.txpa.hidinc.com/add_adhd_agents.pdf|02/13/2014| 57664062688|ADD/ADHD Agents|https://paxpress.txpa.hidinc.com/add_adhd_agents.pdf|02/13/2014| 57664062888|ADD/ADHD Agents|https://paxpress.txpa.hidinc.com/add_adhd_agents.pdf|02/13/2014| 57664062988|ADD/ADHD Agents|https://paxpress.txpa.hidinc.com/add_adhd_agents.pdf|02/13/2014| 57664074513|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 57664074588|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 57664074713|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 57664074788|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 57664077283|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 57664077299|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 57664077383|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 57664077399|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 57664077483|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 57664077499|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 57664077583|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 57664077599|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 57664078386|Anxiolytics and Sedative-Hypnotics|https://paxpress.txpa.hidinc.com/ash.pdf|01/31/2011| 57664078386|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017| 57664078486|Anxiolytics and Sedative-Hypnotics|https://paxpress.txpa.hidinc.com/ash.pdf|01/31/2011| 57664078486|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017| 57664078586|Anxiolytics and Sedative-Hypnotics|https://paxpress.txpa.hidinc.com/ash.pdf|01/31/2011| 57664078586|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017| 57664078686|Anxiolytics and Sedative-Hypnotics|https://paxpress.txpa.hidinc.com/ash.pdf|01/31/2011| 57664078686|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017| 57664078786|Anxiolytics and Sedative-Hypnotics|https://paxpress.txpa.hidinc.com/ash.pdf|01/31/2011| 57664078786|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017| 57664079683|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 57664079699|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 57664079783|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 57664079799|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 57664079883|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 57664079899|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 57664079983|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 57664079999|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 57664080083|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 57664080099|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 57841130001|GI Motility Agents|https://paxpress.txpa.hidinc.com/GImotility.pdf|01/18/2017| 57841130101|GI Motility Agents|https://paxpress.txpa.hidinc.com/GImotility.pdf|01/18/2017| 57841130103|GI Motility Agents|https://paxpress.txpa.hidinc.com/GImotility.pdf|01/18/2017| 57844010501|ADD/ADHD Agents|https://paxpress.txpa.hidinc.com/add_adhd_agents.pdf|02/13/2014| 57844011001|ADD/ADHD Agents|https://paxpress.txpa.hidinc.com/add_adhd_agents.pdf|02/13/2014| 57844011201|ADD/ADHD Agents|https://paxpress.txpa.hidinc.com/add_adhd_agents.pdf|02/13/2014| 57844011501|ADD/ADHD Agents|https://paxpress.txpa.hidinc.com/add_adhd_agents.pdf|02/13/2014| 57844011701|ADD/ADHD Agents|https://paxpress.txpa.hidinc.com/add_adhd_agents.pdf|02/13/2014| 57844012001|ADD/ADHD Agents|https://paxpress.txpa.hidinc.com/add_adhd_agents.pdf|02/13/2014| 57844013001|ADD/ADHD Agents|https://paxpress.txpa.hidinc.com/add_adhd_agents.pdf|02/13/2014| 57894006002|Cytokine and CAM Antagonists|https://paxpress.txpa.hidinc.com/cytokine.pdf|03/27/2018| 57894006003|Cytokine and CAM Antagonists|https://paxpress.txpa.hidinc.com/cytokine.pdf|03/27/2018| 57894006103|Cytokine and CAM Antagonists|https://paxpress.txpa.hidinc.com/cytokine.pdf|03/27/2018| 57894007001|Cytokine and CAM Antagonists|https://paxpress.txpa.hidinc.com/cytokine.pdf|03/27/2018| 57894007002|Cytokine and CAM Antagonists|https://paxpress.txpa.hidinc.com/cytokine.pdf|03/27/2018| 57894007101|Cytokine and CAM Antagonists|https://paxpress.txpa.hidinc.com/cytokine.pdf|03/27/2018| 57894007102|Cytokine and CAM Antagonists|https://paxpress.txpa.hidinc.com/cytokine.pdf|03/27/2018| 57894035001|Cytokine and CAM Antagonists|https://paxpress.txpa.hidinc.com/cytokine.pdf|03/27/2018| 57894064001|Cytokine and CAM Antagonists|https://paxpress.txpa.hidinc.com/cytokine.pdf|03/27/2018| 57894064011|Cytokine and CAM Antagonists|https://paxpress.txpa.hidinc.com/cytokine.pdf|03/27/2018| 58406001004|Cytokine and CAM Antagonists|https://paxpress.txpa.hidinc.com/cytokine.pdf|03/27/2018| 58406002104|Cytokine and CAM Antagonists|https://paxpress.txpa.hidinc.com/cytokine.pdf|03/27/2018| 58406003204|Cytokine and CAM Antagonists|https://paxpress.txpa.hidinc.com/cytokine.pdf|03/27/2018| 58406004401|Cytokine and CAM Antagonists|https://paxpress.txpa.hidinc.com/cytokine.pdf|03/27/2018| 58406004404|Cytokine and CAM Antagonists|https://paxpress.txpa.hidinc.com/cytokine.pdf|03/27/2018| 58468002101|Phosphate Binders|https://paxpress.txpa.hidinc.com/phosphate_binders.pdf|01/31/2011|01/31/2024 58468004001|Enzymes|https://paxpress.txpa.hidinc.com/enzymes.pdf|11/20/2019| 58468004101|Enzymes|https://paxpress.txpa.hidinc.com/enzymes.pdf|11/20/2019| 58468007001|Enzymes|https://paxpress.txpa.hidinc.com/enzymes.pdf|11/20/2019| 58468013001|Phosphate Binders|https://paxpress.txpa.hidinc.com/phosphate_binders.pdf|01/31/2011| 58468013102|Phosphate Binders|https://paxpress.txpa.hidinc.com/phosphate_binders.pdf|01/31/2011| 58657050004|Cough and Cold Agents|https://paxpress.txpa.hidinc.com/Cough%20&%20Cold.pdf|12/15/2015| 58657050004|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017| 58657050004|Opioid Clinical Policy (MME and days supply limits)|https://paxpress.txpa.hidinc.com/opc.pdf|09/01/2020| 58657050016|Cough and Cold Agents|https://paxpress.txpa.hidinc.com/Cough%20&%20Cold.pdf|12/15/2015| 58657050016|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017| 58657050016|Opioid Clinical Policy (MME and days supply limits)|https://paxpress.txpa.hidinc.com/opc.pdf|09/01/2020| 58657064501|Carisoprodol Overuse|https://paxpress.txpa.hidinc.com/soma.pdf|01/31/2011|08/23/2023 58657064501|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017|08/23/2023 58657064510|Carisoprodol Overuse|https://paxpress.txpa.hidinc.com/soma.pdf|01/31/2011|09/30/2023 58657064510|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017|09/30/2023 58657064550|Carisoprodol Overuse|https://paxpress.txpa.hidinc.com/soma.pdf|01/31/2011|09/30/2023 58657064550|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017|09/30/2023 58657070001|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016| 58657070101|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016| 58657070201|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016| 58657070301|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016| 58657070310|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016| 58657070401|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016| 58657070501|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016| 58809019860|Cough and Cold Agents|https://paxpress.txpa.hidinc.com/Cough%20&%20Cold.pdf|12/15/2015| 58809019860|Dextromethorphan Overutilization|https://paxpress.txpa.hidinc.com/dextro.pdf|07/16/2012| 58809055508|Cough and Cold Agents|https://paxpress.txpa.hidinc.com/Cough%20&%20Cold.pdf|12/15/2015| 58809065150|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 58809072904|Cough and Cold Agents|https://paxpress.txpa.hidinc.com/Cough%20&%20Cold.pdf|12/15/2015| 58809072904|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 58809085008|Cough and Cold Agents|https://paxpress.txpa.hidinc.com/Cough%20&%20Cold.pdf|12/15/2015| 58809099901|Cough and Cold Agents|https://paxpress.txpa.hidinc.com/Cough%20&%20Cold.pdf|12/15/2015| 58809099901|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 59011027160|Opiate Overutilization|https://paxpress.txpa.hidinc.com/opiate.pdf|11/05/2013| 59011027160|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017| 59011027160|Opioid Clinical Policy (MME and days supply limits)|https://paxpress.txpa.hidinc.com/opc.pdf|09/01/2020| 59011027260|Opiate Overutilization|https://paxpress.txpa.hidinc.com/opiate.pdf|11/05/2013| 59011027260|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017| 59011027260|Opioid Clinical Policy (MME and days supply limits)|https://paxpress.txpa.hidinc.com/opc.pdf|09/01/2020| 59011027360|Opiate Overutilization|https://paxpress.txpa.hidinc.com/opiate.pdf|11/05/2013| 59011027360|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017| 59011027360|Opioid Clinical Policy (MME and days supply limits)|https://paxpress.txpa.hidinc.com/opc.pdf|09/01/2020| 59011027460|Opiate Overutilization|https://paxpress.txpa.hidinc.com/opiate.pdf|11/05/2013| 59011027460|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017| 59011027460|Opioid Clinical Policy (MME and days supply limits)|https://paxpress.txpa.hidinc.com/opc.pdf|09/01/2020| 59011027560|Opiate Overutilization|https://paxpress.txpa.hidinc.com/opiate.pdf|11/05/2013| 59011027560|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017| 59011027560|Opioid Clinical Policy (MME and days supply limits)|https://paxpress.txpa.hidinc.com/opc.pdf|09/01/2020| 59011027660|Opiate Overutilization|https://paxpress.txpa.hidinc.com/opiate.pdf|11/05/2013| 59011027660|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017| 59011027660|Opioid Clinical Policy (MME and days supply limits)|https://paxpress.txpa.hidinc.com/opc.pdf|09/01/2020| 59011027760|Opiate Overutilization|https://paxpress.txpa.hidinc.com/opiate.pdf|11/05/2013| 59011027760|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017| 59011027760|Opioid Clinical Policy (MME and days supply limits)|https://paxpress.txpa.hidinc.com/opc.pdf|09/01/2020| 59011041010|Opiate Overutilization|https://paxpress.txpa.hidinc.com/opiate.pdf|11/05/2013| 59011041010|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017| 59011041010|Opioid Clinical Policy (MME and days supply limits)|https://paxpress.txpa.hidinc.com/opc.pdf|09/01/2020| 59011041010|Oxycontin / Narcotic Analgesic|https://paxpress.txpa.hidinc.com/oxycontin.pdf|01/31/2011| 59011041510|Opiate Overutilization|https://paxpress.txpa.hidinc.com/opiate.pdf|11/05/2013| 59011041510|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017| 59011041510|Opioid Clinical Policy (MME and days supply limits)|https://paxpress.txpa.hidinc.com/opc.pdf|09/01/2020| 59011041510|Oxycontin / Narcotic Analgesic|https://paxpress.txpa.hidinc.com/oxycontin.pdf|01/31/2011| 59011042010|Opiate Overutilization|https://paxpress.txpa.hidinc.com/opiate.pdf|11/05/2013| 59011042010|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017| 59011042010|Opioid Clinical Policy (MME and days supply limits)|https://paxpress.txpa.hidinc.com/opc.pdf|09/01/2020| 59011042010|Oxycontin / Narcotic Analgesic|https://paxpress.txpa.hidinc.com/oxycontin.pdf|01/31/2011| 59011043010|Opiate Overutilization|https://paxpress.txpa.hidinc.com/opiate.pdf|11/05/2013| 59011043010|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017| 59011043010|Opioid Clinical Policy (MME and days supply limits)|https://paxpress.txpa.hidinc.com/opc.pdf|09/01/2020| 59011043010|Oxycontin / Narcotic Analgesic|https://paxpress.txpa.hidinc.com/oxycontin.pdf|01/31/2011| 59011044010|Opiate Overutilization|https://paxpress.txpa.hidinc.com/opiate.pdf|11/05/2013| 59011044010|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017| 59011044010|Opioid Clinical Policy (MME and days supply limits)|https://paxpress.txpa.hidinc.com/opc.pdf|09/01/2020| 59011044010|Oxycontin / Narcotic Analgesic|https://paxpress.txpa.hidinc.com/oxycontin.pdf|01/31/2011| 59011046010|Opiate Overutilization|https://paxpress.txpa.hidinc.com/opiate.pdf|11/05/2013| 59011046010|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017| 59011046010|Opioid Clinical Policy (MME and days supply limits)|https://paxpress.txpa.hidinc.com/opc.pdf|09/01/2020| 59011046010|Oxycontin / Narcotic Analgesic|https://paxpress.txpa.hidinc.com/oxycontin.pdf|01/31/2011| 59011048010|Opiate Overutilization|https://paxpress.txpa.hidinc.com/opiate.pdf|11/05/2013| 59011048010|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017| 59011048010|Opioid Clinical Policy (MME and days supply limits)|https://paxpress.txpa.hidinc.com/opc.pdf|09/01/2020| 59011048010|Oxycontin / Narcotic Analgesic|https://paxpress.txpa.hidinc.com/oxycontin.pdf|01/31/2011| 59011075004|Opiate Overutilization|https://paxpress.txpa.hidinc.com/opiate.pdf|11/05/2013| 59011075004|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017| 59011075004|Opioid Clinical Policy (MME and days supply limits)|https://paxpress.txpa.hidinc.com/opc.pdf|09/01/2020| 59011075104|Opiate Overutilization|https://paxpress.txpa.hidinc.com/opiate.pdf|11/05/2013| 59011075104|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017| 59011075104|Opioid Clinical Policy (MME and days supply limits)|https://paxpress.txpa.hidinc.com/opc.pdf|09/01/2020| 59011075204|Opiate Overutilization|https://paxpress.txpa.hidinc.com/opiate.pdf|11/05/2013| 59011075204|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017| 59011075204|Opioid Clinical Policy (MME and days supply limits)|https://paxpress.txpa.hidinc.com/opc.pdf|09/01/2020| 59011075704|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017| 59011075704|Opioid Clinical Policy (MME and days supply limits)|https://paxpress.txpa.hidinc.com/opc.pdf|09/01/2020| 59011075804|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017| 59011075804|Opioid Clinical Policy (MME and days supply limits)|https://paxpress.txpa.hidinc.com/opc.pdf|09/01/2020| 59148000613|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016| 59148000713|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016| 59148000813|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016| 59148000913|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016| 59148001013|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016| 59148001113|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016| 59148001871|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016| 59148001971|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016| 59148003513|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016| 59148003613|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016| 59148003713|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016| 59148003813|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016| 59148003913|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016| 59148004013|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016| 59148004580|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016| 59148007280|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016| 59310011106|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 59310011406|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 59310012906|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 59310013606|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 59310020006|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 59310030240|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 59310030480|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 59310031106|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 59310057922|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|10/01/2023 59310058020|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 59385001201|Buprenorphine Agents|https://paxpress.txpa.hidinc.com/buprenorphine_agents.pdf|04/23/2013| 59385001201|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017| 59385001230|Buprenorphine Agents|https://paxpress.txpa.hidinc.com/buprenorphine_agents.pdf|04/23/2013| 59385001230|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017| 59385001401|Buprenorphine Agents|https://paxpress.txpa.hidinc.com/buprenorphine_agents.pdf|04/23/2013| 59385001401|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017| 59385001430|Buprenorphine Agents|https://paxpress.txpa.hidinc.com/buprenorphine_agents.pdf|04/23/2013| 59385001430|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017| 59385001601|Buprenorphine Agents|https://paxpress.txpa.hidinc.com/buprenorphine_agents.pdf|04/23/2013| 59385001601|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017| 59385001630|Buprenorphine Agents|https://paxpress.txpa.hidinc.com/buprenorphine_agents.pdf|04/23/2013| 59385001630|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017| 59385002160|Opiate Overutilization|https://paxpress.txpa.hidinc.com/opiate.pdf|11/05/2013| 59385002160|Opioid Clinical Policy (MME and days supply limits)|https://paxpress.txpa.hidinc.com/opc.pdf|09/01/2020| 59385002260|Opiate Overutilization|https://paxpress.txpa.hidinc.com/opiate.pdf|11/05/2013| 59385002260|Opioid Clinical Policy (MME and days supply limits)|https://paxpress.txpa.hidinc.com/opc.pdf|09/01/2020| 59385002360|Opiate Overutilization|https://paxpress.txpa.hidinc.com/opiate.pdf|11/05/2013| 59385002360|Opioid Clinical Policy (MME and days supply limits)|https://paxpress.txpa.hidinc.com/opc.pdf|09/01/2020| 59385002460|Opiate Overutilization|https://paxpress.txpa.hidinc.com/opiate.pdf|11/05/2013| 59385002460|Opioid Clinical Policy (MME and days supply limits)|https://paxpress.txpa.hidinc.com/opc.pdf|09/01/2020| 59385002560|Opiate Overutilization|https://paxpress.txpa.hidinc.com/opiate.pdf|11/05/2013| 59385002560|Opioid Clinical Policy (MME and days supply limits)|https://paxpress.txpa.hidinc.com/opc.pdf|09/01/2020| 59385002660|Opiate Overutilization|https://paxpress.txpa.hidinc.com/opiate.pdf|11/05/2013| 59385002760|Opiate Overutilization|https://paxpress.txpa.hidinc.com/opiate.pdf|11/05/2013| 59385002760|Opioid Clinical Policy (MME and days supply limits)|https://paxpress.txpa.hidinc.com/opc.pdf|09/01/2020| 59385004130|GI Motility Agents|https://paxpress.txpa.hidinc.com/GImotility.pdf|01/18/2017| 59417010110|ADD/ADHD Agents|https://paxpress.txpa.hidinc.com/add_adhd_agents.pdf|02/13/2014| 59417010210|ADD/ADHD Agents|https://paxpress.txpa.hidinc.com/add_adhd_agents.pdf|02/13/2014| 59417010310|ADD/ADHD Agents|https://paxpress.txpa.hidinc.com/add_adhd_agents.pdf|02/13/2014| 59417010410|ADD/ADHD Agents|https://paxpress.txpa.hidinc.com/add_adhd_agents.pdf|02/13/2014| 59417010510|ADD/ADHD Agents|https://paxpress.txpa.hidinc.com/add_adhd_agents.pdf|02/13/2014| 59417010610|ADD/ADHD Agents|https://paxpress.txpa.hidinc.com/add_adhd_agents.pdf|02/13/2014| 59417010710|ADD/ADHD Agents|https://paxpress.txpa.hidinc.com/add_adhd_agents.pdf|02/13/2014| 59417011501|ADD/ADHD Agents|https://paxpress.txpa.hidinc.com/add_adhd_agents.pdf|02/13/2014| 59417011601|ADD/ADHD Agents|https://paxpress.txpa.hidinc.com/add_adhd_agents.pdf|02/13/2014| 59417011701|ADD/ADHD Agents|https://paxpress.txpa.hidinc.com/add_adhd_agents.pdf|02/13/2014| 59417011801|ADD/ADHD Agents|https://paxpress.txpa.hidinc.com/add_adhd_agents.pdf|02/13/2014| 59417011901|ADD/ADHD Agents|https://paxpress.txpa.hidinc.com/add_adhd_agents.pdf|02/13/2014| 59417012001|ADD/ADHD Agents|https://paxpress.txpa.hidinc.com/add_adhd_agents.pdf|02/13/2014| 59617001502|Allergen Extracts|https://paxpress.txpa.hidinc.com/allergen_extracts.pdf|09/01/2015| 59630075050|ADD/ADHD Agents|https://paxpress.txpa.hidinc.com/add_adhd_agents.pdf|02/13/2014| 59630075550|ADD/ADHD Agents|https://paxpress.txpa.hidinc.com/add_adhd_agents.pdf|02/13/2014| 59651001060|Ranexa|https://paxpress.txpa.hidinc.com/ranexa.pdf|05/25/2012| 59651003212|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 59651003247|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 59651004730|CNS Stimulants|https://paxpress.txpa.hidinc.com/provigil.pdf|02/06/2018| 59651010469|Antimigraine Agents Triptans|https://paxpress.txpa.hidinc.com/triptans.pdf|04/04/2023| 59651010569|Antimigraine Agents Triptans|https://paxpress.txpa.hidinc.com/triptans.pdf|04/04/2023| 59651011055|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016| 59651030601|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017| 59651030605|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017| 59651032930|Leukotriene Modifiers|https://paxpress.txpa.hidinc.com/leukotriene.pdf|12/15/2015| 59651035308|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 59651036001|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 59651036005|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 59651036101|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 59651036105|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 59651036201|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 59651036205|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 59651048401|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 59651048499|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 59651048501|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 59651048601|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 59651048701|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 59651048801|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 59651048901|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 59651049101|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 59651072201|Anxiolytics and Sedative-Hypnotics|https://paxpress.txpa.hidinc.com/ash.pdf|01/31/2011| 59651072201|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017| 59651072301|Anxiolytics and Sedative-Hypnotics|https://paxpress.txpa.hidinc.com/ash.pdf|01/31/2011| 59651072301|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017| 59651072399|Anxiolytics and Sedative-Hypnotics|https://paxpress.txpa.hidinc.com/ash.pdf|01/31/2011| 59651072399|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017| 59651072401|Anxiolytics and Sedative-Hypnotics|https://paxpress.txpa.hidinc.com/ash.pdf|01/31/2011| 59651072401|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017| 59651072405|Anxiolytics and Sedative-Hypnotics|https://paxpress.txpa.hidinc.com/ash.pdf|01/31/2011| 59651072405|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017| 59676030201|Erythropoiesis-Stimulating Proteins|https://paxpress.txpa.hidinc.com/esa.pdf|09/24/2013| 59676030301|Erythropoiesis-Stimulating Proteins|https://paxpress.txpa.hidinc.com/esa.pdf|09/24/2013| 59676030401|Erythropoiesis-Stimulating Proteins|https://paxpress.txpa.hidinc.com/esa.pdf|09/24/2013| 59676031001|Erythropoiesis-Stimulating Proteins|https://paxpress.txpa.hidinc.com/esa.pdf|09/24/2013| 59676031002|Erythropoiesis-Stimulating Proteins|https://paxpress.txpa.hidinc.com/esa.pdf|09/24/2013| 59676031204|Erythropoiesis-Stimulating Proteins|https://paxpress.txpa.hidinc.com/esa.pdf|09/24/2013| 59676032004|Erythropoiesis-Stimulating Proteins|https://paxpress.txpa.hidinc.com/esa.pdf|09/24/2013| 59676034001|Erythropoiesis-Stimulating Proteins|https://paxpress.txpa.hidinc.com/esa.pdf|09/24/2013| 59746000103|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 59746000106|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 59746000204|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 59746000314|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 59746001032|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016| 59746001504|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 59746002022|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016| 59746003022|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016| 59746004022|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016| 59746005022|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016| 59746012106|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 59746012110|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 59746012206|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 59746012210|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 59746017106|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 59746017110|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 59746017206|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 59746017210|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 59746017306|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 59746017310|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 59746017506|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 59746017509|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 59746017706|Cyclobenzaprine|https://paxpress.txpa.hidinc.com/cyclobenzaprine.pdf|01/31/2011| 59746017706|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017| 59746017710|Cyclobenzaprine|https://paxpress.txpa.hidinc.com/cyclobenzaprine.pdf|01/31/2011| 59746017710|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017| 59746021106|Cyclobenzaprine|https://paxpress.txpa.hidinc.com/cyclobenzaprine.pdf|01/31/2011| 59746021106|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017| 59746021110|Cyclobenzaprine|https://paxpress.txpa.hidinc.com/cyclobenzaprine.pdf|01/31/2011| 59746021110|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017| 59746030632|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016| 59746030732|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016| 59746030832|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016| 59746030932|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016| 59746033310|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 59746033390|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 59746033410|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 59746033430|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 59746033490|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 59746033510|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 59746033530|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 59746033590|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 59746033730|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 59746033790|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 59746033830|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 59746033890|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 59746033930|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 59746033990|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 59746036030|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 59746036190|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 59746036290|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 59746036390|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 59746044730|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 59746044790|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 59746044830|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 59746044890|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 59746044930|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 59746044990|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 59762002801|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 59762002802|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 59762002901|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 59762003301|PDE5-Inhibitors|https://paxpress.txpa.hidinc.com/revatio.pdf|01/31/2011| 59762004901|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 59762005001|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 59762005101|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 59762005701|Anxiolytics and Sedative-Hypnotics|https://paxpress.txpa.hidinc.com/ash.pdf|05/28/2015| 59762005701|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017| 59762005901|Anxiolytics and Sedative-Hypnotics|https://paxpress.txpa.hidinc.com/ash.pdf|05/28/2015| 59762005901|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017| 59762006601|Anxiolytics and Sedative-Hypnotics|https://paxpress.txpa.hidinc.com/ash.pdf|05/28/2015| 59762006601|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017| 59762006801|Anxiolytics and Sedative-Hypnotics|https://paxpress.txpa.hidinc.com/ash.pdf|05/28/2015| 59762006801|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017| 59762007301|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 59762007401|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 59762007501|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 59762014501|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 59762015501|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/04/2016|08/23/2023 59762015502|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/04/2016|08/23/2023 59762015601|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/04/2016|08/23/2023 59762015602|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/04/2016| 59762015701|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/04/2016| 59762015702|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/04/2016|08/31/2023 59762015801|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/04/2016| 59762015802|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/04/2016|08/31/2023 59762151501|COX-2 Inhibitors|https://paxpress.txpa.hidinc.com/cox2.pdf|01/31/2011| 59762151501|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/04/2016| 59762151601|COX-2 Inhibitors|https://paxpress.txpa.hidinc.com/cox2.pdf|01/31/2011| 59762151601|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/04/2016| 59762151603|COX-2 Inhibitors|https://paxpress.txpa.hidinc.com/cox2.pdf|01/31/2011| 59762151603|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/04/2016| 59762151701|COX-2 Inhibitors|https://paxpress.txpa.hidinc.com/cox2.pdf|01/31/2011| 59762151701|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/04/2016| 59762151703|COX-2 Inhibitors|https://paxpress.txpa.hidinc.com/cox2.pdf|01/31/2011| 59762151703|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/04/2016| 59762151802|COX-2 Inhibitors|https://paxpress.txpa.hidinc.com/cox2.pdf|01/31/2011| 59762151802|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/04/2016| 59762200201|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016|05/31/2024 59762200301|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016|05/31/2024 59762200401|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016|05/31/2024 59762205801|PDE5-Inhibitors|https://paxpress.txpa.hidinc.com/revatio.pdf|09/01/2015| 59762232101|Antimigraine Agents Triptans|https://paxpress.txpa.hidinc.com/triptans.pdf|04/04/2023|01/31/2024 59762232201|Antimigraine Agents Triptans|https://paxpress.txpa.hidinc.com/triptans.pdf|04/04/2023|03/31/2024 59762371709|Anxiolytics and Sedative-Hypnotics|https://paxpress.txpa.hidinc.com/ash.pdf|01/31/2011| 59762371709|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017| 59762371803|Anxiolytics and Sedative-Hypnotics|https://paxpress.txpa.hidinc.com/ash.pdf|01/31/2011| 59762371803|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017| 59762371809|Anxiolytics and Sedative-Hypnotics|https://paxpress.txpa.hidinc.com/ash.pdf|01/31/2011| 59762371809|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017| 59762371901|Anxiolytics and Sedative-Hypnotics|https://paxpress.txpa.hidinc.com/ash.pdf|05/28/2015| 59762371901|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017| 59762371903|Anxiolytics and Sedative-Hypnotics|https://paxpress.txpa.hidinc.com/ash.pdf|05/28/2015| 59762371903|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017| 59762371904|Anxiolytics and Sedative-Hypnotics|https://paxpress.txpa.hidinc.com/ash.pdf|05/28/2015| 59762371904|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017| 59762372001|Anxiolytics and Sedative-Hypnotics|https://paxpress.txpa.hidinc.com/ash.pdf|05/28/2015| 59762372001|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017| 59762372003|Anxiolytics and Sedative-Hypnotics|https://paxpress.txpa.hidinc.com/ash.pdf|05/28/2015| 59762372003|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017| 59762372004|Anxiolytics and Sedative-Hypnotics|https://paxpress.txpa.hidinc.com/ash.pdf|05/28/2015| 59762372004|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017| 59762372101|Anxiolytics and Sedative-Hypnotics|https://paxpress.txpa.hidinc.com/ash.pdf|05/28/2015| 59762372101|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017| 59762372103|Anxiolytics and Sedative-Hypnotics|https://paxpress.txpa.hidinc.com/ash.pdf|05/28/2015| 59762372103|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017| 59762372104|Anxiolytics and Sedative-Hypnotics|https://paxpress.txpa.hidinc.com/ash.pdf|05/28/2015| 59762372104|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017| 59762372201|Anxiolytics and Sedative-Hypnotics|https://paxpress.txpa.hidinc.com/ash.pdf|05/28/2015| 59762372201|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017| 59762372203|Anxiolytics and Sedative-Hypnotics|https://paxpress.txpa.hidinc.com/ash.pdf|05/28/2015| 59762372203|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017| 59762444002|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 59762444003|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 59762501401|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|04/30/2025 59762505007|Gabapentin Agents|https://paxpress.txpa.hidinc.com/neurontin.pdf|01/31/2011| 59762600201|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|04/30/2026 59922063101|Phosphate Binders|https://paxpress.txpa.hidinc.com/phosphate_binders.pdf|01/31/2011| 60219167301|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016| 60219167401|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016| 60219167501|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016| 60219167601|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016| 60219167701|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017| 60219170501|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 60219170601|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 60219170607|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 60219170701|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 60219170705|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 60219170801|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 60219170805|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 60219204301|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 60219204401|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 60219205601|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 60429058611|Buprenorphine Agents|https://paxpress.txpa.hidinc.com/buprenorphine_agents.pdf|04/23/2013| 60429058611|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017| 60429058630|Buprenorphine Agents|https://paxpress.txpa.hidinc.com/buprenorphine_agents.pdf|04/23/2013| 60429058630|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017| 60429058633|Buprenorphine Agents|https://paxpress.txpa.hidinc.com/buprenorphine_agents.pdf|04/23/2013| 60429058633|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017| 60429058711|Buprenorphine Agents|https://paxpress.txpa.hidinc.com/buprenorphine_agents.pdf|04/23/2013| 60429058711|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017| 60429058730|Buprenorphine Agents|https://paxpress.txpa.hidinc.com/buprenorphine_agents.pdf|04/23/2013| 60429058730|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017| 60429058733|Buprenorphine Agents|https://paxpress.txpa.hidinc.com/buprenorphine_agents.pdf|04/23/2013| 60429058733|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017| 60432015004|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 60432015016|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 60432021208|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 60432024516|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017| 60432024516|Opioid Clinical Policy (MME and days supply limits)|https://paxpress.txpa.hidinc.com/opc.pdf|09/01/2020| 60432027504|Cough and Cold Agents|https://paxpress.txpa.hidinc.com/Cough%20&%20Cold.pdf|12/15/2015| 60432027504|Dextromethorphan Overutilization|https://paxpress.txpa.hidinc.com/dextro.pdf|07/16/2012| 60432027504|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 60432027516|Cough and Cold Agents|https://paxpress.txpa.hidinc.com/Cough%20&%20Cold.pdf|12/15/2015| 60432027516|Dextromethorphan Overutilization|https://paxpress.txpa.hidinc.com/dextro.pdf|07/16/2012| 60432027516|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 60432045516|Cough and Cold Agents|https://paxpress.txpa.hidinc.com/Cough%20&%20Cold.pdf|12/15/2015| 60432045516|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017| 60432045516|Opioid Clinical Policy (MME and days supply limits)|https://paxpress.txpa.hidinc.com/opc.pdf|09/01/2020| 60432046608|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 60432060416|Cough and Cold Agents|https://paxpress.txpa.hidinc.com/Cough%20&%20Cold.pdf|12/15/2015|03/15/2024 60432060416|Dextromethorphan Overutilization|https://paxpress.txpa.hidinc.com/dextro.pdf|07/16/2012|03/15/2024 60432060416|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|03/15/2024 60432060416|Promethazine Utilization|https://paxpress.txpa.hidinc.com/phenergan.pdf|01/31/2011|03/15/2024 60432060616|Cough and Cold Agents|https://paxpress.txpa.hidinc.com/Cough%20&%20Cold.pdf|12/15/2015| 60432060616|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 60432060616|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017| 60432060616|Opioid Clinical Policy (MME and days supply limits)|https://paxpress.txpa.hidinc.com/opc.pdf|09/01/2020| 60432060616|Promethazine Utilization|https://paxpress.txpa.hidinc.com/phenergan.pdf|01/31/2011| 60432060816|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 60432060816|Promethazine Utilization|https://paxpress.txpa.hidinc.com/phenergan.pdf|01/31/2011| 60432070605|Opiate Overutilization|https://paxpress.txpa.hidinc.com/opiate.pdf|11/05/2013| 60432070605|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017| 60432070605|Opioid Clinical Policy (MME and days supply limits)|https://paxpress.txpa.hidinc.com/opc.pdf|09/01/2020| 60505003901|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 60505004001|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 60505004101|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 60505010201|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 60505011201|Gabapentin Agents|https://paxpress.txpa.hidinc.com/neurontin.pdf|01/31/2011|08/23/2023 60505011208|Gabapentin Agents|https://paxpress.txpa.hidinc.com/neurontin.pdf|01/31/2011|08/23/2023 60505011401|Gabapentin Agents|https://paxpress.txpa.hidinc.com/neurontin.pdf|01/31/2011|08/23/2023 60505011405|Gabapentin Agents|https://paxpress.txpa.hidinc.com/neurontin.pdf|01/31/2011|08/23/2023 60505014708|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 60505016805|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/04/2016| 60505016809|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/04/2016| 60505016907|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/04/2016| 60505016909|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/04/2016| 60505017007|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/04/2016| 60505017009|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/04/2016| 60505020801|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|08/23/2023 60505025701|Desmopressin|https://paxpress.txpa.hidinc.com/desmopressin.pdf|05/25/2012| 60505025801|Desmopressin|https://paxpress.txpa.hidinc.com/desmopressin.pdf|05/25/2012| 60505026101|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|08/23/2023 60505026301|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|08/23/2023 60505026401|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|08/23/2023 60505040405|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016| 60505040603|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 60505079100|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 60505079104|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|08/23/2023 60505079200|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 60505079204|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|05/31/2024 60505079300|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 60505079304|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|08/23/2023 60505079400|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 60505079404|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 60505079501|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 60505079504|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 60505079600|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 60505079604|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 60505079800|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 60505079804|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 60505081301|Opiate Overutilization|https://paxpress.txpa.hidinc.com/opiate.pdf|11/05/2013| 60505081301|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017| 60505081301|Opioid Clinical Policy (MME and days supply limits)|https://paxpress.txpa.hidinc.com/opc.pdf|09/01/2020| 60505083305|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 60505084805|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|08/31/2023 60505132305|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/04/2016| 60505132309|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/04/2016| 60505252603|CNS Stimulants|https://paxpress.txpa.hidinc.com/provigil.pdf|11/06/2012| 60505252703|CNS Stimulants|https://paxpress.txpa.hidinc.com/provigil.pdf|11/06/2012| 60505252806|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016| 60505252906|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016| 60505253006|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016| 60505253106|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016| 60505255101|Gabapentin Agents|https://paxpress.txpa.hidinc.com/neurontin.pdf|01/31/2011|08/23/2023 60505255105|Gabapentin Agents|https://paxpress.txpa.hidinc.com/neurontin.pdf|01/31/2011|08/23/2023 60505255201|Gabapentin Agents|https://paxpress.txpa.hidinc.com/neurontin.pdf|01/31/2011|08/23/2023 60505255205|Gabapentin Agents|https://paxpress.txpa.hidinc.com/neurontin.pdf|01/31/2011|08/23/2023 60505257808|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/04/2016| 60505257809|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/04/2016| 60505257908|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/04/2016| 60505257909|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/04/2016| 60505258008|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/04/2016| 60505258009|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/04/2016| 60505263301|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|08/23/2023 60505263308|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|08/23/2023 60505264401|Opiate Overutilization|https://paxpress.txpa.hidinc.com/opiate.pdf|11/05/2013|08/23/2023 60505264401|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017|08/23/2023 60505264401|Opioid Clinical Policy (MME and days supply limits)|https://paxpress.txpa.hidinc.com/opc.pdf|09/01/2020|08/23/2023 60505264405|Opiate Overutilization|https://paxpress.txpa.hidinc.com/opiate.pdf|11/05/2013|08/23/2023 60505264405|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017|08/23/2023 60505264405|Opioid Clinical Policy (MME and days supply limits)|https://paxpress.txpa.hidinc.com/opc.pdf|09/01/2020|08/23/2023 60505265601|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 60505265605|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 60505265701|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 60505265705|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 60505267108|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/04/2016| 60505267109|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/04/2016| 60505267303|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016| 60505267403|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016| 60505267503|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016| 60505267603|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016| 60505267703|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016| 60505283003|ADD/ADHD Agents|https://paxpress.txpa.hidinc.com/add_adhd_agents.pdf|02/13/2014| 60505283103|ADD/ADHD Agents|https://paxpress.txpa.hidinc.com/add_adhd_agents.pdf|02/13/2014| 60505283203|ADD/ADHD Agents|https://paxpress.txpa.hidinc.com/add_adhd_agents.pdf|02/13/2014| 60505283303|ADD/ADHD Agents|https://paxpress.txpa.hidinc.com/add_adhd_agents.pdf|02/13/2014| 60505283403|ADD/ADHD Agents|https://paxpress.txpa.hidinc.com/add_adhd_agents.pdf|02/13/2014| 60505283503|ADD/ADHD Agents|https://paxpress.txpa.hidinc.com/add_adhd_agents.pdf|02/13/2014| 60505283603|ADD/ADHD Agents|https://paxpress.txpa.hidinc.com/add_adhd_agents.pdf|02/13/2014| 60505307503|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016| 60505311003|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016| 60505311008|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016| 60505311108|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016| 60505311208|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016| 60505311308|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016| 60505311403|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016| 60505311408|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016| 60505313001|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016|08/23/2023 60505313008|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016|08/23/2023 60505313201|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016|08/23/2023 60505313208|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016|08/23/2023 60505313301|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016|08/23/2023 60505313308|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016|08/23/2023 60505313501|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016|08/23/2023 60505313508|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016|08/23/2023 60505313706|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016|08/23/2023 60505313901|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016|08/23/2023 60505314003|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016| 60505314008|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016| 60505317007|Lovaza|https://paxpress.txpa.hidinc.com/lovaza.pdf|07/16/2012| 60505327500|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016| 60505327503|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016| 60505327600|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016| 60505327603|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016| 60505327700|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016| 60505327703|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016| 60505327800|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016| 60505327803|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016| 60505340909|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|08/23/2023 60505347803|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 60505347903|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 60505348303|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 60505348403|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 60505348803|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 60505348903|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 60505349203|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 60505349303|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 60505360303|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|08/23/2023 60505360309|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|08/23/2023 60505360403|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|08/23/2023 60505371309|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|08/23/2023 60505371900|Antimigraine Agents Triptans|https://paxpress.txpa.hidinc.com/triptans.pdf|04/04/2023|08/23/2023 60505372301|Antimigraine Agents Triptans|https://paxpress.txpa.hidinc.com/triptans.pdf|04/04/2023|08/23/2023 60505372401|Antimigraine Agents Triptans|https://paxpress.txpa.hidinc.com/triptans.pdf|04/04/2023|08/23/2023 60505380709|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|08/23/2023 60505380809|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|08/23/2023 60505380909|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|08/23/2023 60505384706|COX-2 Inhibitors|https://paxpress.txpa.hidinc.com/cox2.pdf|01/31/2011| 60505384706|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/04/2016| 60505384801|COX-2 Inhibitors|https://paxpress.txpa.hidinc.com/cox2.pdf|01/31/2011| 60505384801|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/04/2016| 60505384805|COX-2 Inhibitors|https://paxpress.txpa.hidinc.com/cox2.pdf|01/31/2011| 60505384805|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/04/2016| 60505384901|COX-2 Inhibitors|https://paxpress.txpa.hidinc.com/cox2.pdf|01/31/2011| 60505384901|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/04/2016| 60505384905|COX-2 Inhibitors|https://paxpress.txpa.hidinc.com/cox2.pdf|01/31/2011| 60505384905|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/04/2016| 60505388207|VMAT2 Inhibitors|https://paxpress.txpa.hidinc.com/vmat2_inhibitor.pdf|09/25/2018| 60505388307|VMAT2 Inhibitors|https://paxpress.txpa.hidinc.com/vmat2_inhibitor.pdf|09/25/2018| 60505392701|ADD/ADHD Agents|https://paxpress.txpa.hidinc.com/add_adhd_agents.pdf|02/13/2014| 60505392801|ADD/ADHD Agents|https://paxpress.txpa.hidinc.com/add_adhd_agents.pdf|02/13/2014| 60505392901|ADD/ADHD Agents|https://paxpress.txpa.hidinc.com/add_adhd_agents.pdf|02/13/2014| 60505393001|ADD/ADHD Agents|https://paxpress.txpa.hidinc.com/add_adhd_agents.pdf|02/13/2014| 60505397206|Cyclobenzaprine|https://paxpress.txpa.hidinc.com/cyclobenzaprine.pdf|01/31/2011|09/30/2023 60505397206|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017|09/30/2023 60505397306|Cyclobenzaprine|https://paxpress.txpa.hidinc.com/cyclobenzaprine.pdf|01/31/2011|09/30/2023 60505397306|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017|09/30/2023 60505403301|Omega 3 Fatty Acids|https://paxpress.txpa.hidinc.com/lovaza.pdf|03/21/2023| 60505450209|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/04/2016|08/23/2023 60505450309|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/04/2016|08/23/2023 60505450409|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/04/2016|08/23/2023 60505475401|Anxiolytics and Sedative-Hypnotics|https://paxpress.txpa.hidinc.com/ash.pdf|01/31/2011| 60505475401|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017| 60505475501|Anxiolytics and Sedative-Hypnotics|https://paxpress.txpa.hidinc.com/ash.pdf|01/31/2011| 60505475501|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017| 60505475601|Anxiolytics and Sedative-Hypnotics|https://paxpress.txpa.hidinc.com/ash.pdf|01/31/2011| 60505475601|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017| 60505476801|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016| 60505476901|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016| 60505477001|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016| 60505477101|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016| 60505621401|HAE Agents Clinical|https://paxpress.txpa.hidinc.com/HAE.pdf|03/21/2023| 60505707505|Opiate Overutilization|https://paxpress.txpa.hidinc.com/opiate.pdf|11/05/2013| 60505707505|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017| 60505707505|Opioid Clinical Policy (MME and days supply limits)|https://paxpress.txpa.hidinc.com/opc.pdf|09/01/2020| 60505707605|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017| 60505707605|Opioid Clinical Policy (MME and days supply limits)|https://paxpress.txpa.hidinc.com/opc.pdf|09/01/2020| 60505707705|Opiate Overutilization|https://paxpress.txpa.hidinc.com/opiate.pdf|11/05/2013| 60505707705|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017| 60505707705|Opioid Clinical Policy (MME and days supply limits)|https://paxpress.txpa.hidinc.com/opc.pdf|09/01/2020| 60505707805|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017| 60505707805|Opioid Clinical Policy (MME and days supply limits)|https://paxpress.txpa.hidinc.com/opc.pdf|09/01/2020| 60505707905|Opiate Overutilization|https://paxpress.txpa.hidinc.com/opiate.pdf|11/05/2013| 60505707905|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017| 60505707905|Opioid Clinical Policy (MME and days supply limits)|https://paxpress.txpa.hidinc.com/opc.pdf|09/01/2020| 60574411301|Synagis|https://paxpress.txpa.hidinc.com/synagis.pdf|01/31/2011|08/31/2023 60574411401|Synagis|https://paxpress.txpa.hidinc.com/synagis.pdf|01/31/2011|09/30/2023 60631004030|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 60631008030|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 60631041230|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 60687048111|Buprenorphine Agents|https://paxpress.txpa.hidinc.com/buprenorphine_agents.pdf|12/05/2014| 60687048111|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017| 60687048121|Buprenorphine Agents|https://paxpress.txpa.hidinc.com/buprenorphine_agents.pdf|12/05/2014| 60687048121|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017| 60687049211|Buprenorphine Agents|https://paxpress.txpa.hidinc.com/buprenorphine_agents.pdf|12/05/2014| 60687049211|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017| 60687049221|Buprenorphine Agents|https://paxpress.txpa.hidinc.com/buprenorphine_agents.pdf|12/05/2014| 60687049221|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017| 60687062665|Buprenorphine Agents|https://paxpress.txpa.hidinc.com/buprenorphine_agents.pdf|04/23/2013| 60687062665|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017| 60687063765|Buprenorphine Agents|https://paxpress.txpa.hidinc.com/buprenorphine_agents.pdf|04/23/2013| 60687063765|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017| 60846238303|Antimigraine Agents Triptans|https://paxpress.txpa.hidinc.com/triptans.pdf|04/04/2023| 60846238404|Antimigraine Agents Triptans|https://paxpress.txpa.hidinc.com/triptans.pdf|04/04/2023| 60951060270|Opiate Overutilization|https://paxpress.txpa.hidinc.com/opiate.pdf|11/05/2013| 60951060270|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017| 60951060270|Opioid Clinical Policy (MME and days supply limits)|https://paxpress.txpa.hidinc.com/opc.pdf|09/01/2020| 60951060285|Opiate Overutilization|https://paxpress.txpa.hidinc.com/opiate.pdf|11/05/2013| 60951060285|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017| 60951060285|Opioid Clinical Policy (MME and days supply limits)|https://paxpress.txpa.hidinc.com/opc.pdf|09/01/2020| 60951070070|Opiate Overutilization|https://paxpress.txpa.hidinc.com/opiate.pdf|11/05/2013| 60951070070|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017| 60951070070|Opioid Clinical Policy (MME and days supply limits)|https://paxpress.txpa.hidinc.com/opc.pdf|09/01/2020| 60951071270|Opiate Overutilization|https://paxpress.txpa.hidinc.com/opiate.pdf|11/05/2013| 60951071270|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017| 60951071270|Opioid Clinical Policy (MME and days supply limits)|https://paxpress.txpa.hidinc.com/opc.pdf|09/01/2020| 61269060510|Anxiolytics and Sedative-Hypnotics|https://paxpress.txpa.hidinc.com/ash.pdf|01/31/2011| 61269060510|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017| 61269061010|Anxiolytics and Sedative-Hypnotics|https://paxpress.txpa.hidinc.com/ash.pdf|01/31/2011| 61269061010|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017| 61269062010|Anxiolytics and Sedative-Hypnotics|https://paxpress.txpa.hidinc.com/ash.pdf|01/31/2011| 61269062010|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017| 61442010201|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 61442010210|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 61442010260|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 61442010301|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 61442010305|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 61442010310|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 61442010360|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 61442012610|COX-2 Inhibitors|https://paxpress.txpa.hidinc.com/cox2.pdf|01/31/2011| 61442012610|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/04/2016| 61442012710|COX-2 Inhibitors|https://paxpress.txpa.hidinc.com/cox2.pdf|01/31/2011| 61442012710|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/04/2016| 61442014101|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/04/2016| 61442014110|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/04/2016| 61442014201|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/04/2016| 61442014210|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/04/2016| 61442014301|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/04/2016| 61442014310|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/04/2016| 61570007201|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 61570007301|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 61570007401|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 61755002002|Hyperlipidemia Agents|https://paxpress.txpa.hidinc.com/hyperlipidemia.pdf|01/04/2017| 61755002102|Hyperlipidemia Agents|https://paxpress.txpa.hidinc.com/hyperlipidemia.pdf|01/04/2017| 61825016530|Anxiolytics and Sedative-Hypnotics|https://paxpress.txpa.hidinc.com/ash.pdf|01/31/2011| 61825030260|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017| 61874007560|GI Motility Agents|https://paxpress.txpa.hidinc.com/GImotility.pdf|02/06/2018| 61874010060|GI Motility Agents|https://paxpress.txpa.hidinc.com/GImotility.pdf|02/06/2018| 61874011520|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016| 61874011530|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016| 61874013020|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016| 61874013030|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016| 61874014530|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016| 61874016030|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016| 61874017008|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016| 61958080101|Pulmonary Hypertension Agents Clinical|https://paxpress.txpa.hidinc.com/pah.pdf|07/27/2023| 61958080105|Pulmonary Hypertension Agents Clinical|https://paxpress.txpa.hidinc.com/pah.pdf|07/27/2023| 61958080201|Pulmonary Hypertension Agents Clinical|https://paxpress.txpa.hidinc.com/pah.pdf|07/27/2023| 61958080205|Pulmonary Hypertension Agents Clinical|https://paxpress.txpa.hidinc.com/pah.pdf|07/27/2023| 61958090101|Inhaled Antibiotics Clinical|https://paxpress.txpa.hidinc.com/inhaledantibiotics.pdf|05/02/2023| 61958100301|Ranexa|https://paxpress.txpa.hidinc.com/ranexa.pdf|05/25/2012|01/31/2024 61958100401|Ranexa|https://paxpress.txpa.hidinc.com/ranexa.pdf|05/25/2012|01/31/2024 62037072501|ADD/ADHD Agents|https://paxpress.txpa.hidinc.com/add_adhd_agents.pdf|02/13/2014| 62037072601|ADD/ADHD Agents|https://paxpress.txpa.hidinc.com/add_adhd_agents.pdf|02/13/2014| 62037072701|ADD/ADHD Agents|https://paxpress.txpa.hidinc.com/add_adhd_agents.pdf|02/13/2014| 62037073401|ADD/ADHD Agents|https://paxpress.txpa.hidinc.com/add_adhd_agents.pdf|02/13/2014| 62135002007|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 62135002021|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 62135002046|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 62135002160|COX-2 Inhibitors|https://paxpress.txpa.hidinc.com/cox2.pdf|01/31/2011| 62135002160|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/04/2016| 62135002260|COX-2 Inhibitors|https://paxpress.txpa.hidinc.com/cox2.pdf|01/31/2011| 62135002260|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/04/2016| 62135002360|COX-2 Inhibitors|https://paxpress.txpa.hidinc.com/cox2.pdf|01/31/2011| 62135002360|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/04/2016| 62135005741|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 62135005747|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 62135006718|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 62135006790|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 62135006818|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 62135006890|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 62135011437|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 62135014560|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 62135014660|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 62135017660|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 62135019122|Phosphate Binders|https://paxpress.txpa.hidinc.com/phosphate_binders.pdf|01/31/2011| 62135019222|Phosphate Binders|https://paxpress.txpa.hidinc.com/phosphate_binders.pdf|01/31/2011| 62135022060|Anxiolytics and Sedative-Hypnotics|https://paxpress.txpa.hidinc.com/ash.pdf|01/31/2011| 62135022060|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017| 62135022160|Anxiolytics and Sedative-Hypnotics|https://paxpress.txpa.hidinc.com/ash.pdf|01/31/2011| 62135022160|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017| 62135022260|Anxiolytics and Sedative-Hypnotics|https://paxpress.txpa.hidinc.com/ash.pdf|01/31/2011| 62135022260|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017| 62135023690|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 62135024112|Carisoprodol Overuse|https://paxpress.txpa.hidinc.com/soma.pdf|01/31/2011| 62135024112|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017| 62135025037|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 62135025047|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 62135030247|Cough and Cold Agents|https://paxpress.txpa.hidinc.com/Cough%20&%20Cold.pdf|12/15/2015| 62135030247|Dextromethorphan Overutilization|https://paxpress.txpa.hidinc.com/dextro.pdf|07/16/2012| 62135030247|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 62135030248|Cough and Cold Agents|https://paxpress.txpa.hidinc.com/Cough%20&%20Cold.pdf|12/15/2015| 62135030248|Dextromethorphan Overutilization|https://paxpress.txpa.hidinc.com/dextro.pdf|07/16/2012| 62135030248|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 62135040012|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 62135040112|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 62135040212|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 62135041590|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016| 62135041690|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016| 62135041890|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016| 62135041990|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016| 62135042090|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016| 62135042190|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016| 62135042290|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016| 62135042390|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016| 62135042490|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016| 62135043730|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 62135044031|Cough and Cold Agents|https://paxpress.txpa.hidinc.com/Cough%20&%20Cold.pdf|12/15/2015| 62135044090|Cough and Cold Agents|https://paxpress.txpa.hidinc.com/Cough%20&%20Cold.pdf|12/15/2015| 62135044131|Cough and Cold Agents|https://paxpress.txpa.hidinc.com/Cough%20&%20Cold.pdf|12/15/2015| 62135044160|Cough and Cold Agents|https://paxpress.txpa.hidinc.com/Cough%20&%20Cold.pdf|12/15/2015| 62135044805|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 62135044890|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 62135044905|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 62135044990|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 62135045660|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 62135046912|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 62135050247|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 62135069612|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017| 62135076747|Anxiolytics and Sedative-Hypnotics|https://paxpress.txpa.hidinc.com/ash.pdf|01/31/2011| 62135076747|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017| 62135076843|Anxiolytics and Sedative-Hypnotics|https://paxpress.txpa.hidinc.com/ash.pdf|01/31/2011| 62135076843|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017| 62135091738|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 62135092943|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016| 62135094947|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 62135094994|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 62175020432|Leukotriene Modifiers|https://paxpress.txpa.hidinc.com/leukotriene.pdf|12/15/2015| 62175020443|Leukotriene Modifiers|https://paxpress.txpa.hidinc.com/leukotriene.pdf|12/15/2015| 62175020446|Leukotriene Modifiers|https://paxpress.txpa.hidinc.com/leukotriene.pdf|12/15/2015| 62175020532|Leukotriene Modifiers|https://paxpress.txpa.hidinc.com/leukotriene.pdf|12/15/2015| 62175020543|Leukotriene Modifiers|https://paxpress.txpa.hidinc.com/leukotriene.pdf|12/15/2015| 62175020546|Leukotriene Modifiers|https://paxpress.txpa.hidinc.com/leukotriene.pdf|12/15/2015| 62175031037|ADD/ADHD Agents|https://paxpress.txpa.hidinc.com/add_adhd_agents.pdf|02/13/2014| 62175031137|ADD/ADHD Agents|https://paxpress.txpa.hidinc.com/add_adhd_agents.pdf|02/13/2014| 62175031237|ADD/ADHD Agents|https://paxpress.txpa.hidinc.com/add_adhd_agents.pdf|02/13/2014| 62175031337|ADD/ADHD Agents|https://paxpress.txpa.hidinc.com/add_adhd_agents.pdf|02/13/2014| 62175045232|Buprenorphine Agents|https://paxpress.txpa.hidinc.com/buprenorphine_agents.pdf|04/23/2013| 62175045232|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017| 62175045832|Buprenorphine Agents|https://paxpress.txpa.hidinc.com/buprenorphine_agents.pdf|04/23/2013| 62175045832|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017| 62332001931|Anxiolytics and Sedative-Hypnotics|https://paxpress.txpa.hidinc.com/ash.pdf|01/31/2011| 62332001931|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017| 62332002031|Anxiolytics and Sedative-Hypnotics|https://paxpress.txpa.hidinc.com/ash.pdf|01/31/2011| 62332002031|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017| 62332002730|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 62332002790|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 62332002791|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 62332002830|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 62332002890|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 62332002891|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 62332002930|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 62332002990|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 62332002991|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 62332004130|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 62332004190|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 62332004230|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 62332004271|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 62332004290|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 62332004330|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 62332004371|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 62332004390|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 62332004430|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 62332004490|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 62332004571|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 62332004590|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 62332004671|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 62332004690|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 62332004771|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 62332004790|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 62332004830|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 62332004890|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 62332004891|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 62332004930|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 62332004990|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 62332004991|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 62332005030|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 62332005090|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 62332005091|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 62332005130|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 62332005190|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 62332005230|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 62332005290|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 62332006030|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 62332006090|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 62332007971|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 62332007990|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 62332008071|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 62332008090|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 62332008171|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 62332008190|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 62332008271|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 62332008290|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 62332008371|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 62332008390|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 62332008730|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 62332008830|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 62332008930|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 62332009730|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016| 62332009731|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016| 62332009830|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016| 62332009831|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016| 62332009930|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016| 62332009931|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016| 62332010030|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016| 62332010031|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016| 62332010130|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016| 62332010131|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016| 62332010230|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016| 62332010231|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016| 62332010330|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016| 62332010430|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016| 62332011531|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 62332011631|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 62332013130|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 62332013230|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 62332013290|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 62332013330|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 62332013390|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 62332014060|COX-2 Inhibitors|https://paxpress.txpa.hidinc.com/cox2.pdf|01/31/2011| 62332014060|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/04/2016| 62332014131|COX-2 Inhibitors|https://paxpress.txpa.hidinc.com/cox2.pdf|01/31/2011| 62332014131|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/04/2016| 62332014171|COX-2 Inhibitors|https://paxpress.txpa.hidinc.com/cox2.pdf|01/31/2011| 62332014171|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/04/2016| 62332014231|COX-2 Inhibitors|https://paxpress.txpa.hidinc.com/cox2.pdf|01/31/2011| 62332014231|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/04/2016| 62332014271|COX-2 Inhibitors|https://paxpress.txpa.hidinc.com/cox2.pdf|01/31/2011| 62332014271|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/04/2016| 62332014291|COX-2 Inhibitors|https://paxpress.txpa.hidinc.com/cox2.pdf|01/31/2011| 62332014291|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/04/2016| 62332014360|COX-2 Inhibitors|https://paxpress.txpa.hidinc.com/cox2.pdf|01/31/2011| 62332014360|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/04/2016| 62332014930|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 62332014990|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 62332015030|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 62332015090|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 62332015130|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 62332015190|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 62332019831|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016| 62332019860|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016| 62332019931|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016| 62332019960|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016| 62332020530|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 62332020590|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 62332020630|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 62332020690|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 62332020730|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 62332020790|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 62332020830|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 62332020890|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 62332020930|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 62332021030|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 62332021130|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 62332021230|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 62332021330|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 62332021430|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 62332021530|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 62332034130|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 62332034190|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 62332034230|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 62332034290|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 62332034330|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 62332034390|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 62332036406|Anxiolytics and Sedative-Hypnotics|https://paxpress.txpa.hidinc.com/ash.pdf|01/31/2011| 62332036406|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017| 62332036506|Anxiolytics and Sedative-Hypnotics|https://paxpress.txpa.hidinc.com/ash.pdf|01/31/2011| 62332036506|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017| 62332036606|Anxiolytics and Sedative-Hypnotics|https://paxpress.txpa.hidinc.com/ash.pdf|01/31/2011| 62332036606|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017| 62332036706|Anxiolytics and Sedative-Hypnotics|https://paxpress.txpa.hidinc.com/ash.pdf|01/31/2011| 62332036706|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017| 62332036806|Anxiolytics and Sedative-Hypnotics|https://paxpress.txpa.hidinc.com/ash.pdf|01/31/2011| 62332036806|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017| 62332037931|Anxiolytics and Sedative-Hypnotics|https://paxpress.txpa.hidinc.com/ash.pdf|01/31/2011| 62332037931|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017| 62332038031|Anxiolytics and Sedative-Hypnotics|https://paxpress.txpa.hidinc.com/ash.pdf|01/31/2011| 62332038031|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017| 62332038071|Anxiolytics and Sedative-Hypnotics|https://paxpress.txpa.hidinc.com/ash.pdf|01/31/2011| 62332038071|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017| 62332038130|Anxiolytics and Sedative-Hypnotics|https://paxpress.txpa.hidinc.com/ash.pdf|01/31/2011| 62332038130|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017| 62332038231|Anxiolytics and Sedative-Hypnotics|https://paxpress.txpa.hidinc.com/ash.pdf|01/31/2011| 62332038231|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017| 62332038271|Anxiolytics and Sedative-Hypnotics|https://paxpress.txpa.hidinc.com/ash.pdf|01/31/2011| 62332038271|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017| 62332038530|CNS Stimulants|https://paxpress.txpa.hidinc.com/provigil.pdf|11/06/2012| 62332038590|CNS Stimulants|https://paxpress.txpa.hidinc.com/provigil.pdf|11/06/2012| 62332038630|CNS Stimulants|https://paxpress.txpa.hidinc.com/provigil.pdf|11/06/2012| 62332038690|CNS Stimulants|https://paxpress.txpa.hidinc.com/provigil.pdf|11/06/2012| 62332042631|Cough and Cold Agents|https://paxpress.txpa.hidinc.com/Cough%20&%20Cold.pdf|12/15/2015| 62332042671|Cough and Cold Agents|https://paxpress.txpa.hidinc.com/Cough%20&%20Cold.pdf|12/15/2015| 62332042731|Cough and Cold Agents|https://paxpress.txpa.hidinc.com/Cough%20&%20Cold.pdf|12/15/2015| 62332042771|Cough and Cold Agents|https://paxpress.txpa.hidinc.com/Cough%20&%20Cold.pdf|12/15/2015| 62332048712|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 62332049430|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016| 62332049530|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016| 62332049630|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016| 62332049730|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016| 62332049830|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016| 62332054460|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016| 62332058131|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 62332059925|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 62332059925|Ketorolac|https://paxpress.txpa.hidinc.com/ketorolac.pdf|05/25/2012| 62332060025|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 62332060025|Ketorolac|https://paxpress.txpa.hidinc.com/ketorolac.pdf|05/25/2012| 62332060125|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 62332060125|Ketorolac|https://paxpress.txpa.hidinc.com/ketorolac.pdf|05/25/2012| 62332065530|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/04/2016| 62332065560|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/04/2016| 62542030104|Cough and Cold Agents|https://paxpress.txpa.hidinc.com/Cough%20&%20Cold.pdf|12/15/2015| 62542030104|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 62542030104|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017| 62542030104|Opioid Clinical Policy (MME and days supply limits)|https://paxpress.txpa.hidinc.com/opc.pdf|09/01/2020| 62542030117|Cough and Cold Agents|https://paxpress.txpa.hidinc.com/Cough%20&%20Cold.pdf|12/15/2015| 62542030117|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 62542030117|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017| 62542030117|Opioid Clinical Policy (MME and days supply limits)|https://paxpress.txpa.hidinc.com/opc.pdf|09/01/2020| 62559011107|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 62559011111|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 62559013807|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 62559015116|Opiate Overutilization|https://paxpress.txpa.hidinc.com/opiate.pdf|11/05/2013| 62559015116|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017| 62559015116|Opioid Clinical Policy (MME and days supply limits)|https://paxpress.txpa.hidinc.com/opc.pdf|09/01/2020| 62559016701|Opiate Overutilization|https://paxpress.txpa.hidinc.com/opiate.pdf|11/05/2013| 62559016701|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017| 62559016701|Opioid Clinical Policy (MME and days supply limits)|https://paxpress.txpa.hidinc.com/opc.pdf|09/01/2020| 62559025001|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 62559025101|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 62559041401|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 62559041501|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 62559041601|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 62559041701|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 62559064030|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 62559064130|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 62559064230|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 62559064290|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 62559064330|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 62559064390|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 62559065090|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 62559065190|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 62559065290|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 62559066090|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 62559066190|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 62559066290|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 62559084210|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 62559086015|HP Acthar|https://paxpress.txpa.hidinc.com/hp_acthar.pdf|03/08/2016| 62756005940|Pulmonary Hypertension Agents Clinical|https://paxpress.txpa.hidinc.com/pah.pdf|07/27/2023| 62756006040|Pulmonary Hypertension Agents Clinical|https://paxpress.txpa.hidinc.com/pah.pdf|07/27/2023| 62756013702|Gabapentin Agents|https://paxpress.txpa.hidinc.com/neurontin.pdf|01/31/2011| 62756020201|Gabapentin Agents|https://paxpress.txpa.hidinc.com/neurontin.pdf|01/31/2011| 62756020203|Gabapentin Agents|https://paxpress.txpa.hidinc.com/neurontin.pdf|01/31/2011| 62756020401|Gabapentin Agents|https://paxpress.txpa.hidinc.com/neurontin.pdf|01/31/2011| 62756020403|Gabapentin Agents|https://paxpress.txpa.hidinc.com/neurontin.pdf|01/31/2011| 62756036888|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 62756036988|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 62756037088|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 62756043769|Antimigraine Agents Triptans|https://paxpress.txpa.hidinc.com/triptans.pdf|04/04/2023| 62756044602|Carisoprodol Overuse|https://paxpress.txpa.hidinc.com/soma.pdf|01/31/2011| 62756044602|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017| 62756044604|Carisoprodol Overuse|https://paxpress.txpa.hidinc.com/soma.pdf|01/31/2011| 62756044604|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017| 62756044605|Carisoprodol Overuse|https://paxpress.txpa.hidinc.com/soma.pdf|01/31/2011| 62756044605|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017| 62756045983|Buprenorphine Agents|https://paxpress.txpa.hidinc.com/buprenorphine_agents.pdf|12/05/2014| 62756045983|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017| 62756046083|Buprenorphine Agents|https://paxpress.txpa.hidinc.com/buprenorphine_agents.pdf|12/05/2014| 62756046083|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017| 62756052069|Antimigraine Agents Triptans|https://paxpress.txpa.hidinc.com/triptans.pdf|04/04/2023| 62756052088|Antimigraine Agents Triptans|https://paxpress.txpa.hidinc.com/triptans.pdf|04/04/2023| 62756052169|Antimigraine Agents Triptans|https://paxpress.txpa.hidinc.com/triptans.pdf|04/04/2023| 62756052188|Antimigraine Agents Triptans|https://paxpress.txpa.hidinc.com/triptans.pdf|04/04/2023| 62756052269|Antimigraine Agents Triptans|https://paxpress.txpa.hidinc.com/triptans.pdf|04/04/2023| 62756052288|Antimigraine Agents Triptans|https://paxpress.txpa.hidinc.com/triptans.pdf|04/04/2023| 62756055118|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016| 62756055183|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016| 62756055188|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016| 62756055218|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016| 62756055283|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016| 62756055288|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016| 62756055318|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016| 62756055383|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016| 62756055388|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016| 62756055418|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016| 62756055483|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016| 62756055488|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016| 62756055518|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016| 62756055583|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016| 62756055588|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016| 62756055618|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016| 62756055683|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016| 62756055688|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016| 62756075164|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016| 62756075464|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016| 62756075564|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016| 62756075764|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016| 62756096983|Buprenorphine Agents|https://paxpress.txpa.hidinc.com/buprenorphine_agents.pdf|04/23/2013| 62756096983|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017| 62756097083|Buprenorphine Agents|https://paxpress.txpa.hidinc.com/buprenorphine_agents.pdf|04/23/2013| 62756097083|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017| 62856040530|Anxiolytics and Sedative-Hypnotics|https://paxpress.txpa.hidinc.com/ash.pdf|01/31/2011| 62856041030|Anxiolytics and Sedative-Hypnotics|https://paxpress.txpa.hidinc.com/ash.pdf|01/31/2011| 63004871001|HP Acthar|https://paxpress.txpa.hidinc.com/hp_acthar.pdf|03/08/2016| 63090010030|PDE5-Inhibitors|https://paxpress.txpa.hidinc.com/revatio.pdf|01/31/2011| 63304009719|Antimigraine Agents Triptans|https://paxpress.txpa.hidinc.com/triptans.pdf|04/04/2023| 63304009819|Antimigraine Agents Triptans|https://paxpress.txpa.hidinc.com/triptans.pdf|04/04/2023| 63304009919|Antimigraine Agents Triptans|https://paxpress.txpa.hidinc.com/triptans.pdf|04/04/2023| 63304045001|Opiate Overutilization|https://paxpress.txpa.hidinc.com/opiate.pdf|11/05/2013| 63304045001|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017| 63304045001|Opioid Clinical Policy (MME and days supply limits)|https://paxpress.txpa.hidinc.com/opc.pdf|09/01/2020| 63304045101|Opiate Overutilization|https://paxpress.txpa.hidinc.com/opiate.pdf|11/05/2013| 63304045101|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017| 63304045101|Opioid Clinical Policy (MME and days supply limits)|https://paxpress.txpa.hidinc.com/opc.pdf|09/01/2020| 63304045201|Opiate Overutilization|https://paxpress.txpa.hidinc.com/opiate.pdf|11/05/2013| 63304045201|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017| 63304045201|Opioid Clinical Policy (MME and days supply limits)|https://paxpress.txpa.hidinc.com/opc.pdf|09/01/2020| 63304045301|Opiate Overutilization|https://paxpress.txpa.hidinc.com/opiate.pdf|11/05/2013| 63304045301|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017| 63304045301|Opioid Clinical Policy (MME and days supply limits)|https://paxpress.txpa.hidinc.com/opc.pdf|09/01/2020| 63304068301|Opiate Overutilization|https://paxpress.txpa.hidinc.com/opiate.pdf|11/05/2013| 63304068301|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017| 63304068301|Opioid Clinical Policy (MME and days supply limits)|https://paxpress.txpa.hidinc.com/opc.pdf|09/01/2020| 63304068301|Oxycontin / Narcotic Analgesic|https://paxpress.txpa.hidinc.com/oxycontin.pdf|01/31/2011| 63304068401|Opiate Overutilization|https://paxpress.txpa.hidinc.com/opiate.pdf|11/05/2013| 63304068401|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017| 63304068401|Opioid Clinical Policy (MME and days supply limits)|https://paxpress.txpa.hidinc.com/opc.pdf|09/01/2020| 63304068401|Oxycontin / Narcotic Analgesic|https://paxpress.txpa.hidinc.com/oxycontin.pdf|01/31/2011| 63304075801|Opiate Overutilization|https://paxpress.txpa.hidinc.com/opiate.pdf|11/05/2013| 63304075801|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017| 63304075801|Opioid Clinical Policy (MME and days supply limits)|https://paxpress.txpa.hidinc.com/opc.pdf|09/01/2020| 63304082705|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/04/2016| 63304082790|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/04/2016| 63304082805|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/04/2016| 63304082890|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/04/2016| 63304082905|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/04/2016| 63304082990|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/04/2016| 63304083005|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/04/2016| 63304083090|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/04/2016| 63323016202|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 63323016202|Ketorolac|https://paxpress.txpa.hidinc.com/ketorolac.pdf|05/25/2012| 63323028110|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016| 63323047410|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016| 63323057486|HAE Agents Clinical|https://paxpress.txpa.hidinc.com/HAE.pdf|03/21/2023| 63323057493|HAE Agents Clinical|https://paxpress.txpa.hidinc.com/HAE.pdf|03/21/2023| 63402019030|Anxiolytics and Sedative-Hypnotics|https://paxpress.txpa.hidinc.com/ash.pdf|01/31/2011| 63402019103|Anxiolytics and Sedative-Hypnotics|https://paxpress.txpa.hidinc.com/ash.pdf|01/31/2011| 63402019303|Anxiolytics and Sedative-Hypnotics|https://paxpress.txpa.hidinc.com/ash.pdf|01/31/2011| 63402030230|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016| 63402030430|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016| 63402030630|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016| 63402030830|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016| 63402031230|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016| 63402051001|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 63402091130|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/04/2016| 63402091164|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/04/2016| 63459010130|CNS Stimulants|https://paxpress.txpa.hidinc.com/provigil.pdf|11/06/2012| 63459020130|CNS Stimulants|https://paxpress.txpa.hidinc.com/provigil.pdf|11/06/2012| 63459020530|CNS Stimulants|https://paxpress.txpa.hidinc.com/provigil.pdf|02/06/2018| 63459021530|CNS Stimulants|https://paxpress.txpa.hidinc.com/provigil.pdf|02/06/2018| 63459022030|CNS Stimulants|https://paxpress.txpa.hidinc.com/provigil.pdf|02/06/2018| 63459022530|CNS Stimulants|https://paxpress.txpa.hidinc.com/provigil.pdf|02/06/2018| 63459050230|Fentanyl Agents|https://paxpress.txpa.hidinc.com/fentanyl.pdf|01/31/2011|05/31/2024 63459050230|Opiate Overutilization|https://paxpress.txpa.hidinc.com/opiate.pdf|11/05/2013|05/31/2024 63459050230|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017|05/31/2024 63459050230|Opioid Clinical Policy (MME and days supply limits)|https://paxpress.txpa.hidinc.com/opc.pdf|09/01/2020|05/31/2024 63459050430|Fentanyl Agents|https://paxpress.txpa.hidinc.com/fentanyl.pdf|01/31/2011|07/12/2024 63459050430|Opiate Overutilization|https://paxpress.txpa.hidinc.com/opiate.pdf|11/05/2013|07/12/2024 63459050430|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017|07/12/2024 63459050430|Opioid Clinical Policy (MME and days supply limits)|https://paxpress.txpa.hidinc.com/opc.pdf|09/01/2020|07/12/2024 63459050630|Fentanyl Agents|https://paxpress.txpa.hidinc.com/fentanyl.pdf|01/31/2011|05/31/2024 63459050630|Opiate Overutilization|https://paxpress.txpa.hidinc.com/opiate.pdf|11/05/2013|05/31/2024 63459050630|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017|05/31/2024 63459050630|Opioid Clinical Policy (MME and days supply limits)|https://paxpress.txpa.hidinc.com/opc.pdf|09/01/2020|05/31/2024 63459050830|Fentanyl Agents|https://paxpress.txpa.hidinc.com/fentanyl.pdf|01/31/2011|06/30/2024 63459050830|Opiate Overutilization|https://paxpress.txpa.hidinc.com/opiate.pdf|11/05/2013|06/30/2024 63459050830|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017|06/30/2024 63459050830|Opioid Clinical Policy (MME and days supply limits)|https://paxpress.txpa.hidinc.com/opc.pdf|09/01/2020|06/30/2024 63459051230|Fentanyl Agents|https://paxpress.txpa.hidinc.com/fentanyl.pdf|01/31/2011|05/31/2024 63459051230|Opiate Overutilization|https://paxpress.txpa.hidinc.com/opiate.pdf|11/05/2013|05/31/2024 63459051230|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017|05/31/2024 63459051230|Opioid Clinical Policy (MME and days supply limits)|https://paxpress.txpa.hidinc.com/opc.pdf|09/01/2020|05/31/2024 63459051630|Fentanyl Agents|https://paxpress.txpa.hidinc.com/fentanyl.pdf|01/31/2011|08/23/2023 63459051630|Opiate Overutilization|https://paxpress.txpa.hidinc.com/opiate.pdf|11/05/2013|08/23/2023 63459051630|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017|08/23/2023 63459051630|Opioid Clinical Policy (MME and days supply limits)|https://paxpress.txpa.hidinc.com/opc.pdf|09/01/2020|08/23/2023 63459054128|Fentanyl Agents|https://paxpress.txpa.hidinc.com/fentanyl.pdf|09/24/2017| 63459054128|Opiate Overutilization|https://paxpress.txpa.hidinc.com/opiate.pdf|11/05/2013| 63459054128|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017| 63459054128|Opioid Clinical Policy (MME and days supply limits)|https://paxpress.txpa.hidinc.com/opc.pdf|09/01/2020| 63459054228|Fentanyl Agents|https://paxpress.txpa.hidinc.com/fentanyl.pdf|09/24/2017| 63459054228|Opiate Overutilization|https://paxpress.txpa.hidinc.com/opiate.pdf|11/05/2013| 63459054228|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017| 63459054228|Opioid Clinical Policy (MME and days supply limits)|https://paxpress.txpa.hidinc.com/opc.pdf|09/01/2020| 63459054428|Fentanyl Agents|https://paxpress.txpa.hidinc.com/fentanyl.pdf|09/24/2017| 63459054428|Opiate Overutilization|https://paxpress.txpa.hidinc.com/opiate.pdf|11/05/2013| 63459054428|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017| 63459054428|Opioid Clinical Policy (MME and days supply limits)|https://paxpress.txpa.hidinc.com/opc.pdf|09/01/2020| 63459054628|Fentanyl Agents|https://paxpress.txpa.hidinc.com/fentanyl.pdf|09/24/2017| 63459054628|Opiate Overutilization|https://paxpress.txpa.hidinc.com/opiate.pdf|11/05/2013| 63459054628|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017| 63459054628|Opioid Clinical Policy (MME and days supply limits)|https://paxpress.txpa.hidinc.com/opc.pdf|09/01/2020| 63459054828|Fentanyl Agents|https://paxpress.txpa.hidinc.com/fentanyl.pdf|09/24/2017| 63459054828|Opiate Overutilization|https://paxpress.txpa.hidinc.com/opiate.pdf|11/05/2013| 63459054828|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017| 63459054828|Opioid Clinical Policy (MME and days supply limits)|https://paxpress.txpa.hidinc.com/opc.pdf|09/01/2020| 63459070060|Cyclobenzaprine|https://paxpress.txpa.hidinc.com/cyclobenzaprine.pdf|01/31/2011| 63459070060|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017| 63459070160|Cyclobenzaprine|https://paxpress.txpa.hidinc.com/cyclobenzaprine.pdf|01/31/2011| 63459070160|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017| 63481002509|Antimigraine Agents Triptans|https://paxpress.txpa.hidinc.com/triptans.pdf|04/04/2023| 63481062370|Opiate Overutilization|https://paxpress.txpa.hidinc.com/opiate.pdf|11/05/2013| 63481062370|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017| 63481062370|Opioid Clinical Policy (MME and days supply limits)|https://paxpress.txpa.hidinc.com/opc.pdf|09/01/2020| 63481062385|Opiate Overutilization|https://paxpress.txpa.hidinc.com/opiate.pdf|11/05/2013| 63481062385|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017| 63481062385|Opioid Clinical Policy (MME and days supply limits)|https://paxpress.txpa.hidinc.com/opc.pdf|09/01/2020| 63481062770|Opiate Overutilization|https://paxpress.txpa.hidinc.com/opiate.pdf|11/05/2013| 63481062770|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017| 63481062770|Opioid Clinical Policy (MME and days supply limits)|https://paxpress.txpa.hidinc.com/opc.pdf|09/01/2020| 63481062870|Opiate Overutilization|https://paxpress.txpa.hidinc.com/opiate.pdf|11/05/2013| 63481062870|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017| 63481062870|Opioid Clinical Policy (MME and days supply limits)|https://paxpress.txpa.hidinc.com/opc.pdf|09/01/2020| 63481062970|Opiate Overutilization|https://paxpress.txpa.hidinc.com/opiate.pdf|11/05/2013| 63481062970|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017| 63481062970|Opioid Clinical Policy (MME and days supply limits)|https://paxpress.txpa.hidinc.com/opc.pdf|09/01/2020| 63629947501|Buprenorphine Agents|https://paxpress.txpa.hidinc.com/buprenorphine_agents.pdf|12/05/2014| 63629947501|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017| 63629948201|Buprenorphine Agents|https://paxpress.txpa.hidinc.com/buprenorphine_agents.pdf|04/23/2013| 63629948201|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017| 63629948301|Buprenorphine Agents|https://paxpress.txpa.hidinc.com/buprenorphine_agents.pdf|04/23/2013| 63629948301|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017| 63739000333|Anxiolytics and Sedative-Hypnotics|https://paxpress.txpa.hidinc.com/ash.pdf|01/31/2011| 63739000333|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017| 63739000532|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016| 63739021310|Promethazine Utilization|https://paxpress.txpa.hidinc.com/phenergan.pdf|01/31/2011| 63739040310|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 63739048310|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 63739048610|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 63739050832|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016| 63739052610|Anxiolytics and Sedative-Hypnotics|https://paxpress.txpa.hidinc.com/ash.pdf|01/31/2011| 63739056010|Gabapentin Agents|https://paxpress.txpa.hidinc.com/neurontin.pdf|01/31/2011| 63739057010|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/04/2016| 63739057110|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/04/2016| 63739057210|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/04/2016| 63739057310|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/04/2016| 63739066632|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016| 63739067310|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 63739068610|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 63739069810|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 63739098832|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016| 63833082502|HAE Agents Clinical|https://paxpress.txpa.hidinc.com/HAE.pdf|03/21/2023| 63833082802|HAE Agents Clinical|https://paxpress.txpa.hidinc.com/HAE.pdf|03/21/2023| 63833082902|HAE Agents Clinical|https://paxpress.txpa.hidinc.com/HAE.pdf|03/21/2023| 63868008701|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|08/23/2023 63868032550|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|08/23/2023 63868046501|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|08/23/2023 63868046550|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|08/23/2023 63868082354|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|08/23/2023 64380016702|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 64380016802|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 64380017202|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016| 64380017302|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016| 64380017402|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016| 64380017502|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016| 64380018701|Leukotriene Modifiers|https://paxpress.txpa.hidinc.com/leukotriene.pdf|12/15/2015| 64380018801|Leukotriene Modifiers|https://paxpress.txpa.hidinc.com/leukotriene.pdf|12/15/2015| 64380019701|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 64380019801|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 64380019901|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 64380020001|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 64380020101|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 64380071206|Cough and Cold Agents|https://paxpress.txpa.hidinc.com/Cough%20&%20Cold.pdf|12/15/2015| 64380071207|Cough and Cold Agents|https://paxpress.txpa.hidinc.com/Cough%20&%20Cold.pdf|12/15/2015| 64380071306|Cough and Cold Agents|https://paxpress.txpa.hidinc.com/Cough%20&%20Cold.pdf|12/15/2015| 64380071307|Cough and Cold Agents|https://paxpress.txpa.hidinc.com/Cough%20&%20Cold.pdf|12/15/2015| 64380076111|Lovaza|https://paxpress.txpa.hidinc.com/lovaza.pdf|07/16/2012| 64380078206|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 64380078306|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 64380078308|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 64380078406|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 64380078407|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 64380078408|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 64380078506|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 64380078507|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 64380078508|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 64380079506|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 64380079508|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 64380080706|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 64380080707|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 64380080806|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 64380080807|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 64380080906|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 64380080907|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 64380083506|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 64380084206|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 64380084306|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 64380084307|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 64380093304|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 64380093305|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 64380093308|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 64380093404|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 64380093405|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 64380093408|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 64380093504|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 64380093505|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 64380093508|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 64380094906|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 64380097025|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 64380097106|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 64380097206|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 64543004404|Cough and Cold Agents|https://paxpress.txpa.hidinc.com/Cough%20&%20Cold.pdf|12/15/2015| 64543004416|Cough and Cold Agents|https://paxpress.txpa.hidinc.com/Cough%20&%20Cold.pdf|12/15/2015| 64543009790|Cough and Cold Agents|https://paxpress.txpa.hidinc.com/Cough%20&%20Cold.pdf|12/15/2015| 64543009790|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 64543010504|Cough and Cold Agents|https://paxpress.txpa.hidinc.com/Cough%20&%20Cold.pdf|12/15/2015| 64543010504|Dextromethorphan Overutilization|https://paxpress.txpa.hidinc.com/dextro.pdf|07/16/2012| 64543010504|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 64543010516|Cough and Cold Agents|https://paxpress.txpa.hidinc.com/Cough%20&%20Cold.pdf|12/15/2015| 64543010516|Dextromethorphan Overutilization|https://paxpress.txpa.hidinc.com/dextro.pdf|07/16/2012| 64543010516|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 64597030160|Nuedexta|https://paxpress.txpa.hidinc.com/Nuedexta_Clin_Edit_Criteria.pdf|05/02/2017| 64679060416|Cough and Cold Agents|https://paxpress.txpa.hidinc.com/Cough%20&%20Cold.pdf|12/15/2015| 64679060416|Dextromethorphan Overutilization|https://paxpress.txpa.hidinc.com/dextro.pdf|07/16/2012| 64679060416|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 64679060416|Promethazine Utilization|https://paxpress.txpa.hidinc.com/phenergan.pdf|01/31/2011| 64679072801|Antimigraine Agents Triptans|https://paxpress.txpa.hidinc.com/triptans.pdf|04/04/2023| 64764008060|GI Motility Agents|https://paxpress.txpa.hidinc.com/GImotility.pdf|01/18/2017| 64764012303|DPP-4 Inhibitors|https://paxpress.txpa.hidinc.com/dpp4_inhibitor.pdf|09/25/2018| 64764012530|DPP-4 Inhibitors|https://paxpress.txpa.hidinc.com/dpp4_inhibitor.pdf|09/25/2018| 64764024060|GI Motility Agents|https://paxpress.txpa.hidinc.com/GImotility.pdf|01/18/2017| 64764025030|DPP-4 Inhibitors|https://paxpress.txpa.hidinc.com/dpp4_inhibitor.pdf|09/25/2018| 64764025103|DPP-4 Inhibitors|https://paxpress.txpa.hidinc.com/dpp4_inhibitor.pdf|09/25/2018| 64764025303|DPP-4 Inhibitors|https://paxpress.txpa.hidinc.com/dpp4_inhibitor.pdf|09/25/2018| 64764025403|DPP-4 Inhibitors|https://paxpress.txpa.hidinc.com/dpp4_inhibitor.pdf|09/25/2018| 64764030230|Thiazolidinediones|https://paxpress.txpa.hidinc.com/thiazolidinediones.pdf|01/31/2011| 64764030430|Thiazolidinediones|https://paxpress.txpa.hidinc.com/thiazolidinediones.pdf|01/31/2011| 64764033560|DPP-4 Inhibitors|https://paxpress.txpa.hidinc.com/dpp4_inhibitor.pdf|09/25/2018| 64764033760|DPP-4 Inhibitors|https://paxpress.txpa.hidinc.com/dpp4_inhibitor.pdf|09/25/2018| 64764062530|DPP-4 Inhibitors|https://paxpress.txpa.hidinc.com/dpp4_inhibitor.pdf|09/25/2018| 64764080510|Anxiolytics and Sedative-Hypnotics|https://paxpress.txpa.hidinc.com/ash.pdf|01/31/2011| 64764080530|Anxiolytics and Sedative-Hypnotics|https://paxpress.txpa.hidinc.com/ash.pdf|01/31/2011| 64896067151|Antimigraine Agents Triptans|https://paxpress.txpa.hidinc.com/triptans.pdf|04/04/2023|08/23/2023 64896067250|Antimigraine Agents Triptans|https://paxpress.txpa.hidinc.com/triptans.pdf|04/04/2023|08/23/2023 64896068151|Antimigraine Agents Triptans|https://paxpress.txpa.hidinc.com/triptans.pdf|04/04/2023|01/31/2025 64896068251|Antimigraine Agents Triptans|https://paxpress.txpa.hidinc.com/triptans.pdf|04/04/2023|04/30/2024 64896069501|Opiate Overutilization|https://paxpress.txpa.hidinc.com/opiate.pdf|11/05/2013| 64896069501|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017| 64896069501|Opioid Clinical Policy (MME and days supply limits)|https://paxpress.txpa.hidinc.com/opc.pdf|09/01/2020| 64896069513|Opiate Overutilization|https://paxpress.txpa.hidinc.com/opiate.pdf|11/05/2013| 64896069513|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017| 64896069513|Opioid Clinical Policy (MME and days supply limits)|https://paxpress.txpa.hidinc.com/opc.pdf|09/01/2020| 64896069601|Opiate Overutilization|https://paxpress.txpa.hidinc.com/opiate.pdf|11/05/2013| 64896069601|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017| 64896069613|Opiate Overutilization|https://paxpress.txpa.hidinc.com/opiate.pdf|11/05/2013| 64896069613|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017| 64896069701|Opiate Overutilization|https://paxpress.txpa.hidinc.com/opiate.pdf|11/05/2013| 64896069701|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017| 64896069701|Opioid Clinical Policy (MME and days supply limits)|https://paxpress.txpa.hidinc.com/opc.pdf|09/01/2020| 64896069713|Opiate Overutilization|https://paxpress.txpa.hidinc.com/opiate.pdf|11/05/2013| 64896069713|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017| 64896069713|Opioid Clinical Policy (MME and days supply limits)|https://paxpress.txpa.hidinc.com/opc.pdf|09/01/2020| 64896069801|Opiate Overutilization|https://paxpress.txpa.hidinc.com/opiate.pdf|11/05/2013| 64896069801|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017| 64896069801|Opioid Clinical Policy (MME and days supply limits)|https://paxpress.txpa.hidinc.com/opc.pdf|09/01/2020| 64896069813|Opiate Overutilization|https://paxpress.txpa.hidinc.com/opiate.pdf|11/05/2013| 64896069813|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017| 64896069813|Opioid Clinical Policy (MME and days supply limits)|https://paxpress.txpa.hidinc.com/opc.pdf|09/01/2020| 64896069901|Opiate Overutilization|https://paxpress.txpa.hidinc.com/opiate.pdf|11/05/2013| 64896069901|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017| 64896069901|Opioid Clinical Policy (MME and days supply limits)|https://paxpress.txpa.hidinc.com/opc.pdf|09/01/2020| 64896069913|Opiate Overutilization|https://paxpress.txpa.hidinc.com/opiate.pdf|11/05/2013| 64896069913|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017| 64896069913|Opioid Clinical Policy (MME and days supply limits)|https://paxpress.txpa.hidinc.com/opc.pdf|09/01/2020| 64896070001|Opiate Overutilization|https://paxpress.txpa.hidinc.com/opiate.pdf|11/05/2013| 64896070001|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017| 64896070001|Opioid Clinical Policy (MME and days supply limits)|https://paxpress.txpa.hidinc.com/opc.pdf|09/01/2020| 64896070013|Opiate Overutilization|https://paxpress.txpa.hidinc.com/opiate.pdf|11/05/2013| 64896070013|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017| 64896070013|Opioid Clinical Policy (MME and days supply limits)|https://paxpress.txpa.hidinc.com/opc.pdf|09/01/2020| 64896070101|Opiate Overutilization|https://paxpress.txpa.hidinc.com/opiate.pdf|11/05/2013| 64896070101|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017| 64896070101|Opioid Clinical Policy (MME and days supply limits)|https://paxpress.txpa.hidinc.com/opc.pdf|09/01/2020| 64896070113|Opiate Overutilization|https://paxpress.txpa.hidinc.com/opiate.pdf|11/05/2013| 64896070113|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017| 64896070113|Opioid Clinical Policy (MME and days supply limits)|https://paxpress.txpa.hidinc.com/opc.pdf|09/01/2020| 64980019401|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|09/30/2023 64980019601|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|11/30/2023 64980020316|Antimigraine Agents Triptans|https://paxpress.txpa.hidinc.com/triptans.pdf|04/04/2023| 64980020413|Antimigraine Agents Triptans|https://paxpress.txpa.hidinc.com/triptans.pdf|04/04/2023| 64980020612|Leukotriene Modifiers|https://paxpress.txpa.hidinc.com/leukotriene.pdf|12/15/2015| 64980022101|ADD/ADHD Agents|https://paxpress.txpa.hidinc.com/add_adhd_agents.pdf|02/13/2014| 64980025616|Antimigraine Agents Triptans|https://paxpress.txpa.hidinc.com/triptans.pdf|04/04/2023| 64980025713|Antimigraine Agents Triptans|https://paxpress.txpa.hidinc.com/triptans.pdf|04/04/2023| 64980029001|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016| 64980029101|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016| 64980029201|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016| 64980029301|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016| 64980037303|ADD/ADHD Agents|https://paxpress.txpa.hidinc.com/add_adhd_agents.pdf|02/13/2014| 64980037403|ADD/ADHD Agents|https://paxpress.txpa.hidinc.com/add_adhd_agents.pdf|02/13/2014| 64980037503|ADD/ADHD Agents|https://paxpress.txpa.hidinc.com/add_adhd_agents.pdf|02/13/2014| 64980037603|ADD/ADHD Agents|https://paxpress.txpa.hidinc.com/add_adhd_agents.pdf|02/13/2014| 64980037703|ADD/ADHD Agents|https://paxpress.txpa.hidinc.com/add_adhd_agents.pdf|02/13/2014| 64980037803|ADD/ADHD Agents|https://paxpress.txpa.hidinc.com/add_adhd_agents.pdf|02/13/2014| 64980037903|ADD/ADHD Agents|https://paxpress.txpa.hidinc.com/add_adhd_agents.pdf|02/13/2014| 64980047201|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017| 64980050448|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 64980050924|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 64980052603|Nitazoxanide|https://paxpress.txpa.hidinc.com/alinia.pdf|01/31/2011| 64980052621|Nitazoxanide|https://paxpress.txpa.hidinc.com/alinia.pdf|01/31/2011| 64980052681|Nitazoxanide|https://paxpress.txpa.hidinc.com/alinia.pdf|01/31/2011|01/30/2024 65038028699|ADD/ADHD Agents|https://paxpress.txpa.hidinc.com/add_adhd_agents.pdf|10/01/2021| 65038042999|ADD/ADHD Agents|https://paxpress.txpa.hidinc.com/add_adhd_agents.pdf|10/01/2021| 65038056199|ADD/ADHD Agents|https://paxpress.txpa.hidinc.com/add_adhd_agents.pdf|10/01/2021| 65162003310|Opiate Overutilization|https://paxpress.txpa.hidinc.com/opiate.pdf|11/05/2013| 65162003310|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017| 65162003310|Opioid Clinical Policy (MME and days supply limits)|https://paxpress.txpa.hidinc.com/opc.pdf|09/01/2020| 65162003416|Lovaza|https://paxpress.txpa.hidinc.com/lovaza.pdf|07/16/2012| 65162004710|Opiate Overutilization|https://paxpress.txpa.hidinc.com/opiate.pdf|11/05/2013| 65162004710|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017| 65162004710|Opioid Clinical Policy (MME and days supply limits)|https://paxpress.txpa.hidinc.com/opc.pdf|09/01/2020| 65162004750|Opiate Overutilization|https://paxpress.txpa.hidinc.com/opiate.pdf|11/05/2013| 65162004750|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017| 65162004750|Opioid Clinical Policy (MME and days supply limits)|https://paxpress.txpa.hidinc.com/opc.pdf|09/01/2020| 65162004810|Opiate Overutilization|https://paxpress.txpa.hidinc.com/opiate.pdf|11/05/2013| 65162004810|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017| 65162004810|Opioid Clinical Policy (MME and days supply limits)|https://paxpress.txpa.hidinc.com/opc.pdf|09/01/2020| 65162004910|Opiate Overutilization|https://paxpress.txpa.hidinc.com/opiate.pdf|11/05/2013| 65162004910|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017| 65162004910|Opioid Clinical Policy (MME and days supply limits)|https://paxpress.txpa.hidinc.com/opc.pdf|09/01/2020| 65162004950|Opiate Overutilization|https://paxpress.txpa.hidinc.com/opiate.pdf|11/05/2013| 65162004950|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017| 65162004950|Opioid Clinical Policy (MME and days supply limits)|https://paxpress.txpa.hidinc.com/opc.pdf|09/01/2020| 65162005010|Opiate Overutilization|https://paxpress.txpa.hidinc.com/opiate.pdf|11/05/2013| 65162005010|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017| 65162005010|Opioid Clinical Policy (MME and days supply limits)|https://paxpress.txpa.hidinc.com/opc.pdf|09/01/2020| 65162005110|Opiate Overutilization|https://paxpress.txpa.hidinc.com/opiate.pdf|11/05/2013| 65162005110|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017| 65162005110|Opioid Clinical Policy (MME and days supply limits)|https://paxpress.txpa.hidinc.com/opc.pdf|09/01/2020| 65162005150|Opiate Overutilization|https://paxpress.txpa.hidinc.com/opiate.pdf|11/05/2013| 65162005150|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017| 65162005150|Opioid Clinical Policy (MME and days supply limits)|https://paxpress.txpa.hidinc.com/opc.pdf|09/01/2020| 65162005703|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/04/2016| 65162005710|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/04/2016| 65162005827|Phosphate Binders|https://paxpress.txpa.hidinc.com/phosphate_binders.pdf|01/31/2011| 65162008203|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016| 65162010110|Gabapentin Agents|https://paxpress.txpa.hidinc.com/neurontin.pdf|01/31/2011| 65162010111|Gabapentin Agents|https://paxpress.txpa.hidinc.com/neurontin.pdf|01/31/2011| 65162010150|Gabapentin Agents|https://paxpress.txpa.hidinc.com/neurontin.pdf|01/31/2011| 65162010210|Gabapentin Agents|https://paxpress.txpa.hidinc.com/neurontin.pdf|01/31/2011| 65162010211|Gabapentin Agents|https://paxpress.txpa.hidinc.com/neurontin.pdf|01/31/2011| 65162010250|Gabapentin Agents|https://paxpress.txpa.hidinc.com/neurontin.pdf|01/31/2011| 65162010310|Gabapentin Agents|https://paxpress.txpa.hidinc.com/neurontin.pdf|01/31/2011| 65162010350|Gabapentin Agents|https://paxpress.txpa.hidinc.com/neurontin.pdf|01/31/2011| 65162011510|Opiate Overutilization|https://paxpress.txpa.hidinc.com/opiate.pdf|11/05/2013| 65162011510|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017| 65162011510|Opioid Clinical Policy (MME and days supply limits)|https://paxpress.txpa.hidinc.com/opc.pdf|09/01/2020| 65162011511|Opiate Overutilization|https://paxpress.txpa.hidinc.com/opiate.pdf|11/05/2013| 65162011511|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017| 65162011511|Opioid Clinical Policy (MME and days supply limits)|https://paxpress.txpa.hidinc.com/opc.pdf|09/01/2020| 65162011550|Opiate Overutilization|https://paxpress.txpa.hidinc.com/opiate.pdf|11/05/2013| 65162011550|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017| 65162011550|Opioid Clinical Policy (MME and days supply limits)|https://paxpress.txpa.hidinc.com/opc.pdf|09/01/2020| 65162012608|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 65162014808|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 65162014908|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 65162015008|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 65162018810|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 65162018850|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 65162018910|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 65162018950|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 65162019010|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 65162019011|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 65162019050|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 65162020710|Opiate Overutilization|https://paxpress.txpa.hidinc.com/opiate.pdf|11/05/2013| 65162020710|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017| 65162020710|Opioid Clinical Policy (MME and days supply limits)|https://paxpress.txpa.hidinc.com/opc.pdf|09/01/2020| 65162020750|Opiate Overutilization|https://paxpress.txpa.hidinc.com/opiate.pdf|11/05/2013| 65162020750|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017| 65162020750|Opioid Clinical Policy (MME and days supply limits)|https://paxpress.txpa.hidinc.com/opc.pdf|09/01/2020| 65162022621|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 65162022623|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 65162022808|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 65162023109|ADD/ADHD Agents|https://paxpress.txpa.hidinc.com/add_adhd_agents.pdf|02/13/2014|03/14/2024 65162023309|ADD/ADHD Agents|https://paxpress.txpa.hidinc.com/add_adhd_agents.pdf|02/13/2014|03/14/2024 65162023509|ADD/ADHD Agents|https://paxpress.txpa.hidinc.com/add_adhd_agents.pdf|02/13/2014|03/14/2024 65162023709|ADD/ADHD Agents|https://paxpress.txpa.hidinc.com/add_adhd_agents.pdf|02/13/2014|12/31/2023 65162024803|GI Motility Agents|https://paxpress.txpa.hidinc.com/GImotility.pdf|01/18/2017| 65162024903|GI Motility Agents|https://paxpress.txpa.hidinc.com/GImotility.pdf|01/18/2017| 65162028003|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016| 65162028103|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016| 65162028203|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016| 65162028303|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016| 65162035109|PDE5-Inhibitors|https://paxpress.txpa.hidinc.com/revatio.pdf|01/31/2011| 65162041503|Buprenorphine Agents|https://paxpress.txpa.hidinc.com/buprenorphine_agents.pdf|04/23/2013| 65162041503|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017| 65162041603|Buprenorphine Agents|https://paxpress.txpa.hidinc.com/buprenorphine_agents.pdf|04/23/2013| 65162041603|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017| 65162043606|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 65162043806|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 65162044110|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 65162044111|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 65162044210|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 65162044211|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 65162046410|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 65162046450|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 65162046510|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 65162046550|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 65162046609|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 65162046610|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 65162046650|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 65162050603|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 65162050606|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 65162050609|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 65162052110|Promethazine Utilization|https://paxpress.txpa.hidinc.com/phenergan.pdf|01/31/2011| 65162052111|Promethazine Utilization|https://paxpress.txpa.hidinc.com/phenergan.pdf|01/31/2011| 65162052210|Promethazine Utilization|https://paxpress.txpa.hidinc.com/phenergan.pdf|01/31/2011| 65162055310|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017| 65162055610|Anxiolytics and Sedative-Hypnotics|https://paxpress.txpa.hidinc.com/ash.pdf|01/31/2011| 65162055610|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017| 65162055650|Anxiolytics and Sedative-Hypnotics|https://paxpress.txpa.hidinc.com/ash.pdf|01/31/2011| 65162055650|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017| 65162055710|Anxiolytics and Sedative-Hypnotics|https://paxpress.txpa.hidinc.com/ash.pdf|01/31/2011| 65162055710|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017| 65162055750|Anxiolytics and Sedative-Hypnotics|https://paxpress.txpa.hidinc.com/ash.pdf|01/31/2011| 65162055750|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017| 65162062710|Opiate Overutilization|https://paxpress.txpa.hidinc.com/opiate.pdf|11/05/2013| 65162062710|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017| 65162062710|Opioid Clinical Policy (MME and days supply limits)|https://paxpress.txpa.hidinc.com/opc.pdf|09/01/2020| 65162062711|Opiate Overutilization|https://paxpress.txpa.hidinc.com/opiate.pdf|11/05/2013| 65162062711|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017| 65162062711|Opioid Clinical Policy (MME and days supply limits)|https://paxpress.txpa.hidinc.com/opc.pdf|09/01/2020| 65162062750|Opiate Overutilization|https://paxpress.txpa.hidinc.com/opiate.pdf|11/05/2013| 65162062750|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017| 65162062750|Opioid Clinical Policy (MME and days supply limits)|https://paxpress.txpa.hidinc.com/opc.pdf|09/01/2020| 65162067384|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016| 65162067684|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 65162068086|Cough and Cold Agents|https://paxpress.txpa.hidinc.com/Cough%20&%20Cold.pdf|12/15/2015| 65162068086|Dextromethorphan Overutilization|https://paxpress.txpa.hidinc.com/dextro.pdf|07/16/2012| 65162068086|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 65162068086|Promethazine Utilization|https://paxpress.txpa.hidinc.com/phenergan.pdf|01/31/2011| 65162068090|Cough and Cold Agents|https://paxpress.txpa.hidinc.com/Cough%20&%20Cold.pdf|12/15/2015| 65162068090|Dextromethorphan Overutilization|https://paxpress.txpa.hidinc.com/dextro.pdf|07/16/2012| 65162068090|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 65162068090|Promethazine Utilization|https://paxpress.txpa.hidinc.com/phenergan.pdf|01/31/2011| 65162068312|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 65162068784|Anxiolytics and Sedative-Hypnotics|https://paxpress.txpa.hidinc.com/ash.pdf|01/31/2011| 65162068784|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017| 65162069890|Gabapentin Agents|https://paxpress.txpa.hidinc.com/neurontin.pdf|01/31/2011| 65162074510|Promethazine Utilization|https://paxpress.txpa.hidinc.com/phenergan.pdf|01/31/2011| 65162076110|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 65162076111|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 65162076210|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 65162076211|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 65162076310|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 65162076311|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 65162076410|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 65162076411|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 65162076510|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 65162076511|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 65162076610|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 65162076611|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 65162076710|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 65162076711|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 65162076810|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 65162076811|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 65162076910|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 65162076911|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 65162077810|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 65162083366|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|07/20/2024 65162084106|GI Motility Agents|https://paxpress.txpa.hidinc.com/GImotility.pdf|01/18/2017| 65162084206|GI Motility Agents|https://paxpress.txpa.hidinc.com/GImotility.pdf|01/18/2017| 65162087903|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016| 65162088003|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016| 65162088103|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016| 65162088203|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016| 65162089374|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016| 65162089603|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016| 65162089609|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016| 65162089703|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016| 65162089709|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016| 65162089803|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016| 65162089809|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016| 65162089903|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016| 65162089909|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016| 65162090103|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016| 65162090109|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016| 65162090203|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016| 65162090209|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016| 65162091174|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 65162091446|Inhaled Antibiotics Clinical|https://paxpress.txpa.hidinc.com/inhaledantibiotics.pdf|05/02/2023| 65162098908|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 65162099208|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 65162099308|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 65162099508|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 65162099708|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 65597010130|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|09/01/2023 65597010330|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|09/01/2023 65597010430|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|09/01/2023 65597010530|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|09/01/2023 65597010630|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|09/01/2023 65597010730|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|09/01/2023 65597011030|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|09/01/2023 65597011130|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|09/01/2023 65597011230|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|09/01/2023 65597011330|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|09/01/2023 65597011430|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|09/01/2023 65597011530|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|09/01/2023 65597011630|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|09/01/2023 65597011730|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|09/01/2023 65597011830|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|09/01/2023 65597020130|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 65597020230|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 65597020330|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 65649000330|GI Motility Agents|https://paxpress.txpa.hidinc.com/GImotility.pdf|02/06/2018| 65649015090|GI Motility Agents|https://paxpress.txpa.hidinc.com/GImotility.pdf|09/24/2013| 65649030103|Xifaxan|https://paxpress.txpa.hidinc.com/xifaxan.pdf|01/31/2011| 65649030302|Xifaxan|https://paxpress.txpa.hidinc.com/xifaxan.pdf|01/31/2011| 65649031112|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 65649055103|GI Motility Agents|https://paxpress.txpa.hidinc.com/GImotility.pdf|09/24/2013| 65649055204|GI Motility Agents|https://paxpress.txpa.hidinc.com/GImotility.pdf|09/24/2013| 65757040103|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016| 65757040203|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016| 65757040303|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016| 65757040403|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016| 65757050003|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016| 65862005090|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/04/2016| 65862005130|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/04/2016| 65862005190|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/04/2016| 65862005199|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/04/2016| 65862005230|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/04/2016| 65862005290|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/04/2016| 65862005299|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/04/2016| 65862005322|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/04/2016| 65862005330|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/04/2016| 65862005390|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/04/2016| 65862005399|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/04/2016| 65862005430|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/04/2016| 65862005490|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/04/2016| 65862005499|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/04/2016| 65862009701|COX-2 Inhibitors|https://paxpress.txpa.hidinc.com/cox2.pdf|01/31/2011| 65862009701|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/04/2016| 65862009705|COX-2 Inhibitors|https://paxpress.txpa.hidinc.com/cox2.pdf|01/31/2011| 65862009705|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/04/2016| 65862013399|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 65862013401|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 65862013499|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 65862014636|Antimigraine Agents Triptans|https://paxpress.txpa.hidinc.com/triptans.pdf|04/04/2023| 65862014736|Antimigraine Agents Triptans|https://paxpress.txpa.hidinc.com/triptans.pdf|04/04/2023| 65862014836|Antimigraine Agents Triptans|https://paxpress.txpa.hidinc.com/triptans.pdf|04/04/2023| 65862015801|Carisoprodol Overuse|https://paxpress.txpa.hidinc.com/soma.pdf|01/31/2011| 65862015801|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017| 65862015901|Anxiolytics and Sedative-Hypnotics|https://paxpress.txpa.hidinc.com/ash.pdf|01/31/2011| 65862016001|Anxiolytics and Sedative-Hypnotics|https://paxpress.txpa.hidinc.com/ash.pdf|01/31/2011| 65862016190|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 65862016290|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 65862016390|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 65862019105|Cyclobenzaprine|https://paxpress.txpa.hidinc.com/cyclobenzaprine.pdf|01/31/2011| 65862019105|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017| 65862019801|Gabapentin Agents|https://paxpress.txpa.hidinc.com/neurontin.pdf|01/31/2011| 65862019805|Gabapentin Agents|https://paxpress.txpa.hidinc.com/neurontin.pdf|01/31/2011| 65862019899|Gabapentin Agents|https://paxpress.txpa.hidinc.com/neurontin.pdf|01/31/2011| 65862019901|Gabapentin Agents|https://paxpress.txpa.hidinc.com/neurontin.pdf|01/31/2011| 65862019905|Gabapentin Agents|https://paxpress.txpa.hidinc.com/neurontin.pdf|01/31/2011| 65862019999|Gabapentin Agents|https://paxpress.txpa.hidinc.com/neurontin.pdf|01/31/2011| 65862020001|Gabapentin Agents|https://paxpress.txpa.hidinc.com/neurontin.pdf|01/31/2011| 65862020005|Gabapentin Agents|https://paxpress.txpa.hidinc.com/neurontin.pdf|01/31/2011| 65862020190|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 65862020199|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 65862020230|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 65862020290|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 65862020299|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 65862020330|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 65862020390|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 65862020399|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 65862021401|Anxiolytics and Sedative-Hypnotics|https://paxpress.txpa.hidinc.com/ash.pdf|01/31/2011| 65862021501|Anxiolytics and Sedative-Hypnotics|https://paxpress.txpa.hidinc.com/ash.pdf|01/31/2011| 65862029390|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/04/2016| 65862029490|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/04/2016| 65862029590|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/04/2016| 65862029630|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/04/2016| 65862029690|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/04/2016| 65862030801|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 65862030901|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 65862045460|Anxiolytics and Sedative-Hypnotics|https://paxpress.txpa.hidinc.com/ash.pdf|05/28/2015| 65862045460|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017| 65862045560|Anxiolytics and Sedative-Hypnotics|https://paxpress.txpa.hidinc.com/ash.pdf|05/28/2015| 65862045560|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017| 65862045660|Anxiolytics and Sedative-Hypnotics|https://paxpress.txpa.hidinc.com/ash.pdf|05/28/2015| 65862045660|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017| 65862045760|Anxiolytics and Sedative-Hypnotics|https://paxpress.txpa.hidinc.com/ash.pdf|05/28/2015| 65862045760|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017| 65862046830|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 65862046890|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 65862046899|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 65862046930|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 65862046990|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 65862046999|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 65862047030|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 65862047090|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 65862047099|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 65862048901|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016| 65862049001|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016| 65862049101|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016| 65862049301|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016| 65862049460|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016| 65862049501|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016| 65862051205|Thiazolidinediones|https://paxpress.txpa.hidinc.com/thiazolidinediones.pdf|01/31/2011| 65862051230|Thiazolidinediones|https://paxpress.txpa.hidinc.com/thiazolidinediones.pdf|01/31/2011| 65862051290|Thiazolidinediones|https://paxpress.txpa.hidinc.com/thiazolidinediones.pdf|01/31/2011| 65862051305|Thiazolidinediones|https://paxpress.txpa.hidinc.com/thiazolidinediones.pdf|01/31/2011| 65862051330|Thiazolidinediones|https://paxpress.txpa.hidinc.com/thiazolidinediones.pdf|01/31/2011| 65862051405|Thiazolidinediones|https://paxpress.txpa.hidinc.com/thiazolidinediones.pdf|01/31/2011| 65862051430|Thiazolidinediones|https://paxpress.txpa.hidinc.com/thiazolidinediones.pdf|01/31/2011| 65862051501|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 65862051601|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 65862052201|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 65862052205|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 65862052301|Gabapentin Agents|https://paxpress.txpa.hidinc.com/neurontin.pdf|01/31/2011| 65862052305|Gabapentin Agents|https://paxpress.txpa.hidinc.com/neurontin.pdf|01/31/2011| 65862052401|Gabapentin Agents|https://paxpress.txpa.hidinc.com/neurontin.pdf|01/31/2011| 65862052405|Gabapentin Agents|https://paxpress.txpa.hidinc.com/neurontin.pdf|01/31/2011| 65862052518|Thiazolidinediones|https://paxpress.txpa.hidinc.com/thiazolidinediones.pdf|01/31/2011| 65862052560|Thiazolidinediones|https://paxpress.txpa.hidinc.com/thiazolidinediones.pdf|01/31/2011| 65862052618|Thiazolidinediones|https://paxpress.txpa.hidinc.com/thiazolidinediones.pdf|01/31/2011| 65862052660|Thiazolidinediones|https://paxpress.txpa.hidinc.com/thiazolidinediones.pdf|01/31/2011| 65862054799|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 65862054890|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 65862054899|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 65862054990|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 65862054999|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 65862055005|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 65862055090|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 65862055105|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 65862055190|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 65862056130|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016| 65862056199|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016| 65862056230|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016| 65862056299|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016| 65862056330|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016| 65862056399|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016| 65862056430|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016| 65862056499|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016| 65862056530|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016| 65862056599|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016| 65862056630|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016| 65862056699|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016| 65862056790|Leukotriene Modifiers|https://paxpress.txpa.hidinc.com/leukotriene.pdf|12/15/2015| 65862056890|Leukotriene Modifiers|https://paxpress.txpa.hidinc.com/leukotriene.pdf|12/15/2015| 65862057030|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 65862057190|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 65862057290|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 65862057390|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 65862057490|Leukotriene Modifiers|https://paxpress.txpa.hidinc.com/leukotriene.pdf|12/15/2015| 65862059912|Antimigraine Agents Triptans|https://paxpress.txpa.hidinc.com/triptans.pdf|04/04/2023| 65862060012|Antimigraine Agents Triptans|https://paxpress.txpa.hidinc.com/triptans.pdf|04/04/2023| 65862060101|CNS Stimulants|https://paxpress.txpa.hidinc.com/provigil.pdf|11/06/2012| 65862060130|CNS Stimulants|https://paxpress.txpa.hidinc.com/provigil.pdf|11/06/2012| 65862060201|CNS Stimulants|https://paxpress.txpa.hidinc.com/provigil.pdf|11/06/2012| 65862060230|CNS Stimulants|https://paxpress.txpa.hidinc.com/provigil.pdf|11/06/2012| 65862062512|Antimigraine Agents Triptans|https://paxpress.txpa.hidinc.com/triptans.pdf|04/04/2023| 65862062590|Antimigraine Agents Triptans|https://paxpress.txpa.hidinc.com/triptans.pdf|04/04/2023| 65862062612|Antimigraine Agents Triptans|https://paxpress.txpa.hidinc.com/triptans.pdf|04/04/2023| 65862062690|Antimigraine Agents Triptans|https://paxpress.txpa.hidinc.com/triptans.pdf|04/04/2023| 65862065603|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016| 65862065703|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016| 65862065803|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016| 65862065903|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016| 65862066105|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016| 65862066130|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016| 65862066205|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016| 65862066230|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016| 65862066305|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016| 65862066330|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016| 65862066405|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016| 65862066430|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016| 65862066505|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016| 65862066530|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016| 65862066605|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016| 65862066630|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016| 65862067001|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 65862067101|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 65862067201|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 65862067601|Anxiolytics and Sedative-Hypnotics|https://paxpress.txpa.hidinc.com/ash.pdf|05/28/2015| 65862067601|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017| 65862067605|Anxiolytics and Sedative-Hypnotics|https://paxpress.txpa.hidinc.com/ash.pdf|05/28/2015| 65862067605|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017| 65862067699|Anxiolytics and Sedative-Hypnotics|https://paxpress.txpa.hidinc.com/ash.pdf|05/28/2015| 65862067699|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017| 65862067701|Anxiolytics and Sedative-Hypnotics|https://paxpress.txpa.hidinc.com/ash.pdf|05/28/2015| 65862067701|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017| 65862067705|Anxiolytics and Sedative-Hypnotics|https://paxpress.txpa.hidinc.com/ash.pdf|05/28/2015| 65862067705|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017| 65862067799|Anxiolytics and Sedative-Hypnotics|https://paxpress.txpa.hidinc.com/ash.pdf|05/28/2015| 65862067799|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017| 65862067801|Anxiolytics and Sedative-Hypnotics|https://paxpress.txpa.hidinc.com/ash.pdf|05/28/2015| 65862067801|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017| 65862067805|Anxiolytics and Sedative-Hypnotics|https://paxpress.txpa.hidinc.com/ash.pdf|05/28/2015| 65862067805|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017| 65862067899|Anxiolytics and Sedative-Hypnotics|https://paxpress.txpa.hidinc.com/ash.pdf|05/28/2015| 65862067899|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017| 65862067901|Anxiolytics and Sedative-Hypnotics|https://paxpress.txpa.hidinc.com/ash.pdf|05/28/2015| 65862067901|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017| 65862067905|Anxiolytics and Sedative-Hypnotics|https://paxpress.txpa.hidinc.com/ash.pdf|05/28/2015| 65862067905|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017| 65862068890|PDE5-Inhibitors|https://paxpress.txpa.hidinc.com/revatio.pdf|01/31/2011| 65862070260|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016| 65862070360|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016| 65862070460|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016| 65862070560|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016| 65862070901|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/04/2016| 65862070930|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/04/2016| 65862073730|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 65862073830|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 65862073930|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 65862074030|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 65862074130|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 65862074230|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 65862074290|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 65862074330|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 65862074390|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 65862077930|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 65862077990|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 65862078030|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 65862078090|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 65862078130|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 65862078190|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 65862080530|CNS Stimulants|https://paxpress.txpa.hidinc.com/provigil.pdf|02/06/2018| 65862080630|CNS Stimulants|https://paxpress.txpa.hidinc.com/provigil.pdf|02/06/2018| 65862080730|CNS Stimulants|https://paxpress.txpa.hidinc.com/provigil.pdf|02/06/2018| 65862083430|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 65862083530|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 65862083630|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 65862083730|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 65862083830|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 65862084401|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016| 65862084501|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016| 65862084601|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016| 65862084605|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016| 65862084701|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016| 65862085430|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 65862085530|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 65862085630|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 65862085730|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 65862086703|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 65862086730|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 65862086803|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 65862086830|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 65862086903|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 65862086930|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 65862087360|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016| 65862087460|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016| 65862087560|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016| 65862087660|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016| 65862087760|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016| 65862088060|PDE5-Inhibitors|https://paxpress.txpa.hidinc.com/revatio.pdf|01/31/2011| 65862090760|COX-2 Inhibitors|https://paxpress.txpa.hidinc.com/cox2.pdf|01/31/2011| 65862090760|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/04/2016| 65862090801|COX-2 Inhibitors|https://paxpress.txpa.hidinc.com/cox2.pdf|01/31/2011| 65862090801|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/04/2016| 65862090805|COX-2 Inhibitors|https://paxpress.txpa.hidinc.com/cox2.pdf|01/31/2011| 65862090805|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/04/2016| 65862090901|COX-2 Inhibitors|https://paxpress.txpa.hidinc.com/cox2.pdf|01/31/2011| 65862090901|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/04/2016| 65862090905|COX-2 Inhibitors|https://paxpress.txpa.hidinc.com/cox2.pdf|01/31/2011| 65862090905|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/04/2016| 65862091060|COX-2 Inhibitors|https://paxpress.txpa.hidinc.com/cox2.pdf|01/31/2011| 65862091060|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/04/2016| 65862091469|Antimigraine Agents Triptans|https://paxpress.txpa.hidinc.com/triptans.pdf|04/04/2023| 65862091564|Antimigraine Agents Triptans|https://paxpress.txpa.hidinc.com/triptans.pdf|04/04/2023| 65862092127|Phosphate Binders|https://paxpress.txpa.hidinc.com/phosphate_binders.pdf|01/31/2011| 65862092201|Opiate Overutilization|https://paxpress.txpa.hidinc.com/opiate.pdf|11/05/2013| 65862092201|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017| 65862092201|Opioid Clinical Policy (MME and days supply limits)|https://paxpress.txpa.hidinc.com/opc.pdf|09/01/2020| 65862092205|Opiate Overutilization|https://paxpress.txpa.hidinc.com/opiate.pdf|11/05/2013| 65862092205|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017| 65862092205|Opioid Clinical Policy (MME and days supply limits)|https://paxpress.txpa.hidinc.com/opc.pdf|09/01/2020| 65862092836|Antimigraine Agents Triptans|https://paxpress.txpa.hidinc.com/triptans.pdf|04/04/2023| 65862092836|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 65862093090|Phosphate Binders|https://paxpress.txpa.hidinc.com/phosphate_binders.pdf|01/31/2011| 65862093190|Phosphate Binders|https://paxpress.txpa.hidinc.com/phosphate_binders.pdf|01/31/2011| 65862094324|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 65862094424|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 65862094524|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 65862096701|Anxiolytics and Sedative-Hypnotics|https://paxpress.txpa.hidinc.com/ash.pdf|01/31/2011| 65862096730|Anxiolytics and Sedative-Hypnotics|https://paxpress.txpa.hidinc.com/ash.pdf|01/31/2011| 65862096801|Anxiolytics and Sedative-Hypnotics|https://paxpress.txpa.hidinc.com/ash.pdf|01/31/2011| 65862096901|Anxiolytics and Sedative-Hypnotics|https://paxpress.txpa.hidinc.com/ash.pdf|01/31/2011| 65862097603|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 65862097703|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 65862097803|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 65862099830|CNS Stimulants|https://paxpress.txpa.hidinc.com/provigil.pdf|02/06/2018| 66215010106|Pulmonary Hypertension Agents Clinical|https://paxpress.txpa.hidinc.com/pah.pdf|07/27/2023| 66215010206|Pulmonary Hypertension Agents Clinical|https://paxpress.txpa.hidinc.com/pah.pdf|07/27/2023| 66215010314|Pulmonary Hypertension Agents Clinical|https://paxpress.txpa.hidinc.com/pah.pdf|07/27/2023| 66215010356|Pulmonary Hypertension Agents Clinical|https://paxpress.txpa.hidinc.com/pah.pdf|07/27/2023| 66215023256|Pulmonary Hypertension Agents Clinical|https://paxpress.txpa.hidinc.com/pah.pdf|07/27/2023| 66215030200|Pulmonary Hypertension Agents Clinical|https://paxpress.txpa.hidinc.com/pah.pdf|07/27/2023| 66215030230|Pulmonary Hypertension Agents Clinical|https://paxpress.txpa.hidinc.com/pah.pdf|07/27/2023| 66215030300|Pulmonary Hypertension Agents Clinical|https://paxpress.txpa.hidinc.com/pah.pdf|07/27/2023| 66215030330|Pulmonary Hypertension Agents Clinical|https://paxpress.txpa.hidinc.com/pah.pdf|07/27/2023| 66215040201|Pulmonary Hypertension Agents Clinical|https://paxpress.txpa.hidinc.com/pah.pdf|07/27/2023| 66215040301|Pulmonary Hypertension Agents Clinical|https://paxpress.txpa.hidinc.com/pah.pdf|07/27/2023| 66215050130|Pulmonary Hypertension Agents Clinical|https://paxpress.txpa.hidinc.com/pah.pdf|07/27/2023| 66215060206|Pulmonary Hypertension Agents Clinical|https://paxpress.txpa.hidinc.com/pah.pdf|07/27/2023| 66215060214|Pulmonary Hypertension Agents Clinical|https://paxpress.txpa.hidinc.com/pah.pdf|07/27/2023| 66215060406|Pulmonary Hypertension Agents Clinical|https://paxpress.txpa.hidinc.com/pah.pdf|07/27/2023| 66215060606|Pulmonary Hypertension Agents Clinical|https://paxpress.txpa.hidinc.com/pah.pdf|07/27/2023| 66215060806|Pulmonary Hypertension Agents Clinical|https://paxpress.txpa.hidinc.com/pah.pdf|07/27/2023| 66215061006|Pulmonary Hypertension Agents Clinical|https://paxpress.txpa.hidinc.com/pah.pdf|07/27/2023| 66215061206|Pulmonary Hypertension Agents Clinical|https://paxpress.txpa.hidinc.com/pah.pdf|07/27/2023| 66215061406|Pulmonary Hypertension Agents Clinical|https://paxpress.txpa.hidinc.com/pah.pdf|07/27/2023| 66215061606|Pulmonary Hypertension Agents Clinical|https://paxpress.txpa.hidinc.com/pah.pdf|07/27/2023| 66215062820|Pulmonary Hypertension Agents Clinical|https://paxpress.txpa.hidinc.com/pah.pdf|07/27/2023| 66302010101|Pulmonary Hypertension Agents Clinical|https://paxpress.txpa.hidinc.com/pah.pdf|07/27/2023| 66302010201|Pulmonary Hypertension Agents Clinical|https://paxpress.txpa.hidinc.com/pah.pdf|07/27/2023| 66302010501|Pulmonary Hypertension Agents Clinical|https://paxpress.txpa.hidinc.com/pah.pdf|07/27/2023| 66302011001|Pulmonary Hypertension Agents Clinical|https://paxpress.txpa.hidinc.com/pah.pdf|07/27/2023| 66302020601|Pulmonary Hypertension Agents Clinical|https://paxpress.txpa.hidinc.com/pah.pdf|07/27/2023| 66302020602|Pulmonary Hypertension Agents Clinical|https://paxpress.txpa.hidinc.com/pah.pdf|07/27/2023| 66302020603|Pulmonary Hypertension Agents Clinical|https://paxpress.txpa.hidinc.com/pah.pdf|07/27/2023| 66302030001|Pulmonary Hypertension Agents Clinical|https://paxpress.txpa.hidinc.com/pah.pdf|07/27/2023| 66302030201|Pulmonary Hypertension Agents Clinical|https://paxpress.txpa.hidinc.com/pah.pdf|07/27/2023| 66302031001|Pulmonary Hypertension Agents Clinical|https://paxpress.txpa.hidinc.com/pah.pdf|07/27/2023| 66302032501|Pulmonary Hypertension Agents Clinical|https://paxpress.txpa.hidinc.com/pah.pdf|07/27/2023| 66302035001|Pulmonary Hypertension Agents Clinical|https://paxpress.txpa.hidinc.com/pah.pdf|07/27/2023| 66302046760|PDE5-Inhibitors|https://paxpress.txpa.hidinc.com/revatio.pdf|01/31/2011| 66490065020|Anxiolytics and Sedative-Hypnotics|https://paxpress.txpa.hidinc.com/ash.pdf|01/31/2011| 66658010260|Enzymes|https://paxpress.txpa.hidinc.com/enzymes.pdf|11/20/2019| 66658010560|Enzymes|https://paxpress.txpa.hidinc.com/enzymes.pdf|11/20/2019| 66658011060|Enzymes|https://paxpress.txpa.hidinc.com/enzymes.pdf|11/20/2019| 66658012060|Enzymes|https://paxpress.txpa.hidinc.com/enzymes.pdf|11/20/2019| 66658020490|Enzymes|https://paxpress.txpa.hidinc.com/enzymes.pdf|11/20/2019| 66658023001|Synagis|https://paxpress.txpa.hidinc.com/synagis.pdf|01/31/2011| 66658023101|Synagis|https://paxpress.txpa.hidinc.com/synagis.pdf|01/31/2011| 66658023407|Cytokine and CAM Antagonists|https://paxpress.txpa.hidinc.com/cytokine.pdf|03/27/2018| 66689002304|Opiate Overutilization|https://paxpress.txpa.hidinc.com/opiate.pdf|11/05/2013| 66689002304|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017| 66689002304|Opioid Clinical Policy (MME and days supply limits)|https://paxpress.txpa.hidinc.com/opc.pdf|09/01/2020| 66689002316|Opiate Overutilization|https://paxpress.txpa.hidinc.com/opiate.pdf|11/05/2013| 66689002316|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017| 66689002316|Opioid Clinical Policy (MME and days supply limits)|https://paxpress.txpa.hidinc.com/opc.pdf|09/01/2020| 66689002530|Opiate Overutilization|https://paxpress.txpa.hidinc.com/opiate.pdf|11/05/2013|02/13/2024 66689002530|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017|02/13/2024 66689040316|Opiate Overutilization|https://paxpress.txpa.hidinc.com/opiate.pdf|11/05/2013|10/01/2024 66689040316|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017|10/01/2024 66689040316|Opioid Clinical Policy (MME and days supply limits)|https://paxpress.txpa.hidinc.com/opc.pdf|09/01/2020|10/01/2024 66689073505|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016| 66758095985|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|09/30/2024 66869010490|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/04/2016| 66869020490|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/04/2016| 66869040490|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/04/2016| 66993000210|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 66993001968|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 66993007896|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 66993007996|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 66993008096|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 66993008169|Antimigraine Agents Triptans|https://paxpress.txpa.hidinc.com/triptans.pdf|04/04/2023| 66993008269|Antimigraine Agents Triptans|https://paxpress.txpa.hidinc.com/triptans.pdf|04/04/2023| 66993008379|Antimigraine Agents Triptans|https://paxpress.txpa.hidinc.com/triptans.pdf|04/04/2023| 66993008398|Antimigraine Agents Triptans|https://paxpress.txpa.hidinc.com/triptans.pdf|04/04/2023| 66993008479|Antimigraine Agents Triptans|https://paxpress.txpa.hidinc.com/triptans.pdf|04/04/2023| 66993008498|Antimigraine Agents Triptans|https://paxpress.txpa.hidinc.com/triptans.pdf|04/04/2023| 66993008696|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 66993008796|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 66993008896|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 66993013597|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 66993013697|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 66993014130|Aliskiren Containing Agents|https://paxpress.txpa.hidinc.com/aliskiren.pdf|07/16/2012| 66993014230|Aliskiren Containing Agents|https://paxpress.txpa.hidinc.com/aliskiren.pdf|07/16/2012| 66993018802|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 66993019395|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 66993019395|Ketorolac|https://paxpress.txpa.hidinc.com/ketorolac.pdf|02/06/2018| 66993019594|Inhaled Antibiotics Clinical|https://paxpress.txpa.hidinc.com/inhaledantibiotics.pdf|05/02/2023| 66993026330|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 66993026430|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 66993026530|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 66993026630|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 66993026730|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 66993026830|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 66993026930|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 66993027030|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 66993027130|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 66993027230|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 66993027330|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 66993035957|ADD/ADHD Agents|https://paxpress.txpa.hidinc.com/add_adhd_agents.pdf|02/13/2014| 66993042285|Phosphate Binders|https://paxpress.txpa.hidinc.com/phosphate_binders.pdf|01/31/2011| 66993042385|Phosphate Binders|https://paxpress.txpa.hidinc.com/phosphate_binders.pdf|01/31/2011| 66993042485|Phosphate Binders|https://paxpress.txpa.hidinc.com/phosphate_binders.pdf|01/31/2011| 66993048532|Leukotriene Modifiers|https://paxpress.txpa.hidinc.com/leukotriene.pdf|12/15/2015|08/23/2023 66993058497|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 66993058597|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 66993058697|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 66993059402|ADD/ADHD Agents|https://paxpress.txpa.hidinc.com/add_adhd_agents.pdf|02/13/2014| 66993059502|ADD/ADHD Agents|https://paxpress.txpa.hidinc.com/add_adhd_agents.pdf|02/13/2014| 66993059602|ADD/ADHD Agents|https://paxpress.txpa.hidinc.com/add_adhd_agents.pdf|02/13/2014| 66993059702|ADD/ADHD Agents|https://paxpress.txpa.hidinc.com/add_adhd_agents.pdf|02/13/2014| 66993059802|ADD/ADHD Agents|https://paxpress.txpa.hidinc.com/add_adhd_agents.pdf|02/13/2014| 66993059902|ADD/ADHD Agents|https://paxpress.txpa.hidinc.com/add_adhd_agents.pdf|02/13/2014| 66993068030|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016|08/23/2023 66993068130|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016|08/23/2023 66993068230|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016|08/23/2023 66993068330|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016| 66993068430|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016| 66993068530|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016|08/23/2023 66993073002|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 66993082130|Thiazolidinediones|https://paxpress.txpa.hidinc.com/thiazolidinediones.pdf|01/31/2011| 66993082230|Thiazolidinediones|https://paxpress.txpa.hidinc.com/thiazolidinediones.pdf|01/31/2011| 66993084435|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 66993084535|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 66993084635|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 67253065110|Propylthiouracil|https://paxpress.txpa.hidinc.com/ptu.pdf|04/18/2011| 67386042101|VMAT2 Inhibitors|https://paxpress.txpa.hidinc.com/vmat2_inhibitor.pdf|09/25/2018| 67386042201|VMAT2 Inhibitors|https://paxpress.txpa.hidinc.com/vmat2_inhibitor.pdf|09/25/2018| 67457012410|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 67457042612|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016| 67457058210|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 67457058304|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 67457058406|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 67457058508|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 67457059406|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 67877011601|Opiate Overutilization|https://paxpress.txpa.hidinc.com/opiate.pdf|11/05/2013| 67877011601|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017| 67877011601|Opioid Clinical Policy (MME and days supply limits)|https://paxpress.txpa.hidinc.com/opc.pdf|09/01/2020| 67877014601|Anxiolytics and Sedative-Hypnotics|https://paxpress.txpa.hidinc.com/ash.pdf|01/31/2011| 67877014601|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017| 67877014605|Anxiolytics and Sedative-Hypnotics|https://paxpress.txpa.hidinc.com/ash.pdf|01/31/2011| 67877014605|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017| 67877014701|Anxiolytics and Sedative-Hypnotics|https://paxpress.txpa.hidinc.com/ash.pdf|01/31/2011| 67877014701|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017| 67877014705|Anxiolytics and Sedative-Hypnotics|https://paxpress.txpa.hidinc.com/ash.pdf|01/31/2011| 67877014705|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017| 67877014801|Anxiolytics and Sedative-Hypnotics|https://paxpress.txpa.hidinc.com/ash.pdf|01/31/2011| 67877014801|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017| 67877014930|Anxiolytics and Sedative-Hypnotics|https://paxpress.txpa.hidinc.com/ash.pdf|01/31/2011| 67877014930|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017| 67877022201|Gabapentin Agents|https://paxpress.txpa.hidinc.com/neurontin.pdf|01/31/2011| 67877022205|Gabapentin Agents|https://paxpress.txpa.hidinc.com/neurontin.pdf|01/31/2011| 67877022210|Gabapentin Agents|https://paxpress.txpa.hidinc.com/neurontin.pdf|01/31/2011| 67877022301|Gabapentin Agents|https://paxpress.txpa.hidinc.com/neurontin.pdf|01/31/2011| 67877022305|Gabapentin Agents|https://paxpress.txpa.hidinc.com/neurontin.pdf|01/31/2011| 67877022310|Gabapentin Agents|https://paxpress.txpa.hidinc.com/neurontin.pdf|01/31/2011| 67877022401|Gabapentin Agents|https://paxpress.txpa.hidinc.com/neurontin.pdf|01/31/2011| 67877022405|Gabapentin Agents|https://paxpress.txpa.hidinc.com/neurontin.pdf|01/31/2011| 67877022410|Gabapentin Agents|https://paxpress.txpa.hidinc.com/neurontin.pdf|01/31/2011| 67877024201|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016| 67877024210|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016| 67877024601|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016| 67877024610|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016| 67877024710|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016| 67877024760|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016| 67877024801|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016| 67877024810|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016| 67877024901|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016| 67877024910|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016| 67877025001|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016| 67877025010|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016| 67877026118|Antimigraine Agents Triptans|https://paxpress.txpa.hidinc.com/triptans.pdf|04/04/2023| 67877026218|Antimigraine Agents Triptans|https://paxpress.txpa.hidinc.com/triptans.pdf|04/04/2023| 67877031901|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 67877031905|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 67877032001|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 67877032005|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 67877032030|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 67877032050|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 67877032101|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 67877032105|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 67877032130|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 67877032150|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 67877041530|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 67877041690|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 67877041790|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 67877041890|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 67877042801|Gabapentin Agents|https://paxpress.txpa.hidinc.com/neurontin.pdf|01/31/2011| 67877042805|Gabapentin Agents|https://paxpress.txpa.hidinc.com/neurontin.pdf|01/31/2011| 67877042901|Gabapentin Agents|https://paxpress.txpa.hidinc.com/neurontin.pdf|01/31/2011| 67877042905|Gabapentin Agents|https://paxpress.txpa.hidinc.com/neurontin.pdf|01/31/2011| 67877043003|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016| 67877043005|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016| 67877043103|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016| 67877043105|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016| 67877043203|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016| 67877043205|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016| 67877043303|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016| 67877043305|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016| 67877043403|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016| 67877043405|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016| 67877043503|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016| 67877043505|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016| 67877043990|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/04/2016| 67877044005|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/04/2016| 67877044090|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/04/2016| 67877044105|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/04/2016| 67877044190|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/04/2016| 67877044230|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/04/2016| 67877044290|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/04/2016| 67877044530|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 67877044630|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 67877044690|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 67877044730|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 67877044790|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 67877047460|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 67877047560|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 67877047750|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 67877048230|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 67877048284|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 67877048330|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 67877048384|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 67877048430|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 67877048484|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 67877049930|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 67877050030|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 67877050130|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 67877050230|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 67877050730|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 67877050790|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 67877050830|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 67877050890|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 67877050930|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 67877050990|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 67877051030|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 67877051090|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 67877051105|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/04/2016| 67877051110|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/04/2016| 67877051190|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/04/2016| 67877051210|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/04/2016| 67877051290|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/04/2016| 67877051310|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/04/2016| 67877051390|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/04/2016| 67877051405|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/04/2016| 67877051490|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/04/2016| 67877052560|Ranexa|https://paxpress.txpa.hidinc.com/ranexa.pdf|05/25/2012| 67877052660|Ranexa|https://paxpress.txpa.hidinc.com/ranexa.pdf|05/25/2012| 67877057301|Cough and Cold Agents|https://paxpress.txpa.hidinc.com/Cough%20&%20Cold.pdf|12/15/2015| 67877057305|Cough and Cold Agents|https://paxpress.txpa.hidinc.com/Cough%20&%20Cold.pdf|12/15/2015| 67877057401|Cough and Cold Agents|https://paxpress.txpa.hidinc.com/Cough%20&%20Cold.pdf|12/15/2015| 67877057501|Cough and Cold Agents|https://paxpress.txpa.hidinc.com/Cough%20&%20Cold.pdf|12/15/2015| 67877057505|Cough and Cold Agents|https://paxpress.txpa.hidinc.com/Cough%20&%20Cold.pdf|12/15/2015| 67877061601|ADD/ADHD Agents|https://paxpress.txpa.hidinc.com/add_adhd_agents.pdf|02/13/2014| 67877061701|ADD/ADHD Agents|https://paxpress.txpa.hidinc.com/add_adhd_agents.pdf|02/13/2014| 67877061801|ADD/ADHD Agents|https://paxpress.txpa.hidinc.com/add_adhd_agents.pdf|02/13/2014| 67877062690|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 67877063830|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016| 67877063930|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016| 67877064030|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016| 67877064130|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016| 67877064230|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016| 67877065501|ADD/ADHD Agents|https://paxpress.txpa.hidinc.com/add_adhd_agents.pdf|02/13/2014| 67877065601|ADD/ADHD Agents|https://paxpress.txpa.hidinc.com/add_adhd_agents.pdf|02/13/2014| 67877065701|ADD/ADHD Agents|https://paxpress.txpa.hidinc.com/add_adhd_agents.pdf|02/13/2014| 67877065901|Opiate Overutilization|https://paxpress.txpa.hidinc.com/opiate.pdf|11/05/2013| 67877065901|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017| 67877065901|Opioid Clinical Policy (MME and days supply limits)|https://paxpress.txpa.hidinc.com/opc.pdf|09/01/2020| 67877067001|Opiate Overutilization|https://paxpress.txpa.hidinc.com/opiate.pdf|11/05/2013| 67877067001|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017| 67877067001|Opioid Clinical Policy (MME and days supply limits)|https://paxpress.txpa.hidinc.com/opc.pdf|09/01/2020| 67877067101|Opiate Overutilization|https://paxpress.txpa.hidinc.com/opiate.pdf|11/05/2013| 67877067101|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017| 67877067101|Opioid Clinical Policy (MME and days supply limits)|https://paxpress.txpa.hidinc.com/opc.pdf|09/01/2020| 67877067870|Inhaled Antibiotics Clinical|https://paxpress.txpa.hidinc.com/inhaledantibiotics.pdf|05/02/2023| 67877073101|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017| 68001000501|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 68001016100|Promethazine Utilization|https://paxpress.txpa.hidinc.com/phenergan.pdf|01/31/2011| 68001016200|Promethazine Utilization|https://paxpress.txpa.hidinc.com/phenergan.pdf|01/31/2011| 68001016208|Promethazine Utilization|https://paxpress.txpa.hidinc.com/phenergan.pdf|01/31/2011| 68001016300|Promethazine Utilization|https://paxpress.txpa.hidinc.com/phenergan.pdf|01/31/2011| 68001018000|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016| 68001018008|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016| 68001018100|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016| 68001018103|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016| 68001018200|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016| 68001018203|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016| 68001018300|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016| 68001018303|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016| 68001018306|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016| 68001018400|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016| 68001018408|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016| 68001018500|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016| 68001018508|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016| 68001023106|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 68001023206|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 68001024901|Antimigraine Agents Triptans|https://paxpress.txpa.hidinc.com/triptans.pdf|04/04/2023| 68001025001|Antimigraine Agents Triptans|https://paxpress.txpa.hidinc.com/triptans.pdf|04/04/2023| 68001027900|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 68001028000|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 68001028006|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 68001028008|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 68001028100|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 68001028103|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 68001028106|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 68001028108|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 68001031400|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/04/2016| 68001031500|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/04/2016| 68001031508|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/04/2016| 68001031600|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/04/2016| 68001031608|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/04/2016| 68001032500|Desmopressin|https://paxpress.txpa.hidinc.com/desmopressin.pdf|05/25/2012|08/23/2023 68001032600|Desmopressin|https://paxpress.txpa.hidinc.com/desmopressin.pdf|05/25/2012|08/23/2023 68001036103|Leukotriene Modifiers|https://paxpress.txpa.hidinc.com/leukotriene.pdf|12/15/2015| 68001036105|Leukotriene Modifiers|https://paxpress.txpa.hidinc.com/leukotriene.pdf|12/15/2015| 68001036305|PDE5-Inhibitors|https://paxpress.txpa.hidinc.com/revatio.pdf|01/31/2011| 68001041100|Gabapentin Agents|https://paxpress.txpa.hidinc.com/neurontin.pdf|01/31/2011| 68001041103|Gabapentin Agents|https://paxpress.txpa.hidinc.com/neurontin.pdf|01/31/2011| 68001041200|Gabapentin Agents|https://paxpress.txpa.hidinc.com/neurontin.pdf|01/31/2011| 68001041203|Gabapentin Agents|https://paxpress.txpa.hidinc.com/neurontin.pdf|01/31/2011| 68001043594|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|05/30/2024 68001043604|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 68001043697|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 68001043800|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 68001043804|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 68001043896|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 68001043897|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 68001043900|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 68001044000|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 68001044004|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 68001044998|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 68001045006|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016| 68001045106|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016| 68001045206|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016| 68001045306|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016| 68001045742|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 68001045842|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 68001045942|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 68001046042|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 68001046142|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 68001046242|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 68001046342|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 68001046441|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 68001048500|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017| 68001051106|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016| 68001051206|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016|07/06/2024 68001051306|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016| 68001051406|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016|07/06/2024 68001051506|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016| 68001052192|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 68001052800|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 68001052900|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 68001052908|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 68001055855|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 68001055969|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 68001056055|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 68025004610|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017| 68025004710|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017| 68025006530|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 68025006630|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 68025006730|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 68047012016|Cough and Cold Agents|https://paxpress.txpa.hidinc.com/Cough%20&%20Cold.pdf|12/15/2015| 68047012016|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 68047012916|Cough and Cold Agents|https://paxpress.txpa.hidinc.com/Cough%20&%20Cold.pdf|12/15/2015| 68047012916|Dextromethorphan Overutilization|https://paxpress.txpa.hidinc.com/dextro.pdf|07/16/2012| 68047012916|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 68047014316|Cough and Cold Agents|https://paxpress.txpa.hidinc.com/Cough%20&%20Cold.pdf|12/15/2015| 68047014316|Dextromethorphan Overutilization|https://paxpress.txpa.hidinc.com/dextro.pdf|07/16/2012| 68047014316|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 68047018516|Cough and Cold Agents|https://paxpress.txpa.hidinc.com/Cough%20&%20Cold.pdf|12/15/2015| 68047018516|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 68047018616|Cough and Cold Agents|https://paxpress.txpa.hidinc.com/Cough%20&%20Cold.pdf|12/15/2015| 68047018616|Dextromethorphan Overutilization|https://paxpress.txpa.hidinc.com/dextro.pdf|07/16/2012| 68047018616|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 68047070221|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 68047070235|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 68047070251|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 68135002001|Enzymes|https://paxpress.txpa.hidinc.com/enzymes.pdf|11/20/2019| 68135010001|Enzymes|https://paxpress.txpa.hidinc.com/enzymes.pdf|11/20/2019| 68180015301|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 68180015302|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 68180016916|Leukotriene Modifiers|https://paxpress.txpa.hidinc.com/leukotriene.pdf|12/15/2015| 68180018506|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 68180019306|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 68180019406|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 68180019506|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 68180021506|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 68180021509|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 68180021606|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 68180021609|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 68180021706|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 68180021709|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 68180028301|PDE5-Inhibitors|https://paxpress.txpa.hidinc.com/revatio.pdf|09/01/2015| 68180032201|Anxiolytics and Sedative-Hypnotics|https://paxpress.txpa.hidinc.com/ash.pdf|01/31/2011| 68180032301|Anxiolytics and Sedative-Hypnotics|https://paxpress.txpa.hidinc.com/ash.pdf|01/31/2011| 68180032401|Anxiolytics and Sedative-Hypnotics|https://paxpress.txpa.hidinc.com/ash.pdf|01/31/2011| 68180033107|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016| 68180033207|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016| 68180033307|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016| 68180033407|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016| 68180037603|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 68180037703|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 68180037803|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 68180039507|COX-2 Inhibitors|https://paxpress.txpa.hidinc.com/cox2.pdf|01/31/2011| 68180039507|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/04/2016| 68180039601|COX-2 Inhibitors|https://paxpress.txpa.hidinc.com/cox2.pdf|01/31/2011| 68180039601|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/04/2016| 68180039602|COX-2 Inhibitors|https://paxpress.txpa.hidinc.com/cox2.pdf|01/31/2011| 68180039602|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/04/2016| 68180039807|COX-2 Inhibitors|https://paxpress.txpa.hidinc.com/cox2.pdf|01/31/2011| 68180039807|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/04/2016| 68180039901|COX-2 Inhibitors|https://paxpress.txpa.hidinc.com/cox2.pdf|01/31/2011| 68180039901|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/04/2016| 68180044501|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016| 68180044503|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016| 68180044601|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016| 68180044603|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016| 68180044701|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016| 68180044703|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016| 68180044801|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016| 68180044802|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016| 68180044901|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016| 68180044902|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016| 68180044907|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016| 68180045001|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016| 68180045002|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016| 68180046403|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/04/2016| 68180046406|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/04/2016| 68180046409|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/04/2016| 68180046503|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/04/2016| 68180046506|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/04/2016| 68180046509|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/04/2016| 68180046701|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/04/2016| 68180046703|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/04/2016| 68180046707|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/04/2016| 68180046801|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/04/2016| 68180046803|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/04/2016| 68180046805|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/04/2016| 68180046807|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/04/2016| 68180046901|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/04/2016| 68180046903|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/04/2016| 68180046905|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/04/2016| 68180046907|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/04/2016| 68180047801|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/04/2016| 68180047802|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/04/2016| 68180047803|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/04/2016| 68180047901|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/04/2016| 68180047902|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/04/2016| 68180047903|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/04/2016| 68180049001|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|08/23/2023 68180049101|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|08/23/2023 68180050101|COX-2 Inhibitors|https://paxpress.txpa.hidinc.com/cox2.pdf|01/31/2011| 68180050101|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/04/2016| 68180050103|COX-2 Inhibitors|https://paxpress.txpa.hidinc.com/cox2.pdf|01/31/2011| 68180050103|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/04/2016| 68180050201|COX-2 Inhibitors|https://paxpress.txpa.hidinc.com/cox2.pdf|01/31/2011| 68180050201|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/04/2016| 68180050203|COX-2 Inhibitors|https://paxpress.txpa.hidinc.com/cox2.pdf|01/31/2011| 68180050203|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/04/2016| 68180051801|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 68180051802|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 68180051830|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 68180051901|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 68180051902|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 68180051930|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 68180052001|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 68180052002|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 68180052030|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 68180052306|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016| 68180052406|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016| 68180052506|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016| 68180052606|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016| 68180053801|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 68180060607|ADD/ADHD Agents|https://paxpress.txpa.hidinc.com/add_adhd_agents.pdf|02/13/2014| 68180061207|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016| 68180061307|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016| 68180061407|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016| 68180061507|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016| 68180061607|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016| 68180063502|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/04/2016| 68180063509|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/04/2016| 68180063602|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/04/2016| 68180063609|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/04/2016| 68180063702|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/04/2016| 68180063709|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/04/2016| 68180063802|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/04/2016| 68180063809|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/04/2016| 68180067006|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016| 68180067106|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016| 68180067206|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016| 68180067306|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016| 68180067406|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016| 68180069706|Opiate Overutilization|https://paxpress.txpa.hidinc.com/opiate.pdf|11/05/2013| 68180069706|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017| 68180069706|Opioid Clinical Policy (MME and days supply limits)|https://paxpress.txpa.hidinc.com/opc.pdf|09/01/2020| 68180069806|Opiate Overutilization|https://paxpress.txpa.hidinc.com/opiate.pdf|11/05/2013| 68180069806|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017| 68180069806|Opioid Clinical Policy (MME and days supply limits)|https://paxpress.txpa.hidinc.com/opc.pdf|09/01/2020| 68180069906|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017| 68180077901|Anxiolytics and Sedative-Hypnotics|https://paxpress.txpa.hidinc.com/ash.pdf|01/31/2011| 68180078001|Anxiolytics and Sedative-Hypnotics|https://paxpress.txpa.hidinc.com/ash.pdf|01/31/2011| 68180081942|Phosphate Binders|https://paxpress.txpa.hidinc.com/phosphate_binders.pdf|01/31/2011| 68180082046|Phosphate Binders|https://paxpress.txpa.hidinc.com/phosphate_binders.pdf|01/31/2011| 68180082147|Phosphate Binders|https://paxpress.txpa.hidinc.com/phosphate_binders.pdf|01/31/2011| 68180082709|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 68180082809|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 68180096256|Inhaled Antibiotics Clinical|https://paxpress.txpa.hidinc.com/inhaledantibiotics.pdf|05/02/2023| 68180096301|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 68180098430|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 68308002003|Opiate Overutilization|https://paxpress.txpa.hidinc.com/opiate.pdf|11/05/2013| 68308002003|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017| 68308011501|ADD/ADHD Agents|https://paxpress.txpa.hidinc.com/add_adhd_agents.pdf|02/13/2014| 68308014501|Opiate Overutilization|https://paxpress.txpa.hidinc.com/opiate.pdf|11/05/2013| 68308014501|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017| 68308014501|Opioid Clinical Policy (MME and days supply limits)|https://paxpress.txpa.hidinc.com/opc.pdf|09/01/2020| 68308047547|Opiate Overutilization|https://paxpress.txpa.hidinc.com/opiate.pdf|11/05/2013| 68308047547|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017| 68308047547|Opioid Clinical Policy (MME and days supply limits)|https://paxpress.txpa.hidinc.com/opc.pdf|09/01/2020| 68308048047|Opiate Overutilization|https://paxpress.txpa.hidinc.com/opiate.pdf|11/05/2013| 68308048047|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017| 68308048047|Opioid Clinical Policy (MME and days supply limits)|https://paxpress.txpa.hidinc.com/opc.pdf|09/01/2020| 68308070301|Topical Immunomodulators|https://paxpress.txpa.hidinc.com/immunomodulators.pdf|01/31/2011| 68308070360|Topical Immunomodulators|https://paxpress.txpa.hidinc.com/immunomodulators.pdf|01/31/2011| 68382004001|Promethazine Utilization|https://paxpress.txpa.hidinc.com/phenergan.pdf|01/31/2011| 68382004101|Promethazine Utilization|https://paxpress.txpa.hidinc.com/phenergan.pdf|01/31/2011| 68382004105|Promethazine Utilization|https://paxpress.txpa.hidinc.com/phenergan.pdf|01/31/2011| 68382004110|Promethazine Utilization|https://paxpress.txpa.hidinc.com/phenergan.pdf|01/31/2011| 68382004201|Promethazine Utilization|https://paxpress.txpa.hidinc.com/phenergan.pdf|01/31/2011| 68382005001|COX-2 Inhibitors|https://paxpress.txpa.hidinc.com/cox2.pdf|01/31/2011| 68382005001|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/04/2016| 68382005005|COX-2 Inhibitors|https://paxpress.txpa.hidinc.com/cox2.pdf|01/31/2011| 68382005005|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/04/2016| 68382005101|COX-2 Inhibitors|https://paxpress.txpa.hidinc.com/cox2.pdf|01/31/2011| 68382005101|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/04/2016| 68382005105|COX-2 Inhibitors|https://paxpress.txpa.hidinc.com/cox2.pdf|01/31/2011| 68382005105|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/04/2016| 68382007901|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016| 68382007910|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016| 68382008001|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016| 68382008101|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016| 68382009101|Cough and Cold Agents|https://paxpress.txpa.hidinc.com/Cough%20&%20Cold.pdf|12/15/2015| 68382011205|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016| 68382011214|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016| 68382011305|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016| 68382011314|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016| 68382011405|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016| 68382011414|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016| 68382011505|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016| 68382011514|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016| 68382011605|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016| 68382011614|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016| 68382011705|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016| 68382011714|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016| 68382013506|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 68382013510|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 68382013516|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 68382013606|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 68382013610|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 68382013616|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 68382013706|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 68382013710|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 68382013716|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 68382020401|Gabapentin Agents|https://paxpress.txpa.hidinc.com/neurontin.pdf|01/31/2011| 68382020405|Gabapentin Agents|https://paxpress.txpa.hidinc.com/neurontin.pdf|01/31/2011| 68382020501|Gabapentin Agents|https://paxpress.txpa.hidinc.com/neurontin.pdf|01/31/2011| 68382020505|Gabapentin Agents|https://paxpress.txpa.hidinc.com/neurontin.pdf|01/31/2011| 68382024701|Cough and Cold Agents|https://paxpress.txpa.hidinc.com/Cough%20&%20Cold.pdf|12/15/2015| 68382024705|Cough and Cold Agents|https://paxpress.txpa.hidinc.com/Cough%20&%20Cold.pdf|12/15/2015| 68382024910|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/04/2016| 68382024916|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/04/2016| 68382025010|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/04/2016| 68382025016|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/04/2016| 68382025110|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/04/2016| 68382025116|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/04/2016| 68382025210|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/04/2016| 68382025216|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/04/2016| 68382027101|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 68382027114|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 68382027201|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 68382027301|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 68382027314|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 68382040701|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016| 68382040801|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016| 68382040901|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016| 68382044614|Pulmonary Hypertension Agents Clinical|https://paxpress.txpa.hidinc.com/pah.pdf|07/27/2023| 68382044714|Pulmonary Hypertension Agents Clinical|https://paxpress.txpa.hidinc.com/pah.pdf|07/27/2023| 68382047178|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 68382047278|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 68382047378|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 68382059101|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016| 68382059201|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016| 68382059301|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016| 68382059401|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016| 68382071586|Antimigraine Agents Triptans|https://paxpress.txpa.hidinc.com/triptans.pdf|04/04/2023| 68382071782|Antimigraine Agents Triptans|https://paxpress.txpa.hidinc.com/triptans.pdf|04/04/2023| 68382072116|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 68382072216|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 68382082427|Phosphate Binders|https://paxpress.txpa.hidinc.com/phosphate_binders.pdf|01/31/2011|02/16/2024 68382085601|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 68382085605|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 68382085701|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 68382085705|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 68382085906|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016| 68382091601|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 68382091634|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 68382091711|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 68382091818|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 68382091911|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 68382092286|Antimigraine Agents Triptans|https://paxpress.txpa.hidinc.com/triptans.pdf|04/04/2023| 68382092386|Antimigraine Agents Triptans|https://paxpress.txpa.hidinc.com/triptans.pdf|04/04/2023| 68382095601|ADD/ADHD Agents|https://paxpress.txpa.hidinc.com/add_adhd_agents.pdf|02/13/2014|08/31/2023 68382096506|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016| 68382096616|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016| 68382096706|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016| 68382096806|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016| 68462011233|Antiemetic Agents|https://paxpress.txpa.hidinc.com/antiemetics.pdf|01/31/2011| 68462012601|Gabapentin Agents|https://paxpress.txpa.hidinc.com/neurontin.pdf|01/31/2011| 68462012605|Gabapentin Agents|https://paxpress.txpa.hidinc.com/neurontin.pdf|01/31/2011| 68462012701|Gabapentin Agents|https://paxpress.txpa.hidinc.com/neurontin.pdf|01/31/2011| 68462012705|Gabapentin Agents|https://paxpress.txpa.hidinc.com/neurontin.pdf|01/31/2011| 68462017801|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 68462017901|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 68462017905|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 68462018801|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 68462018805|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 68462018901|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 68462018905|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 68462019001|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 68462019005|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 68462019030|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 68462019505|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/04/2016| 68462019590|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/04/2016| 68462019605|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/04/2016| 68462019690|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/04/2016| 68462019705|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/04/2016| 68462019790|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/04/2016| 68462019805|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/04/2016| 68462019890|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/04/2016| 68462019913|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 68462019930|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 68462020013|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 68462020030|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 68462020113|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 68462020130|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 68462026110|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/04/2016| 68462026190|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/04/2016| 68462026210|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/04/2016| 68462026290|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/04/2016| 68462026310|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/04/2016| 68462026390|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/04/2016| 68462026405|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/04/2016| 68462026430|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/04/2016| 68462026530|ADD/ADHD Agents|https://paxpress.txpa.hidinc.com/add_adhd_agents.pdf|02/13/2014| 68462026630|ADD/ADHD Agents|https://paxpress.txpa.hidinc.com/add_adhd_agents.pdf|02/13/2014| 68462026730|ADD/ADHD Agents|https://paxpress.txpa.hidinc.com/add_adhd_agents.pdf|02/13/2014| 68462026830|ADD/ADHD Agents|https://paxpress.txpa.hidinc.com/add_adhd_agents.pdf|02/13/2014| 68462026930|ADD/ADHD Agents|https://paxpress.txpa.hidinc.com/add_adhd_agents.pdf|02/13/2014| 68462027030|ADD/ADHD Agents|https://paxpress.txpa.hidinc.com/add_adhd_agents.pdf|02/13/2014| 68462027130|ADD/ADHD Agents|https://paxpress.txpa.hidinc.com/add_adhd_agents.pdf|02/13/2014| 68462027501|Desmopressin|https://paxpress.txpa.hidinc.com/desmopressin.pdf|05/25/2012|02/29/2024 68462027601|Desmopressin|https://paxpress.txpa.hidinc.com/desmopressin.pdf|05/25/2012|02/29/2024 68462030201|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 68462030205|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 68462031960|Ranexa|https://paxpress.txpa.hidinc.com/ranexa.pdf|05/25/2012| 68462032060|Ranexa|https://paxpress.txpa.hidinc.com/ranexa.pdf|05/25/2012| 68462032130|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 68462032230|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 68462032290|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 68462032330|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 68462032430|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 68462032501|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 68462032560|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 68462032590|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 68462034690|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|07/13/2024 68462035594|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 68462038201|Anxiolytics and Sedative-Hypnotics|https://paxpress.txpa.hidinc.com/ash.pdf|01/31/2011| 68462038301|Anxiolytics and Sedative-Hypnotics|https://paxpress.txpa.hidinc.com/ash.pdf|01/31/2011| 68462038401|Anxiolytics and Sedative-Hypnotics|https://paxpress.txpa.hidinc.com/ash.pdf|01/31/2011| 68462040601|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 68462040610|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 68462043630|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 68462043690|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 68462043730|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 68462043790|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 68462043830|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 68462043890|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 68462044626|Phosphate Binders|https://paxpress.txpa.hidinc.com/phosphate_binders.pdf|01/31/2011| 68462044718|Phosphate Binders|https://paxpress.txpa.hidinc.com/phosphate_binders.pdf|01/31/2011| 68462046599|Antimigraine Agents Triptans|https://paxpress.txpa.hidinc.com/triptans.pdf|04/04/2023| 68462046699|Antimigraine Agents Triptans|https://paxpress.txpa.hidinc.com/triptans.pdf|04/04/2023| 68462046706|Antimigraine Agents Triptans|https://paxpress.txpa.hidinc.com/triptans.pdf|04/04/2023| 68462046740|Antimigraine Agents Triptans|https://paxpress.txpa.hidinc.com/triptans.pdf|04/04/2023| 68462046746|Antimigraine Agents Triptans|https://paxpress.txpa.hidinc.com/triptans.pdf|04/04/2023| 68462046806|Antimigraine Agents Triptans|https://paxpress.txpa.hidinc.com/triptans.pdf|04/04/2023| 68462046840|Antimigraine Agents Triptans|https://paxpress.txpa.hidinc.com/triptans.pdf|04/04/2023| 68462049776|Antimigraine Agents Triptans|https://paxpress.txpa.hidinc.com/triptans.pdf|04/04/2023| 68462049833|Antimigraine Agents Triptans|https://paxpress.txpa.hidinc.com/triptans.pdf|04/04/2023| 68462049976|Antimigraine Agents Triptans|https://paxpress.txpa.hidinc.com/triptans.pdf|04/04/2023| 68462050033|Antimigraine Agents Triptans|https://paxpress.txpa.hidinc.com/triptans.pdf|04/04/2023| 68462053435|Topical Immunomodulators|https://paxpress.txpa.hidinc.com/immunomodulators.pdf|01/31/2011| 68462053465|Topical Immunomodulators|https://paxpress.txpa.hidinc.com/immunomodulators.pdf|01/31/2011| 68462053494|Topical Immunomodulators|https://paxpress.txpa.hidinc.com/immunomodulators.pdf|01/31/2011| 68462053670|Imiquimod|https://paxpress.txpa.hidinc.com/imiquimod.pdf|07/16/2012| 68462056630|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 68462056690|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 68462056730|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 68462056790|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 68462056830|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 68462056890|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 68462056930|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 68462056990|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 68462058340|Antiemetic Agents|https://paxpress.txpa.hidinc.com/antiemetics.pdf|01/31/2011| 68462058385|Antiemetic Agents|https://paxpress.txpa.hidinc.com/antiemetics.pdf|01/31/2011| 68462058458|Antiemetic Agents|https://paxpress.txpa.hidinc.com/antiemetics.pdf|01/31/2011| 68462058476|Antiemetic Agents|https://paxpress.txpa.hidinc.com/antiemetics.pdf|01/31/2011| 68462058576|Antiemetic Agents|https://paxpress.txpa.hidinc.com/antiemetics.pdf|01/31/2011| 68462060935|Topical Immunomodulators|https://paxpress.txpa.hidinc.com/immunomodulators.pdf|01/31/2011| 68462060965|Topical Immunomodulators|https://paxpress.txpa.hidinc.com/immunomodulators.pdf|01/31/2011| 68462060994|Topical Immunomodulators|https://paxpress.txpa.hidinc.com/immunomodulators.pdf|01/31/2011| 68462065629|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 68462065684|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 68462065729|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 68462065784|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 68462065790|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 68462069497|Antimigraine Agents Triptans|https://paxpress.txpa.hidinc.com/triptans.pdf|04/04/2023| 68462071171|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 68462071188|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 68462084011|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 68462084013|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 68462084111|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 68462084113|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 68462084211|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 68462084213|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 68462086101|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016| 68462086201|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016| 68462086301|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016| 68462086401|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016| 68462086501|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016| 68462087801|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 68462087805|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 68462087830|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 68462087901|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 68462087905|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 68462087930|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 68462088001|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 68462088005|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 68462088030|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 68546017060|VMAT2 Inhibitors|https://paxpress.txpa.hidinc.com/vmat2_inhibitor.pdf|09/25/2018| 68546017160|VMAT2 Inhibitors|https://paxpress.txpa.hidinc.com/vmat2_inhibitor.pdf|09/25/2018| 68546017260|VMAT2 Inhibitors|https://paxpress.txpa.hidinc.com/vmat2_inhibitor.pdf|09/25/2018| 68546047056|VMAT2 Inhibitors|https://paxpress.txpa.hidinc.com/vmat2_inhibitor.pdf|09/25/2018| 68546047156|VMAT2 Inhibitors|https://paxpress.txpa.hidinc.com/vmat2_inhibitor.pdf|09/25/2018| 68546047256|VMAT2 Inhibitors|https://paxpress.txpa.hidinc.com/vmat2_inhibitor.pdf|09/25/2018| 68645047054|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/04/2016| 68645051054|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 68645052754|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/04/2016| 68645055654|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 68645055754|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 68645055854|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 68645056054|Leukotriene Modifiers|https://paxpress.txpa.hidinc.com/leukotriene.pdf|12/15/2015| 68645056259|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 68645056354|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 68645056690|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/04/2016| 68645056790|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/04/2016| 68645058654|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 68645058854|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 68645059954|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 68682010301|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 68682011001|Topical Immunomodulators|https://paxpress.txpa.hidinc.com/immunomodulators.pdf|01/31/2011| 68682011102|Topical Immunomodulators|https://paxpress.txpa.hidinc.com/immunomodulators.pdf|01/31/2011| 68682011203|Topical Immunomodulators|https://paxpress.txpa.hidinc.com/immunomodulators.pdf|01/31/2011| 68682027275|Imiquimod|https://paxpress.txpa.hidinc.com/imiquimod.pdf|07/16/2012| 68682042112|VMAT2 Inhibitors|https://paxpress.txpa.hidinc.com/vmat2_inhibitor.pdf|09/25/2018| 68682042225|VMAT2 Inhibitors|https://paxpress.txpa.hidinc.com/vmat2_inhibitor.pdf|09/25/2018| 68682065020|Anxiolytics and Sedative-Hypnotics|https://paxpress.txpa.hidinc.com/ash.pdf|01/31/2011| 68682065220|Anxiolytics and Sedative-Hypnotics|https://paxpress.txpa.hidinc.com/ash.pdf|01/31/2011| 68682065520|Anxiolytics and Sedative-Hypnotics|https://paxpress.txpa.hidinc.com/ash.pdf|01/31/2011| 68727010001|Xyrem|https://paxpress.txpa.hidinc.com/xyrem.pdf|02/17/2011| 68727035001|CNS Stimulants|https://paxpress.txpa.hidinc.com/provigil.pdf|04/14/2020|10/20/2023 68727035101|CNS Stimulants|https://paxpress.txpa.hidinc.com/provigil.pdf|04/14/2020|10/20/2023 68875010201|Gattex|https://paxpress.txpa.hidinc.com/gattex.pdf|06/06/2023| 68968017203|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016| 68968017303|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016| 68968017403|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016| 68968051408|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 68968052508|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 68968341008|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 68968342508|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 68968343708|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 68968345008|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 68968347508|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 68968555203|ADD/ADHD Agents|https://paxpress.txpa.hidinc.com/add_adhd_agents.pdf|02/13/2014| 68968555303|ADD/ADHD Agents|https://paxpress.txpa.hidinc.com/add_adhd_agents.pdf|02/13/2014| 68968555403|ADD/ADHD Agents|https://paxpress.txpa.hidinc.com/add_adhd_agents.pdf|02/13/2014| 68968555503|ADD/ADHD Agents|https://paxpress.txpa.hidinc.com/add_adhd_agents.pdf|02/13/2014| 69097014260|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 69097015807|COX-2 Inhibitors|https://paxpress.txpa.hidinc.com/cox2.pdf|01/31/2011| 69097015807|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/04/2016| 69097015812|COX-2 Inhibitors|https://paxpress.txpa.hidinc.com/cox2.pdf|01/31/2011| 69097015812|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/04/2016| 69097015815|COX-2 Inhibitors|https://paxpress.txpa.hidinc.com/cox2.pdf|01/31/2011| 69097015815|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/04/2016| 69097015907|COX-2 Inhibitors|https://paxpress.txpa.hidinc.com/cox2.pdf|01/31/2011| 69097015907|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/04/2016| 69097015912|COX-2 Inhibitors|https://paxpress.txpa.hidinc.com/cox2.pdf|01/31/2011| 69097015912|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/04/2016| 69097015915|COX-2 Inhibitors|https://paxpress.txpa.hidinc.com/cox2.pdf|01/31/2011| 69097015915|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/04/2016| 69097016864|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/04/2016| 69097016887|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/04/2016| 69097017353|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/04/2016| 69097017364|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/04/2016| 69097031853|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 69097031887|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 69097031953|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 69097031987|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 69097032153|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 69097032187|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 69097038602|Pulmonary Hypertension Agents Clinical|https://paxpress.txpa.hidinc.com/pah.pdf|07/27/2023| 69097038702|Pulmonary Hypertension Agents Clinical|https://paxpress.txpa.hidinc.com/pah.pdf|07/27/2023| 69097042003|COX-2 Inhibitors|https://paxpress.txpa.hidinc.com/cox2.pdf|01/31/2011| 69097042003|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/04/2016| 69097042107|COX-2 Inhibitors|https://paxpress.txpa.hidinc.com/cox2.pdf|01/31/2011| 69097042107|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/04/2016| 69097042112|COX-2 Inhibitors|https://paxpress.txpa.hidinc.com/cox2.pdf|01/31/2011| 69097042112|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/04/2016| 69097042207|COX-2 Inhibitors|https://paxpress.txpa.hidinc.com/cox2.pdf|01/31/2011| 69097042207|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/04/2016| 69097042212|COX-2 Inhibitors|https://paxpress.txpa.hidinc.com/cox2.pdf|01/31/2011| 69097042212|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/04/2016| 69097042303|COX-2 Inhibitors|https://paxpress.txpa.hidinc.com/cox2.pdf|01/31/2011| 69097042303|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/04/2016| 69097052444|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 69097052603|PDE5-Inhibitors|https://paxpress.txpa.hidinc.com/revatio.pdf|01/31/2011| 69097064448|Antimigraine Agents Triptans|https://paxpress.txpa.hidinc.com/triptans.pdf|04/04/2023| 69097081307|Gabapentin Agents|https://paxpress.txpa.hidinc.com/neurontin.pdf|01/31/2011| 69097081312|Gabapentin Agents|https://paxpress.txpa.hidinc.com/neurontin.pdf|01/31/2011| 69097081507|Gabapentin Agents|https://paxpress.txpa.hidinc.com/neurontin.pdf|01/31/2011| 69097081512|Gabapentin Agents|https://paxpress.txpa.hidinc.com/neurontin.pdf|01/31/2011| 69097082502|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/04/2016| 69097082507|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/04/2016| 69097082515|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/04/2016| 69097084053|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/04/2016| 69097084064|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/04/2016| 69097084087|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/04/2016| 69097084507|Cyclobenzaprine|https://paxpress.txpa.hidinc.com/cyclobenzaprine.pdf|01/31/2011| 69097084507|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017| 69097084607|Cyclobenzaprine|https://paxpress.txpa.hidinc.com/cyclobenzaprine.pdf|01/31/2011| 69097084607|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017| 69097084615|Cyclobenzaprine|https://paxpress.txpa.hidinc.com/cyclobenzaprine.pdf|01/31/2011| 69097084615|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017| 69097086283|Phosphate Binders|https://paxpress.txpa.hidinc.com/phosphate_binders.pdf|01/31/2011| 69097086585|Antimigraine Agents Triptans|https://paxpress.txpa.hidinc.com/triptans.pdf|04/04/2023|08/04/2024 69097086685|Antimigraine Agents Triptans|https://paxpress.txpa.hidinc.com/triptans.pdf|04/04/2023|08/04/2024 69097093498|Phosphate Binders|https://paxpress.txpa.hidinc.com/phosphate_binders.pdf|01/31/2011| 69097093598|Phosphate Binders|https://paxpress.txpa.hidinc.com/phosphate_binders.pdf|01/31/2011| 69097093698|Phosphate Binders|https://paxpress.txpa.hidinc.com/phosphate_binders.pdf|01/31/2011| 69097094307|Gabapentin Agents|https://paxpress.txpa.hidinc.com/neurontin.pdf|01/31/2011| 69097094312|Gabapentin Agents|https://paxpress.txpa.hidinc.com/neurontin.pdf|01/31/2011| 69097094405|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/04/2016| 69097094415|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/04/2016|02/15/2024 69097094505|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/04/2016| 69097094512|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/04/2016|08/23/2023 69097094605|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/04/2016| 69097094615|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/04/2016|08/23/2023 69097094705|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/04/2016| 69097094712|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/04/2016|08/23/2023 69097096507|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 69097096512|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 69097096607|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 69097096612|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 69097096793|Phosphate Binders|https://paxpress.txpa.hidinc.com/phosphate_binders.pdf|01/31/2011| 69097096807|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 69097096812|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 69097096907|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 69097096912|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 69097097107|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 69097097112|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 69097097207|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 69097097307|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 69097097407|Anxiolytics and Sedative-Hypnotics|https://paxpress.txpa.hidinc.com/ash.pdf|01/31/2011| 69097097407|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017| 69097097507|Anxiolytics and Sedative-Hypnotics|https://paxpress.txpa.hidinc.com/ash.pdf|01/31/2011| 69097097507|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017| 69117002102|COX-2 Inhibitors|https://paxpress.txpa.hidinc.com/cox2.pdf|01/31/2011| 69117002102|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/04/2016| 69117002103|COX-2 Inhibitors|https://paxpress.txpa.hidinc.com/cox2.pdf|01/31/2011| 69117002103|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/04/2016| 69117002202|COX-2 Inhibitors|https://paxpress.txpa.hidinc.com/cox2.pdf|01/31/2011| 69117002202|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/04/2016| 69117002203|COX-2 Inhibitors|https://paxpress.txpa.hidinc.com/cox2.pdf|01/31/2011| 69117002203|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/04/2016| 69230020105|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 69230030001|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 69230030005|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 69230030030|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 69230030401|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 69230030405|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 69230030811|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 69230030812|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 69230030911|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 69230030912|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 69230031011|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 69230031012|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 69230031111|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 69230031112|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 69230031611|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 69230031701|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 69230031703|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 69230032110|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 69230032131|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 69230032133|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 69230032212|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 69238105401|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016| 69238105601|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016| 69238105801|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016| 69238106001|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016| 69238106201|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016| 69238112001|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 69238115503|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 69238115603|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 69238115703|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 69238115803|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 69238120202|Opiate Overutilization|https://paxpress.txpa.hidinc.com/opiate.pdf|11/05/2013| 69238120202|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017| 69238120202|Opioid Clinical Policy (MME and days supply limits)|https://paxpress.txpa.hidinc.com/opc.pdf|09/01/2020| 69238120302|Opiate Overutilization|https://paxpress.txpa.hidinc.com/opiate.pdf|11/05/2013| 69238120302|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017| 69238120302|Opioid Clinical Policy (MME and days supply limits)|https://paxpress.txpa.hidinc.com/opc.pdf|09/01/2020| 69238120402|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017| 69238120402|Opioid Clinical Policy (MME and days supply limits)|https://paxpress.txpa.hidinc.com/opc.pdf|09/01/2020| 69238120502|Opiate Overutilization|https://paxpress.txpa.hidinc.com/opiate.pdf|11/05/2013| 69238120502|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017| 69238120502|Opioid Clinical Policy (MME and days supply limits)|https://paxpress.txpa.hidinc.com/opc.pdf|09/01/2020| 69238134201|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 69238134301|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 69238134603|PDE5-Inhibitors|https://paxpress.txpa.hidinc.com/revatio.pdf|01/31/2011| 69238134703|PDE5-Inhibitors|https://paxpress.txpa.hidinc.com/revatio.pdf|11/04/2019| 69238134803|PDE5-Inhibitors|https://paxpress.txpa.hidinc.com/revatio.pdf|01/31/2011| 69238134903|PDE5-Inhibitors|https://paxpress.txpa.hidinc.com/revatio.pdf|01/31/2011| 69238142606|ADD/ADHD Agents|https://paxpress.txpa.hidinc.com/add_adhd_agents.pdf|02/13/2014| 69238150502|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017| 69238150502|Opioid Clinical Policy (MME and days supply limits)|https://paxpress.txpa.hidinc.com/opc.pdf|09/01/2020| 69238153909|Antimigraine Agents Triptans|https://paxpress.txpa.hidinc.com/triptans.pdf|04/04/2023| 69238156301|ADD/ADHD Agents|https://paxpress.txpa.hidinc.com/add_adhd_agents.pdf|02/13/2014| 69238156401|ADD/ADHD Agents|https://paxpress.txpa.hidinc.com/add_adhd_agents.pdf|02/13/2014| 69238157401|PDE5-Inhibitors|https://paxpress.txpa.hidinc.com/revatio.pdf|09/01/2015| 69238167801|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016| 69238167901|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016| 69238168001|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016| 69238168101|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016| 69238173002|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 69238199301|Opiate Overutilization|https://paxpress.txpa.hidinc.com/opiate.pdf|11/05/2013| 69238199301|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017| 69238199301|Opioid Clinical Policy (MME and days supply limits)|https://paxpress.txpa.hidinc.com/opc.pdf|09/01/2020| 69238200606|Antimigraine Agents Triptans|https://paxpress.txpa.hidinc.com/triptans.pdf|04/04/2023|03/24/2024 69238200706|Antimigraine Agents Triptans|https://paxpress.txpa.hidinc.com/triptans.pdf|04/04/2023| 69238205301|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 69238212209|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 69238229401|Opiate Overutilization|https://paxpress.txpa.hidinc.com/opiate.pdf|11/05/2013| 69238229401|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017| 69238229401|Opioid Clinical Policy (MME and days supply limits)|https://paxpress.txpa.hidinc.com/opc.pdf|09/01/2020| 69238229401|Oxycontin / Narcotic Analgesic|https://paxpress.txpa.hidinc.com/oxycontin.pdf|01/31/2011| 69238229601|Opiate Overutilization|https://paxpress.txpa.hidinc.com/opiate.pdf|11/05/2013| 69238229601|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017| 69238229601|Opioid Clinical Policy (MME and days supply limits)|https://paxpress.txpa.hidinc.com/opc.pdf|09/01/2020| 69238229601|Oxycontin / Narcotic Analgesic|https://paxpress.txpa.hidinc.com/oxycontin.pdf|01/31/2011| 69238229801|Opiate Overutilization|https://paxpress.txpa.hidinc.com/opiate.pdf|11/05/2013| 69238229801|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017| 69238229801|Opioid Clinical Policy (MME and days supply limits)|https://paxpress.txpa.hidinc.com/opc.pdf|09/01/2020| 69238229801|Oxycontin / Narcotic Analgesic|https://paxpress.txpa.hidinc.com/oxycontin.pdf|01/31/2011| 69238230001|Opiate Overutilization|https://paxpress.txpa.hidinc.com/opiate.pdf|11/05/2013| 69238230001|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017| 69238230001|Opioid Clinical Policy (MME and days supply limits)|https://paxpress.txpa.hidinc.com/opc.pdf|09/01/2020| 69238230001|Oxycontin / Narcotic Analgesic|https://paxpress.txpa.hidinc.com/oxycontin.pdf|01/31/2011| 69238254803|Anxiolytics and Sedative-Hypnotics|https://paxpress.txpa.hidinc.com/ash.pdf|11/16/2021| 69292055001|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 69292058001|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016| 69292058201|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016| 69292058401|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016| 69292058601|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016| 69292058610|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016| 69292058801|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016| 69292059001|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016| 69315013001|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 69315013010|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 69315013101|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 69315013110|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 69315015501|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 69315015510|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 69315024812|Cough and Cold Agents|https://paxpress.txpa.hidinc.com/Cough%20&%20Cold.pdf|12/15/2015| 69315024812|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017| 69315024812|Opioid Clinical Policy (MME and days supply limits)|https://paxpress.txpa.hidinc.com/opc.pdf|09/01/2020| 69315024848|Cough and Cold Agents|https://paxpress.txpa.hidinc.com/Cough%20&%20Cold.pdf|12/15/2015| 69315024848|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017| 69315024848|Opioid Clinical Policy (MME and days supply limits)|https://paxpress.txpa.hidinc.com/opc.pdf|09/01/2020| 69315027520|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 69315090401|Anxiolytics and Sedative-Hypnotics|https://paxpress.txpa.hidinc.com/ash.pdf|01/31/2011| 69315090401|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017| 69315090405|Anxiolytics and Sedative-Hypnotics|https://paxpress.txpa.hidinc.com/ash.pdf|01/31/2011| 69315090405|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017| 69315090410|Anxiolytics and Sedative-Hypnotics|https://paxpress.txpa.hidinc.com/ash.pdf|01/31/2011| 69315090410|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017| 69315090501|Anxiolytics and Sedative-Hypnotics|https://paxpress.txpa.hidinc.com/ash.pdf|01/31/2011| 69315090501|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017| 69315090505|Anxiolytics and Sedative-Hypnotics|https://paxpress.txpa.hidinc.com/ash.pdf|01/31/2011| 69315090505|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017| 69315090510|Anxiolytics and Sedative-Hypnotics|https://paxpress.txpa.hidinc.com/ash.pdf|01/31/2011| 69315090510|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017| 69315090601|Anxiolytics and Sedative-Hypnotics|https://paxpress.txpa.hidinc.com/ash.pdf|01/31/2011| 69315090601|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017| 69315090605|Anxiolytics and Sedative-Hypnotics|https://paxpress.txpa.hidinc.com/ash.pdf|01/31/2011| 69315090605|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017| 69315090610|Anxiolytics and Sedative-Hypnotics|https://paxpress.txpa.hidinc.com/ash.pdf|01/31/2011| 69315090610|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017| 69339013012|Leukotriene Modifiers|https://paxpress.txpa.hidinc.com/leukotriene.pdf|12/15/2015|07/01/2024 69339017703|CNS Stimulants|https://paxpress.txpa.hidinc.com/provigil.pdf|02/06/2018| 69339017803|CNS Stimulants|https://paxpress.txpa.hidinc.com/provigil.pdf|02/06/2018| 69339017903|CNS Stimulants|https://paxpress.txpa.hidinc.com/provigil.pdf|02/06/2018| 69339018003|CNS Stimulants|https://paxpress.txpa.hidinc.com/provigil.pdf|02/06/2018| 69367013106|Gabapentin Agents|https://paxpress.txpa.hidinc.com/neurontin.pdf|01/31/2011| 69367013206|Gabapentin Agents|https://paxpress.txpa.hidinc.com/neurontin.pdf|01/31/2011| 69367013306|Gabapentin Agents|https://paxpress.txpa.hidinc.com/neurontin.pdf|01/31/2011| 69367013406|Gabapentin Agents|https://paxpress.txpa.hidinc.com/neurontin.pdf|01/31/2011| 69367013506|Gabapentin Agents|https://paxpress.txpa.hidinc.com/neurontin.pdf|01/31/2011| 69367018316|Cough and Cold Agents|https://paxpress.txpa.hidinc.com/Cough%20&%20Cold.pdf|12/15/2015| 69367018316|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 69367018408|Cough and Cold Agents|https://paxpress.txpa.hidinc.com/Cough%20&%20Cold.pdf|12/15/2015| 69367019760|Cough and Cold Agents|https://paxpress.txpa.hidinc.com/Cough%20&%20Cold.pdf|12/15/2015| 69367019760|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 69367019890|Cough and Cold Agents|https://paxpress.txpa.hidinc.com/Cough%20&%20Cold.pdf|12/15/2015| 69367019890|Dextromethorphan Overutilization|https://paxpress.txpa.hidinc.com/dextro.pdf|07/16/2012| 69367019901|Cough and Cold Agents|https://paxpress.txpa.hidinc.com/Cough%20&%20Cold.pdf|12/15/2015| 69367019901|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 69367021901|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 69367021905|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 69367021910|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 69367023809|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 69367024101|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 69367024105|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 69367024201|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 69367024205|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 69367024601|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 69367024610|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 69367025330|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 69367025501|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017| 69367025505|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017| 69367025601|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017| 69367025605|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017| 69367027204|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017| 69367027204|Opioid Clinical Policy (MME and days supply limits)|https://paxpress.txpa.hidinc.com/opc.pdf|09/01/2020| 69367027216|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017| 69367027216|Opioid Clinical Policy (MME and days supply limits)|https://paxpress.txpa.hidinc.com/opc.pdf|09/01/2020| 69367028705|Leukotriene Modifiers|https://paxpress.txpa.hidinc.com/leukotriene.pdf|12/15/2015| 69367028709|Leukotriene Modifiers|https://paxpress.txpa.hidinc.com/leukotriene.pdf|12/15/2015| 69367029360|Ranexa|https://paxpress.txpa.hidinc.com/ranexa.pdf|05/25/2012| 69367029460|Ranexa|https://paxpress.txpa.hidinc.com/ranexa.pdf|05/25/2012| 69367030101|COX-2 Inhibitors|https://paxpress.txpa.hidinc.com/cox2.pdf|01/31/2011| 69367030101|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/04/2016| 69367030105|COX-2 Inhibitors|https://paxpress.txpa.hidinc.com/cox2.pdf|01/31/2011| 69367030105|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/04/2016| 69367030201|COX-2 Inhibitors|https://paxpress.txpa.hidinc.com/cox2.pdf|01/31/2011| 69367030201|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/04/2016| 69367030205|COX-2 Inhibitors|https://paxpress.txpa.hidinc.com/cox2.pdf|01/31/2011| 69367030205|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/04/2016| 69367034305|Gabapentin Agents|https://paxpress.txpa.hidinc.com/neurontin.pdf|01/31/2011| 69367034405|Gabapentin Agents|https://paxpress.txpa.hidinc.com/neurontin.pdf|01/31/2011| 69367034505|Gabapentin Agents|https://paxpress.txpa.hidinc.com/neurontin.pdf|01/31/2011| 69367034605|Gabapentin Agents|https://paxpress.txpa.hidinc.com/neurontin.pdf|01/31/2011| 69367034705|Gabapentin Agents|https://paxpress.txpa.hidinc.com/neurontin.pdf|01/31/2011| 69452010513|Leukotriene Modifiers|https://paxpress.txpa.hidinc.com/leukotriene.pdf|12/15/2015|08/23/2023 69452010519|Leukotriene Modifiers|https://paxpress.txpa.hidinc.com/leukotriene.pdf|12/15/2015|08/23/2023 69452010532|Leukotriene Modifiers|https://paxpress.txpa.hidinc.com/leukotriene.pdf|12/15/2015|08/23/2023 69452010613|Leukotriene Modifiers|https://paxpress.txpa.hidinc.com/leukotriene.pdf|12/15/2015|08/23/2023 69452010619|Leukotriene Modifiers|https://paxpress.txpa.hidinc.com/leukotriene.pdf|12/15/2015| 69452010713|Leukotriene Modifiers|https://paxpress.txpa.hidinc.com/leukotriene.pdf|12/15/2015| 69452010719|Leukotriene Modifiers|https://paxpress.txpa.hidinc.com/leukotriene.pdf|12/15/2015| 69452012619|Phosphate Binders|https://paxpress.txpa.hidinc.com/phosphate_binders.pdf|01/31/2011| 69452012719|Phosphate Binders|https://paxpress.txpa.hidinc.com/phosphate_binders.pdf|01/31/2011| 69452014320|Cough and Cold Agents|https://paxpress.txpa.hidinc.com/Cough%20&%20Cold.pdf|12/15/2015| 69452014330|Cough and Cold Agents|https://paxpress.txpa.hidinc.com/Cough%20&%20Cold.pdf|12/15/2015| 69452014420|Cough and Cold Agents|https://paxpress.txpa.hidinc.com/Cough%20&%20Cold.pdf|12/15/2015| 69452014430|Cough and Cold Agents|https://paxpress.txpa.hidinc.com/Cough%20&%20Cold.pdf|12/15/2015| 69452015673|Antimigraine Agents Triptans|https://paxpress.txpa.hidinc.com/triptans.pdf|04/04/2023| 69452015773|Antimigraine Agents Triptans|https://paxpress.txpa.hidinc.com/triptans.pdf|04/04/2023| 69452017522|Lovaza|https://paxpress.txpa.hidinc.com/lovaza.pdf|07/16/2012| 69452022720|ADD/ADHD Agents|https://paxpress.txpa.hidinc.com/add_adhd_agents.pdf|12/18/2019| 69452022820|ADD/ADHD Agents|https://paxpress.txpa.hidinc.com/add_adhd_agents.pdf|12/18/2019| 69452033813|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016| 69452033913|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016| 69452034172|Antimigraine Agents Triptans|https://paxpress.txpa.hidinc.com/triptans.pdf|04/04/2023| 69452034213|CNS Stimulants|https://paxpress.txpa.hidinc.com/provigil.pdf|11/06/2012| 69452034313|CNS Stimulants|https://paxpress.txpa.hidinc.com/provigil.pdf|11/06/2012| 69452034472|Antimigraine Agents Triptans|https://paxpress.txpa.hidinc.com/triptans.pdf|04/04/2023| 69452034572|Antimigraine Agents Triptans|https://paxpress.txpa.hidinc.com/triptans.pdf|04/04/2023| 69452034672|Antimigraine Agents Triptans|https://paxpress.txpa.hidinc.com/triptans.pdf|04/04/2023| 69452034713|Anxiolytics and Sedative-Hypnotics|https://paxpress.txpa.hidinc.com/ash.pdf|01/31/2011| 69452034820|Anxiolytics and Sedative-Hypnotics|https://paxpress.txpa.hidinc.com/ash.pdf|01/31/2011| 69452034920|Anxiolytics and Sedative-Hypnotics|https://paxpress.txpa.hidinc.com/ash.pdf|01/31/2011| 69452035001|Antiemetic Agents|https://paxpress.txpa.hidinc.com/antiemetics.pdf|01/31/2011| 69543010710|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 69543010750|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 69543038030|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016| 69543038090|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016|08/03/2024 69543038130|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016| 69543038190|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016|07/07/2024 69543038230|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016| 69543038290|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016|08/03/2024 69543038330|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016| 69543038390|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016| 69543038430|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016|08/03/2024 69543038490|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016|08/03/2024 69543038530|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016| 69543038590|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016|08/03/2024 69543038810|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 69543038810|Ketorolac|https://paxpress.txpa.hidinc.com/ketorolac.pdf|05/25/2012| 69543041710|Opiate Overutilization|https://paxpress.txpa.hidinc.com/opiate.pdf|11/05/2013| 69543041710|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017| 69543041710|Opioid Clinical Policy (MME and days supply limits)|https://paxpress.txpa.hidinc.com/opc.pdf|09/01/2020| 69543042510|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 69543042610|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 69584011110|Carisoprodol Overuse|https://paxpress.txpa.hidinc.com/soma.pdf|01/31/2011| 69584011110|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017| 69584011190|Carisoprodol Overuse|https://paxpress.txpa.hidinc.com/soma.pdf|01/31/2011| 69584011190|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017| 69584036110|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 69584036190|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 69584036195|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 69584036210|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 69584061110|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017| 69584061150|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017| 69584061210|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017| 69584061250|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017| 69639010101|Antiemetic Agents|https://paxpress.txpa.hidinc.com/antiemetics.pdf|01/31/2011| 69680014395|Phosphate Binders|https://paxpress.txpa.hidinc.com/phosphate_binders.pdf|01/31/2011|08/23/2023 69784042012|Lovaza|https://paxpress.txpa.hidinc.com/lovaza.pdf|07/16/2012| 69784050001|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 69784050101|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 69784055001|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 69809012605|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016| 69809012705|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016| 69918010101|Desmopressin|https://paxpress.txpa.hidinc.com/desmopressin.pdf|05/25/2012| 69918020101|Desmopressin|https://paxpress.txpa.hidinc.com/desmopressin.pdf|05/25/2012| 69918089910|Desmopressin|https://paxpress.txpa.hidinc.com/desmopressin.pdf|05/25/2012| 69918090110|Desmopressin|https://paxpress.txpa.hidinc.com/desmopressin.pdf|05/25/2012| 70000000101|Cough and Cold Agents|https://paxpress.txpa.hidinc.com/Cough%20&%20Cold.pdf|12/15/2015| 70000000301|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 70000000302|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 70000000601|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 70000000701|Cough and Cold Agents|https://paxpress.txpa.hidinc.com/Cough%20&%20Cold.pdf|12/15/2015|09/03/2023 70000000701|Dextromethorphan Overutilization|https://paxpress.txpa.hidinc.com/dextro.pdf|07/16/2012|09/03/2023 70000000801|Cough and Cold Agents|https://paxpress.txpa.hidinc.com/Cough%20&%20Cold.pdf|12/15/2015|09/29/2023 70000000801|Dextromethorphan Overutilization|https://paxpress.txpa.hidinc.com/dextro.pdf|07/16/2012|09/29/2023 70000004201|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 70000004701|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 70000005501|Cough and Cold Agents|https://paxpress.txpa.hidinc.com/Cough%20&%20Cold.pdf|12/15/2015| 70000005601|Cough and Cold Agents|https://paxpress.txpa.hidinc.com/Cough%20&%20Cold.pdf|12/15/2015| 70000005601|Dextromethorphan Overutilization|https://paxpress.txpa.hidinc.com/dextro.pdf|07/16/2012| 70000005701|Cough and Cold Agents|https://paxpress.txpa.hidinc.com/Cough%20&%20Cold.pdf|12/15/2015| 70000005701|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 70000009701|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 70000012501|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 70000012901|Cough and Cold Agents|https://paxpress.txpa.hidinc.com/Cough%20&%20Cold.pdf|12/15/2015| 70000012901|Dextromethorphan Overutilization|https://paxpress.txpa.hidinc.com/dextro.pdf|07/16/2012| 70000013201|Cough and Cold Agents|https://paxpress.txpa.hidinc.com/Cough%20&%20Cold.pdf|12/15/2015| 70000013301|Cough and Cold Agents|https://paxpress.txpa.hidinc.com/Cough%20&%20Cold.pdf|12/15/2015|08/23/2023 70000013301|Dextromethorphan Overutilization|https://paxpress.txpa.hidinc.com/dextro.pdf|07/16/2012|08/23/2023 70000013601|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 70000013602|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 70000013603|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 70000014101|Cough and Cold Agents|https://paxpress.txpa.hidinc.com/Cough%20&%20Cold.pdf|12/15/2015| 70000015601|Dextromethorphan Overutilization|https://paxpress.txpa.hidinc.com/dextro.pdf|07/16/2012| 70000015701|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 70000016001|Cough and Cold Agents|https://paxpress.txpa.hidinc.com/Cough%20&%20Cold.pdf|12/15/2015|07/05/2024 70000016001|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|07/05/2024 70000016002|Cough and Cold Agents|https://paxpress.txpa.hidinc.com/Cough%20&%20Cold.pdf|12/15/2015| 70000016002|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 70000016201|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 70000016202|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 70000017101|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|10/20/2023 70000017103|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 70000017105|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 70000017106|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 70000017501|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 70000017502|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 70000017503|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 70000017505|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 70000017508|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 70000017601|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 70000017604|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 70000017605|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 70000018101|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 70000018701|Cough and Cold Agents|https://paxpress.txpa.hidinc.com/Cough%20&%20Cold.pdf|12/15/2015| 70000018701|Dextromethorphan Overutilization|https://paxpress.txpa.hidinc.com/dextro.pdf|07/16/2012| 70000018901|Cough and Cold Agents|https://paxpress.txpa.hidinc.com/Cough%20&%20Cold.pdf|12/15/2015| 70000018901|Dextromethorphan Overutilization|https://paxpress.txpa.hidinc.com/dextro.pdf|07/16/2012| 70000018901|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 70000019101|Dextromethorphan Overutilization|https://paxpress.txpa.hidinc.com/dextro.pdf|07/16/2012|09/03/2023 70000019102|Dextromethorphan Overutilization|https://paxpress.txpa.hidinc.com/dextro.pdf|07/16/2012| 70000019301|Cough and Cold Agents|https://paxpress.txpa.hidinc.com/Cough%20&%20Cold.pdf|12/15/2015| 70000019301|Dextromethorphan Overutilization|https://paxpress.txpa.hidinc.com/dextro.pdf|07/16/2012| 70000019301|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 70000019501|Cough and Cold Agents|https://paxpress.txpa.hidinc.com/Cough%20&%20Cold.pdf|12/15/2015| 70000019501|Dextromethorphan Overutilization|https://paxpress.txpa.hidinc.com/dextro.pdf|07/16/2012| 70000020102|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 70000020103|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|10/20/2023 70000020105|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 70000020106|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 70000020701|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 70000020702|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 70000021101|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 70000021301|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 70000021302|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 70000021303|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 70000021304|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 70000021306|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 70000021401|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 70000021501|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 70000023901|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 70000025901|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|09/13/2023 70000026101|Cough and Cold Agents|https://paxpress.txpa.hidinc.com/Cough%20&%20Cold.pdf|12/15/2015| 70000026201|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 70000026301|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 70000026302|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 70000026401|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 70000027801|Cough and Cold Agents|https://paxpress.txpa.hidinc.com/Cough%20&%20Cold.pdf|12/15/2015| 70000027801|Dextromethorphan Overutilization|https://paxpress.txpa.hidinc.com/dextro.pdf|07/16/2012| 70000028901|Dextromethorphan Overutilization|https://paxpress.txpa.hidinc.com/dextro.pdf|07/16/2012| 70000029101|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 70000029801|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 70000029901|Cough and Cold Agents|https://paxpress.txpa.hidinc.com/Cough%20&%20Cold.pdf|12/15/2015|02/13/2024 70000029902|Cough and Cold Agents|https://paxpress.txpa.hidinc.com/Cough%20&%20Cold.pdf|12/15/2015|10/20/2023 70000030101|Cough and Cold Agents|https://paxpress.txpa.hidinc.com/Cough%20&%20Cold.pdf|12/15/2015|09/03/2023 70000030101|Dextromethorphan Overutilization|https://paxpress.txpa.hidinc.com/dextro.pdf|07/16/2012|09/03/2023 70000030201|Cough and Cold Agents|https://paxpress.txpa.hidinc.com/Cough%20&%20Cold.pdf|12/15/2015| 70000030201|Dextromethorphan Overutilization|https://paxpress.txpa.hidinc.com/dextro.pdf|07/16/2012| 70000030801|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|10/12/2023 70000030802|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|10/12/2023 70000032401|Dextromethorphan Overutilization|https://paxpress.txpa.hidinc.com/dextro.pdf|07/16/2012| 70000032401|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 70000036101|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 70000036102|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 70000036103|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 70000036104|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 70000036105|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 70000036201|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 70000036202|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 70000038001|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 70000038002|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 70000038004|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 70000038701|Cough and Cold Agents|https://paxpress.txpa.hidinc.com/Cough%20&%20Cold.pdf|12/15/2015| 70000038701|Dextromethorphan Overutilization|https://paxpress.txpa.hidinc.com/dextro.pdf|07/16/2012| 70000038702|Cough and Cold Agents|https://paxpress.txpa.hidinc.com/Cough%20&%20Cold.pdf|12/15/2015|09/03/2023 70000038702|Dextromethorphan Overutilization|https://paxpress.txpa.hidinc.com/dextro.pdf|07/16/2012|09/03/2023 70000046401|Cough and Cold Agents|https://paxpress.txpa.hidinc.com/Cough%20&%20Cold.pdf|12/15/2015| 70000046401|Dextromethorphan Overutilization|https://paxpress.txpa.hidinc.com/dextro.pdf|07/16/2012| 70000046402|Cough and Cold Agents|https://paxpress.txpa.hidinc.com/Cough%20&%20Cold.pdf|12/15/2015| 70000046402|Dextromethorphan Overutilization|https://paxpress.txpa.hidinc.com/dextro.pdf|07/16/2012| 70000047301|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 70000047401|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 70000047402|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|09/26/2023 70000047901|Cough and Cold Agents|https://paxpress.txpa.hidinc.com/Cough%20&%20Cold.pdf|12/15/2015| 70000047902|Cough and Cold Agents|https://paxpress.txpa.hidinc.com/Cough%20&%20Cold.pdf|12/15/2015| 70000049101|Cough and Cold Agents|https://paxpress.txpa.hidinc.com/Cough%20&%20Cold.pdf|12/15/2015| 70000049101|Dextromethorphan Overutilization|https://paxpress.txpa.hidinc.com/dextro.pdf|07/16/2012| 70000049201|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 70000050401|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 70000050402|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 70000050403|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 70000051501|Dextromethorphan Overutilization|https://paxpress.txpa.hidinc.com/dextro.pdf|07/16/2012| 70000051601|Dextromethorphan Overutilization|https://paxpress.txpa.hidinc.com/dextro.pdf|07/16/2012| 70000051602|Dextromethorphan Overutilization|https://paxpress.txpa.hidinc.com/dextro.pdf|07/16/2012| 70000051801|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 70000051802|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 70000052501|Dextromethorphan Overutilization|https://paxpress.txpa.hidinc.com/dextro.pdf|07/16/2012| 70000052701|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 70000055501|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 70000055502|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 70000055503|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 70000056501|Cough and Cold Agents|https://paxpress.txpa.hidinc.com/Cough%20&%20Cold.pdf|12/15/2015| 70000056501|Dextromethorphan Overutilization|https://paxpress.txpa.hidinc.com/dextro.pdf|07/16/2012| 70000057101|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 70000057102|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 70000057103|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 70000058001|Cough and Cold Agents|https://paxpress.txpa.hidinc.com/Cough%20&%20Cold.pdf|12/15/2015| 70000058002|Cough and Cold Agents|https://paxpress.txpa.hidinc.com/Cough%20&%20Cold.pdf|12/15/2015| 70000058301|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 70000058501|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 70000058601|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 70000059701|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 70000059702|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 70000060201|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 70000060501|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 70000060601|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 70000060701|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 70000060801|Cough and Cold Agents|https://paxpress.txpa.hidinc.com/Cough%20&%20Cold.pdf|12/15/2015| 70000061601|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 70000063101|Cough and Cold Agents|https://paxpress.txpa.hidinc.com/Cough%20&%20Cold.pdf|12/15/2015| 70000063101|Dextromethorphan Overutilization|https://paxpress.txpa.hidinc.com/dextro.pdf|07/16/2012| 70000063101|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 70010000401|ADD/ADHD Agents|https://paxpress.txpa.hidinc.com/add_adhd_agents.pdf|02/13/2014| 70010000501|ADD/ADHD Agents|https://paxpress.txpa.hidinc.com/add_adhd_agents.pdf|02/13/2014| 70010000601|ADD/ADHD Agents|https://paxpress.txpa.hidinc.com/add_adhd_agents.pdf|02/13/2014| 70010000701|ADD/ADHD Agents|https://paxpress.txpa.hidinc.com/add_adhd_agents.pdf|02/13/2014| 70010000801|ADD/ADHD Agents|https://paxpress.txpa.hidinc.com/add_adhd_agents.pdf|02/13/2014| 70010000901|ADD/ADHD Agents|https://paxpress.txpa.hidinc.com/add_adhd_agents.pdf|02/13/2014| 70010001001|ADD/ADHD Agents|https://paxpress.txpa.hidinc.com/add_adhd_agents.pdf|02/13/2014| 70010001101|ADD/ADHD Agents|https://paxpress.txpa.hidinc.com/add_adhd_agents.pdf|02/13/2014| 70010001201|ADD/ADHD Agents|https://paxpress.txpa.hidinc.com/add_adhd_agents.pdf|02/13/2014| 70010001301|ADD/ADHD Agents|https://paxpress.txpa.hidinc.com/add_adhd_agents.pdf|02/13/2014| 70010001401|ADD/ADHD Agents|https://paxpress.txpa.hidinc.com/add_adhd_agents.pdf|02/13/2014| 70010001501|ADD/ADHD Agents|https://paxpress.txpa.hidinc.com/add_adhd_agents.pdf|02/13/2014| 70010001603|ADD/ADHD Agents|https://paxpress.txpa.hidinc.com/add_adhd_agents.pdf|02/13/2014| 70010002803|Anxiolytics and Sedative-Hypnotics|https://paxpress.txpa.hidinc.com/ash.pdf|01/31/2011| 70010003001|ADD/ADHD Agents|https://paxpress.txpa.hidinc.com/add_adhd_agents.pdf|02/13/2014| 70010003101|ADD/ADHD Agents|https://paxpress.txpa.hidinc.com/add_adhd_agents.pdf|02/13/2014| 70010003201|ADD/ADHD Agents|https://paxpress.txpa.hidinc.com/add_adhd_agents.pdf|02/13/2014| 70010003301|ADD/ADHD Agents|https://paxpress.txpa.hidinc.com/add_adhd_agents.pdf|02/13/2014| 70010003401|ADD/ADHD Agents|https://paxpress.txpa.hidinc.com/add_adhd_agents.pdf|02/13/2014| 70010004001|ADD/ADHD Agents|https://paxpress.txpa.hidinc.com/add_adhd_agents.pdf|02/13/2014| 70010004101|ADD/ADHD Agents|https://paxpress.txpa.hidinc.com/add_adhd_agents.pdf|02/13/2014| 70010004201|ADD/ADHD Agents|https://paxpress.txpa.hidinc.com/add_adhd_agents.pdf|02/13/2014| 70010004301|ADD/ADHD Agents|https://paxpress.txpa.hidinc.com/add_adhd_agents.pdf|02/13/2014| 70010010801|Gabapentin Agents|https://paxpress.txpa.hidinc.com/neurontin.pdf|01/31/2011|01/01/2024 70010010805|Gabapentin Agents|https://paxpress.txpa.hidinc.com/neurontin.pdf|01/31/2011|01/01/2024 70010010810|Gabapentin Agents|https://paxpress.txpa.hidinc.com/neurontin.pdf|01/31/2011|01/01/2024 70010010901|Gabapentin Agents|https://paxpress.txpa.hidinc.com/neurontin.pdf|01/31/2011|01/01/2024 70010010905|Gabapentin Agents|https://paxpress.txpa.hidinc.com/neurontin.pdf|01/31/2011|01/01/2024 70010010910|Gabapentin Agents|https://paxpress.txpa.hidinc.com/neurontin.pdf|01/31/2011|01/01/2024 70010011801|Gabapentin Agents|https://paxpress.txpa.hidinc.com/neurontin.pdf|01/31/2011|01/01/2024 70010011805|Gabapentin Agents|https://paxpress.txpa.hidinc.com/neurontin.pdf|01/31/2011|01/01/2024 70010013701|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 70010013705|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 70010013801|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 70010013805|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 70010013901|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 70010013905|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 70010013910|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 70010016201|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 70010016305|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 70010019905|Cough and Cold Agents|https://paxpress.txpa.hidinc.com/Cough%20&%20Cold.pdf|12/15/2015| 70010074203|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 70010074209|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 70010074210|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 70010074303|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 70010074309|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 70010074310|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 70010075401|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017| 70010075405|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017| 70010077001|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017| 70010077005|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017| 70010092601|Gabapentin Agents|https://paxpress.txpa.hidinc.com/neurontin.pdf|01/31/2011| 70010092605|Gabapentin Agents|https://paxpress.txpa.hidinc.com/neurontin.pdf|01/31/2011| 70010092610|Gabapentin Agents|https://paxpress.txpa.hidinc.com/neurontin.pdf|01/31/2011| 70010092701|Gabapentin Agents|https://paxpress.txpa.hidinc.com/neurontin.pdf|01/31/2011| 70010092705|Gabapentin Agents|https://paxpress.txpa.hidinc.com/neurontin.pdf|01/31/2011| 70010092710|Gabapentin Agents|https://paxpress.txpa.hidinc.com/neurontin.pdf|01/31/2011| 70069080401|Antimigraine Agents Triptans|https://paxpress.txpa.hidinc.com/triptans.pdf|04/04/2023| 70069080405|Antimigraine Agents Triptans|https://paxpress.txpa.hidinc.com/triptans.pdf|04/04/2023| 70165000530|ADD/ADHD Agents|https://paxpress.txpa.hidinc.com/add_adhd_agents.pdf|01/26/2017| 70165001030|ADD/ADHD Agents|https://paxpress.txpa.hidinc.com/add_adhd_agents.pdf|01/26/2017| 70165001530|ADD/ADHD Agents|https://paxpress.txpa.hidinc.com/add_adhd_agents.pdf|01/26/2017| 70165002030|ADD/ADHD Agents|https://paxpress.txpa.hidinc.com/add_adhd_agents.pdf|01/26/2017| 70165002530|ADD/ADHD Agents|https://paxpress.txpa.hidinc.com/add_adhd_agents.pdf|01/26/2017| 70165003030|ADD/ADHD Agents|https://paxpress.txpa.hidinc.com/add_adhd_agents.pdf|01/26/2017| 70165010030|ADD/ADHD Agents|https://paxpress.txpa.hidinc.com/add_adhd_agents.pdf|02/13/2014| 70165020030|ADD/ADHD Agents|https://paxpress.txpa.hidinc.com/add_adhd_agents.pdf|02/13/2014| 70165030030|ADD/ADHD Agents|https://paxpress.txpa.hidinc.com/add_adhd_agents.pdf|02/13/2014| 70199000401|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 70199001401|Cyclobenzaprine|https://paxpress.txpa.hidinc.com/cyclobenzaprine.pdf|01/31/2011| 70199001401|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017| 70370106001|VMAT2 Inhibitors|https://paxpress.txpa.hidinc.com/vmat2_inhibitor.pdf|09/25/2018| 70370108001|VMAT2 Inhibitors|https://paxpress.txpa.hidinc.com/vmat2_inhibitor.pdf|09/25/2018| 70370204001|VMAT2 Inhibitors|https://paxpress.txpa.hidinc.com/vmat2_inhibitor.pdf|09/25/2018| 70370204806|VMAT2 Inhibitors|https://paxpress.txpa.hidinc.com/vmat2_inhibitor.pdf|09/25/2018| 70377000112|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/04/2016| 70377000114|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/04/2016| 70377000115|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/04/2016| 70377000212|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/04/2016| 70377000214|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/04/2016| 70377000215|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/04/2016| 70377000312|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/04/2016| 70377000314|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/04/2016| 70377000315|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/04/2016| 70377000412|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/04/2016| 70377000414|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/04/2016| 70377000415|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/04/2016| 70377000512|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/04/2016| 70377000514|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/04/2016| 70377000515|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/04/2016| 70377000612|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/04/2016| 70377000613|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/04/2016| 70377000712|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/04/2016| 70377000713|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/04/2016| 70377000812|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/04/2016| 70377000813|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/04/2016| 70377000911|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/04/2016| 70377000912|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/04/2016| 70377000913|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/04/2016| 70377002711|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/04/2016| 70377002713|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/04/2016| 70377002811|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/04/2016| 70377002813|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/04/2016| 70377002911|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/04/2016| 70377002913|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/04/2016| 70377003012|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/04/2016| 70377003014|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/04/2016| 70377004512|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/04/2016| 70377004514|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/04/2016| 70377004612|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/04/2016| 70377004614|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/04/2016| 70377004712|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/04/2016| 70377004714|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/04/2016| 70377004812|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/04/2016| 70377004813|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/04/2016| 70436003901|ADD/ADHD Agents|https://paxpress.txpa.hidinc.com/add_adhd_agents.pdf|02/13/2014| 70436004001|ADD/ADHD Agents|https://paxpress.txpa.hidinc.com/add_adhd_agents.pdf|02/13/2014| 70436004101|ADD/ADHD Agents|https://paxpress.txpa.hidinc.com/add_adhd_agents.pdf|02/13/2014| 70436004201|ADD/ADHD Agents|https://paxpress.txpa.hidinc.com/add_adhd_agents.pdf|02/13/2014| 70436009006|Leukotriene Modifiers|https://paxpress.txpa.hidinc.com/leukotriene.pdf|12/15/2015| 70436009106|Leukotriene Modifiers|https://paxpress.txpa.hidinc.com/leukotriene.pdf|12/15/2015| 70436015541|Cough and Cold Agents|https://paxpress.txpa.hidinc.com/Cough%20&%20Cold.pdf|12/15/2015| 70436015541|Dextromethorphan Overutilization|https://paxpress.txpa.hidinc.com/dextro.pdf|07/16/2012| 70436015541|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 70436015541|Promethazine Utilization|https://paxpress.txpa.hidinc.com/phenergan.pdf|01/31/2011| 70436015542|Cough and Cold Agents|https://paxpress.txpa.hidinc.com/Cough%20&%20Cold.pdf|12/15/2015| 70436015542|Dextromethorphan Overutilization|https://paxpress.txpa.hidinc.com/dextro.pdf|07/16/2012| 70436015542|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 70436015542|Promethazine Utilization|https://paxpress.txpa.hidinc.com/phenergan.pdf|01/31/2011| 70505020260|Enzymes|https://paxpress.txpa.hidinc.com/enzymes.pdf|11/20/2019| 70505020560|Enzymes|https://paxpress.txpa.hidinc.com/enzymes.pdf|11/20/2019| 70505021060|Enzymes|https://paxpress.txpa.hidinc.com/enzymes.pdf|11/20/2019| 70515071101|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 70515071201|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 70644089999|Inhaled Antibiotics Clinical|https://paxpress.txpa.hidinc.com/inhaledantibiotics.pdf|05/02/2023| 70700014335|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 70700014435|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 70700014535|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 70700018501|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017| 70700027210|Anxiolytics and Sedative-Hypnotics|https://paxpress.txpa.hidinc.com/ash.pdf|01/31/2011| 70700027230|Anxiolytics and Sedative-Hypnotics|https://paxpress.txpa.hidinc.com/ash.pdf|01/31/2011| 70700027322|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 70700027422|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 70700027522|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 70709000060|Enzymes|https://paxpress.txpa.hidinc.com/enzymes.pdf|11/20/2019| 70709000260|Enzymes|https://paxpress.txpa.hidinc.com/enzymes.pdf|11/20/2019| 70709000560|Enzymes|https://paxpress.txpa.hidinc.com/enzymes.pdf|11/20/2019| 70710111000|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 70710111001|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 70710112901|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016| 70710113001|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016| 70710113101|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016| 70710113201|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016| 70710113301|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016| 70710116100|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 70710116101|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 70710116200|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 70710116201|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 70710116701|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 70710116801|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 70710117903|Pulmonary Hypertension Agents Clinical|https://paxpress.txpa.hidinc.com/pah.pdf|07/27/2023| 70710118003|Pulmonary Hypertension Agents Clinical|https://paxpress.txpa.hidinc.com/pah.pdf|07/27/2023| 70710128901|Anxiolytics and Sedative-Hypnotics|https://paxpress.txpa.hidinc.com/ash.pdf|01/31/2011| 70710128901|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017| 70710128905|Anxiolytics and Sedative-Hypnotics|https://paxpress.txpa.hidinc.com/ash.pdf|01/31/2011| 70710128905|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017| 70710134401|Anxiolytics and Sedative-Hypnotics|https://paxpress.txpa.hidinc.com/ash.pdf|01/31/2011| 70710134403|Anxiolytics and Sedative-Hypnotics|https://paxpress.txpa.hidinc.com/ash.pdf|01/31/2011| 70710148801|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016| 70710148901|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016| 70710149001|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016| 70710149005|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016| 70710149101|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016| 70710149105|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016| 70710151406|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 70710151409|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 70710151506|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 70710151509|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 70710151606|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 70710151609|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 70710151706|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 70710151709|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 70710152101|Anxiolytics and Sedative-Hypnotics|https://paxpress.txpa.hidinc.com/ash.pdf|01/31/2011| 70710152101|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017| 70710171001|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 70710171001|Ketorolac|https://paxpress.txpa.hidinc.com/ketorolac.pdf|05/25/2012| 70710171604|PDE5-Inhibitors|https://paxpress.txpa.hidinc.com/revatio.pdf|09/01/2015| 70710175706|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 70710175806|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 70710175906|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 70710176006|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 70710176106|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 70710176206|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 70710176306|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 70710183201|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 70748017326|Phosphate Binders|https://paxpress.txpa.hidinc.com/phosphate_binders.pdf|01/31/2011| 70748017530|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/04/2016| 70748017560|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/04/2016| 70748021507|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|01/12/2024 70748021607|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 70748025730|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/04/2016| 70748026130|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/04/2016| 70748026160|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/04/2016| 70748031209|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 70748033501|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 70752010112|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 70756042322|Lovaza|https://paxpress.txpa.hidinc.com/lovaza.pdf|07/16/2012| 70756060860|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/04/2016| 70756060870|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/04/2016| 70756061260|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/04/2016| 70756061270|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/04/2016| 70756070130|GI Motility Agents|https://paxpress.txpa.hidinc.com/GImotility.pdf|01/18/2017| 70756070230|GI Motility Agents|https://paxpress.txpa.hidinc.com/GImotility.pdf|01/18/2017| 70756070360|Ranexa|https://paxpress.txpa.hidinc.com/ranexa.pdf|05/25/2012| 70756070460|Ranexa|https://paxpress.txpa.hidinc.com/ranexa.pdf|05/25/2012| 70756080930|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 70756080990|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 70756081030|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 70756081090|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 70756081230|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 70756081290|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 70756081330|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 70756081390|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 70756081430|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 70756081490|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 70839011230|Aliskiren Containing Agents|https://paxpress.txpa.hidinc.com/aliskiren.pdf|07/16/2012| 70839011230|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 70839012530|Aliskiren Containing Agents|https://paxpress.txpa.hidinc.com/aliskiren.pdf|07/16/2012| 70839012530|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 70839015030|Aliskiren Containing Agents|https://paxpress.txpa.hidinc.com/aliskiren.pdf|07/16/2012| 70839030030|Aliskiren Containing Agents|https://paxpress.txpa.hidinc.com/aliskiren.pdf|07/16/2012| 70839031230|Aliskiren Containing Agents|https://paxpress.txpa.hidinc.com/aliskiren.pdf|07/16/2012| 70839031230|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 70839032530|Aliskiren Containing Agents|https://paxpress.txpa.hidinc.com/aliskiren.pdf|07/16/2012| 70839032530|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 70954001410|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016| 70954001510|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016| 70954001610|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016| 70954001710|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016| 70954005610|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 70954005620|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 70954005710|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 70954005810|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 70954005820|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 70954005830|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 70954005840|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 70954005910|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 70954005920|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 70954005930|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 70954005940|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 70954006010|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 70954006020|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 70954006030|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 70954006110|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 70954008510|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017| 70954008520|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017| 70954015110|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 70954015710|Anxiolytics and Sedative-Hypnotics|https://paxpress.txpa.hidinc.com/ash.pdf|01/31/2011| 70954015710|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017| 70954015810|Anxiolytics and Sedative-Hypnotics|https://paxpress.txpa.hidinc.com/ash.pdf|01/31/2011| 70954015810|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017| 70954015910|Anxiolytics and Sedative-Hypnotics|https://paxpress.txpa.hidinc.com/ash.pdf|01/31/2011| 70954015910|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017| 70954016810|PDE5-Inhibitors|https://paxpress.txpa.hidinc.com/revatio.pdf|09/01/2015| 70954027310|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016| 70954027410|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016| 70954027510|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016| 70954027520|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016|07/31/2024 70954027610|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016| 70954027620|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016|03/31/2024 70954039010|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 70954039110|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 70954040110|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 70954040210|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 70954040310|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 70954040410|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 70954041210|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 70954041230|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 70954041240|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 70954041310|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 70954041330|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 70954041340|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 70954041410|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 70954041430|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 70954041440|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 70954048010|Anxiolytics and Sedative-Hypnotics|https://paxpress.txpa.hidinc.com/ash.pdf|01/31/2011| 70954048010|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017| 70954048110|Anxiolytics and Sedative-Hypnotics|https://paxpress.txpa.hidinc.com/ash.pdf|01/31/2011| 70954048110|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017| 71093011104|Gabapentin Agents|https://paxpress.txpa.hidinc.com/neurontin.pdf|01/31/2011| 71093011105|Gabapentin Agents|https://paxpress.txpa.hidinc.com/neurontin.pdf|01/31/2011| 71093011204|Gabapentin Agents|https://paxpress.txpa.hidinc.com/neurontin.pdf|01/31/2011| 71093011205|Gabapentin Agents|https://paxpress.txpa.hidinc.com/neurontin.pdf|01/31/2011| 71093012004|Gabapentin Agents|https://paxpress.txpa.hidinc.com/neurontin.pdf|01/31/2011| 71093012005|Gabapentin Agents|https://paxpress.txpa.hidinc.com/neurontin.pdf|01/31/2011| 71093012104|Gabapentin Agents|https://paxpress.txpa.hidinc.com/neurontin.pdf|01/31/2011| 71093012105|Gabapentin Agents|https://paxpress.txpa.hidinc.com/neurontin.pdf|01/31/2011| 71093012204|Gabapentin Agents|https://paxpress.txpa.hidinc.com/neurontin.pdf|01/31/2011| 71093012205|Gabapentin Agents|https://paxpress.txpa.hidinc.com/neurontin.pdf|01/31/2011| 71093013602|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016| 71093013702|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016| 71093013802|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016| 71093013902|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016| 71274035001|HAE Agents Clinical|https://paxpress.txpa.hidinc.com/HAE.pdf|03/21/2023| 71274035002|HAE Agents Clinical|https://paxpress.txpa.hidinc.com/HAE.pdf|03/21/2023| 71335095001|Buprenorphine Agents|https://paxpress.txpa.hidinc.com/buprenorphine_agents.pdf|12/05/2014| 71335095001|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017| 71335095002|Buprenorphine Agents|https://paxpress.txpa.hidinc.com/buprenorphine_agents.pdf|12/05/2014| 71335095002|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017| 71335095003|Buprenorphine Agents|https://paxpress.txpa.hidinc.com/buprenorphine_agents.pdf|12/05/2014| 71335095003|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017| 71335115401|Buprenorphine Agents|https://paxpress.txpa.hidinc.com/buprenorphine_agents.pdf|12/05/2014| 71335115401|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017| 71335115402|Buprenorphine Agents|https://paxpress.txpa.hidinc.com/buprenorphine_agents.pdf|12/05/2014| 71335115402|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017| 71335115403|Buprenorphine Agents|https://paxpress.txpa.hidinc.com/buprenorphine_agents.pdf|12/05/2014| 71335115403|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017| 71335116301|Buprenorphine Agents|https://paxpress.txpa.hidinc.com/buprenorphine_agents.pdf|12/05/2014| 71335116301|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017| 71335116302|Buprenorphine Agents|https://paxpress.txpa.hidinc.com/buprenorphine_agents.pdf|12/05/2014| 71335116302|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017| 71335116303|Buprenorphine Agents|https://paxpress.txpa.hidinc.com/buprenorphine_agents.pdf|12/05/2014| 71335116303|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017| 71335129601|Buprenorphine Agents|https://paxpress.txpa.hidinc.com/buprenorphine_agents.pdf|04/23/2013| 71335129601|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017| 71335137801|Buprenorphine Agents|https://paxpress.txpa.hidinc.com/buprenorphine_agents.pdf|04/23/2013| 71335137801|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017| 71335172501|Buprenorphine Agents|https://paxpress.txpa.hidinc.com/buprenorphine_agents.pdf|04/23/2013| 71335172501|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017| 71335172502|Buprenorphine Agents|https://paxpress.txpa.hidinc.com/buprenorphine_agents.pdf|04/23/2013| 71335172502|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017| 71335185801|Buprenorphine Agents|https://paxpress.txpa.hidinc.com/buprenorphine_agents.pdf|04/23/2013| 71335185801|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017| 71335185802|Buprenorphine Agents|https://paxpress.txpa.hidinc.com/buprenorphine_agents.pdf|04/23/2013| 71335185802|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017| 71376020103|ADD/ADHD Agents|https://paxpress.txpa.hidinc.com/add_adhd_agents.pdf|09/24/2017| 71376020203|ADD/ADHD Agents|https://paxpress.txpa.hidinc.com/add_adhd_agents.pdf|09/24/2017| 71376020303|ADD/ADHD Agents|https://paxpress.txpa.hidinc.com/add_adhd_agents.pdf|09/24/2017| 71376020403|ADD/ADHD Agents|https://paxpress.txpa.hidinc.com/add_adhd_agents.pdf|09/24/2017| 71376020503|ADD/ADHD Agents|https://paxpress.txpa.hidinc.com/add_adhd_agents.pdf|09/24/2017| 71904010001|Enzymes|https://paxpress.txpa.hidinc.com/enzymes.pdf|06/30/2021| 71921017061|Antimigraine Agents Triptans|https://paxpress.txpa.hidinc.com/triptans.pdf|04/04/2023| 71930001912|Opiate Overutilization|https://paxpress.txpa.hidinc.com/opiate.pdf|11/05/2013| 71930001912|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017| 71930001912|Opioid Clinical Policy (MME and days supply limits)|https://paxpress.txpa.hidinc.com/opc.pdf|09/01/2020| 71930001913|Opiate Overutilization|https://paxpress.txpa.hidinc.com/opiate.pdf|11/05/2013| 71930001913|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017| 71930001913|Opioid Clinical Policy (MME and days supply limits)|https://paxpress.txpa.hidinc.com/opc.pdf|09/01/2020| 71930001952|Opiate Overutilization|https://paxpress.txpa.hidinc.com/opiate.pdf|11/05/2013| 71930001952|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017| 71930001952|Opioid Clinical Policy (MME and days supply limits)|https://paxpress.txpa.hidinc.com/opc.pdf|09/01/2020| 71930002012|Opiate Overutilization|https://paxpress.txpa.hidinc.com/opiate.pdf|11/05/2013| 71930002012|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017| 71930002012|Opioid Clinical Policy (MME and days supply limits)|https://paxpress.txpa.hidinc.com/opc.pdf|09/01/2020| 71930002052|Opiate Overutilization|https://paxpress.txpa.hidinc.com/opiate.pdf|11/05/2013| 71930002052|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017| 71930002052|Opioid Clinical Policy (MME and days supply limits)|https://paxpress.txpa.hidinc.com/opc.pdf|09/01/2020| 71930002112|Opiate Overutilization|https://paxpress.txpa.hidinc.com/opiate.pdf|11/05/2013| 71930002112|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017| 71930002112|Opioid Clinical Policy (MME and days supply limits)|https://paxpress.txpa.hidinc.com/opc.pdf|09/01/2020| 71930002152|Opiate Overutilization|https://paxpress.txpa.hidinc.com/opiate.pdf|11/05/2013| 71930002152|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017| 71930002152|Opioid Clinical Policy (MME and days supply limits)|https://paxpress.txpa.hidinc.com/opc.pdf|09/01/2020| 71930002243|Opiate Overutilization|https://paxpress.txpa.hidinc.com/opiate.pdf|11/05/2013| 71930002243|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017| 71930002243|Opioid Clinical Policy (MME and days supply limits)|https://paxpress.txpa.hidinc.com/opc.pdf|09/01/2020| 71930002330|Opiate Overutilization|https://paxpress.txpa.hidinc.com/opiate.pdf|11/05/2013| 71930002330|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017| 71930002452|ADD/ADHD Agents|https://paxpress.txpa.hidinc.com/add_adhd_agents.pdf|02/13/2014| 71930002552|ADD/ADHD Agents|https://paxpress.txpa.hidinc.com/add_adhd_agents.pdf|02/13/2014| 71930002643|Cough and Cold Agents|https://paxpress.txpa.hidinc.com/Cough%20&%20Cold.pdf|12/15/2015| 71930002643|Dextromethorphan Overutilization|https://paxpress.txpa.hidinc.com/dextro.pdf|07/16/2012| 71930002643|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 71930002743|Opiate Overutilization|https://paxpress.txpa.hidinc.com/opiate.pdf|11/05/2013| 71930002743|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017| 71930002743|Opioid Clinical Policy (MME and days supply limits)|https://paxpress.txpa.hidinc.com/opc.pdf|09/01/2020| 71930004212|Opiate Overutilization|https://paxpress.txpa.hidinc.com/opiate.pdf|11/05/2013| 71930004212|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017| 71930004212|Opioid Clinical Policy (MME and days supply limits)|https://paxpress.txpa.hidinc.com/opc.pdf|09/01/2020| 71930004252|Opiate Overutilization|https://paxpress.txpa.hidinc.com/opiate.pdf|11/05/2013| 71930004252|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017| 71930004252|Opioid Clinical Policy (MME and days supply limits)|https://paxpress.txpa.hidinc.com/opc.pdf|09/01/2020| 71930004312|Opiate Overutilization|https://paxpress.txpa.hidinc.com/opiate.pdf|11/05/2013| 71930004312|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017| 71930004312|Opioid Clinical Policy (MME and days supply limits)|https://paxpress.txpa.hidinc.com/opc.pdf|09/01/2020| 71930004352|Opiate Overutilization|https://paxpress.txpa.hidinc.com/opiate.pdf|11/05/2013| 71930004352|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017| 71930004352|Opioid Clinical Policy (MME and days supply limits)|https://paxpress.txpa.hidinc.com/opc.pdf|09/01/2020| 71930004412|Opiate Overutilization|https://paxpress.txpa.hidinc.com/opiate.pdf|11/05/2013| 71930004412|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017| 71930004412|Opioid Clinical Policy (MME and days supply limits)|https://paxpress.txpa.hidinc.com/opc.pdf|09/01/2020| 71930004452|Opiate Overutilization|https://paxpress.txpa.hidinc.com/opiate.pdf|11/05/2013| 71930004452|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017| 71930004452|Opioid Clinical Policy (MME and days supply limits)|https://paxpress.txpa.hidinc.com/opc.pdf|09/01/2020| 71930004512|Opiate Overutilization|https://paxpress.txpa.hidinc.com/opiate.pdf|11/05/2013| 71930004512|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017| 71930004512|Opioid Clinical Policy (MME and days supply limits)|https://paxpress.txpa.hidinc.com/opc.pdf|09/01/2020| 71930004552|Opiate Overutilization|https://paxpress.txpa.hidinc.com/opiate.pdf|11/05/2013| 71930004552|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017| 71930004552|Opioid Clinical Policy (MME and days supply limits)|https://paxpress.txpa.hidinc.com/opc.pdf|09/01/2020| 71930004612|Opiate Overutilization|https://paxpress.txpa.hidinc.com/opiate.pdf|11/05/2013| 71930004612|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017| 71930004612|Opioid Clinical Policy (MME and days supply limits)|https://paxpress.txpa.hidinc.com/opc.pdf|09/01/2020| 71930004652|Opiate Overutilization|https://paxpress.txpa.hidinc.com/opiate.pdf|11/05/2013| 71930004652|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017| 71930004652|Opioid Clinical Policy (MME and days supply limits)|https://paxpress.txpa.hidinc.com/opc.pdf|09/01/2020| 71930004712|Opiate Overutilization|https://paxpress.txpa.hidinc.com/opiate.pdf|11/05/2013| 71930004712|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017| 71930004712|Opioid Clinical Policy (MME and days supply limits)|https://paxpress.txpa.hidinc.com/opc.pdf|09/01/2020| 71930004752|Opiate Overutilization|https://paxpress.txpa.hidinc.com/opiate.pdf|11/05/2013| 71930004752|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017| 71930004752|Opioid Clinical Policy (MME and days supply limits)|https://paxpress.txpa.hidinc.com/opc.pdf|09/01/2020| 71930005412|Opiate Overutilization|https://paxpress.txpa.hidinc.com/opiate.pdf|11/05/2013| 71930005412|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017| 71930005412|Opioid Clinical Policy (MME and days supply limits)|https://paxpress.txpa.hidinc.com/opc.pdf|09/01/2020| 71930005452|Opiate Overutilization|https://paxpress.txpa.hidinc.com/opiate.pdf|11/05/2013| 71930005452|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017| 71930005452|Opioid Clinical Policy (MME and days supply limits)|https://paxpress.txpa.hidinc.com/opc.pdf|09/01/2020| 71930005512|Opiate Overutilization|https://paxpress.txpa.hidinc.com/opiate.pdf|11/05/2013| 71930005512|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017| 71930005512|Opioid Clinical Policy (MME and days supply limits)|https://paxpress.txpa.hidinc.com/opc.pdf|09/01/2020| 71930005552|Opiate Overutilization|https://paxpress.txpa.hidinc.com/opiate.pdf|11/05/2013| 71930005552|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017| 71930005552|Opioid Clinical Policy (MME and days supply limits)|https://paxpress.txpa.hidinc.com/opc.pdf|09/01/2020| 71930005612|Opiate Overutilization|https://paxpress.txpa.hidinc.com/opiate.pdf|11/05/2013| 71930005612|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017| 71930005612|Opioid Clinical Policy (MME and days supply limits)|https://paxpress.txpa.hidinc.com/opc.pdf|09/01/2020| 71930005652|Opiate Overutilization|https://paxpress.txpa.hidinc.com/opiate.pdf|11/05/2013| 71930005652|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017| 71930005652|Opioid Clinical Policy (MME and days supply limits)|https://paxpress.txpa.hidinc.com/opc.pdf|09/01/2020| 71993026530|Anxiolytics and Sedative-Hypnotics|https://paxpress.txpa.hidinc.com/ash.pdf|01/31/2011| 72060014230|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016|06/30/2024 72060014240|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016| 72124000101|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/04/2016|08/23/2023 72205000390|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/04/2016| 72205000399|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/04/2016| 72205000490|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/04/2016| 72205000499|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/04/2016| 72205000530|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/04/2016| 72205000590|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/04/2016| 72205000599|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/04/2016| 72205002205|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/04/2016| 72205002290|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/04/2016| 72205002305|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/04/2016| 72205002390|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/04/2016| 72205002405|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/04/2016| 72205002490|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/04/2016| 72205002505|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/04/2016| 72205002590|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/04/2016| 72205002790|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/04/2016| 72205002799|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/04/2016| 72205010491|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016| 72205010591|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016| 72205010691|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016| 72205010791|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016| 72241002203|COX-2 Inhibitors|https://paxpress.txpa.hidinc.com/cox2.pdf|01/31/2011| 72241002203|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/04/2016| 72241002305|COX-2 Inhibitors|https://paxpress.txpa.hidinc.com/cox2.pdf|01/31/2011| 72241002305|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/04/2016| 72241002310|COX-2 Inhibitors|https://paxpress.txpa.hidinc.com/cox2.pdf|01/31/2011| 72241002310|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/04/2016| 72241002405|COX-2 Inhibitors|https://paxpress.txpa.hidinc.com/cox2.pdf|01/31/2011| 72241002405|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/04/2016| 72241002410|COX-2 Inhibitors|https://paxpress.txpa.hidinc.com/cox2.pdf|01/31/2011| 72241002410|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/04/2016| 72241002503|COX-2 Inhibitors|https://paxpress.txpa.hidinc.com/cox2.pdf|01/31/2011| 72241002503|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/04/2016| 72319002102|Ranexa|https://paxpress.txpa.hidinc.com/ranexa.pdf|05/25/2012| 72319002202|Ranexa|https://paxpress.txpa.hidinc.com/ranexa.pdf|05/25/2012| 72485010125|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 72495020105|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 72495020210|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 72511040001|Cytokine and CAM Antagonists|https://paxpress.txpa.hidinc.com/cytokine.pdf|07/27/2023| 72511075001|Hyperlipidemia Agents|https://paxpress.txpa.hidinc.com/hyperlipidemia.pdf|01/04/2017| 72511076002|Hyperlipidemia Agents|https://paxpress.txpa.hidinc.com/hyperlipidemia.pdf|01/04/2017| 72511077001|Hyperlipidemia Agents|https://paxpress.txpa.hidinc.com/hyperlipidemia.pdf|01/04/2017| 72516001101|ADD/ADHD Agents|https://paxpress.txpa.hidinc.com/add_adhd_agents.pdf|02/13/2014| 72516001201|ADD/ADHD Agents|https://paxpress.txpa.hidinc.com/add_adhd_agents.pdf|02/13/2014| 72516001301|ADD/ADHD Agents|https://paxpress.txpa.hidinc.com/add_adhd_agents.pdf|02/13/2014| 72516001401|ADD/ADHD Agents|https://paxpress.txpa.hidinc.com/add_adhd_agents.pdf|02/13/2014| 72516001601|ADD/ADHD Agents|https://paxpress.txpa.hidinc.com/add_adhd_agents.pdf|02/13/2014| 72578000506|CNS Stimulants|https://paxpress.txpa.hidinc.com/provigil.pdf|11/06/2012| 72578000516|CNS Stimulants|https://paxpress.txpa.hidinc.com/provigil.pdf|11/06/2012| 72578000601|CNS Stimulants|https://paxpress.txpa.hidinc.com/provigil.pdf|11/06/2012| 72578000606|CNS Stimulants|https://paxpress.txpa.hidinc.com/provigil.pdf|11/06/2012| 72578000616|CNS Stimulants|https://paxpress.txpa.hidinc.com/provigil.pdf|11/06/2012| 72578006414|Ranexa|https://paxpress.txpa.hidinc.com/ranexa.pdf|05/25/2012| 72578006514|Ranexa|https://paxpress.txpa.hidinc.com/ranexa.pdf|05/25/2012| 72578009001|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 72578009010|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 72578010606|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016| 72578010678|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016| 72578010706|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016| 72578010778|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016| 72603011201|Anxiolytics and Sedative-Hypnotics|https://paxpress.txpa.hidinc.com/ash.pdf|01/31/2011| 72603011201|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017| 72603011301|Anxiolytics and Sedative-Hypnotics|https://paxpress.txpa.hidinc.com/ash.pdf|01/31/2011| 72603011301|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017| 72603011401|Anxiolytics and Sedative-Hypnotics|https://paxpress.txpa.hidinc.com/ash.pdf|01/31/2011| 72603011401|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017| 72603012901|Omega 3 Fatty Acids|https://paxpress.txpa.hidinc.com/lovaza.pdf|03/21/2023| 72606050602|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 72606050702|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 72606050802|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 72606057001|Thiazolidinediones|https://paxpress.txpa.hidinc.com/thiazolidinediones.pdf|01/31/2011| 72606057002|Thiazolidinediones|https://paxpress.txpa.hidinc.com/thiazolidinediones.pdf|01/31/2011| 72606057003|Thiazolidinediones|https://paxpress.txpa.hidinc.com/thiazolidinediones.pdf|01/31/2011| 72606057101|Thiazolidinediones|https://paxpress.txpa.hidinc.com/thiazolidinediones.pdf|01/31/2011| 72606057102|Thiazolidinediones|https://paxpress.txpa.hidinc.com/thiazolidinediones.pdf|01/31/2011| 72606057103|Thiazolidinediones|https://paxpress.txpa.hidinc.com/thiazolidinediones.pdf|01/31/2011| 72606057201|Thiazolidinediones|https://paxpress.txpa.hidinc.com/thiazolidinediones.pdf|01/31/2011| 72606057202|Thiazolidinediones|https://paxpress.txpa.hidinc.com/thiazolidinediones.pdf|01/31/2011| 72606057203|Thiazolidinediones|https://paxpress.txpa.hidinc.com/thiazolidinediones.pdf|01/31/2011| 72618300002|CGRP Agents Acute|https://paxpress.txpa.hidinc.com/cgrpacute.pdf|04/04/2023| 72618300002|CGRP Agents Prophylaxis|https://paxpress.txpa.hidinc.com/cgrpchronic.pdf|11/22/2022| 72647033101|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 72647033104|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 72769010101|HAE Agents Clinical|https://paxpress.txpa.hidinc.com/HAE.pdf|03/21/2023| 72786010101|Sickle Cell Disease Agents|https://paxpress.txpa.hidinc.com/sicklecell.pdf|04/05/2022| 72786011102|Sickle Cell Disease Agents|https://paxpress.txpa.hidinc.com/sicklecell.pdf|04/05/2022| 72786011103|Sickle Cell Disease Agents|https://paxpress.txpa.hidinc.com/sicklecell.pdf|04/05/2022| 72888000801|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017| 72888001200|Cyclobenzaprine|https://paxpress.txpa.hidinc.com/cyclobenzaprine.pdf|01/31/2011| 72888001200|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017| 72888001201|Cyclobenzaprine|https://paxpress.txpa.hidinc.com/cyclobenzaprine.pdf|01/31/2011| 72888001201|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017| 72888001205|Cyclobenzaprine|https://paxpress.txpa.hidinc.com/cyclobenzaprine.pdf|01/31/2011| 72888001205|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017| 72888001301|Cyclobenzaprine|https://paxpress.txpa.hidinc.com/cyclobenzaprine.pdf|01/31/2011| 72888001301|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017| 72888001400|Cyclobenzaprine|https://paxpress.txpa.hidinc.com/cyclobenzaprine.pdf|01/31/2011| 72888001400|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017| 72888001401|Cyclobenzaprine|https://paxpress.txpa.hidinc.com/cyclobenzaprine.pdf|01/31/2011| 72888001401|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017| 72888001405|Cyclobenzaprine|https://paxpress.txpa.hidinc.com/cyclobenzaprine.pdf|01/31/2011| 72888001405|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017| 72888001800|PDE5-Inhibitors|https://paxpress.txpa.hidinc.com/revatio.pdf|01/31/2011| 72888001890|PDE5-Inhibitors|https://paxpress.txpa.hidinc.com/revatio.pdf|01/31/2011| 72888002909|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 72888002911|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 72888007301|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 72888007305|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 72888008000|Opiate Overutilization|https://paxpress.txpa.hidinc.com/opiate.pdf|11/05/2013| 72888008000|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017| 72888008000|Opioid Clinical Policy (MME and days supply limits)|https://paxpress.txpa.hidinc.com/opc.pdf|09/01/2020| 72888008001|Opiate Overutilization|https://paxpress.txpa.hidinc.com/opiate.pdf|11/05/2013| 72888008001|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017| 72888008001|Opioid Clinical Policy (MME and days supply limits)|https://paxpress.txpa.hidinc.com/opc.pdf|09/01/2020| 72888008005|Opiate Overutilization|https://paxpress.txpa.hidinc.com/opiate.pdf|11/05/2013| 72888008005|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017| 72888008005|Opioid Clinical Policy (MME and days supply limits)|https://paxpress.txpa.hidinc.com/opc.pdf|09/01/2020| 72888008630|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 72888009401|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 72888009405|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 72888009501|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 72888009505|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 72888015200|Anxiolytics and Sedative-Hypnotics|https://paxpress.txpa.hidinc.com/ash.pdf|01/31/2011| 72888015200|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017| 72888015201|Anxiolytics and Sedative-Hypnotics|https://paxpress.txpa.hidinc.com/ash.pdf|01/31/2011| 72888015201|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017| 72888015205|Anxiolytics and Sedative-Hypnotics|https://paxpress.txpa.hidinc.com/ash.pdf|01/31/2011| 72888015205|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017| 72888015300|Anxiolytics and Sedative-Hypnotics|https://paxpress.txpa.hidinc.com/ash.pdf|01/31/2011| 72888015300|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017| 72888015301|Anxiolytics and Sedative-Hypnotics|https://paxpress.txpa.hidinc.com/ash.pdf|01/31/2011| 72888015301|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017| 72888015305|Anxiolytics and Sedative-Hypnotics|https://paxpress.txpa.hidinc.com/ash.pdf|01/31/2011| 72888015305|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017| 72888015401|Anxiolytics and Sedative-Hypnotics|https://paxpress.txpa.hidinc.com/ash.pdf|01/31/2011| 72888015401|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017| 72888015405|Anxiolytics and Sedative-Hypnotics|https://paxpress.txpa.hidinc.com/ash.pdf|01/31/2011| 72888015405|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017| 73289006001|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/04/2016| 73289006002|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/04/2016| 73352008630|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 73604091404|Cytokine and CAM Antagonists|https://paxpress.txpa.hidinc.com/cytokine.pdf|03/27/2018| 75834020501|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 75834020601|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 75834023660|COX-2 Inhibitors|https://paxpress.txpa.hidinc.com/cox2.pdf|01/31/2011| 75834023660|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/04/2016| 75834023701|COX-2 Inhibitors|https://paxpress.txpa.hidinc.com/cox2.pdf|01/31/2011| 75834023701|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/04/2016| 75834023705|COX-2 Inhibitors|https://paxpress.txpa.hidinc.com/cox2.pdf|01/31/2011| 75834023705|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/04/2016| 75834023801|COX-2 Inhibitors|https://paxpress.txpa.hidinc.com/cox2.pdf|01/31/2011| 75834023801|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/04/2016| 75834023805|COX-2 Inhibitors|https://paxpress.txpa.hidinc.com/cox2.pdf|01/31/2011| 75834023805|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/04/2016| 75834023960|COX-2 Inhibitors|https://paxpress.txpa.hidinc.com/cox2.pdf|01/31/2011|11/30/2023 75834023960|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/04/2016|11/30/2023 75834025501|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/04/2016| 75834025550|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/04/2016| 75834025590|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/04/2016| 75834025601|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/04/2016| 75834025650|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/04/2016| 75834025690|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/04/2016| 75834025701|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/04/2016| 75834025750|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/04/2016| 75834025790|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/04/2016| 75834025801|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/04/2016| 75834025850|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/04/2016| 75834025890|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/04/2016| 75834026460|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 75834026560|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 75987001003|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 75987003004|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 75987003104|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 75987004005|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 76204001055|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 76204001155|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 76204001801|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 76204020001|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 76204020025|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 76204020030|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 76204020060|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 76204060005|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/04/2016| 76204060012|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/04/2016| 76204060030|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/04/2016| 76204060060|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/04/2016| 76204070001|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 76204070025|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 76204080001|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 76204080025|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 76204090001|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 76204090025|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 76282015201|COX-2 Inhibitors|https://paxpress.txpa.hidinc.com/cox2.pdf|01/31/2011| 76282015201|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/04/2016| 76282015210|COX-2 Inhibitors|https://paxpress.txpa.hidinc.com/cox2.pdf|01/31/2011| 76282015210|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/04/2016| 76282015301|COX-2 Inhibitors|https://paxpress.txpa.hidinc.com/cox2.pdf|01/31/2011| 76282015301|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/04/2016| 76282015310|COX-2 Inhibitors|https://paxpress.txpa.hidinc.com/cox2.pdf|01/31/2011| 76282015310|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/04/2016| 76282025701|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 76282025801|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 76282037702|Phosphate Binders|https://paxpress.txpa.hidinc.com/phosphate_binders.pdf|01/31/2011| 76282040501|Gabapentin Agents|https://paxpress.txpa.hidinc.com/neurontin.pdf|01/31/2011| 76282040505|Gabapentin Agents|https://paxpress.txpa.hidinc.com/neurontin.pdf|01/31/2011| 76282040590|Gabapentin Agents|https://paxpress.txpa.hidinc.com/neurontin.pdf|01/31/2011| 76282040601|Gabapentin Agents|https://paxpress.txpa.hidinc.com/neurontin.pdf|01/31/2011| 76282040605|Gabapentin Agents|https://paxpress.txpa.hidinc.com/neurontin.pdf|01/31/2011| 76282040690|Gabapentin Agents|https://paxpress.txpa.hidinc.com/neurontin.pdf|01/31/2011| 76282040727|Phosphate Binders|https://paxpress.txpa.hidinc.com/phosphate_binders.pdf|01/31/2011| 76282044601|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 76282044605|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 76282044610|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 76282044690|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 76282044701|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 76282044705|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 76282044710|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 76282044790|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 76282044801|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 76282044805|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 76282044810|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 76282044890|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 76282047690|Phosphate Binders|https://paxpress.txpa.hidinc.com/phosphate_binders.pdf|04/05/2022| 76282047790|Phosphate Binders|https://paxpress.txpa.hidinc.com/phosphate_binders.pdf|04/05/2022| 76282047890|Phosphate Binders|https://paxpress.txpa.hidinc.com/phosphate_binders.pdf|04/05/2022| 76282064038|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 76282064138|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 76282067942|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 76385011801|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 76385011901|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 76385012301|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017| 76385012350|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017| 76385012401|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017| 76385012450|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017| 76385013001|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 76431010501|Hyperlipidemia Clinical|https://paxpress.txpa.hidinc.com/hyperlipidemia.pdf|05/23/2023| 76431011001|Hyperlipidemia Clinical|https://paxpress.txpa.hidinc.com/hyperlipidemia.pdf|05/23/2023| 76431012001|Hyperlipidemia Clinical|https://paxpress.txpa.hidinc.com/hyperlipidemia.pdf|05/23/2023| 76431013001|Hyperlipidemia Clinical|https://paxpress.txpa.hidinc.com/hyperlipidemia.pdf|05/23/2023| 78206011201|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 78206011301|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 78206011401|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 78206011402|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 78206011403|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 78206011404|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 78206011501|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 78206011901|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 78206012001|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 78206012101|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 78206012201|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 78206012202|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 78206012301|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 78206012302|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 78206012501|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 78206012601|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 78206012602|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 78206012701|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 78206012702|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 78206013901|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 78206013902|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 78206014001|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 78206014002|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 78206014101|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 78206014102|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 78206014201|Antimigraine Agents Triptans|https://paxpress.txpa.hidinc.com/triptans.pdf|04/04/2023| 78206014301|Antimigraine Agents Triptans|https://paxpress.txpa.hidinc.com/triptans.pdf|04/04/2023| 78206017001|Leukotriene Modifiers|https://paxpress.txpa.hidinc.com/leukotriene.pdf|12/15/2015| 78206017101|Leukotriene Modifiers|https://paxpress.txpa.hidinc.com/leukotriene.pdf|12/15/2015| 78206017201|Leukotriene Modifiers|https://paxpress.txpa.hidinc.com/leukotriene.pdf|12/15/2015| 78206017202|Leukotriene Modifiers|https://paxpress.txpa.hidinc.com/leukotriene.pdf|12/15/2015| 78206017301|Leukotriene Modifiers|https://paxpress.txpa.hidinc.com/leukotriene.pdf|12/15/2015| 78206017401|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 78206017402|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 78206017501|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 78206017502|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 78206017601|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 78206017602|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 78206017701|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 78206017702|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 78206018001|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/04/2016| 78206018002|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/04/2016| 78206018101|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/04/2016| 78206018102|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/04/2016| 78206018201|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/04/2016| 78206018202|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/04/2016| 80491782503|Anxiolytics and Sedative-Hypnotics|https://paxpress.txpa.hidinc.com/ash.pdf|01/31/2011| 80491785003|Anxiolytics and Sedative-Hypnotics|https://paxpress.txpa.hidinc.com/ash.pdf|01/31/2011| 81968035001|CNS Stimulants|https://paxpress.txpa.hidinc.com/provigil.pdf|04/14/2020| 81968035101|CNS Stimulants|https://paxpress.txpa.hidinc.com/provigil.pdf|04/14/2020| 82009000110|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/04/2016| 82009000190|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/04/2016| 82009000210|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/04/2016| 82009000310|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/04/2016| 82009000410|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/04/2016| 82009000610|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/04/2016| 82009000710|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/04/2016| 82009000790|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/04/2016| 82009000805|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/04/2016| 82009001210|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/04/2016| 82009001605|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/04/2016| 82009001790|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/04/2016| 82009001990|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/04/2016| 82009002030|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/04/2016| 82009004210|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 82009004310|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 82009004410|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 82347040505|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013| 90096012101|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016| 90096012201|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016| 90096012301|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016| 90096012401|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016| 90096013101|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016| 90096013201|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016| 90096013301|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016| 90096013401|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016| 90096013501|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016| 99207027028|Imiquimod|https://paxpress.txpa.hidinc.com/imiquimod.pdf|07/16/2012|